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Abstract 
UK care home residents are frail, dependent and multimorbid. General practitioners 
(GPs) provide their healthcare but there is evidence that existing provision fails to 
meet their needs. Comprehensive Geriatric Assessment (CGA) comprises 
comprehensive multidisciplinary assessment, goal setting and frequent review. This 
thesis considers a possible role for CGA in UK care homes through three research 
projects. 
The Care Home Literature Review (CHoLiR) was a systematic mapping review of 
randomized controlled trials (RCTs) in care homes. It found no evidence supporting 
CGA as a whole but described some CGA components supported by RCTs: advanced 
care planning; interventions to reduce prescribing; staff education around dementia 
and end-of-life; calcium/vitamin D and alendronate in preventing fractures and 
osteoporosis; vaccination/neuraminidase inhibitors in preventing influenza; 
functional incidental and bladder training for incontinence; and 
risperidone/olanzapine for agitation.  
The Care Home Outcome Study (CHOS) was a longitudinal cohort study recording 
dependency, cognition, behaviour, diagnoses, prescribing, nutrition and healthcare 
resource use in 227 residents across 11 care homes over six months. It reported high 
levels of dependency, cognitive impairment, malnutrition, multimorbidity and 
frequent behavioural disturbance. Polypharmacy and prescribing errors were 
common.  Variability between homes and individuals was significant for most 
baseline and outcome measures. 
Staff Interviews in Care Homes (STICH) was a qualitative interview study of 32 staff 
working with care homes including: GPs; care home managers and nurses; NHS 
community nurses and specialist practitioners. It described care defined by 
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discontinuity and lack-of-anticipation; driven by communication failure, inadequate 
training and expertise in frail older patients, and arbitrary boundaries between care 
homes and the NHS which interfered with care. 
Using the findings of these studies, the author proposes a model of care which is 
multidisciplinary, guided by comprehensive assessment, reinforced by frequent 
review and delivered by experts in the care of frail older patients: CGA has a role in 
UK care homes. 
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Chapter 1 Ȃ Introduction 
1.1. Care Homes and the prevailing model of healthcare 
Care homes were defined in the UK Care Standards Act 2000 ĂƐ  “establishments 
providing accommodation, together with nursing or personal care, for persons who 
are or have been ill, who have or have had a mental disorder, who are disabled or 
ŝŶĨŝƌŵ ?ŽƌĂƌĞŽƌŚĂǀĞďĞĞŶĚĞƉĞŶĚĞŶƚŽŶĂůĐŽŚŽůŽƌĚƌƵŐƐ ?1.  Under the taxonomy 
outlined in this act, UK long-term care establishments were classified either as care 
homes (often called residential homes) or care homes with nursing (often called 
nursing homes).  Only 8.6% of residents who live in care homes are under 702.     
4% of people over 65 in the UK live in care homes3.  The best-available evidence 
suggests that they represent a frail and dependent population with multiple co-
morbidities.  A 2004 census of 16,043 residents living across 244 UK care homes 
owned by BUPA, a large international corporate care home provider operating in the 
UK, reported 76% of residents to require assistance with their mobility or be 
immobile, 78% to have at least one form of mental impairment and 71% to be 
incontinent2.   The same survey recorded the prevalence ŽĨ ? ? “ĂĚŵŝƐƐŝŽŶĚŝĂŐŶŽƐĞƐ ?
 W with the most prevalent being dementia, frailty, stroke and sight impairment, 
present in 36%, 25%, 22% and 13% of residents respectively. The year 2000 Health 
Survey for England3 reported 75% of care home residents to be severely disabled.    
Care home residents have become more dependent over the past 25 years.  Data 
collected in 1982 revealed 43% of residents to be independently self-caring, 64% to 
be fully-continent and 49% to be fully oriented and aware4.  These data came from 
6947 residents of 175 homes, comprising the entire local authority care home 
provision of North Yorkshire, Derbyshire, Kirklees and Nottinghamshire and it is likely 
that they were broadly comparable with the BUPA study, given the consistency of 
Chapter 1  W Introduction 
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methods applied. Postulated reasons for the increased dependency over this time 
were: the closure of National Health Service (NHS) long-stay inpatient beds for frail 
older patients, with the movement of these patients into care homes5; the advent of 
intermediate care services, meaning that increasingly frail patients could be 
accommodated within their own homes, potentially selecting out only the frailest 
members of society for care homes6; and the standardisation of NHS continuing care 
funding models, with the consequence that an increasing number of patients with 
complex health needs were funded by the NHS to be cared for in the private care 
home sector7. Over the same time-frame there was a gradual increase in average 
care home size, the proportion of care homes owned by the private sector and the 
proportion of private sector homes owned by large national or multinational 
corporate chains7.  
The demand for care home services is predicted to rise.  The mean age of the UK 
population is increasing.  National census data from 2006 showed 21% of the UK 
population to be aged over 65.  This figure was projected to reach 28% by 2031, 
equating to a rise in the absolute number of over 65s from 13 to 20 million people8.  
Assuming no change in the prevalence of dependency, Wittenberg et al, on behalf of 
the Joseph Rowntree Foundation, predicted that the number of care home places in 
the UK would have to expand by 150% by 20519. These predictions were 
conservative. Harwood et al10 used data from the Global Burden of Disease Study on 
prevalence of 483 medical diagnoses around the globe and attached disability tariffs 
to these in order to project levels of physical dependency for the next 50 years.  Their 
results suggested that prevalence of dependency in established market economies 
would increase by 31% over this time. Barring a significant change to the structure of 
health and social care in the UK, care homes will therefore be part  W and probably a 
growing part  W of UK long-term care provision for the foreseeable future. Given the 
Chapter 1  W Introduction 
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magnitude of predicted demographic change, this is likely to happen regardless of 
policy initiatives by health and social care providers to attempt to provide care to 
more people in their own homes11. 
Although care homes have evolved significantly over the last 15-20 years, healthcare 
support for UK care home residents has remained largely unchanged. It continues to 
be provided predominantly by General Practitioners (GPs), with support from district 
nurses and a team of community based allied health professionals, as part of the 
General Medical Services (GMS) contract. There is, for the most part, little difference 
between the models of care provided to care home residents and to patients who 
live in their own homes12.  
Shortcomings with existing healthcare arrangements have been demonstrated.  
There has been evidence of poor prescribing. The Care Home Use of Medication 
Survey (CHUMS)13 reviewed 256 residents across 55 homes in 2006-7, revealing the 
mean number of prescriptions to be 7.6 per person (more than four medications is 
recognised to be an independent risk factor for falls in older patients14) and identified 
one or more prescribing error in 70% of those studied.  The rate of neuroleptic 
prescribing in care homes has been reported to be as high as 24-28%, which is much 
higher than would be expected15, and is an indicator of practice deviating 
significantly from the recommendations of the UK Medicines and Healthcare 
Products Regulatory Agency (MHRA)16.  There has been evidence of inequality of 
access to NHS resources to the disadvantage of care home residents. Steves et al17 
conducted a national survey of NHS Primary Care Trusts (PCTs) in 2008, in which 25% 
of trusts reported inequality of access to services for physiotherapy and occupational 
therapy and 35% for district nursing.  There has been evidence that existing incentive 
ĨƌĂŵĞǁŽƌŬƐĨŽƌ'WƐĚŽŶ ?ƚƐĞƌǀĞĐĂƌĞŚŽŵĞƌĞƐŝĚĞŶƚƐǁĞůů ?Shah et al18, in 2011, used 
Chapter 1  W Introduction 
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a large primary care database to compare how 10,387 care home residents and 
403,259 community dwelling patients had the NHS Quality Outcomes Framework 
(QOF) applied.  QOF is a scheme whereby GPs are paid financial incentives for 
achieving health promotion-related performance targets amongst their patients  W 
payments are made when a pre-determined threshold of patients achieve the 
performance targets (examples being prescribing of beta blockers in coronary vessel 
disease or appropriate use of retinal screening in patients with type 2 diabetes).  
They reported a significantly higher incidence of exemption reporting  W where GPs 
documented that QOF targets were inappropriate  W and lower attainment of quality 
indicators for care home residents.  These findings suggested that either QOF targets 
were less relevant in the care home population than in community-dwelling patients, 
or that they were appropriate but difficult to achieve.   
Thus current arrangements are associated with high prescribing error rates and 
inequality of access to specialist services. The high incidence of QOF exemptions, 
meanwhile, either reflects a failure of existing models to deliver quality care to care 
homes, or suggests that QOF has little to offer in driving quality healthcare for care 
homes. It is perhaps unsurprising, in this context, that a 2010 survey of GPs by the 
 “WƵůƐĞ ?magazine revealed that 61% believed current arrangements for the medical 
care of care home residents were inadequate19; a view supported by 40% of 330 
geriatricians surveyed in 2011 by the British Geriatrics Society (BGS)20. These 
concerns have been mirrored by the Care Quality Commission (CQC)  W which 
launched a special review investigating the issue of differential access to and quality 
of healthcare for care home residents in March 201021, the results of which are 
awaiting publication.  Despite a lack of nationally co-ordinated policy for healthcare 
in care homes, it is clear that there are also widespread concerns regarding existing 
Chapter 1  W Introduction 
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models of care within the NHS - 90% of NHS trusts surveyed in 2008 reported that 
they had launched initiatives to improve medical care in care homes17.   
1.2. Comprehensive Geriatric Assessment (CGA) 
/Ŷ  ? ? ? ? ƌ DĂƌũŽƌŝĞ tĂƌƌĞŶ ƉƵďůŝƐŚĞĚ ŚĞƌ ƐĞŵŝŶĂů ƉĂƉĞƌŽŶ  “ĂƌĞ ŽĨ ƚŚĞ ŚƌŽŶŝĐ
^ŝĐŬ ?22 23 in which she used her experience as deputy medical superintendent of the 
West Middlesex Hospital to lay out some fundamental principles of geriatric 
medicine.  These included methodical review of patients, separating out those who 
were ambulant and amenable to rehabilitation from those who were bed-bound and 
required long-term care, and those with cognitive impairment with or without 
behavioural and psychiatric disturbance.  She made a case that older patients should 
be cared for in the general hospital, by experts rather than by novices, and that their 
care should be the focus of training for doctors and nurses.  She argued that care 
should be holistic and multidisciplinary, with particular attention to nutrition, 
occupational therapy, mobility and environment.  She suggested that, with such 
ĂƚƚĞŶƚŝŽŶ ?ŵĂŶǇƉĂƚŝĞŶƚƐƉƌĞǀŝŽƵƐůǇ ůĂďĞůůĞĚ  “ŝŶĐƵƌĂďůĞ ?ĐŽƵůĚďĞĞǆƉĞĐƚĞĚƚŽƐŚŽǁ
 “ƐŽŵĞŵĞĂƐƵƌĞŽĨŝŵƉƌŽǀĞŵĞŶƚ ? ? 
These principles espoused by Warren  W thoughtful, comprehensive, multidisciplinary 
assessment to target rehabilitation interventions towards patients most likely to 
benefit  W gradually evolved to form the central tenet of geriatric medicine, 
Comprehensive Geriatric Assessment (CGA)23 ?   ' ŚĂƐ ďĞĞŶ ĚĞĨŝŶĞĚ ĂƐ ?  “
multidimensional interdisciplinary diagnostic process focused on determining a frail 
ĞůĚĞƌůǇƉĞƌƐŽŶ ?ƐŵĞĚŝĐĂů ?ƉƐǇĐŚŽůŽŐŝĐĂůĂŶĚĨƵŶĐƚŝonal capability in order to develop a 
coordinated and integrated plan for treatment and long-term follow-ƵƉ ? ?24  The term 
is a misnomer, in that it is taken to encompass not just the assessment process but 
also the integrated care plan that emerges from it.  In their systematic review of 
randomized controlled trials (RCTs) evaluating CGA, Ellis and Langhorne listed the 
Chapter 1  W Introduction 
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constituent parts of the interventions studied, illustrating that  W whilst assessment 
was the common feature of all programmes  W most also incorporated components of 
goal setting for treatment.  The other features common to most of the interventions 
evaluated were multidisciplinarity  W the core multidisciplinary team (MDT) 
comprising geriatrician, nurse, physio- and occupational therapist, with or without 
supplementary team members including social workers, dieticians, speech and 
language therapists and psychologists; and regular meetings of the MDT25 (see Table 
1). 
Table 1 - The Composition of CGA Interventions Studied by RCT - adapted from Ellis and 
Langhorne
25
 
  Comprehensive 
assessment 
шDd ?
weekly 
Goal 
setting 
Assessment 
tools 
Protocols Ward 
environment 
OP 
follow-
up 
Epstein
21
  ?  ? à  ?       
Fretwell
22
  ?  ? à  ?       
Gayton
23
  ?  ? à         
Hogan
24
  ?  ? à         
Hogan
25
  ?  ? à        ? 
Naughton
26
  ?  ?  ?        ? 
Reuben
27
  ?  ? à  ?      ? 
Saltz
28
  ?  ? à  ?       
Thomas
29
  ?  ? à  ?       
Winograd
30
  ?  ? à         
Applegate
12
  ?  ?  ?        ? 
Asplund
13
  ?  ?  ?         
Cohen
14
  ?  ?  ?  ?      ? 
Collard
31
  ?  ?          ? 
Counsell
15
  ?  ?  ?    ?  ?   
Harris
16
  ?             
Landefeld
17
  ?  ?  ?    ?  ?   
Nikolaus
18
  ?      ?      ? 
Rubenstein
19
  ?  ?  ?  ?      ? 
Saltvedt
20
  ?  ?  ?    ?     
à  = recommended only             
Evidence of the effectiveness of CGA emerged almost from the point of its inception.  
Warren, for example, was able to rehabilitate and discharge large numbers of 
patients, whom it had previously been assumed would die in the infirmary, to the 
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community  W reducing the number of long-term inpatients from 714 to 240 and 
increasing bed-turnover three-fold in the process26.  A large meta-analysis of 
randomized controlled trials (RCTs) of CGA, conducted in 1993, reviewed 28 studies 
including 4959 subjects allocated to CGA and 4912 to control27 across a number of 
inpatient and outpatient settings.  Regardless of setting, patients receiving CGA were 
more likely to be living at home and less likely to be functionally or cognitively 
impaired at 6 and 12 month follow-up respectively.  A recent Cochrane review 
considered 22 trials of CGA in an acute hospital setting including 10,315 participants 
and found that patients receiving CGA were less likely to be institutionalised, suffer 
death or deterioration, and more likely to experience cognitive improvement at 12 
month follow-up28. In the community setting, CGA has been shown to result in 
improved outcomes, over routine care, in the day hospital setting29 and community 
hospital-based early supportive discharge30. 
The populations in which CGA has been shown to be successful are universally old  W 
cut-offs vary from >65 years to >75 years  W and usually frail25. Frailty comes with a 
ŶƵŵďĞƌ ŽĨ ĚĞĨŝŶŝƚŝŽŶƐ ? ďƵƚ ƚŚĞ ƚǁŽ ƉƌĞĚŽŵŝŶĂŶƚ ĚĞĨŝŶŝƚŝŽŶƐ ĂƌĞ ŽĨ  “a biologic 
syndrome of decreased reserve and resistance to stressors, resulting from cumulative 
declines across multiple physiologic systems, and causing vulnerability to adverse 
ŽƵƚĐŽŵĞƐ ?31; or of a collection of accumulated deficits which place a person at 
increased risk of future adverse event32. Many geriatricians maintain, simply, that 
ƚŚĞǇ  “ŬŶŽǁ ŝƚ ǁŚĞŶ ƚŚĞǇ ƐĞĞ ŝƚ ? ? ZĞŐĂƌĚůĞƐƐ ŽĨ ƚŚĞ ĚĞĨŝŶŝƚŝŽŶ ĂĚŽƉƚĞĚ ? ĨĞǁ ǁŽƵůĚ
doubt, based upon the prevalence of disability and diagnoses stated above, that care 
home residents are frail  W indeed, significantly frailer than the cohorts in which CGA 
has been shown to work.  It is seems reasonable to assert, in this context, that CGA 
may have a role. 
Chapter 1  W Introduction 
13 
 
1.3. Models of healthcare to care homes apart from GMS 
A number of alternative service models for providing healthcare to care homes have 
been described within the NHS. Four of these were singled out for special 
consideration by the Continuing Care Special Interest Group of the BGS in 200612.   
The first of these linked a single GP practice with a single home, with an additional 
payment made to the practice in exchange for providing additional services  W for 
example weekly visits and regular review. A second model allocated additional 
payments to all GPs who looked after care home residents but nominated one 
ƉƌĂĐƚŝĐĞ ĂƐ Ă  “ůĞĂĚ ƉƌĂĐƚŝĐĞ ? ĨŽƌ ĞĂĐŚ ŚŽŵĞ ? ǁith a further additional payment 
reflecting this responsibility.  Tied to the lead practice payment was the expectation 
that the practice would co-ordinate education and infection control for the home.  A 
third model established Ă  “ĐĂƌĞ ŚŽŵĞ ƉƌĂĐƚŝĐĞ ? ǁŚĞƌe a single practice was 
contracted to care exclusively for care home residents within a given catchment area.  
Patients were encouraged to migrate to the care home practice from their usual 
doctor.  To facilitate its work with frail older patients, the practice also employed 
physio- and occupational therapists and specialist nurses.  The fourth model 
established combined services  W bringing together a GP, geriatrician and senior 
community nurse  W which then provided exclusive medical care to homes within a 
specific catchment area. These models, when considered in this order, might be seen 
as ascending a hierarchy of CGA, with the former two interventions systematising 
care, without necessarily adding components of comprehensive assessment, goal 
setting or multidisciplinarity.  The latter interventions, whilst they incorporated 
multidisciplinarity, did not specifically adopt detailed multidisciplinary assessment 
followed by goal setting and regular review. That is to say, although some were more 
comprehensive than others, all fell short of full-CGA based upon the descriptions 
published.   
Chapter 1  W Introduction 
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To find evidence of CGA in the care home setting, it is necessary to look outside of 
the UK. The most commonly cited example of CGA in care home practice is Evercare, 
a US Medicare-funded programme of care specifically designed to support nursing 
home residents  W residents voluntarily opt-into the programme, with the remainder 
receiving standard Medicare-funded healthcare.   
A report written in 2002 for the US Centres for Medicare and Medicaid Services 
(CMS)33 evaluated the demonstration programme upon which Evercare was based. It 
reported that residents opting for Evercare received support from Nurse 
Practitioners (NPs) at a ratio of 1 nursing practitioner per 100 residents. NPs 
conducted comprehensive assessments, triggered appropriate referrals to allied 
health professionals and acted as case managers liaising with and between patients, 
their families, nursing home staff and primary care physicians. They averaged 20 
minutes per patient per day and thus were able to frequently adjust and change 
management plans. They had the option of support from a geriatrician as required. 
They played a role in educating nursing staff. In addition to the NP, Evercare also 
modified the model of reimbursement for primary care physicians, such that they 
were reimbursed for family or multidisciplinary team meetings, which would not 
have been the case under routine Medicare arrangements.  Evercare residents were 
reported to show a similar level of overall dependency to the wider US nursing home 
population but have a slightly higher prevalence of dementia34.   
A subsequent observational cohort study compared 664 residents receiving Evercare, 
with 885 controls from within the same homes and 1490 controls from homes where 
no resident received Evercare.  Residents were followed for 18 months. Those 
receiving Evercare had significantly lower rates of preventable admissions by 
comparison with both control groups35.  This was largely achieved by the 
Chapter 1  W Introduction 
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implemenƚĂƚŝŽŶ ŽĨ  “ŝŶƚĞŶƐŝǀĞ ƐĞƌǀŝĐĞ ĚĂǇƐ ? ǁŚĞƌĞ ƚŚĞ ŶƵƌƐŝŶŐ ŚŽŵĞ ǁĂƐ ƉƌŽǀŝĚĞĚ
with additional reimbursement in order to continue to support the resident in their 
home, rather than having them admitted to hospital.  There was no difference in 
mortality between the two groups and no difference in measures of healthcare 
quality using the US care home Minimum Dataset.  The cost-effectiveness of the 
intervention was not calculated.  
Evercare, as described, had many of the features of CGA. It was defined by regular 
assessment, regular review, multidisciplinarity and frequent interactions between 
the disciplines involved. However, whilst it is clear that it had an important influence 
over admissions to hospital, it is not clear that it improved health outcomes for 
residents. It may simply have changed their venue of care, by diverting 
reimbursement from one care venue (acute hospital) to another (nursing home)  W 
albeit that the venue to which reimbursement was diverted was cheaper. 
The other commonly cited example of CGA in care homes comes from the 
Netherlands, which has a highly developed specialty of care home medicine  W with a 
national association of care home physicians and more care home medics than 
geriatricians registered to practice36. Numerous articles have been published citing 
high quality care in Dutch care homes as a consequence of regular involvement of 
physicians, describing a process which incorporates comprehensive, frequent 
assessment and regular input from an expert multidisciplinary team37 38. Yet, because 
care home physicians and the MDTs which they lead have been a part of life in the 
Netherlands for four decades, their intervention has not been subjected to rigorous 
evaluation of the sort seen for Evercare. When the Dutch care model has been 
subjected to comparison with other countries where MDT involvement in 
management is not routine, it has not always been shown to deliver the best 
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outcomes  W an important example being the comparison in pressure ulcer prevalence 
between Dutch and German homes recorded using the Dutch National Prevalence 
Measurement in 2003, reporting a prevalence in the Netherlands 1.5 times greater 
than in Germany39.  
This latter study, however, raises an important point  W that international 
comparisons of care homes are difficult because the long term sector is significantly 
different between countries.  Depending on the country studied between 2% and 
14.5% of people over the age of 65 years will live in care homes, whilst the funding, 
focus and day-to-day running of long term care facilities varies between nations40. 
Dutch care homes are large, averaging 173 residents per home, and each home has a 
permanent staff including doctors, physiotherapists, occupational therapists, speech 
and language therapists and psychologists36.  40% of those living in Dutch care homes 
are short-term residents, there for rehabilitation.  This model of care is much more 
akin to the now discontinued model of NHS long-term care beds than it is to the 
current UK care home sector. In the USA, 86% of residents are cared for in homes 
with 100 or more residents41, compared with an average home occupancy in the UK 
of 26 for residential homes and 44 for nursing homes42. There is also the 
consideration of the differing healthcare sectors with which homes must interact. 
That the UK and US healthcare economies, for example, are very different is well 
understood.   
Thus the lessons to be learned from overseas, whilst important, should not be 
overstated. Evercare, despite its success, could not be imported into the UK as an 
 “ŽĨĨ-the-ƉĞŐ ? ƐŽůƵƚŝŽŶ ďĞĐĂƵƐĞ ƚŚĞ ĐĂƌĞ ŚŽŵĞ ƉŽƉƵůĂƚŝŽŶ ? ƚŚĞ ŚĞĂůƚŚ ƐĞƌǀŝĐĞ ĂŶĚ
models of remuneration and revenue flow in the UK are very different. A model of 
care home physicians, as seen in the Netherlands, could only be implemented in the 
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UK after comprehensive evaluation to consider how it would impact on a different 
cohort of residents and how it would integrate with, or replace, existing models of 
care. These are important, therefore, not as examples of services to be emulated, but 
because they illustrate that CGA has been successfully implemented in other 
countries and has been championed in both instances as delivering high quality care 
to frail older patients  W it is both feasible and seems to make a difference to clinical 
outcomes. 
1.4. Does CGA have a role in Care Homes? 
So, care home residents have been shown to be complex and frail, and existing 
models of care have been shown to inadequately meet their needs. CGA has been 
demonstrated to deliver effective healthcare to frail older patients in other settings 
within the UK and to result in improved clinical outcomes. It has been shown to be 
feasible in long-term care facilities in other countries and has been championed as 
delivering high quality care in these settings. The NHS has engaged in a search for 
satisfactory models of healthcare for care homes  W yet none of the models described 
in the literature so far have all the components of CGA. 
There is some equipoise here.  CGA has not worked in every cohort in which it has 
been tested. When tested in nurse-led intermediate care it failed to show any effect 
on objective clinical outcomes at 6 months43.  When tested in therapist-led care 
home-based early facilitated discharge, it resulted in a shortened duration of acute 
hospital stay but increased the overall time spent away from home and failed to 
show any objective improvement in clinical markers44. The reason it may have failed 
ƚŽŵĂŬĞĂĚŝĨĨĞƌĞŶĐĞ ŝŶďŽƚŚŽĨ ƚŚĞƐĞĐŽŶƚĞǆƚƐ ŝƐ ƚŚĂƚ ƚŚĞǇĐŽŵƉƌŝƐĞĚ  “ƐƚĞƉ-ĚŽǁŶ ?
interventions, where many of the components of CGA might have taken place before 
residents reached the intervention, minimising the impact that could be made. Its 
failure, however, serves to emphasise the fact that the successful implementation of 
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CGA is context-dependent and a detailed understanding of the context in which it 
might be implemented is essential in considering its possible role. 
CGA is a complex intervention. Complex  interventions are defined by the UK Medical 
ZĞƐĞĂƌĐŚ ŽƵŶĐŝů  ?DZ ? ĂƐ  “ƚŚŽƐĞ ǁŚŝĐŚ ĐŽŵƉƌŝƐĞ Ă ŶƵŵďĞƌ ŽĨ ƐĞƉĂƌĂƚe elements 
which seem essential to the proper functioning of the intervention, although the 
 ‘ĂĐƚŝǀĞ ŝŶŐƌĞĚŝĞŶƚ ? ŽĨ ƚŚĞ ŝŶƚĞƌǀĞŶƚŝŽŶ ƚŚĂƚ ŝƐ ĞĨĨĞĐƚŝǀĞ ŝƐĚŝĨĨŝĐƵůƚ ƚŽ ƐƉĞĐŝĨǇ ?45.  
Evercare has been used as an example of a complex intervention by the MRC46.  
The MRC Framework for Design and Evaluation of Complex Interventions to Improve 
Health45 breaks the evaluative process for complex interventions into discrete steps 
which, as illustrated in figure 1, have been defined to replicate the discrete phases 
seen when developing and evaluating a drug therapy.    
 
Figure 1 - The Medical Research Council Framework for Design and Evaluation of Complex 
Interventions, reproduced from Campbell et al 
45
 
The analogy with pharmaceutical trials emphasises the importance of preparatory 
work.  Thus, where one would spend a long time in the laboratory developing, 
refining and conducting animal tests for a new drug compound, one must devote 
similar effort to ensure a sound theoretical basis for a complex intervention through, 
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for example, recourse to the literature and gathering data about the context in which 
the intervention would be delivered.  
CGA has already been comprehensively described and evaluated in a number of 
other settings. In considering whether CGA had a role in care homes, the uncertainty 
was less around what comprised CGA and more about whether it had relevance to 
the care home setting. The question was one of context. 
Against this background, this thesis describes a programme of research designed to 
address the question of whether CGA had a role in care homes by addressing the 
uncertainties about the context in which it would be implemented. It did so by 
conducting three pieces of research: 
 The Care Home Literature review (CHoLiR) was designed to describe the 
research conducted using RCTs in care homes to establish whether an 
evidence base for CGA  W or component interventions which might comprise 
part of CGA  W had already been built. This is described in chapter 2. 
 The Care Home Outcome Study (CHOS) was designed to comprehensively 
describe the health and functional status of care home residents, and how 
they use NHS resources. This is described in chapter 3. 
 The Staff Interviews in Care Homes (STICH) study was designed to describe 
how care home staff and the healthcare professionals who work with them 
ŝĚĞŶƚŝĨǇ ĂŶĚ ƌĞƐƉŽŶĚ ƚŽ ĐŚĂŶŐĞƐ ŝŶ ƌĞƐŝĚĞŶƚƐ ? ŚĞĂůƚŚ ? This is described in 
chapter 4. 
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Chapter 2 Ȃ The Care Home Literature Review 
(CHoLiR) 
2.1. Introduction 
The first step in considering a possible role for CGA in care homes was to look at 
whether it had already been evaluated in this setting. This was a relatively complex 
proposition since CGA is by definition an intervention comprised of multiple more 
focussed assessments and interventions25.  Thus, it was necessary not only to 
establish whether an intervention correctly identified and described as CGA had been 
subjected to formal evaluation in a care home setting, but also whether component 
assessments and interventions had been evaluated, either together or in isolation, 
such that they might contribute to an understanding of the role of CGA in care 
homes. 
A literature review was designed to collate randomised controlled studies (RCTs) 
already undertaken in care homes with the aim of describing existing research to 
establish whether some or all components of CGA had already been evaluated  W and 
whether they had been evaluated in a combined form as CGA.  Given the nature of 
CGA  W comprising functional, physical, cognitive and behavioural assessments and 
establishing management priorities regardless of professional or specialty boundaries 
 W it was clear that this review would require to be both broad and inclusive. 
2.2. Aim 
To describe the research conducted using RCTs in care homes to establish whether 
an evidence-base for CGA  W or component interventions which might comprise part 
of CGA  W had already been built.  
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2.3. Methodology 
2.3.1. Why randomized controlled trials? 
Randomized controlled trials (RCTs) are commonly held to represent a gold-standard 
in empirical evaluation of medical interventions47.  They comprise, for example, the 
highest tier of medical evidence under the GRADE system, used in the evaluation of 
evidence for medical guidelines by the World Health Organization, the American 
College of Physicians, the American Thoracic Society, the Cochrane Collaboration, the 
Scottish Intercollegiate Guidelines Network and the UK National Institute of Clinical 
Excellence48-50. The rationale for this is well rehearsed, that randomization minimizes 
the effects of both confounding and selection bias and that the addition of blinding, 
where possible, minimises the potential for bias at multiple levels51.  This position is 
well supported by empirical studies suggesting that randomization and concealment 
of treatment allocation reduces bias in trials of clinical interventions52 53. 
There are limitations to RCTs, several of which are particularly relevant in the care 
home setting.  The multiple comorbidities which are common in frail older patients 
introduce confounding. The most appropriate response to this is to identify all 
confounding variables and appropriately power RCTs to take account of them  W often 
resulting in very large studies. A less constructive  W but relatively common  W response 
is to avoid confounding by limiting studies to particular sub-cohorts of older patients 
and a consequent tension between the internal validity of RCTs and their 
generalisability to the older population is well recognized54.  Many of the healthcare 
interventions commonly conducted in a care home setting, for example continence 
and falls prevention interventions, are complex  W often involving multiple staff 
members from multiple agencies and targeting syndromes which are multifactorial 
and influenced by biological, psychological and social variables.  The MRC Framework 
for Design and Evaluation of Complex Interventions to Improve Health45, as already 
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discussed, describes an approach to these problems which leans heavily on detailed 
mixed-methods preparatory work to define the intervention, its target population 
and appropriate outcome measures prior to conducting RCTs.  Such preparatory 
work is complicated and the research paradigms it draws upon are relatively 
subjective, such that the target population or outcome measures adopted in a 
subsequent RCT may be flawed  W with consequent failure to demonstrate the success 
of an intervention. True double-blind studies are difficult in complex interventions 
where no placebo is readily available55 56  W if consultant geriatrician review, for 
example, were to constitute the intervention in an RCT, then it would be impossible 
to blind participants to the fact that they had received the intervention.  Even where 
participants are adequately blinded, the possibility of cross-contamination in a care 
home setting, where control residents might, either accidentally or intentionally, 
experience changes in practice as a consequence of the intervention, is 
considerable57.  This has led to cluster randomization strategies, usually used as a 
means of avoiding contamination by diffusion (where the behaviour of staff or 
residents in the control arm is altered), which demand large sample sizes and, in 
themselves, run the risk of introducing bias by failing to identify key confounding 
variables at the whole-home level58.       
These concerns underline the limitations of RCTs and hence the importance of 
mixed-methods research in understanding healthcare interventions in care homes.  
They do not, however, mean that there is nothing of value to be gleaned from RCTs. 
Even the most extreme critics of RCTs  W Bayesian statisticians have challenged the 
assumption that confounding can be satisfactorily accounted for through 
randomization59 and interpretivists have challenged the very assumption of reality 
upon which positivistic experimentation is based60  W have recognised the need for 
relatively robust evidence upon which clinicians can base critical healthcare decisions 
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and that RCTs have a role in providing such evidence (even if they would prefer that 
Bayesian statistics, or qualitative paradigms such as critical realism, were brought to 
bear on RCT-derived data in addition to probability theory)61 62. 
Given that the aim of this review was to establish whether an evidence-base for CGA, 
or its component interventions, had already been established in care homes  W a 
review of RCTs seemed both appropriate and defensible. The findings of these would, 
of course, have to be interpreted with caution given the various limitations described 
above.  
2.3.2. Choosing a mode of literature review 
The work of Grant and Booth63 was consulted in considering which mode of literature 
review to adopt in order to most effectively fulfil the aims. In 2009, these authors 
conducted a series of scoping reviews and reviewed commonly applied terminology 
in conducting literature reviews, before categorising these according to a Search, 
Appraisal, Synthesis and Analysis (SALSA) framework. Their resulting typology 
outlined 14 modes of literature review:  critical, literature, systematic mapping, 
meta-analysis, mixed study, overview, qualitative systematic, rapid, scoping, state-of-
the-art, systematic, systematic search and review, systematized and umbrella 
reviews. In deciding which approach to take here, their SALSA framework and 
accompanying descriptions63 were reviewed and, from amongst the types described, 
a systematic mapping review was identified as most closely meeting the aims as 
stated.   
The /ŶƐƚŝƚƵƚĞ ŽĨ ĚƵĐĂƚŝŽŶ ?ƐEvidence for Policy and Practice Information and Co-
ordinating Centre (EPPI)64 has published specific guidance on conducting systematic 
mapping reviews, which it calls systematic descriptive maps, in educational subjects.  
It defines them as describing, rather than scrutinising in-depth and 
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critically appraising, the research  W allowing reviewers to address a much broader 
field than is possible when conducting a narrower synthesis of research findings.  In 
conducting a mapping review, studies are coded against a keywording strategy.  EPPI 
provides an example of an educational keywording strategy which is not immediately 
transferable to a healthcare context but provides examples of the sort of domains 
recorded, including country and language of study, type and topic of study and study 
setting65. 
A key strength of the systematic mapping review has been the ability to identify gaps 
in the literature and focus on key research targets going forward63, making it very 
well suited as a methodology to address the aims stated here.  It was identified as a 
methodology which would allow a potentially very large number of research trials, 
encompassing not only CGA but also component interventions from across a number 
of disciplines, to be considered.   
The gold standard methodologies for healthcare literature reviews are commonly 
held to be systematic review and meta-analysis (sometimes called quantitative 
systematic review).  These seek to minimize confounding and bias through inclusive 
search strategies and careful evaluation of the quality of research before reporting  W 
and, in the case of meta-analysis, pooling  W the results of studies in a transparent 
manner designed to facilitate clinical decision making66. They have come to comprise 
a cornerstone of guideline preparation and clinical decision making and are integral 
to the work of the Cochrane Collaboration67.  Systematic review was not adopted 
here because its key strength  W the need to quality-assess articles for inclusion66  W 
was felt to represent a shortcoming in this context. A consequence of rigorous quality 
assessment is that, whilst the resulting list of publications represents a 
comprehensive list of the studies in an area which meet specified quality criteria, the 
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review does not effectively map all the work undertaken around a given topic.   For 
this review, whilst it was important to capture large and methodologically rigorous 
studies which might effectively make (or dismiss) the case for CGA, it was felt to be 
unlikely that studies of such importance would exist and have gone largely 
unrecognised by the geriatric medicine community. It was therefore important, in 
addition, to map all work undertaken that might help, in summation, to consider the 
case for CGA or its component interventions, or build an overview of specific topics 
for research going forward.  Systematic review would not achieve this as well as a 
systematic mapping review would.  Meta-analysis, meanwhile, was clearly out of the 
question, given the wide-ranging nature of the literature surrounding CGA and the 
need for meta-analysis to focus around studies measuring a common treatment 
effect68.  
2.3.3. Choosing sources for the literature review 
Electronic bibliographic databases are a common starting point for healthcare 
literature reviews.  Medline, maintained by the US National Library of Medicine, is 
frequently the database of first choice for physicians and biomedical researchers, in 
part because of its ready accessibility through the free Pubmed interface69. It is 
recommended in the Cochrane handbook as a cornerstone of systematic review70 
and its centrality to effective literature searching is well recognised in the literature 
on methodology of systematic reviews, with other databases evaluated for their 
value as additions, rather than alternatives, to Medline71.   
Embase is a product of Excerpta Medical Ltd. and is comparable in size and depth to 
Medline.  Both have broadly comparable sensitivity and specificity for correct 
identification of common article types72.   The degree of overlap between Embase 
and Medline varies, depending upon the discipline studied, from 5.1%-87%73-80.  
Embase has more comprehensive coverage of the pharmaceutical literature81 and is 
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commonly cited as having broader international coverage than Medline82-84. It is 
commonly used as a standalone bibliographic database by clinicians working outside 
the US and UK85.  Within the systematic review literature, however, Embase is more 
commonly considered as an augmentation than an alternative to Medline  W with the 
recommendation being that decisions around its inclusion, or otherwise, in search 
protocols be framed in terms of the time and personnel resources available, traded 
against the potential gain in citation coverage from an Embase search70 71 85.   
Medline and Embase have a predominantly biomedical focus, however a significant 
number of healthcare interventions for care home residents are delivered by non-
physicians, including occupational therapists, physiotherapists, psychologists, nurses 
and care assistants.  These disciplines each have a literature-base which is covered to 
a greater or lesser extent by Medline and Embase86-88.  Additional databases 
potentially contributing to literature searches in these disciplines are the Allied and 
complimentary MEdicine Database (AMED), the Cumulative Index to Nursing and 
Allied Health Literature (CINAHL), the British Nursing Index (BNI) and the PSYCHinfo 
psychological abstracts database. 
ƐĞƌŝĞƐŽĨĂƌƚŝĐůĞƐƵƐĞĚƌĂĚĨŽƌĚ ?Ɛ ůĂǁŽĨƐĐĂƚƚĞƌŝŶŐ ?ĂŶ ŝ ĨŽƌŵĂƚŝŽn science theory 
stating that  “ĨŽƌĂŶǇĚŝƐĐŝpline, a relatively small core of journals can be expected to 
ĂĐĐŽƵŶƚĨŽƌĂĚŝƐƉƌŽƉŽƌƚŝŽŶĂƚĞĂŵŽƵŶƚŽĨƚŚĞůŝƚĞƌĂƚƵƌĞ ?89, to identify a core body of 
literature relevant to nursing and allied health disciplines.  This method involves 
selecting one or two leading journals in a discipline, then retrospectively searching 
the reference lists from these journals and recording all journals cited.  The number 
ŽĨ ĐŝƚĂƚŝŽŶƐ ŝƐ ƚŚĞŶ ƵƐĞĚ ƚŽ ŝĚĞŶƚŝĨǇ ũŽƵƌŶĂůƐ ĂƐ  “ĐŽƌĞ ? ? Žƌ ǌŽŶĞ  ? ?  “ŶĞǆƚ ŵŽƐƚ
ƌĞůĞǀĂŶƚ ? ?ŽƌǌŽŶĞ  ?, ĂŶĚ “ƵŶůŝŬĞůǇƚŽďĞŽĨƌĞůĞǀĂŶĐĞ ? ?ŽƌǌŽŶĞ  ? ? dŚĞĐŽǀĞƌĂŐĞŽĨ
articles in each zone can then be used to evaluate the relative contribution of 
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bibliographic databases to literature searches in the discipline. Using this 
methodology, Wakiji86 evaluated coverage of the physiotherapy literature by 
commonly-used electronic databases, identifying 14 zone 1 and 95 zone 2 journals 
and evaluating coverage of citations from these across Medline, Embase, CINAHL and 
AMED.  Medline was found to provide 95-100% coverage of zone 1 and also to 
provide the most comprehensive coverage of zone 2.  Of those journals not covered 
by Medline, CINAHL provided "some" coverage for seven, Embase for six, and AMED 
for five.  AMED covered 11 core journals and 33 peripheral ones, whilst CINAHL 
covered 8 core and 20 peripheral.  57% of journals covered by CINAHL were also 
covered by AMED, although where a journal was covered by CINAHL its citation rate 
tended to be higher, with a mean citation index of 3.1 (indicating 50-74% coverage of 
citations from included journals) compared with 1.9 for AMED (indicating 25-49% 
coverage of citations from included journals).  Reed87 conducted a similar evaluation 
for occupational therapy citations across three zone 1 and 117 zone 2 articles, 
evaluating their coverage by MEDLINE, CINAHL and PSYCHinfo and demonstrating 
coverage of 71%, 52% and 46% respectively.  It was noted that there were eight titles 
specific to occupational therapy which received comprehensive coverage only in 
CINAHL. Allen et al88 led a programme of related research addressing the nursing 
literature across multiple sub-specialties and using a wider array of databases. Their 
main results are summarized in Table 2. 
Table 2 - Citation coverage index for commonly used electronic bibliographic databases by 
nursing speciality - abridged from a table by Allen et al
88
 
Nursing area of specialty CINAHL PubMed Embase PsychINFO 
General Nursing: USA 2.78 3.41 1.78 0.27 
Gerontological Nursing 0.51 3.29 1.76 1.27 
Case Management Nursing 2.23 3.30 1.78 0.71 
Nurse Practitioners 1.87 3.62 2.31 0.54 
Community/Public Health Nursing 2.72 3.35 1.46 1.13 
General Nursing: International 2.50 3.32 1.94 0.41 
Rehabilitation nursing 2.52 3.25 2.07 1.15 
Average scores for Zone 1 and Zone 2 in each study; based upon database coverage score: 5 
(95-100%); 4 (75-94%); 3 (50-74%); 2 (25-49%); 1 (1-24%) 
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For UK-based studies, the British Nursing Index (BNI) constitutes an important 
additional resource worthy of consideration. It is cited by its proponents as providing 
the most up-to-date bibliographic database for core UK nursing journals90 and to 
contain material not cited in other commonly used bibliographic databases91. It has 
not been subjected to comprehensive evaluation along the lines described above, 
possibly due to it not being seen as a direct competitor to the other bibliographic 
databases due to its narrow geographical and disciplinary focus.  Where it has been 
evaluated, it has been demonstrated to have higher precision but significantly lower 
sensitivity than CINAHL92.  In a systematic review of hospital pharmacy in the UK it 
contributed 5.7% of citations, more than Embase, CINAHL or AMED (which 
contributed 5.3%, 3.2% and 0.4% respectively)93, an important additional observation 
was that BNI generated relatively fewer articles than other databases  W 81 compared 
with 2860 and 1034 for Medline and CINAHL respectively  W indicating high citation 
yield from relatively little additional effort and supporting the conclusions drawn 
elsewhere about its high precision. 
Clearly, a comprehensive search, involving all available bibliographic databases 
represents the gold standard but is unlikely to be achievable in the context of all but 
the most highly resourced studies. In the case of this review, it was clear that a multi-
disciplinary focus was necessary and thus inclusion of CINAHL and AMED in addition 
to Medline was essential.  Given the international variations in care home practice40 
and that the central drive of this thesis was to explore the role of CGA in UK-style 
care homes, the UK-oriented focus of BNI made its inclusion important.   
All electronic bibliographic databases are limited to those journals which they choose 
to index, with selection criteria focussing around scope and coverage, scientific 
quality, quality of editorial, production quality, types of content, and geographic 
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coverage94.  These criteria vary between databases, resulting in the differential 
coverage of citations already discussed.  One consequence of the selection criteria is 
Ă ƉŽƚĞŶƚŝĂůůǇ ůĂƌŐĞ ďŽĚǇ ŽĨ ůŝƚĞƌĂƚƵƌĞ ? ŽĨƚĞŶ ƚĞƌŵĞĚ  “ŐƌĞǇ ůŝƚĞƌĂƚƵƌĞ ? ?which the 
databases fail to cover. dŚĞ ĨŽƌŵĂů ĚĞĨŝŶŝƚŝŽŶ ŽĨ ŐƌĞǇ ůŝƚĞƌĂƚƵƌĞ ŝƐ  “information 
produced on all levels of government, academia, business and industry in electronic 
and print formats not controlled by commercial publishing, i.e. where publishing is 
ŶŽƚƚŚĞƉƌŝŵĂƌǇĂĐƚŝǀŝƚǇŽĨƚŚĞƉƌŽĚƵĐŝŶŐďŽĚǇ ?95. It includes but is not restricted to 
theses, dissertations, guidelines, publications from government agencies and 
charitable organisations and newspaper articles.  In the context of randomized 
controlled trials, the most commonly cited grey literature source is conference 
proceedings, which are often of sufficient quality in terms of conduct and reporting 
for inclusion in Cochrane systematic reviews96.  Attempts to analyse these grey 
literature RCTs suggest that they differ from published articles predominantly 
through smaller magnitude of treatment effect and through smaller sample size96.  
The smaller treatment effect can influence pooled results and has been cited as a 
potent case for inclusion of grey literature RCTs in meta-analyses96 97.  RCTs from the 
grey literature are, however, more likely to be methodologically flawed or report 
allocation concealment strategies inadequately98. 
Strategies for searching the grey literature have been developed including research 
registry searches, searching conference abstracts, hand-searching journal citations 
and using internet search engines99.  These strategies vary considerably in their yield 
but are almost universally labour intensive.  Given that the broad topic coverage 
already identified as key to addressing the research aims would already tax the 
limited time and personnel resources at the disposal of a PhD research project, and 
the uncertainty around the quality of RCT data yielded from the grey literature, it was 
difficult to justify conducting such a review for this thesis.  As this was neither a 
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formal systematic review nor a meta-analysis, the previously stated concerns about 
significant bias resulting from non-inclusion of grey-literature were of limited 
relevance.   
2.3.4. Developing a search protocol 
Because CGA is needs driven, holistic and multidisciplinary25, it could comprise 
almost any intervention delivered to frail older patients.  These interventions, when 
evaluated as isolated interventions might not be viewed or indexed as part of CGA.  
As such, a search strategy using clinical intervention as the index was impracticable  W 
searches using CGA as a search term would risk missing large amounts of data from 
studies evaluating component interventions, whilst individual searches for all 
possible component interventions would be impossibly expansive. 
In absence of being able to search studies by intervention, the next most obvious 
search was by ůŽĐƵƐŽĨ ĐĂƌĞ ?  Ɛ ŽƵƚůŝŶĞĚ ŝŶ ƚŚĞ ŝŶƚƌŽĚƵĐƚŝŽŶ ?  “ĐĂƌĞ ŚŽŵĞ ? ŝƐĂ h<
specific terminology and was not represented in the Medical Subject Headings 
(MeSH) for Medline.  A search of MeSH yielded the correspondiŶŐ ƚĞƌŵƐ  “EƵƌƐŝŶŐ
,ŽŵĞ ? ? “ZĞƐŝĚĞŶƚŝĂů&ĂĐŝůŝƚŝĞƐ ?ĂŶĚ “,ŽŵĞƐĨŽƌƚŚĞŐĞĚ ? ?dŚĞĐŽƌƌĞƐponding terms 
ĨŽƌ /E,> ǁĞƌĞ  “EursŝŶŐ ,ŽŵĞƐ ? ?  “ZĞƐŝĚĞŶƚŝĂů &ĂĐŝůŝƚŝĞƐ ? ?  “^ŬŝůůĞĚ EƵƌƐŝŶŐ
FĂĐŝůŝƚŝĞƐ ? ? ĨŽƌ D ǁĞƌĞ  “EƵƌƐŝŶŐ ŚŽŵĞƐ ? ?  “>ŽŶŐ ƚĞƌŵĐĂƌĞ ? ĂŶĚ  “ZĞƐŝĚĞŶƚŝĂů
fĂĐŝůŝƚŝĞƐ ?ĂŶĚĨŽƌƚŚĞE/ǁĞƌĞ “EƵƌƐŝŶŐ,ŽŵĞƐ ? ? “ZĞƐŝĚŶƚŝĂůĂƌĞ ?ĂŶĚ “>ŽŶŐ-term 
ĐĂƌĞ ? ? 
Clearly such broad terms would yield a large number of results from long-term care 
institutions in other countries which would differ in several ways from the long-term 
care setting in the UK40.  There are, however, sufficient commonalities between the 
frail older populations housed in long-term care settings across countries to believe 
that lessons learned from other countries might be applicable within the UK37. 
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Further, it was impossible to be certain a priori what proportion of citations would be 
relevant and, within the framework of a systematic mapping review, inclusion of 
possibly irrelevant citations was preferable to a failure to build a comprehensive 
picture of the research conducted to date.  
2.4. The research team 
Recognising the significant amount of work to be undertaken, a research team was 
formed to comprise: Dr Adam Gordon (AG), an academic geriatrician; Dr Jon Mamo 
(JM), a trainee physician; Dr Calum Forrester-Paton (CFP), a trainee physician; Dr Rob 
Jones (RJ), an academic old age psychiatrist; Professor John Gladman (JG), a 
professorial-level academic geriatrician and PhD-supervisor for AG; and Dr Pip Logan 
(PL), an academic occupational therapist and second PhD-supervisor for AG. 
AG designed the search protocol, led development of the keywording strategy, 
ĚĞƐŝŐŶĞĚ ĂŶĚ ŵĂŝŶƚĂŝŶĞĚ ƚŚĞ DŝĐƌŽƐŽĨƚ ĐĐĞƐƐ ? ĚĂƚĂďĂƐĞ ĨŽƌ ĐŽůůĂƚŝŽŶ ŽĨ ƌĞƐƵůƚƐ ?
conducted the initial search of electronic bibliographic databases and read the 
abstracts of all articles in full before identifying those articles to be included at final 
review.  He sourced hard copies of articles, distributed articles for review and acted 
as first reviewer for 1/6 of articles shortlisted for full-review.  He acted as second 
reviewer for all articles and conducted all analyses from the resulting database.  JG 
and PL helped to develop the keywording strategy and also acted as first reviewer for 
1/6 of articles short-listed for full-review.  The remaining researchers: CFP, RJ and JM 
acted as first reviewer for 1/6 of articles short-listed for full review. 
2.5. Methods 
Medline (1950-June 2009) was searched using the terms  “EƵƌƐŝŶŐ ,ŽŵĞ ? ?
 “ZĞƐŝĚĞŶƚŝĂů &ĂĐŝůŝƚŝĞƐ ? ĂŶĚ  “,ŽŵĞƐ ĨŽƌ ƚŚĞ ŐĞĚ ? ? ĐŽŵďŝŶĞĚ ƵƐŝŶŐ ƚŚĞ  “KZ ?
command.  Results were limited for English language and randomized controlled 
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trials.  CINAHL with full text (1978-June 2009) was seĂƌĐŚĞĚ ĨŽƌ  “EƵƌƐŝŶŐ ,ŽŵĞƐ ? ?
 “ZĞƐŝĚĞŶƚŝĂů &ĂĐŝůŝƚŝĞƐ ? ?  “^ŬŝůůĞĚ EƵƌƐŝŶŐ &ĂĐŝůŝƚŝĞƐ ? ? ƌĞƐƵůƚƐ ǁĞƌĞ ůŝŵŝƚĞĚ ĨŽƌ
randomized controlled trials and Medline citations were excluded. The Allied and 
Complementary Medicine Database (AMED) (1985-June 2009) was searched for 
 “EƵƌƐŝŶŐ ŚŽŵĞƐ ? ?  “>ŽŶŐ ƚĞƌŵ ĐĂƌĞ ? ĂŶĚ  “ZĞƐŝĚĞŶƚŝĂů ĨĂĐŝůŝƚŝĞƐ ? ĐŽŵďŝŶĞĚ ƵƐŝŶŐ ƚŚĞ
 “KZ ?ĐŽŵŵĂŶĚĂŶĚ “ZĂŶĚŽŵŝǌĞĚĐŽŶƚƌŽůůĞĚƚƌŝĂů ?ƵƐŝŶŐƚŚĞ  “E ?ĐŽŵŵĂŶĚ ? dŚĞ
British Nursing Index and Archive (BNI) (1985-:ƵŶĞ ? ? ? ? ?ǁĂƐƐĞĂƌĐŚĞĚĨŽƌ “EƵƌƐŝŶŐ
,ŽŵĞƐ ? ?  “ZĞƐŝĚĞŶƚŝĂůĂƌĞ ?ĂŶĚ  “>ŽŶŐ-ƚĞƌŵĐĂƌĞ ?  W it was not possible to limit the 
results from this database further as no filter for RCTs was available.  Abstracts were 
reviewed by a single reviewer for descriptions of interventions evaluated using RCTs 
in residential, nursing or care homes.  Those including such a description were 
included in the review; those which did not were discarded. 
A keywording strategy, of the type described by EPPI65, was developed by three 
researchers (AG/PL/JG) using an iterative approach and a random sample of 20 
articles. The articles were reviewed repetitively and key descriptors of the article 
recorded at each review.  The researchers met regularly to discuss the keywording 
strategy and the articles. This process was concluded when no new descriptors were 
identified on two subsequent reviews.  The resulting framework described: year of 
publication, country of publication, individual or cluster randomization, stratified or 
non-stratified randomization, method of stratification, blinding strategy 
(patient/investigators/both/neither), target of intervention, intervention treatment, 
control treatment, number of subjects (total/intervention/control), number of 
clusters (total/intervention/control), outcome measures and results.   
The remaining articles were then divided amongst six reviewers (AG, PL, JRG, JM, RJ, 
CFP) who acted as primary reviewers and were asked to classify them according to 
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the keywording strategy.  As a final measure, all articles were then read by the lead 
researcher (AG) who acted as second reviewer to ensure consistency of classification.  
Disagreements in classification were resolved by consensus. 
Classifications against the keywording strategy were entered onto a Microsoft 
ĐĐĞƐƐ ? ĚĂƚĂďĂƐĞ ? ǁŚŝĐŚ ĂĐƚĞĚ ĂƐ ƚŚĞ ďĂƐŝƐ ŽĨ ĂŶĂůǇƐŝƐ ?  ĂƚĂ ǁĞƌĞ ĂŶĂůǇƐĞĚ ĨŽƌ
publication rate by year, country of publication, type of randomization, blinding, type 
of intervention, target of intervention and study outcome.  Those articles specifically 
considering CGA or case management in the elderly were selected out for more 
detailed narrative review, which was undertaken by AG. 
2.6. Results 
3226 unique articles were identified when the results from all databases were 
pooled.  Based upon review of abstracts, 331 were identified as describing RCTs of 
interventions in care homes.   
 
Figure 2 - PRISMA diagram for CHoLiR literature review 
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A further 40 articles were excluded at full review: 15 described studies which were 
not RCTs; 15 described research conducted in settings other than long-term 
institutional care (9 community-based; 6 hospital-based); 4 were methods papers; 2 
were duplicate publications; 2 were post-hoc sub-analyses of RCTs; one was a 
feasibility study and one a review article.  This left 291 articles which were 
considered in full. A PRISMA diagram is shown in Figure 2. 
The number of articles published by each of the top 10 most prolific countries are 
shown in Table 3.  The majority of studies were conducted in the United States.  
When grouped by continent, 161 articles came from North America, 87 articles from 
Europe, 23 from Asia, 16 from Australasia and 2 from South America.  Only four 
articles were produced by international collaborations and only three of these by 
intercontinental groups.   
Table 3 - Number of articles by country 
Country Number of articles 
USA   145 
UK 24 
Netherlands 23 
Canada 16 
Australia 12 
Japan 8 
Sweden 7 
China (H.K.) 7 
Norway 6 
France 6 
Countries with 5 or fewer articles each were Germany, Belgium, Italy, Taiwan, New Zealand, 
Finland, Turkey, Spain, Australia, Austria, Chile, Israel, Denmark, Korea, Iceland, India, Mexico, 
Lithuania and Russia. 
Publication dates ranged from 1976-2009 with a mean article age of 8 years (median 
6 years).  The years with the most publications were 2006 and 2007.  Publication rate 
by year is shown in Figure 3. 
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Figure 3 - Number of articles published by year 
The randomization strategies used are outlined in Table 4.  The most common 
strategy was non-stratified individual randomization. There were 43 stratified 
individually randomised trials. Crossover designs were infrequently employed but 
used more commonly for individually randomized than cluster randomized trials. 
Table 4 - Randomization strategies used 
Design Stratified Non-stratified 
Cluster 23 45 
Cluster Crossover 2 7 
Individual Patient 42 149 
Individual Patient Crossover 1 23 
In cluster randomized controlled trials, the median number of clusters was 13 (range 
2-223) and the median number of participants per cluster was 22 (range 1.18-
177.79).  A scatter plot of cluster number and size is shown in Figure 4. 
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Figure 4 - Scatterplot of cluster number vs size 
Where stratified randomization was used, the variables used for stratification in 
individual and cluster randomized studies are shown in Table 5 and Table 6 
respectively.  In the case of individual stratified randomization, 12/43 (28%) studies 
used two or more variables for stratification, whilst for cluster stratified 
randomization, 13/25 (52%) used two or more variables.  No study used more than 3 
stratification variables and the average number of stratification variables per study 
was 1.53.  
Table 5 - Variables used for stratification of individual randomization 
Variable used for stratified randomization Number of studies 
Clinical features of residents 27 
Care home 10 
Age 8 
Care home attributes 5 
Gender 5 
Ethnicity 1 
Source of recruitment 1 
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Table 6 - Variables used for stratification of cluster randomization 
Variable used for stratified randomization Number of studies 
Care home size 12 
Geographical location 6 
Type of home (residential vs. nursing) 6 
Proprietary status (private vs state vs charitable) 4 
Aspects of residents' medical care (rate of drug 
prescribing/catheterisation) 4 
Quality of care markers 3 
Organisational characteristics of the homes 2 
Age of residents  1 
GP 1 
Blinding strategies employed are shown in Table 7. 
Table 7 - Blinding strategies used 
Blinding Strategy/Type of Intervention Number of studies 
Double blind  85 
Pharmacological 57 
Vaccine 10 
Dental and oral health 5 
Nutritional 4 
Physical therapy 3 
Education of Staff 2 
Case Management/Comprehensive Geriatric Assessment 2 
Home administration 1 
Psychological of behavioural therapy 1 
Outcome assessor blinded only  72 
Physical therapy 25 
Occupational therapy, aids and appliances 15 
Education of staff 13 
Pharmacological 5 
Psychological or behavioural therapy 4 
Case Management/Comprehensive Geriatric Assessment 3 
Nutritional 2 
Home administration 2 
Nursing interventions not covered elsewhere 1 
Dental and oral health 1 
Vaccine 1 
Participant blinded only  7 
Pharmacological 3 
Nutritional 2 
Physical therapy 1 
Dental and Oral Health 1 
Unblinded  128 
Physical therapy 23 
Occupational therapy, aids and appliances 23 
Pharmacological 18 
Nutritional 12 
Education of staff 12 
Home administration 12 
Psychological or behavioural therapy 9 
Nursing interventions not covered elsewhere 5 
Dental and Oral Health 5 
Case Management/Comprehensive Geriatric Assessment 5 
Vaccine 3 
Aromatherapy 1 
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The types of intervention investigated are shown in Table 8.  The proportion (%) 
cluster randomized is also included as a possible marker of methodological quality, 
which is considered in depth in the discussion.  Several studies combined 
interventions in more than one domain, for example pharmacological with physical 
therapy.  Where this was the case, the study was counted for all relevant domains. 
Table 8 - Types of intervention studied at RCT 
Type of Intervention 
Number of studies 
 
Number (%) cluster 
randomized 
Pharmacological 87 7 (8%) 
Physical therapy 56 8 (14%) 
Occupational therapy, aids and 
appliances 45 
 
13 (29%) 
Education of staff 32 25 (78%) 
Nutritional 21 6 (29%) 
Psychological or Behavioural therapy 15 
 
1 (7%) 
Home administration 15 9 (60%) 
Dental and oral health 14 1 (7%) 
Vaccine 14 1 (7%) 
Case Management/Comprehensive 
Geriatric Assessment 10 
 
4 (40%) 
Nursing interventions not covered 
elsewhere 6 
 
2 (33%) 
Aromatherapy 1 0 (0%) 
These are now considered in turn. 
2.6.1. RCTs of Pharmacological interventions 
This heading included RCTs evaluating drugs, their combinations and routes of 
administration, as well as trials of drug cessation and changes to prescribing, 
dispensing and drug management.  This included trials of vitamin therapies where 
the primary target was not malnutrition.   
71 studies were trials of drug therapies, the most commonly evaluated therapies 
being antipsychotics, vitamin D supplementation and neuraminidase inhibitors for 
treatment or prophylaxis of influenza (see Table 9). 
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Table 9 - Studies evaluating pharmacological interventions 
Type of drug Number of studies Total Number of subjects 
Antipsychotic
100-112
 13 2155 
Vitamin D
113-120
 8 8447 
Antibiotic/antibacterial
121-127
 7 360 
Hormones 7 800 
Megestrol
128-130
 3 189 
Melatonin
131-133
 3 579 
Oestrogen/progesterone
134
 1 32 
Other vitamins and minerals 8 2695 
Multivitamins
135-137
 3 1963 
L-arginine
138 139
 2 58 
Vitamin E
140
 1 551 
Vitamin A
141
 1 109 
Ferrous gluconate
142
 1 14 
Neuraminidase inhibitors
143-148
 6 2390 
Antidepressants
149-152
 4 176 
Donepezil 
153-155
 3 480 
Anticholinergics
156 157
 2 113 
Laxatives
158 159
 2 264 
Paracetamol
160 161
 2 64 
Bisphosphonates
113 162
 2 358 
Others
163-168
 7 595 
A further seven trials were of drug cessation, predominantly in neuroleptics (see 
Table 10). 
Table 10 - Studies evaluating drug cessation 
Class of drug stopped 
Number of 
studies 
Total number of 
subjects 
Neuroleptics
169-172
 4 156 
Antidepressants
173
 1 70 
Benzodiazepines
174
 1 37 
Dopaminergic therapy for Parkinson's 
disease
175
 1 11 
Nine studies evaluated changes to the prescribing or dispensing of medications, of 
which the most commonly evaluated intervention was medication review by a 
pharmacist (see Table 11). 
Table 11 - Studies evaluating changes to prescribing or dispensing 
Intervention evaluated 
Number of 
studies 
Total number of 
subjects 
Medication review by pharmacist
176-179
 4 4301 
Team prescribing meetings
180
 1 1854 
Protocol for antibiotic prescribing
181
 1 4267 
Pharmacy outreach visits to care homes
182
 1 715 
Education on drugs management
183
 1 675 
Pharmacy discharge co-ordinator from 
hospital
184
 1 110 
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2.6.2. RCTs of Physical therapy interventions 
This included RCTs of physiotherapy as defined by the UK Chartered Society of 
Physiotherapy185, including exercise therapy, manipulation and electrotherapy, as 
well as other physical therapies, such as light therapy.  Therapies included here might 
be delivered by physiotherapists or other professional groups.   
Table 12 - Studies evaluating physical therapies 
Intervention evaluated Number of studies Total number of subjects 
Exercise therapy 
   Generic
186-203
 
   Functional incidental Training
204-213
 
   Seated exercise
214-217
 
   Wheelchair Bicycling
218 219 
34 
18 
10 
4 
2 
3758 
2199 
1200 
250 
109 
Light therapy 
   Bright light therapy
132 133 204 213 220-225
 
   Ultraviolet light therapy
226 
11 
10 
1 
811 
766 
45 
Physiotherapy as a service
227 228
 2 309 
Massage therapy
229 230
 2 86 
Tai Chi
231
 1 139 
Ultrasound therapy
232
 1 88 
Yoga
233
 1 50 
Vibration therapy
234
 1 42 
TENS
235
 1 34 
Reflexology
236
 1 21 
Cervical mobilization therapy
237
 1 15 
2.6.3. RCTs of Occupational Therapy, Aids and Appliances 
This included RCTs of Occupational Therapy as defined by the World Federation of 
Occupational Therapists238.  It incorporated a wide range of interventions which 
share the common goal of maximising social and societal participation for residents, 
including aids, environmental modification, recreational therapy, multifaceted 
interventions for falls, continence and ADLs. 
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Table 13 - Studies evaluating OT, Aids and Appliance 
Intervention evaluated 
Number of 
studies 
Total number of 
subjects 
Aids 
Hip protectors
202 239-246
 
Pet therapy
247 248
 
Mattresses and cushions
249 250
 
Toothbrushes
251 252
 
Spectacles
253
 
Bathing systems
254
 
Continence aids
255
 
19 
10 
2 
2 
2 
1 
1 
1 
11471 
9761 
182 
116 
51 
142 
29 
24 
Recreational or vocational therapy
256-265
 10 461 
Falls prevention
202 215 266-269
 6 1798 
Bladder training or other continence 
intervention
207 270-273
 5 497 
Goal-oriented, ADL-targeted therapy
274-277
 4 916 
Occupational therapy as a service
227 278
 2 233 
2.6.4. RCTs of Educational Interventions 
This included RCTs of educational interventions delivered to care home staff, 
residents or healthcare professionals. 
Table 14 - Studies evaluating educational interventions 
Intervention evaluated 
Number of 
studies 
Total number of 
subjects 
Dementia management education
262 279-283
 6 2065 
Education around falls prevention/bone health
188 
267 268 284 285
 5 7675 
Education around communication
286-289
 4 1757 
Education around palliative care
290-293
 4 1166 
Education around prescribing
177 294 295
 3 3738 
Others
277 296 297
 3 805 
Education around physical restraint
298-300
 3 758 
Education around oral healthcare
301 302
 2 632 
Interpersonal skills training for staff
182 303
 2 43 
2.6.5. RCTs of Nutritional Interventions 
This included interventions aimed at preventing or correcting malnutrition, including 
vitamin supplementation and dietary fortification.  Where vitamin supplements were 
used for an alternative indication, such as modulating immune function, treating 
osteoporosis or improving muscle strength, they were included under 
pharmacological treatments above. 
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Table 15 - Studies evaluating nutritional interventions 
Intervention evaluated Number of studies Total number of subjects 
Nutritional supplementation
186 304-314
 12 1053 
Organisation of mealtimes
315-318
 4 520 
Bran in diet
319 320
 2 42 
Probiotics
321
 1 209 
Flavour enhancers
322
 1 93 
Low-lactose diet
323
 1 51 
2.6.6. RCTs of Psychological and Behavioural Interventions 
This included RCTs of therapies which used psychological or behavioural strategies. 
Table 16 - Studies evaluating psychological and behavioural interventions 
Intervention evaluated Number of studies Total number of subjects 
Emotion-oriented care
153 274 324-328
 7 502 
Behavioural therapy
329-331
 3 195 
Self-worth therapy
332 333
 2 160 
Reality orientation
153 334
 2 47 
Cognitive behavioural therapy
335 336
 1 21 
2.6.7. RCTs of interventions in home administration 
This included studies where the main focus was a change to care home governance 
through implementation of new policies, protocols or systems. 
Table 17 - Studies evaluating interventions in care home administration 
Intervention evaluated Number of studies Total number of subjects 
Quality improvement initiatives
182 236 337-343
 9 12530 
Changes to family role/visitation
344-347
 4 276 
Others
348 349
 2 541 
2.6.8. RCTs of dental and oral health interventions 
This incorporated interventions designed to either improve, or prevent deterioration 
in, oral health.  It included interventions delivered by dentists, care home staff and 
the residents themselves. 
Table 18 - Studies evaluating dental and oral health interventions 
Intervention evaluated Number of studies Total number of subjects 
Oral care/toothbrushing
186 251 252 303 350
 5 321 
Fluoride therapy
351-353
 3 148 
Oral healthcare education for carers
301 302
 2 632 
Chlorhexidine mouthwash/gum
354 355
 2 138 
Advanced restorative dentistry
356
 1 162 
Denture care
357
 1 24 
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2.6.9. RCTs of vaccines 
RCTs of vaccines were classified separately from drugs because of their differing 
mode of action (immunological as opposed to pharmacological). 
Table 19 - Studies evaluating vaccines 
Intervention evaluated Number of studies Total number of subjects 
Influenza vaccination
358-370
 13 5314 
Pneumococcal vaccination
371
 1 118 
2.6.10. RCTs of interventions in case management/ CGA 
This heading included RCTs where CGA, case or disease management was evaluated 
as a single intervention.  CGA was defined according to the Ellis and Langhorne25 and 
Stuck27 definitions and case and disease management according to the NHS long-
term conditions framework11. 
Table 20 - Studies evaluating interventions in case management/comprehensive geriatric 
assessment 
Interventions evaluated Number of studies Total number of subjects 
Psychogeriatric case management
279 329 372-376
 6 673 
Disease management
377 378
 2 203 
Comprehensive geriatric assessment
379 380
 2 187 
2.6.11. RCTs of nursing interventions not covered elsewhere 
This included studies of interventions delivered by nursing or care staff which did not 
fit under any of the other headings  W although clearly many interventions described 
under other headings might also be delivered by nursing staff. 
Table 21 - Studies evaluating nursing interventions 
Intervention evaluated Number of studies Total number of subjects 
Barrier nursing methods
381
 1 283 
Pressure ulcer care
382
 1 235 
Continence interventions
383
 1 80 
Comfort touch
384
 1 45 
Bathing interventions
385 386
 2 57 
2.6.12. Targets of interventions 
In the context of CGA, which builds interventions around the needs of patients 
regardless of professional or disciplinary boundaries, the targets of interventions 
were arguably more important than the discipline by which they were provided. 
These are summarised in Table 22. 
Chapter 2  W The Care Home Literature Review (CHoLiR) 
44 
 
Table 22 - Targets of interventions 
Target of interventions Number of studies 
Behaviour 44 
Prescribing 20 
Malnutrition 20 
Influenza 19 
Quality of Life 19 
Depression 18 
Mobility 14 
Oral Health 13 
Falls 12 
Quality of Care 12 
Urinary incontinence 12 
Cognitive performance 11 
Sleep 10 
Fractures 8 
Immunity 8 
Physical Function 8 
Decubitus Ulcers 7 
Osteoporosis 7 
Pain 7 
Constipation 5 
Respiratory infection 5 
Physical Restraint Use 3 
Skin Health 3 
Vitamin D deficiency 3 
General health 2 
Swallowing 2 
Compliance with OT 1 
COPD 1 
Cough Reflex Sensitivity 1 
Dehydration 1 
Dementia 1 
Faecal Incontinence 1 
Hypertension 1 
Interpersonal skills 1 
Microbial colonization 1 
UTI 1 
Given that targets are a logical means by which to classify studies when considering 
CGA - a comprehensive summary of interventions, outcome measures and study 
findings, grouped by target, was compiled.  Due to the length of the resulting table, 
this can be found in Appendix 2.
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2.7. Discussion 
An explosion of interest in care home research was evident from a doubling of the 
publication rate over 10 years (Figure 3).  Much of this activity had taken place in the 
USA.  There were some caveats, which are discussed in section 2.7.5, around possible 
biases introduced by the literature search methodology which could have resulted in 
over-representation of studies from Anglophone countries in general, and North 
America in particular.  It is, however, unlikely that these could fully explain the clear 
lead established by North American researchers.  The US predominance reflects, to 
some extent, the picture seen across all medical disciplines represented in the 
published literature which has been attributed, in part, to the higher levels of 
funding-support available to US researchers393.  It may also reflect widespread 
professionalization in the long-term care sector in the US  W where physicians, 
including statutorily appointed medical directors, have had an integral role in 
providing nursing home care394 and administrators are certified and licensed395.  The 
emergence of the Journal of the American Medical Directors Association (JAMDA) as 
the 7th highest impact factor journal in the Gerontology and Geriatrics category of the 
Thomson Reuters Journal Citation Index in 2009396 was an example of the growing 
influence of this sector in the US over the preceding 10 years. In the UK, by 
comparison, over the same period long-term care was only beginning to be 
recognised as a healthcare sector in its own right and no special certification was 
available to, or required of, doctors, nurses or administrators to work within it397.  
Whether the larger role played by doctors, a group traditionally associated with 
professional enfranchisement, in the US long-term care sector played a role in its 
professionalization is unclear. It is, however, worth noting that the Netherlands had a 
care home article publication rate per head of capita 3.5 times greater than the UK 
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over the period studied and that the long term care sector in the Netherlands has 
been defined by the prominent leadership role played by its physicians37.   
As discussed earlier, differences in the organisation, funding and resident mix 
between US and UK care homes40 over this period were such that it might be 
anticipated that few of the findings reported here would be applicable in the UK 
setting. However most were.  The exceptions were studies considering quality 
assurance measures based around the US Minimum Data Set (MDS) 339 342, which was 
not routinely used in the UK during the study period, and those evaluating 
medications not licensed in the UK111 122 126 144 145. Others seemed initially to have 
limited relevance to the UK setting, an example being those studies which 
investigated educational programmes to reduce the use of formal physical 
restraints298-300 not widely used in the UK398.  However on further consideration, for 
example when these were considered in the context of the prevalent use of less 
formal restraints, such as cot sides or tray tables399, clear lessons were identifiable. 
Considering the central question of this thesis, around the role of CGA in care homes, 
those articles specifically focussing on CGA and case management in care homes 
which were selected out for narrative review are considered first.  Lessons from the 
broader literature concerning component interventions which might comprise part of 
CGA are then discussed. Finally, methodological issues identified through the review, 
which might be important to future research evaluating the role of CGA in this 
setting, are presented.     
2.7.1. Trials evaluating CGA and case management 
Of the ten studies classified under this heading, one was a trial of disease 
management for COPD in the care home setting377.  The remaining nine considered 
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comprehensive geriatric assessment, comprehensive psychogeriatric assessment, or 
case management as their primary intervention and are reviewed here. 
2.7.1.1. CGA/case management targeting behaviour 
Three studies considered the role of CGA in treating behavioural disturbance in care 
home residents with dementia. 
Opie et al373 evaluated individually targeted psychosocial, nursing and medical 
interventions delivered by a team comprising a psychologist, psychiatrist and nurses 
in 99 Australian nursing home residents.  Their research design was governed by 
resource limitations and somewhat complex.  Participating homes (n=42) were asked 
each to identify two residents with behavioural disturbance.  Where more than two 
residents were identified in a home, those with the most frequent and severe 
behaviours  W seemingly based upon staff accounts  W were selected for participation.  
Participants were cluster randomized at a whole home level (n=2 per cluster) to 
receive either early or late intervention, the late participants acting as the control 
group. The rationale for this design was based upon the anticipation that homes 
would refuse to participate if only offered a control intervention.  They delivered a 
mean number of interventions of 4.6 per resident with 46 receiving input from all 
three disciplines in the team, a further 47 receiving interventions from two team 
members and six receiving monodisciplinary input.  The types of intervention used 
are illustrated in Table 23.   
Chapter 2  W The Care Home Literature Review (CHoLiR) 
48 
 
Table 23 - Summary of interventions undertaken in context of Comprehensive 
Psychogeriatric Assessment by Opie et al
373
 
Description of intervention n 
Medical 93 
Commence psychotropic 15 
Change type/dose/timing of psychotropic 7 
Change pain management 18 
Request test/medical treatment 8 
Nursing 141 
Timing/approach to ADL (e.g. Bathing) 50 
Communication, aggression management 31 
Comfort (e.g. Seating) 18 
Rest periods 16 
Snack foods 12 
Other (e.g. Removing restraint) 14 
Psychosocial 213 
Radio, audiotapes 29 
Environmental change 23 
Behaviour modification 21 
Regular walks 19 
Touch/massage 14 
Aromatherapy 14 
Books, pictures 14 
Personalized activity 11 
Reminiscence 11 
Social interaction 10 
Staff cultural kit  9 
Companion resident 9 
Other  29 
It is worth noting that the taxonomy applied by Opie et al differed from that applied 
in this review, so that interventions which would be regarded as occupational 
therapy (environmental modification) or physical therapy (massage) in the context of 
this review were regarded as psychosocial by Opie.  That such interventions took 
place, albeit under the auspices of different professions than in a medical MDT, 
underline that the intervention here represented CGA.   
The  results were not convincingly positive, with a failure to demonstrate significant 
difference between groups for either Behaviour Assessment Graphical System (BAGS) 
or the Cohen Mansfield Agitation Inventory (CMAI), although there were some 
differences between groups in more generic staff reports of behaviour (arguably 
irrelevant as staff were unblinded to the treatment allocation).  The authors 
ĂƚƚƌŝďƵƚĞĚ ƚŚŝƐ ? ŝŶ ƉĂƌƚ ? ƚŽ Ă ĐŽŵƉůĞǆ ƐƚƵĚǇ ĚĞƐŝŐŶ ǁŚŝĐŚ ŝŶƚƌŽĚƵĐĞĚ Ă  “,ĂǁƚŚŽƌŶĞ
ĞĨĨĞĐƚ ? W a significant improvement in outcome measures in both groups over time, 
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triggered by positive behaviours associated with being observed400.  A more likely 
explanation for the failure to demonstrate a treatment effect, not mentioned by the 
authors, was that the time-lag between intervention for the early and delayed 
treatment arms was one week.  In the context of behavioural modification, this left 
very little time for treatments to be initiated or take effect.  This suggests a possible 
failure to understand the mechanism of CGA, which requires for the prescribed 
interventions to both be instituted and take effect before any treatment effect can 
be measured. 
Cohen-Mansfield et al330 considered the role of a behavioural case management 
programme in 167 residents of 12 US nursing homes.  Homes were cluster 
randomized at an individual home level to receive either: detailed assessment led by 
a geriatrician in conjunction with care home staff, coupled to commencement of 
tailored interventions which included pain management but predominantly 
comprised activity-oriented therapies such as doll therapy, music therapy, or 
provision of videos or books; or a control intervention comprising education for care 
home staff around syndromes of agitation, their aetiologies and non-pharmacological 
treatments.  The components of the intervention were not detailed.  The 
intervention period lasted 10 days with behavioural observations conducted within 
four designated hours of the first and last three days of the intervention using the 
Agitated Behaviours Mapping Instrument (ABMI) for agitation and an observational 
measure of positive and negative affect developed and validated de novo by the 
study group.  They reported a reduction in the number of observed aggressive 
behaviours and an increase in the number of behaviours suggestive of positive affect 
in the treatment arm.  A major caveat, however, as for the Opie study, is the short 
latency of follow-up which means that many behavioural interventions would not 
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have had time to become established  W in which light the positive outcome is 
somewhat difficult to explain. 
Brodaty et al376 evaluated a comprehensive psychogeriatric evaluation in 86 subjects 
from 11 Australian nursing homes, the targets of the intervention being abnormal 
behaviour and/or depression in the context of dementia. The intervention 
incorporated physical and psychiatric examinations and involved psychiatrists, 
psychiatric nurses and nursing home staff.  Although the assessment was quantified, 
the nature of the resulting interventions was not.  Participants underwent individual 
randomization, stratified by care home size, to receive either comprehensive 
psychogeriatric assessment, a conventional psychogeriatrician only consult, or usual 
care.  Although the psychiatric morbidity of participants in all three arms improved 
significantly there was no difference between groups on a battery of indices including 
the Even Briefer Assessment Scale for Depression (EBAS-DEP), Hamilton Rating Scale 
for Depression (HAM-D), Cornell Scale for Depression in Dementia (CSDD), Geriatric 
Depression Scale (GDS), Neuropsychiatric Inventory (NPI), SAD faces, Behavioural 
Pathology in Alzheimer's Disease Rating Scale (BEHAVE-AD), Scale for the Assessment 
of Positive Symptoms (SAPS) and clinical interview.  The outcome assessor was 
blinded for the interview data only.  The duration of follow-up in this study was more 
appropriate at 12 weeks, however the other systematic failures, namely failure to 
cluster randomize and to adequately blind outcome assessors draw the findings into 
question.      
2.7.1.2. CGA/case management targeting depression 
Two studies considered the role of case management in treating depression, the first 
of these by Brodaty et al376 has been discussed already. The second, by McCurren et 
al
372, randomized 85 US nursing home residents with a GDS > 10 and a Folstein Mini-
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mental State Examination (MMSE) > 19 to receive either comprehensive assessment 
and care planning by a specialist nurse practitioner, or usual care.  Randomization 
was stratified by GDS (mild vs. severe depression) at baseline using block 
permutation.  All participants received once weekly visits by the nurse and twice 
weekly visits by a team of volunteers, who were trained and supervised by the nurse.  
Outcome assessors were blinded.  The intervention was designed in response to 
individual needs but was universally based around talking therapies, without 
reference to either physical comorbidity or prescribing.  It continued for 24 weeks, 
with outcome assessments (GDS, the mood subset of MDS, MMSE, Salamon-Conte 
Life Satisfaction in the Elderly Scale (LSES) and functional ability) measured at 12 and 
24 weeks.  The treatment group had a significantly lower GDS at follow-up both by 
comparison with baseline and the control group.  However, although a successful 
intervention, with components of cĂƐĞ ŵĂŶĂŐĞŵĞŶƚ ? ƚŚŝƐ ƐƚƵĚǇ ĚŽĞƐŶ ?ƚ ĐŽŶƚƌŝďƵƚĞ
much to the understanding of CGA in this setting due to the narrow focus of both the 
assessment and the intervention. 
2.7.1.3. CGA/case management targeting quality of life 
Kotynia-English et al374 took the somewhat different approach of an intervention 
which conducted a comprehensive psychogeriatric assessment routinely on patients 
admitted to care homes in the area around Perth, Australia.  106 new admissions to 
22 homes were given a battery of tests incorporating the GDS, Health of the Nation 
Outcome Scale for over 65s (HoNOS 65+), MMSE and NPI and were then randomized 
without respect to the outcome of these baseline variables.  Those in the treatment 
arm with significant psychiatric morbidity were referred to mental health services, 
whilst those in the control arm received usual care.  The group found no difference in 
the average number of medical contacts, self-rated health, use of psychotropic or 
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PRN medication, use of physical restraint, mortality, or mental health outcomes, as 
measured by the GDS-15, HoNOS 65+ and NPI between groups at 12 month follow-
up.  They concluded that screening did not significantly augment the mechanisms 
already in place to support and treat psychiatric morbidity in the cohort.  Alternative 
interpretations are that the screening tools used were insufficiently sensitive and 
specific to identify treatable psychiatric morbidity in this cohort, or that the 
treatments instituted by the mental health team, which were not quantified in the 
research article, were ineffective in modifying outcomes. 
Orrell et al378 recruited 24 UK care homes in pairs matched for size, locality and 
registering body.  11 residents were selected at random from all residents with 
dementia within each home.  One home in each pair was then allocated at random to 
treatment or control.  Residents in both the treatment and the control arms 
underwent a comprehensive needs assessment at baseline and 20 week follow-up 
using the Camberwell Assessment of Needs Questionnaire (CANE)  W a comprehensive 
tool which identifies individual needs and encompasses medical, social, psychological 
and environmental domains. Intervention homes were supported by an MDT 
comprising a mental health nurse and clinical psychologist who had access to the 
CANE results and used these to build individualised care plans, whilst control homes 
received usual care.  The MDT visited intervention homes for 2 hours every fortnight 
to ensure that the individualised care plans progressed as intended.  The intervention 
did not have any effect on either unmet needs measured using CANE or quality of life 
measured using the YƵĂůŝƚǇŽĨ>ŝĨĞŝŶůǌŚĞŝŵĞƌ ?ƐŝƐĞĂƐĞ^ĐĂůĞ (QoL-AD).   
With this intervention, although the focus of the CANE was admirably wide, the 
narrow skill range of the MDT employed, which again focussed on a psychiatric skill-
set at the expense of somatic domains, may have adversely influenced the impact of 
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the intervention and the results can be taken to have only passing relevance to CGA 
in its broader sense. 
2.7.1.4. CGA/Case management targeting pain 
Kovach et al378 conducted an RCT of an intervention targeting unmet needs in 
dementia in residents of US nursing homes which had many features of CGA even 
though it was delivered predominantly by nurses.  The procedure, called a serial test 
intervention (STI) comprised multiple stages which incorporated behavioural, 
physical and affective assessments before escalating through non-pharmacological 
measures for discomfort, onto analgesics and then psychotropic therapies.  Specialist 
help was enlisted using prompts within the STI tool at appropriate intervals.  114 
residents across 14 homes were cluster randomized to receive either the 
intervention or a control intervention comprising an unrelated educational 
programme for staff.  The geographical isolation of the homes and the nature of the 
control intervention were such that double blinding was possible.  Outcomes were 
measured using the ŝƐĐŽŵĨŽƌƚ^ĐĂůĞĨŽƌĞŵĞŶƚŝĂŽĨƚŚĞůǌŚĞŝŵĞƌ ?ƐƚǇƉĞ (DS-DAT) 
and BEHAVE-AD, with DS-DAT demonstrating significant reduction in discomfort in 
the intervention arm.  No corresponding change in behaviour was seen.  Although 
apparently a robust analysis of a CGA-like intervention, the study did not seem to 
account for clustering in either its power calculation or analysis of outcomes, thus 
almost certainly over-estimating treatment effects and underestimating the size of 
confidence intervals.  The results must therefore be treated with caution.  
Chapman et al379 evaluated CGA delivered by Advanced Illness Care Teams (AICTs) in 
US nursing homes.  AICTs comprised doctors, nurses, physio- and occupational 
therapists, social workers and psychologists.  They conducted a holistic assessment at 
baseline and implemented individualized treatment plans based upon this over an 8 
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week period.  Although the intervention was reported as a generalized holistic 
intervention, it is clear from the outcomes measured  W CMAI; Face, Legs, Arms, 
Crying and Consolability pain scale (FLACC); CSDD; Pain in Advanced Dementia scale 
(PAINAD)  W that the primary targets were pain and psychiatric morbidity.  It was an 
individualised partial-crossover study, with the randomization and cross-over 
mechanisms reported in oblique terms that made them difficult to fully comprehend 
but, by the time of analysis, 57 residents had been seen by the AICT and 61 had 
received routine care only.  The study was reported as double blind  W although quite 
how double blinding was maintained in the context of a multi-disciplinary 
intervention delivered at the individual level within an institutional setting is unclear.  
The only test to demonstrate a difference between groups difference was CMAI, 
which showed a significant reduction in physically non-aggressive behaviour only.  
Although the intervention tested here was clearly a variant of CGA, the 
methodological issues surrounding the study are such that this does not inform the 
debate around CGA in care homes to any great extent. 
2.7.1.5. CGA/case management targeting general health 
Cavalieri et al380 evaluated physician-led CGA, with support from an MDT comprising 
nursing, physio- and occupational therapy, in a nursing home setting.  69 residents 
were individually randomized to receive either CGA or usual care in an unblinded 
study. They recorded significantly greater use of outpatient health services but a 
significantly lower average number of prescriptions in the CGA group.  There was no 
difference in hospital admissions or longevity between groups.  There is a face 
validity to these findings, however the fact that this was a statistically underpowered, 
unblinded study means that it can be taken, at most, as a spur to further research.  
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2.7.2. Trials evaluating components of CGA 
Considering the table in Appendix 2, a number of clinically relevant outcomes were 
identified which are summarised here. 
For interventions targeting behaviour, results of drug studies were mixed.  Most 
evidence was available for risperidone100 105 107 109 110 401 and olanzapine103 108, both of 
which were shown to be effective in correcting behavioural and psychiatric 
symptoms in dementia (BPSD) against behavioural scales including NPI, BEHAVE-AD 
and the Clinical Global Impression Scale (CGI).  Adverse events were recorded 
including extra-pyramidal gait symptoms, gait disorder and somnolence and were 
more frequently recorded in risperidone studies (although it should be noted that no 
direct comparison between olanzapine and risperidone had been undertaken in this 
setting). These findings come with significant caveats, given the UK Medicines and 
,ĞĂůƚŚĐĂƌĞ WƌŽĚƵĐƚƐ ZĞŐƵůĂƚŽƌǇ ŐĞŶĐǇ  ?D,Z ? ?Ɛ ƌĞĐŽŵŵĞŶĚĂƚŝŽŶ ĂŐĂŝŶƐƚ
prescribing risperidone and olanzapine in the elderly16.  They do, however, provide 
evidence upon which to base practice on the rare occasions when specialist 
prescribers feel there is a clear indication for antipsychotics402.  In the context of the 
MHRA recommendations, it is important that two small studies suggested that 
antipsychotic therapy could be safely withdrawn without significant adverse 
events171 172.   
Although reports were mixed and treatment effects typically small, there was some 
evidence to suggest a role for non-pharmacological behavioural management in care 
homes.  A study of physical activity in 134 care home residents showed no 
improvement in behaviour despite significant improvement in physical performance 
parameters193, however when a physical activity programme was coupled to 
guidelines surrounding psychotropic medication and regular educational rounds, a 
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reduction in agitation and physical restraint were witnessed262.  It is not clear what 
proportion of the treatment effect in this latter study can be attributed to exercise 
and what to the changes in prescribing. Three small studies of music therapy 
suggested a possible role in reducing agitated behaviours260 261 264. Staff education280 
286 288 293 around communication in dementia led to a reduction in the prevalence of 
agitated behaviours in several small studies. Under the heading of psychological and 
behavioural therapies, an RCT in 92 residents comparing a psychomotor activation 
programme with usual care demonstrated improvements in both agitation and group 
behaviour263.  Lavender aromatherapy demonstrated significant improvements in 
both NPI and CMAI scores in a study of 70 residents when compared with sunflower 
oil (placebo) aromatherapy388. A small study suggested that towel bathing and 
person-centred showering may have a positive effect on agitated behaviour when 
compared with usual care386.  For most of these interventions, there was sufficient 
evidence to suggest some merit in further, more comprehensive, evaluation but 
insufficient evidence to support immediate widespread adoption.   
Seven studies targeting prescribing looked at incorporating pharmacist review, with 
or without physician involvement, into clinical pathways either on or after admission 
to care home176-179 182 184 389.  Five of these reduced176 177 179 184 389 and two had no 
effect upon178 182 the number of drugs prescribed per resident.  For the most part this 
was without either harm or clinical benefit176 177 389, although one study did report a 
reduced readmission rate184 and another reduced falls rate179.  One study reported an 
increase in aggressive behaviour measured using the CRBRS following reduction in 
number of prescriptions176.  Other, more targeted interventions suggested it was safe 
to withdraw hypnotics174, neuroleptics169 170, anti-depressants173 and even anti-
Parkinsonian175 therapy in selected cohorts  W although these findings all come from 
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studies which were small and underpowered to detect the type of adverse events 
they claimed to dismiss. 
The influence of care home staff over prescribing was evident from three studies 
which evaluated educational packages delivered to care home staff around 
psychopharmacology and which demonstrated significant reductions in the number 
of antipsychotics prescribed per resident in intervention homes183 282 292.  Similar 
effects were shown for NSAIDs following an educational package around pain 
management294.    
For interventions targeting nutrition the most convincing, clinically meaningful 
outcomes (improvements in body weight and/or anthropometric measurements) 
were demonstrated for nutritional supplementation using vitamins and/or 
minerals307 309 312 313 and protein-energy supplementation186 310 311 314.  Although these 
were predominantly small studies, the consistency of interventions applied and 
results yielded were convincing.  Given the homogeneity of intervention and 
outcome measures, these studies might be appropriate for future meta-analysis.  
Other interventions to demonstrate clinically meaningful positive outcomes were the 
use of family-style dining arrangements316 317 and the provision of feeding 
assistance315. Although there were 20 studies targeting malnutrition, and several of 
these interventions would have been expected also to have affected dehydration, 
only one study312 used an outcome measure (fluid intake) which would allow 
meaningful conclusions to be drawn about hydration status.  Only one study 
specifically targeted dehydration, demonstrating that a prompted preferred 
beverage programme can significantly improve fluid intake and lower blood urea 
nitrate277. 
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For interventions targeting depression, drugs tested in this setting showed no 
benefit149-152, with the caveat that studies were small and therefore likely to be 
statistically underpowered. Studies of physical therapies including light therapy224, 
exercise therapy218 219 336 and yoga233, although also small in size, were more positive.  
A trial of self-worth therapy in 63 Taiwanese care home residents showed a 
significant reduction of depressive symptoms in the treatment arm332.  One caution 
with such small trials is that they may be underpowered to detect adverse outcomes, 
even though they show a small treatment effect. These findings suggest that further 
research activity might be legitimately focussed around either pharmacological or 
non-pharmacological management but none of these studies is sufficiently powerful, 
in isolation or combination, to drive clinical management. Case management studies 
targeting depression in this setting were mixed and are discussed under CGA/case 
management above. 
In studies focussing on influenza, prophylaxis studies, although mixed, suggested a 
likely role for zanamavir or oseltamivir in prophylaxis of influenza in care home 
settings143 144 148.  Most of the vaccine studies, meanwhile, compared different 
preparations or doses of influenza vaccine360 361 363 365 367-369.  Where influenza 
vaccination was compared to placebo, either in the context of resident or staff 
vaccination, it was shown to be effective358 359 390. Comprehensive reviews of this 
literature are published elsewhere403.    
Several studies targeted quality of life with positive outcomes including: physical 
therapy  W tai chi, back rubs 230 231; occupational therapy, aids and appliance focussed 
interventions  W spectacle correction of eyesight, engagement in teaching activities 
and pets247 253 256; psychological therapies  W self-esteem counselling and life-review 
programmes325 333; and staff training in end of life care and dementia281 290. However, 
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there are difficulties with measuring quality of life in the care home setting  W 
discussed in section 2.7.4.  W which mean that these results come with significant 
caveats. The challenge to these findings is not whether a measurable change 
occurred but what the measured change actually means  W is it really an objective 
measure of quality of life or a multi-dimensional measure, which is actually detecting 
changes in psychiatric or physical morbidity or cognition? Much of the work targeting 
quality of life going forward will require to focus on reliable quality of life measures in 
care home residents before further effort is expended on interventions to improve 
these. 
A number of physical and occupational therapy interventions had positive effects on 
outcomes including measures of postural stability, flexibility and gait187 192 195 197 200 202 
208 210 216 217 234. These challenge the assertion that care home residents might be 
 “ďĞǇŽŶĚ ƌĞŚĂďŝůŝƚĂƚŝŽŶ ? ĂŶĚ ĂƌĞ ĨƵƌƚŚĞƌ ƐƵƉƉŽƌƚĞĚ ďǇ ƚŚĞ ƉŽƐŝƚŝǀĞ ŽƵƚĐŽŵĞƐ ĨŽƌ
physio- and occupational therapy when used to target physical function203 227 228 278.  
As a group of articles they represent a legitimate target for more detailed review, 
possibly including meta-analysis, given the homogeneity of interventions and 
outcomes measures across studies. 
Studies targeting falls, fractures and osteoporosis are perhaps best considered 
together, given the considerable clinical overlap between these domains.  The 
literature studied suggested that calcium and vitamin D had a role in preventing falls 
and fractures116 and that bisphosphonates had a role in osteoporosis162. Reports from 
trials of RCTs of falls prevention programmes were mixed with some reporting a 
reduction in falls188 266 and others reporting only a trend towards this267 268.  A 
fracture-preventative effect from hip protectors was not shown in this cohort240 243. 
Chapter 2  W The Care Home Literature Review (CHoLiR) 
60 
 
Several trials evaluating various aspects of oral health and the impact of dentistry 
showed positive outcomes in terms of measures of oral hygiene121 302 350 353. No 
convincing effect on wider health status was demonstrated.  
Most striking amongst the interventions targeting quality of care were those 
focussing on end-of-life care where a large study evaluating staff training around 
death and dying demonstrated improvements in attitudes towards dying patients290, 
whilst an advanced directive support programme343 and interviews assessing 
appropriateness for hospice care236 were able to influence the number of 
inappropriate admissions to hospital and transfer to hospice care respectively.  These 
latter two studies were large and, although unblinded, used objective outcomes 
(number of admissions, venue of care) that were unlikely to be significantly 
influenced by observer bias. 
Regarding incontinence, none of the drug-based interventions studied were shown to 
be effective125 134 156 157. Non-pharmacological therapies, including functional 
incidental training, bladder training and mobility interventions demonstrated more 
positive outcomes270-273 292.  For functional incidental training and bladder training 
the studies were sufficiently large and well designed to consider these treatments 
effective. 
In studies targeting cognition, some medium-sized RCTs evaluating drugs had mixed 
results but probably showed no benefit overall154 155 167.  A number of small studies 
evaluating physical and behavioural therapy interventions were positive but were 
insufficiently homogenous in terms of interventions or outcome measures to either 
steer clinical decision making or inform systematic review and further research in 
these areas is clearly merited153 198 203 263 331. 
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Regarding sleep, several drug, physical therapy and nursing studies failed to show 
much benefit131 133 163 204-206 213 220 223, however the studies were small and statistically 
underpowered.  A conceptual challenge to research in this area seems to have been 
the realisation that positive outcomes are more likely when multiple interventions 
are combined.  Further research evaluating combinations of drugs (predominantly 
melatonin), physical therapies (predominantly light and exercise) and nursing 
interventions (predominantly sleep hygiene and daylight stimulation) have been 
proposed404.   
2.7.3. Trials of CGA and its components Ȃ a summary 
To draw the key findings on CGA and its components together: 
 CGA had not been well tested as a whole intervention in this setting.  Studies 
either showed significant methodological flaws or tested focussed models of 
case management  W predominantly focussing on psychological parameters  W 
that ĚŝĚŶ ?ƚ address the hypothesis that holistic, comprehensive, 
multidisciplinary assessment and subsequent management planning could 
change management and patient outcomes. 
 Some components of CGA were shown to work.  This was the case for: 
advanced care planning; pharmacy interventions to reduce prescribing; staff 
education around prescribing, dementia and end-of-life care; calcium and 
vitamin D in preventing fractures; alendronate in preventing osteoporosis; 
influenza vaccination; oseltamivir or zanamivir for influenza prophylaxis; 
functional incidental training and bladder training for incontinence; and 
risperidone and olanzapine for agitated behaviours in carefully selected 
patients under expert guidance. 
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 One component of CGA  W hip protectors  W was shown not-to-work in this 
setting. 
 Some groups of studies were sufficiently homogenous, both in terms of 
intervention and outcome measures applied, to merit more detailed 
systematic review and/or meta-analysis.  This was the case for nutritional 
supplementation and interventions targeting mobility. 
 For most other domains there was an equivocal body of evidence, with small, 
diverse, or methodologically unsound, studies which failed to provide a 
robust evidence to drive clinical practice. Further research would be required 
to provide this.  
2.7.4. Methodological issues in care home research 
A number of methodological issues affecting the conduct of research in care homes 
were identified. These are relevant to the central argument of this thesis in so much 
as they would influence how research to evaluate CGA in this setting might be 
designed. 
Considering the outcome measures shown in Appendix 2, the majority of studies 
used resident, proxy or observer completed questionnaires.  Although a detailed 
interrogation of the metrics of these is beyond the scope of this thesis, several of the 
resident response measures have shortcomings at the extremes of cognitive or 
physical frailty which mean that they almost certainly represent inadequate tools for 
describing the care home population.  To provide some examples: the GDS, used as 
an outcome measure in 29 studies here, has been shown to be less sensitive and 
specific in the care home population than in the wider community and alternative 
diagnostic cut-offs have been suggested405 which were not used in any of the studies 
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reported here; the Hospital Anxiety and Depression Scale (HADS), used in two 
studies, is not designed for application in the care home setting and has not been 
evaluated in advanced dementia406; and the 28-item General Health Questionnaire 
(GHQ-28), used in two studies, becomes largely unusable in advanced dementia due 
to the complex cognitive constructs employed407. 
Of greater concern than the selection of inappropriate measures for studies, 
however, was the use of measures which, even though well validated in the care 
home setting and advanced cognitive impairment (for example NPI408, CSDD409, 
CMAI410, BEHAVE-AD411), were entirely dependent on observations or proxy accounts 
for their completion. Such observations and proxy accounts came predominantly 
from care home staff, whose reliability as proxies is uncertain.  Kane et al412 
considered the effectiveness of staff as quality of life (QoL) proxies for care home 
residents by comparing responses of 50 communicative care home residents to 
questionnaires summarising QoL and emotional wellbeing with proxy responses from 
staff and family members.  Notably, from a study where the authors had sought to 
exclude poorly communicative participants, they were able to obtain meaningful 
responses from only 60% of residents.  The correlation of staff responses with those 
ŽĨƌĞƐŝĚĞŶƚƐǁĂƐůŽǁĨŽƌYŽ>ĚŽŵĂŝŶƐ ?WĞĂƌƐŽŶ ?Ɛr=0.131-0.365) and non-existent to 
low for emotional domains (r=0.071-0.176).  Family members performed consistently 
better than staff but only just so.  Lum et al413 compared MDS measures of ADL 
performance in 3385 care home residents with data recorded at interviews with 
residents, family and staff members, demonstrating poor-moderate agreement 
between all interviewees and MDS observations.  Agreement was calculated using 
&ůĞŝƐƐ ?ŬĂƉƉĂ Wa statistic widely used to assess inter-observer variability414  W and was, 
at best, fair for each of ƌĞƐŝĚĞŶƚƐ  ?ʃA? ? ? ? ?- ? ? ? ? ? ? ƐƚĂĨĨ  ?ʃA? ? ? ? ?-0.50) and family 
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ŵĞŵďĞƌƐ ?ʃA? ? ? ? ?-0.52).  The reliability of proxy measures in those residents unable 
to communicate is even less certain and convincing solutions as to how to measure 
outcomes in these residents have not yet been developed.   
The role of blinding in a trial becomes particularly important where subjective 
outcome measures, such as the proxies already described, are employed.  Wood et 
al
415 conducted a meta-epidemiological analysis comprising 146 meta-analyses of 
1346 trials to investigate the association between inadequate blinding and biased 
estimates of treatment effect.  They used a ratio of odds ratios as a measure of bias 
and reported this to be 0.75 (95%CI 0.61-0.93) for subjective outcome measures and 
1.01 (0.92 to 1.10) for objective outcome measures.  Given this, it is worrying that 
128 (44%) of the studies reviewed here were unblinded.  Only 85 (29%) were double-
blind and, in the absence of double-blinding, only 72 (25%) blinded the outcome 
assessor.  As expected, most of the double-blind studies evaluated drugs or vaccines, 
these interventions being readily amenable to patient blinding.  Non-pharmacological 
interventions, predominantly in physical and occupational therapy, comprised the 
majority of single outcome-assessor blinded studies and also the bulk of unblinded 
studies. 
The difficulties of blinding participants to rehabilitation interventions are well 
documented55 56  W whilst placebo interventions are available for some physiotherapy 
interventions, such as seated exercises in lieu of weight-bearing exercises197, it can be 
difficult to blind participants to all aspects of rehabilitation, for example whether 
they have received walking aids from a therapist.  This can introduce performance 
bias  W changes in the way in which participants are dealt with influenced by 
knowledge of their treatment allocation416.  However of far greater concern, 
particularly when subjective outcome measures are employed, is ascertainment bias 
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 W where outcome assessors are influenced in their measurements by knowledge of 
treatment allocation417.  In this context, blinding of outcome assessors becomes an 
imperative if the RCT methodology is to be of use at all416. 
The picture may not be as bad as it initially seems.  Montori et al418 reviewed 200 
articles from five leading journals in 2002 and found less than 25% to explicitly report 
their blinding status.  The Consolidated Standard of Supporting Trials (CONSORT) 
group continue to consider the reporting of blinding to be grossly inadequate417.  So 
the failure may be in reporting, rather than conduct. However, the failure to 
adequately report blinding perhaps indicates a naivety about its importance in this 
context. 
Very few of the articles reviewed considered the numerous possible sources of 
unblinding for outcome assessors in the context of care homes where they have to 
come into contact with staff, residents, family members and a built environment all 
of which may be effected by the intervention. These issues are compounded in 
cluster randomization, where accidental unblinding of a single participant can 
unmask treatment allocation for an entire cluster. 
Table 4 shows that 77 (26%) studies employed cluster randomization, the majority of 
these being RCTs of non-pharmacological interventions relating to education of staff, 
home administration, occupational and physical therapy.  The use of cluster 
randomization in these topic areas is perhaps unsurprising given the nature of such 
interventions and the stated aims of cluster randomization as: avoiding cross-
contamination by staff providing aspects of the intervention to participants in the 
control arm; and allocating trial interventions in a way which simulates how they 
would be delivered in clinical practice (i.e. at a whole home level)419.  However, as 
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shown in Table 8, 48% of the studies in these topic areas were not cluster 
randomized even when in some instances, such as continence interventions273 420 or 
inclusion of physical exercises into daily routines (functional incidental training)205 213 
421-423, cross-contamination by staff might be expected. This implies that either the 
benefits of cluster randomization were not universally agreed or understood, or 
more likely that the cumbersome methodological considerations associated with 
cluster randomization are a deterrent.  At the forefront of these are the difficult 
statistics which need to be undertaken to adequately power and appropriately 
analyse cluster randomized RCTs and the prohibitively large sample sizes which may 
be required to allow such statistical analysis424.   
That is not to say that, where conducted, cluster randomization was always done 
well.  Whilst this review did not include a detailed analysis of randomization 
methodology for each study, some useful overarching points can be made by 
considering the number and sizes of clusters as illustrated in Figure 4. Sample size 
calculation for cluster randomization is notoriously complex as it must determine 
both an optimum number and size of clusters, which in turn depends upon the 
presence of identified pretest co-variables and the amount of inter-cluster 
correlation (sometime expressed in terms of between cluster variance)425.  Whilst this 
makes it difficult to comment upon the size and number of clusters recorded per 
trial, it is worth noting in the context of care homes that there is likely to be a fair 
degree of intra-cluster correlation for many important variables such as dependency, 
cognitive impairment, levels of prescribing and comorbidities  W as all of these are 
affected by institutional policies around client selection and day-to-day management, 
which are also likely to differ between homes. A rule of thumb is that the higher the 
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intra-cluster correlation, the higher the number of clusters required to achieve 
statistical precision (see Table 24).  
Table 24 - Effect of intra-cluster correlation on sample size in cluster randomized trials 
assuming a constant cluster/person cost ratio, derived from Raudenbush
425
 
Intracluster 
coƌƌĞůĂƚŝŽŶ ?ʌ ? 
Number of participants per 
cluster 
Number of 
clusters 
Sampling variance 
 ?ɶ1) 
0.01 14 31 0.0103 
0.05 6 61 0.0133 
0.1 4 80 0.0156 
0.2 3 104 0.0186 
0.5 1 146 0.0233* 
 ?ɶ1 A? ? ? ? ? ? ?ŝƐƌĞŐĂƌĚĞĚĂƐůĂĐŬŝŶŐƐĂŵƉůŝŶŐƉƌĞĐŝƐŝŽŶĨŽƌƚŚĞƉƵƌƉŽƐĞof this 
analysis. 
The number of clusters in the reviewed articles ranged from 2-223.  At the lower end 
of this spectrum, where a single coin toss determines the treatment allocation of all 
trial participants, the trials were unlikely to have any properties of randomization.  
The cluster-size ranged from 1-177.  Although small cluster size does not generate 
statistical problems per se, one has to question the rationale for using cluster 
methodology, with associated loss of statistical power, in a situation where there is 
just over one participant per cluster.  It should be noted from Table 24 that there is 
an inverse relationship between the optimum size and number of clusters required 
and that this is not the relationship demonstrated in Figure 4, where most studies 
have both a small average size and number of clusters. Taken cumulatively, these 
data would tend to suggest that, although the rationale for cluster randomization is 
sound, the methodology is imperfectly applied in practice  W probably because of the 
technical difficulties encountered in doing so.  
Stratification, where participants are separated into strata which are randomized 
separately, is used as a means of preventing unequal distribution of important co-
variables which may confound the outcome measure across treatment and control 
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arms417. It can be a useful mechanism to control for confounding, particularly in small 
studies where the likelihood that key co-variables might be unequally distributed 
between treatment and control arms is high.  Although formulae exist to calculate 
the maximum parsimonious number of strata appropriate for an RCT based upon 
sample size, the general rule regarding their use is the fewer strata used the 
better426. Overstratification results in failure to fill permuted blocks, with the 
consequence that less relevant stratifying variables may cloud the effects of 
important ones427.  In this context it is reassuring to note the low mean number of 
strata (1.53) across the articles reviewed and that no study exceeded 3 stratifying 
variables. The variables chosen by researchers for stratification provide some insights 
into what they regard as important confounding variables in the care home setting, 
with organisational features of care homes (type, size, geographical location, 
proprietary status) featuring highly.  This further underlines the complex interaction 
between home and individual which must be allowed for in evaluating all but the 
most simple interventions in this setting. 
One disadvantage of stratification is that it requires block-permuted randomization 
to make it work417.  This is both more complex than simple randomization and more 
predictable, running the risk of loss of allocation concealment unless further complex 
safeguards, such as variable size block-permuted randomization, are used. Given that 
many of the stratification variables chosen in the reviewed articles focussed around 
care home organization, i.e. care home cluster level variables, an alternative strategy 
would be to account for confounding by appropriately powered cluster 
randomization. Some studies reviewed chose to use stratified cluster randomization 
but, given the technical difficulties exemplified in the reviewed literature, it is 
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tempting to suggest that adopting one strategy and doing it well is preferable to 
doing both inadequately  W unless there was a grossly compelling case to use both. 
To summarise the findings around methodology.  Pharmacological and vaccine 
related studies were most likely to be double-blind and physical and occupational 
therapy studies to be unblinded. Many of the outcome measures used were 
subjective, raising concerns with trials where outcome assessors were not blinded. In 
addition, the wider reliance on proxies draws into question the robustness of many 
of the findings reported.  Cluster randomized studies were most likely to be related 
to education, home management, or occupational or physical therapy  W however, 
almost half the studies in these areas were not cluster randomized, raising issues 
around cross-contamination.  Cluster randomization was imperfectly executed, with 
many studies having clusters which were too small or too few.  Stratification was 
conducted parsimoniously with a tendency to select variables focussed around care 
home structure and organisation. 
Considering these, one can start to propose some rules for conducting an RCT in a 
care home setting: 
 Subjective outcome measures should be avoided. 
 Where the use of such measures is unavoidable (and often no alternative will 
be available), blinding of both participants and outcome assessors is 
preferable. 
 Where double-blinding is impossible (and for many rehabilitation 
interventions it will be), then blinding of outcome assessors is essential. 
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 Where an intervention is such that contamination by diffusion is unlikely 
(such as a drug or vaccine based study) then individual randomization is most 
straightforward and to be preferred. 
 Where contamination by diffusion is likely, as in rehabilitation, management 
or educational interventions, cluster randomization is to be considered but 
power calculations must be conducted in a manner that allows for clustering. 
 Stratification of randomization, particularly cluster randomization, should 
only be used where there is reason to believe that a study will be significantly 
biased in its absence.  Where it is used it should be used parsimoniously. It 
may be that adequately powering a cluster-randomized trial is preferable to 
introducing additional complexity with block-permuted stratified 
randomization. 
These rules highlight the huge technical challenges of conducting methodologically 
sound RCTs in a care home setting.  It is clear that in some instances, for example 
when adequately powered cluster-randomization results in an impossibly large 
sample or when blinding of outcome assessors is impossible, that they will be difficult 
to follow.  The dilemma then is between performing a methodologically unsound 
RCT, or accepting the limitations of the RCT in the care home setting and opting for 
an alternative research design when the research question cannot be addressed by 
these means. 
Some of the most convincing trials conducted in the care home setting to date have 
not been RCTs.  The Evercare study35, as discussed in Chapter 1, is an example of a 
case-control observational study, which incorporated large numbers of participants, 
collected meaningful and objective outcome measures and yielded believable, 
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clinically relevant outcomes which have both reinforced practice within the US and 
spurred practitioners elsewhere in the world to reconsider their own practices.  It 
would have been an enormous technical and political challenge to have conducted 
this study within the framework of an RCT, with randomization of customers away 
from an intervention they wanted to buy and randomization of homes away from an 
intervention they wanted to deliver as part of their business model.  Within the 
context of the US healthcare system, where the primacy of patient choice over 
healthcare is often asserted to be a central tenet428, it may even have been unethical 
to subject it to RCT. 
An alternative standpoint, which may be true for many research questions in the care 
home setting, is that the RCT will be the correct research methodology in the future 
but that further developmental work is required before methodologically-sound RCTs 
can be run.  Consider, for example, the central question for this thesis of whether 
CGA has a role in the care home setting.  For this to be evaluated by RCT the possible 
components of CGA in the care home setting would have to enumerated and 
described, so that they could be counted, and outcome measures which capture the 
treatment effect of CGA would have to be identified.  It is not clear what these 
outcome measures could be: an objective measure of quality of life, which is 
validated in the care home setting, is not yet available429 430; resident satisfaction  
measures, although available, have not been convincingly evaluated at the extremes 
of cognitive impairment431; time to death is likely to be a blunt statistical tool in a 
population with a short life expectancy and is challenged by the, albeit controversial, 
standpoint that there may be measurable health states which are worse than 
death432; recording healthcare admissions, or healthcare contacts, as outcome 
variables raises the challenge of separating appropriate and desirable resource use 
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from inappropriate resource use which is harmful to the resident.  Thus whilst an RCT 
might, feasibly, be a way to address the issue of CGA in this setting, a considerable 
amount of developmental work is required before such a trial could be conducted in 
a robust fashion. 
When considered in this context, the question may be whether the MRC framework 
for the evaluation of complex interventions has been sufficiently adopted in care 
home research. The analogy to drug development might be used as justification for 
much more time and thought to be expended in the pre-RCT phases.  The average 
time spent on phase I-II of new drug development, the phases during which safety is 
verified, optimum dose established and outcome measures developed, is 47.3 
months, at an average cost of $23.5 million433.  Over half of new drugs tested fail to 
make it past phase two, having been found to be unsafe or ineffective434.  The time 
and financial resources made available for development of complex interventions are 
both smaller and less flexible  W an NHS National Institute of Health Research 
Programme Grant, for example, comprises £2 million over five years, during which 
there is a expectation that a team of investigators would, at least, reach the end of 
phase II in the MRC framework435.    Perhaps in this context, the pragmatic RCT is one 
never undertaken.     
So to the above rules one must add a preface: 
 Consider whether an RCT is the correct methodology for the research 
question. 
 If an RCT is the correct methodology consider the following: 
o Is the research intervention adequately described? 
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o Are objective outcome measures available and are these validated in 
the care home setting? 
 /ĨƚŚĞĂŶƐǁĞƌƚŽĞŝƚŚĞƌŽĨƚŚĞĂďŽǀĞŝƐ “ŶŽ ? ?ƚŚĞŶĨƵƌƚŚĞƌĚĞǀĞůŽƉŵĞŶƚĂůǁŽƌŬ
is required before moving to RCT. 
2.7.5. Limitations and strengths 
CHoLiR had a number of weaknesses.  It was a systematic mapping review and, as 
such, provided an overview of the topics covered and broad issues raised by the 
literature available, with only a superficial assessment of quality of the research 
undertaken or its reporting.  It focussed only on RCTs and the significant 
shortcomings of RCTs in this setting mean that potentially important pieces of 
research conducted using other methodologies will have been overlooked  W the 
Evercare study being an example.  
Another possible limitation is highlighted by the predominance of Anglophone 
countries - the top five most published countries amongst articles retrieved were 
either Anglophone (US, UK, Canada, Australia) or have a strong tradition of publishing 
in English-language journals (the Netherlands)436. This might represent a bias 
introduced by limiting the Medline search to English language journals  W researchers 
from Asian countries, in particular, have been noted to publish less frequently in 
these393  W which may have been further compounded by the decision to exclude 
Embase from the search.  Data from Elsevier in 2010 reported that 51% of Embase 
citations came from Western Europe, 30% from North America and 5% from Asia, 
compared with 41%, 44% and 3% for the same regions in Medline84.  However, given 
these stated differences in coverage, it seems unlikely that database selection, even 
if it introduced some bias, could have fully explained the US predominance amongst 
articles retrieved.  A different but related question is whether the exclusion of 
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foreign-language articles could have substantively changed the clinically relevant 
findings.  A NIHR Health Technology Assessment conducted by Egger et al98 in 2003 
ĞǀĂůƵĂƚĞĚ ƚŚĞĞĨĨĞĐƚŽĨ ŝŶĐůƵƐŝŽŶŽĨ  “ŚĂƌĚ ƚŽ ĨŝŶĚ ? ƐƚƵĚŝĞƐ ŝŶ ƐǇƐƚĞŵĂƚŝĐ ƌĞǀŝĞǁƐ ?  /ƚ
identified potential reasons for studies being hard to find as not being published, 
coming from non-Pubmed indexed publications and being published in languages 
other than English.  By considering meta-ĂŶĂůǇƐĞƐ ǁŝƚŚ  “ŚĂƌĚ ƚŽ ĨŝŶĚ ? ƐƚƵĚŝĞƐ
included and excluded, the authors concluded that non-English non-Pubmed indexed 
publications showed larger treatment effects.  Whilst missing such studies is of less 
importance in the context of a systematic mapping review than meta-analysis, there 
is no doubt that some strongly positive studies could have been missed in this way.  
The failure to include allocation concealment as a variable in the keywording 
framework was a potentially important oversight.  CONSORT regard allocation 
concealment during randomization as central to effective conduct of the RCT417 and, 
where broad value judgements have been made about the quality of the studies 
retrieved on the basis of other methodological variables such as blinding and 
randomization strategy, it seems potentially remiss not also to have reviewed this. 
Allocation concealment during randomization is, however, methodologically 
straightforward and there is no reason to anticipate that the methodology applied 
would be substantively different for randomization in the care home setting than in 
other settings. The failure to record explicitly in the keywording framework whether 
stratified randomization was associated with blocking (given that it does not work 
without417) is another potentially important oversight in this respect.  However, this 
was a systematic mapping review with the primary aim of identifying overarching 
methodological themes and key clinical lessons and, as such, detailed appraisal of the 
quality of the retrieved literature was beyond its remit. Indeed, having attempted to 
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do this with the resources available would probably have made the review 
impossible to complete.  
The review had two main strengths. Firstly, it was unique in drawing together all the 
RCT literature from care homes around the world and therefore allowed the question 
of whether CGA, or its component interventions, had been trialled in care homes to 
be addressed with some degree of confidence. Secondly, it used the bounded 
methodology of a systematic mapping review to describe diverse literature retrieved 
against a specific keywording framework, allowing articles to be described and 
compared, without there being any need to try to evaluate them collectively.  The 
pitfalls of applying alternative literature review methodologies in this context is clear 
from the previous work of Peet et al437, who attempted in 2004 to combine 58 papers 
from 37 randomised and non-randomised controlled studies across diverse 
interventions in the care home setting using meta-analysis and found it difficult to 
derive meaningful conclusions from the summed results of such heterogeneous 
research. 
2.8. Conclusions 
There was no evidence that CGA had been satisfactorily evaluated in care homes. The 
RCTs which were identified as evaluating CGA-type interventions either focussed on 
relatively narrow, predominantly psychogeriatric, interventions, or suffered 
significant methodological flaws that served to undermine their conclusions.   
Several component parts of CGA had, however, been effectively evaluated at RCT 
and shown to work  W these were advanced care planning; pharmacy interventions to 
reduce prescribing; staff education around prescribing, dementia and end-of-life 
care; calcium and vitamin D in preventing fractures; alendronate in preventing 
osteoporosis; influenza vaccination; oseltamivir or zanamivir for influenza 
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prophylaxis; functional incidental training and bladder training for incontinence; and 
risperidone and olanzapine for agitated behaviours in carefully selected patients 
under expert guidance. Only one component of CGA, the use of hip protectors, had 
been shown conclusively not to work. For a number of other components, the 
literature was inconclusive, in part due to the methodological shortcomings of a 
significant proportion of the RCTs reviewed. 
RCTs clearly have a role in care homes and, where they represent the correct 
methodology for the research question, as in the large trials of staff influenza 
vaccination or pharmacist-led medication reviews reported here, they have delivered 
clinically meaningful outcomes. There are, however, significant methodological 
challenges in adequately randomizing and blinding care home residents to 
interventions at RCT and the literature reviewed here suggests that the research 
community has so far failed to meet these.  Such is the extent of the challenges and 
the manifest failure to accommodate them that RCT methodology might, at times, be 
best abandoned.  On other occasions, it may be best postponed. One reason why 
RCTs should be postponed is the shortcomings of many of the outcome measures 
currently applied in the care home setting, many of which are unacceptably objective 
when applied in the context of respondents with advanced cognitive impairment, 
whilst others simply have not been validated in this setting. 
Coming back to the question of CGA, the literature reviewed  W whilst it supported the 
use of many components of CGA  W left a number of gaps. Allowing for these, the 
breadth of interventions evaluated and the relatively broad spectrum of targets for 
which effective interventions were identified, suggest that evidence-based 
healthcare for care home residents would require to be multidisciplinary: with 
expertise required in exercise therapy, continence management, prescribing in older 
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patients, management of behavioural and psychiatric symptoms of dementia and 
end-of-life care. It seems logical to suggest that such broad-ranging expertise would 
be most effective when informed by comprehensive assessment and co-ordinated by 
regular interdisciplinary communication, as are inherent in CGA. A number of the 
gaps in our understanding of how to care for care home residents might be filled by 
RCT data collected from older, frail cohorts in other settings such as the community, 
or acute hospitals. It would be likely that, by doing so, additional components of CGA 
could be considered in this setting. It is, however, impossible to work out which data, 
from which alternative settings, should be applied in care homes without first 
describing in some detail the health and functional status of care home residents and 
how they interact with health services to receive healthcare.  These will be described 
in Chapters 3 and 4. The question of whether, and how, the existing evidence might 
inform the case for CGA in care homes will be revisited in Chapter 5. 
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Chapter 3 Ȃ The Care Home Outcome Study (CHOS) 
3.1. Introduction 
Chapter 2 demonstrated the lack of an evidence base for CGA in care homes when 
considered as a whole intervention.  It did, however, highlight a number of 
components of CGA which were supported by RCT findings. It concluded by stating 
that evidence generated in other settings, including acute and community 
healthcare, might be extrapolated to fill the gaps in understanding about a role for 
CGA. This would depend upon the extent to which care home residents resembled, 
or differed from, frail older patients seen elsewhere. 
Building a detailed understanding of the health and functional status of care home 
residents was a logical next step, partially to address the issue of cross-applicability of 
evidence from other sectors as already described and partially to address the more 
basic question of whether care home residents were a cohort in which a cogent case 
for CGA could be made on the basis of need.  
Several research studies had already described health and functional status in care 
home residents but were either out-of-date, had been designed to address issues 
other than the routine delivery of healthcare or suffered methodological 
shortcomings.  
The Office of Population and Census Studies (OPCS) survey of disability in Great 
Britain438, conducted in 1988, sampled one in 13 long-term care establishments at 
random and gathered data from permanent residents, defined as those living in 
institutions for more than 6 months. Researchers interviewed one in four residents 
from smaller establishments and one in 12 residents from larger establishments. It 
collected comprehensive data on disability in locomotion, reaching and stretching, 
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dexterity, seeing, hearing, continence, communication, personal care, behaviour, 
intellectual functioning, consciousness and digestion directly from the resident, or a 
proxy when the resident was unable to provide answers. These findings were cited to 
summarise the prevalence of disability in care homes as recently as the Laing and 
Buisson 2009 UK Market Survey of Care Homes7.  However, as described in Chapter 
1, there have been significant changes in healthcare provision for frail older patients, 
which have resulted in increased dependency in the care home population, over in 
the intervening period.  In this context, data which was over 20 years old was likely to 
have significant limitations and was unlikely to be sufficiently contemporaneous to 
build a case for CGA. 
More recently, Bebbington et al439, working on behalf of the UK Personal and Social 
Services Research Unit (PSSRU), conducted a detailed 42-month longitudinal cohort 
study, concluding in the year 2000, which evaluated length of stay, life expectancy 
and total lifetime costs of care for care home residents from the time of admission.  
They reviewed all local authority-funded admissions from 20 local authorities 
selected for representativeness of the wider UK population on the basis of socio-
economic group, population sparsity and migration rate.  They found a median 
survival of 19.6±0.9 months, 11.9±0.9 months and 26.8±1.0 months for the whole 
sample, nursing homes and residential homes respectively.  Amongst their cohort, 
18% were totally dependent (Barthel score 1-4), 23% had severe dependency 
(Barthel score 5-8), 24% moderate dependency (Barthel score 9-12), 21% low 
dependency (Barthel score 13-16) and 13% very low dependency (Barthel score A? ? ? ? ?
Using the Minimum Data Set Cognitive Performance Scale 34% had severe confusion, 
46% mild confusion and 20% intact cognition. Medical diagnoses, although 
considered, were reported only in broad terms under the headings dementia, 
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depression, cardiovascular, respiratory, malignancy and stroke.  Diagnoses were used 
as variables in regression analysis, as predictors of changes in functional and 
residential status, and their raw prevalence was not reported.   
Netten et al440 conducted a follow-up survey considering 921 self-funding residents 
across 292 homes which replicated the distribution of purposive sampling variables 
recorded by Bebbington. They found self-funded residents to have higher levels of 
physical and mental functioning than the publicly-funded residents, but to be older.  
They also reported significant differences in the prevalence of disease between their 
cohort and that of Bebbington.  They attributed this to a reporting bias because their 
survey responses came from care home managers and those of Bebbington from 
social workers. The fact that survey responses for both Bebbington and Netten came 
from social care providers without access to healthcare records draws into question 
the accuracy of the diagnostic prevalences recorded, although it is less likely to have 
affected the data around functional and cognitive status and time to death. 
A more health-focused approach was undertaken by Bowman et al2 who undertook a 
census of the residents of UK care homes comprising part of the BUPA chain in 2004, 
recording data from 15483 residents across 244 homes. These findings were already 
touched upon briefly in chapter 1.  They reported 50% of residents to have dementia, 
76% to be immobile and 27% to be immobile, confused and incontinent.  They also 
recorded the prevaleŶĐĞ ŽĨ  ? ?  “ĂĚŵŝƐƐŝŽŶ ĚŝĂŐŶŽƐĞƐ ?  W with the most prevalent 
being dementia, frailty, stroke and sight impairment, present in 36%, 25%, 22% and 
13% of residents respectively. There were, again, issues around reporting bias 
because data were derived from forms completed by care home managers without 
ĂĐĐĞƐƐ ƚŽ ƌĞƐŝĚĞŶƚƐ ? ŵĞĚŝĐĂů ƌĞĐŽƌĚƐ ? /Ŷ ĂĚĚŝƚŝŽŶ ? ƌĞƐƉŽŶƐĞƐ ǁĞƌĞ ƐƵďũĞĐƚŝǀĞ ? ǁŝƚŚ
managers being asked to respond without clear definitions of what comprised 
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dementia, immobility and incontinence.  There were similar issues with the list of 26 
 “ĂĚŵŝƐƐŝŽŶĚŝĂŐŶŽƐĞƐ ?ǁŚŝĐŚĞŶĐŽŵƉĂƐƐĞĚƐǇŶĚƌŽŵĞƐǁŝƚŚǀĂŐƵĞĚŝĂŐŶŽƐƚŝĐĐƌŝƚĞƌŝĂ ?
ƐƵĐŚ ĂƐ  “ĨƌĂŝůƚǇ ? ĂŶĚ  “ĨĂŵŝůǇ ?ƐŽĐŝĂů ƌĞĂƐŽŶƐ ? ŶŽƚ ĨƵůůǇ ĂŐƌĞĞĚ ďǇ ƐƉĞĐŝĂůŝƐƚ
geriatricians, let alone by care home staff.   
Taken in summation, the findings of Bebbington and Netten suggested care home 
residents were disabled, cognitively impaired and near the end-of-their lives  W 
ƉĞƌŚĂƉƐĂĐŽŚŽƌƚ ŝŶǁŚŽŵ'ŵŝŐŚƚ ƌĞĂƐŽŶĂďůǇďĞĂƉƉůŝĞĚ ?ŽǁŵĂŶ ?ƐǁŽƌŬďƵŝůƚ
the case for CGA further, by suggesting that syndromes (incontinence, confusion and 
immobility) and diagnoses (dementia, frailty, stroke and sight impairment) which had 
been shown in other settings to be appropriate targets for CGA, were prevalent in 
care homes. None of the studies, however, provided sufficient detail to make a 
robust case for comprehensive multidisciplinary assessment and planning.   
Looking back at Chapter 1, the assertion that CGA might have a role to play in 
improving care from care home residents was borne less out of observations about 
the prevalence of frailty, dependency and particular diagnoses in care homes, as it 
was out of a recognised failure of existing models of healthcare to treat residents 
equitably and appropriately. Thus any consideration of a possible role for CGA would 
be incomplete without considering how care home residents used NHS resources. 
Data on this was limited largely to the work by Steves et al17 and Shah et al, already 
discussed in Chapter 1.   
Against this background of incomplete data on the health and functional status of 
care home residents, and how they used NHS resources, it was impossible to robustly 
establish, or refute, a role for CGA. To fill this gap, the Care Home Outcome Study 
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(CHOS) set out to build a more comprehensive understanding of the health and 
functional status of care home residents and to describe their use of NHS resources.  
3.2. Aim 
To comprehensively describe the health and functional status of care home 
residents, and how they use NHS resources. 
3.3. Methodology 
3.3.1. Choosing a longitudinal cohort study design 
Given that the stated objective was to describe the care home population in detail 
and there was no identified intervention, an observational  W rather than 
experimental  W cohort modality was adopted.  The description of health status of a 
cohort required that detailed cross-ƐĞĐƚŝŽŶĂů  “ƐŶĂƉ-ƐŚŽƚ ? ĚĂƚĂ be collected.  
However, to measure healthcare resource use and to investigate its association with 
baseline health status, longitudinal follow-up was required.  Taking these factors 
together, an observational longitudinal cohort study with comprehensive cross-
sectional data collection at two data-points, one at baseline and one at conclusion, 
was proposed (see Figure 5). 
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Figure 5 - An observational longitudinal cohort design 
3.3Ǥ ?Ǥǲǳ 
The World Health Organisation (WHO) defines health as a state of complete physical, 
mental and social wellbeing, not simply the absence of disease or infirmity441.  
Beyond the apparent simplicity of this definition, however, the conceptualization of 
health status becomes increasingly complex.  The WHO offers two complementary, 
yet largely exclusive, conceptual frameworks against which health status can be 
described.  The International Classification of Diseases, currently in its 10th iteration 
(ICD- ? ? ? ŝƐ ĚĞƐŝŐŶĞĚ ƚŽ  “describe the general health situation of population 
ŐƌŽƵƉƐ ?442 and yet does so by classifying medical diagnoses  W rather than more 
generic wellbeing  W in detail, subcategorized by organ system and pathological 
process.  The International Classification of Functioning, Disability and Health (ICF)443, 
by contrast, eschews diagnostic criteria in favour of describing health against 
domains comprising: body function and structure, activity, participation and 
environment.  Reconciling these two conceptual models is difficult. In an attempt to 
the operationalise them for the World Health Survey, the WHO identified 16 health 
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domains and 4 health-related domains444, which comprised elements of both ICD-10 
and ICF (see Table 25). 
Table 25 - Health domains used in the World Health Survey 
Health domains Health related domains 
Vision 
Hearing 
Speech 
Digestion 
Bodily excretion  
Fertility 
Sexual activity 
Skin and disfigurement 
Breathing 
Pain 
Affect 
Sleep 
Energy/Vitality 
Cognition 
Communication 
Mobility and Dexterity 
Self care 
Usual activities 
Social functioning 
Participation 
Many of the clinical and research tools used to record health status measure 
domains of the ICF or ICD-10 but have been developed using conceptual frameworks 
different from those of the WHO.  These have often been derived pragmatically 
based around what can be measured and seems clinically meaningful. An example of 
this would be the Folstein Mini-Mental State Examination (MMSE), commonly used in 
clinical practice as a measure of cognitive status and derived pragmatically445.  It also 
ŽƉĞƌĂƚĞƐ ?ŚŽǁĞǀĞƌ ?ǁŝƚŚŝŶ ƚŚĞ  “ĐŽŐŶŝƚŝŽŶ ?ĚŽŵĂŝŶŽĨ ƚŚĞtŽƌůĚ,ealth Survey, the 
 “ĨƵŶĐƚŝŽŶ ?ĚŽŵĂŝŶŽĨƚŚĞ/&ĂŶĚƚŚĞ “ŵĞŶƚĂůĂŶĚďĞŚĂǀŝŽƵƌĂůĚŝƐŽƌĚĞƌƐ ?ĚŽŵĂŝŶŽĨ
the ICD-10. 
In building a comprehensive overview of health status, it was important that the 
measures chosen were clinically-meaningful but also described all domains of health 
as described by the WHO. The rationale for choosing individual measures is covered 
in sections 3.3.2.1-3.3.2.3 below, whilst a summary of how these mapped to the ICD-
10 and ICF as operationalised in the World Health Survey is outlined in Table 26. 
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Table 26 - How indices chosen for CHOS summarised WHO-defined health and health-
related domains 
Health domains Health-related domains 
Vision ICD-10 diagnoses Self care 
 
BI 
EQ-5D Hearing ICD-10 diagnoses 
Speech ICD-10 diagnoses 
Digestion ICD-10 diagnoses 
MNA 
Bodily excretion ICD-10 diagnoses 
BI 
CI 
Usual activities 
 
BI 
EQ-5D 
GHQ-12 
Fertility ICD-10 diagnoses 
Sexual activity ICD-10 diagnoses 
Skin and disfigurement ICD-10 diagnoses 
Breathing ICD-10 diagnoses 
CI 
Social functioning 
 
BI 
EQ-5D 
GHQ-12 Pain ICD-10 diagnoses 
EQ-5D 
Affect ICD-10 diagnoses 
NPI 
GHQ-12 
EQ-5D 
Sleep ICD-10 diagnoses 
NPI 
GHQ-12 
Energy/Vitality GHQ-12 
EQ-5D 
Participation EQ-5D 
GHQ-12 
Cognition ICD-10 diagnoses 
MMSE 
NPI 
CI 
Communication ICD-10 diagnoses 
NPI 
Mobility and Dexterity BI 
EQ-5D 
3.3.2.1. Describing physical wellbeing 
Against the WHO definition, physical function was considered in its broadest sense 
and it seemed reasonable, therefore, to start with measures of functional status. 
Functional status can be measured by careful recording of individual physical and 
mental functions  W for example measures of grip strength, walking speed and short 
term memory  W but is more commonly measured in clinical practice using Activity of 
Daily Living (ADL) scales.  These measure either basic ADLs (such as indoor mobility 
and self care), more advanced instrumental ADLs (such as walking outdoors or 
cooking food), or both.  Given the high levels of recorded disability in surveys of the 
care home population2 3, it was felt likely that instrumental ADL scales would score 
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consistently low and therefore suffer from a significant floor effect (where a 
significant proportion of the variability seen is below the lowest extreme of the score 
and hence not recordable) and hence a basic ADL score was sought.   
The most widely used basic ADL score in UK clinical practice is the Barthel Index 
(BI)446, which includes domains in continence, feeding, grooming, bathing, dressing, 
transferring, mobilising and the ability to climb stairs.  Originally scored out of 100, it 
was modified by Collin and Wade447 in 1988 to be scored out of 20, with some 
changes to scoring guidelines to take account of identified uncertainties.  It has good 
test-retest and inter-rater reliability448.   
The BI has two main shortcomings: firstly, it is an ordinal scale, where numerical 
values do little to reflect severity of functional impairment  W a patient with a Barthel 
score of 7, for example, is not twice as functionally impaired as one with a score of 
14; secondly, it suffers from a significant ceiling effect  W thus a patient with a 
maximum Barthel score of 20 may still be significantly disabled, despite being able to 
perform all of the basic ADLs outlined in the score449.  Despite these shortcomings, it 
is recommended by the British Geriatrics Society450 and Intercollegiate Stroke 
Working Party451 for use in frail older patients and patients with stroke, largely 
because the core aspects of dependency measured by the Barthel index are 
important both to patients and to health and social service providers, who need to 
arrange for physical dependency to be met. 
Given the predominance of the BI in UK clinical practice, any ADL measure chosen 
over it would have to have very clear advantages.  Commonly-cited alternatives are 
the Functional Independence Measure (FIM) and Katz ADL scale452.  The FIM453 was 
developed specifically to address the deficiencies of the BI.  It is bidimensional, with 
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physical and cognitive subdomains, and can be weighted such that it behaves as an 
interval scale454  W where points are equal and equate directly to physical function  W 
with possible increased utility in long term follow-up.  Despite these apparent 
advantages, head-to-head trials of the BI and FIM show little difference in sensitivity, 
specificity or responsiveness to change455 456.  The Katz ADL scale457 is less 
comprehensive than the BI and has at its core a hierarchy of physical functions 
(based on expectations of the order that these would recover following 
rehabilitation) which is not universally accepted458 459.  Although well-validated460 461, 
it is supported by incomplete reliability data with no published data on test-retest 
reliability452.  Given that neither the FIM nor the Katz ADL score had clearly 
demonstrable superiority over the BI, they were rejected as alternatives. 
Medical morbidity is an important determinant of physical wellbeing and it was 
therefore important to describe this in detail.  This was done using the ICD-10.  As 
illustrated in Table 25, the ICD-10  W because of its comprehensive nature and 
ďĞĐĂƵƐĞŝƚůŝĞƐĂƚƚŚĞŚĞĂƌƚŽĨŵƵĐŚŽĨƚŚĞt,K ?ƐŽƉĞƌĂƚŝŽŶĂůŝƐĂƚŝŽŶŽĨǁŚĂƚŝƚŵĞĂŶƐ
to be healthy  W is an intuitive place to start when measuring medical morbidity. An 
additional advantage is that medical data in the UK is coded against health resource 
group (HRG) codes which are based upon the ICD-10 - making it technically quite 
straightforward to code health-record entries against it.  
It is rare for the type of frail older patients seen in care homes (as described by 
Bowman et al2) to have just one diagnosis and whilst comorbidity, defined as co-
occurrence of multiple diseases in one person462, can be described using a simple list 
of active medical diagnoses, a number of indices have been developed which weight 
diagnoses according to their prognostic importance.  The rationale for using such 
indices is that they can provide, on the basis of a raw score, the means of selecting 
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patients for clinical interventions or research programmes  W something which one 
might struggle to do simply on the basis of a list of ICD-10 codes.  De Groot et al 
conducted a systematic review of the available co-morbidity classifications in 2003 
and concluded that four  W the Cumulative Illness Rating Scale (CIRS), Kaplan index, 
Index of Co-existent Disease (ICED) and the Charlson Comorbidity Index (CI)  W had 
undergone adequate validation for use in clinical studies463.  Of these, the CIRS and CI 
have been modified to account for the effects of age464 465  W an important 
consideration in care homes.   
The CIRS scores 13 body systems according to level of impairment, where 0 = no 
impairment and 4 = life-threatening impairment  W with scores being made against 
guidelines in the CIRS user manual466.  A modified manual, the CIRS-Geriatric (CIRS-G) 
manual, has been produced to take accounts of differing prevalence of illnesses in 
older patients464.   
The CI records the presence or absence of 19 conditions which were chosen and 
weighted according to how strongly they predict mortality.  The weightings were 
based on longitudinal follow-up of 685 patients over 10 years in New York during the 
1970s and 80s467 but have been validated in numerous other populations since463.  
The CI has also been modified to take account of the effects of age on comorbidity  W 
producing a combined age-morbidity index465.   
The main criticism of the CI is that the weightings applied to conditions, based upon 
how strongly they predict mortality, do not hold true for all populations  W with liver 
disease, HIV positivity and metastatic cancer being demonstrated as over-weighted in 
the CI by estimates from subsequent studies468.  Of particular concern here is the 
weighting of HIV, since survival following diagnosis of HIV increased four-fold in the 
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10 year period following publication of the CI469 and has continued to improve since.  
Given, though, that HIV is not routinely seen in UK care home practice, this was not 
important in the context of CHOS.   
Both the CIRS-G and CI have good inter-rater470 471 and test-retest472 473 reliability.  
The CI is easier to use than the CIRS-G because no interpretation of disease severity is 
required and  W given that CHOS proposed to use a battery of tests and therefore 
minimising assessment burden was important  W it was chosen for inclusion on this 
basis.   
Digestion and bodily excretion are factors of nutrition and it therefore seemed 
reasonable to include a nutrition index.  In addition malnutrition is recognised to be a 
prevalent problem in care homes474 and is recognised to be a risk factor for mortality 
in older patients475.  Nutritional assessment measures are a relatively recent 
development and have not yet generated as extensive a literature base as some of 
the other measures described. The Mini-Nutritional Assessment (MNA) was chosen 
for inclusion on the basis that it had been validated in the elderly and shown to be 
predictive both of future functional status and mortality476.  It asks questions about a 
patienƚ ?ƐĂƉƉĞƚŝƚĞ ?ĞĂƚŝŶŐŚĂďŝƚƐ ?ƌĞĐĞŶƚǁĞŝŐŚƚ ůŽƐƐĂŶĚƵƐĞƐŵĞĂƐƵƌĞŵĞŶƚƐŽĨĂƌŵ
and calf circumference477  W these can be used as a proxy for body mass index, which 
is important as weight can be difficult to record in frail, dependent patients.  
3.3.2.2. Describing social wellbeing 
Social wellbeing is a difficult concept with which to contend although, within the 
context of the WHO definition of health, it is clearly an individual phenomenon and 
separate from societal wellbeing. When those domains obviously related to physical 
or mental wellbeing are removed from Table 25, those remaining  W self care, usual 
activities, social functioning and participation  W map very well to descriptors of 
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health-related quality of life (HRQoL).  Indeed, when trying to quantify the social 
domain of health for the World Health Survey, the WHO used the WHO Disability 
Assessment Scale (WHO-DAS) which  W despite some largely unresolved debate over 
whether measures of disability and HRQoL indices are measuring similar, overlapping 
or discrete domains478 479  W is broadly accepted to be a generic HRQoL measure480. 
The HRQoL measure most commonly used in evaluation of healthcare interventions 
in the UK is the EQ-5D.  This measures five health-related dimensions  W mobility, self-
care, pain/discomfort, usual activities and anxiety/depression  W across three levels of 
utility  W no problems, some problems, severe problems.  This results in a system 
which can describe up to 243 health states481.  The reason for the pre-eminence of 
the EQ-5D in the UK is primarily that it has been chosen for cost-utility evaluations by 
the National Institute of Clinical Excellence (NICE) and therefore lies at the centre of 
NHS policy49 50.   
The predominance of the EQ-5D over other measures in UK health policymaking 
might be taken as adequate justification alone for its inclusion in the study.  The EQ-
5D does, however, compare favourably to other measures.  A Health Technology 
Assessment review comparing the EQ-5D to other HRQoL measures including the 
Quality of Well-ĞŝŶŐ^ĐĂůĞ ?Yt ? ?ZŽƐƐĞƌ ?ƐĚŝƐĂďŝůŝƚǇ ?ĚŝƐƚƌĞƐƐƐĐĂůĞ ?ƚŚĞ,ĞĂůƚŚhƚŝůŝƚǇ
Index (HUI; mark I to III) and the 15D found the EQ-5D to be briefer than other 
measures, to have better test-retest reliability, and to be broadly equivalent in terms 
of descriptive and empirical validity482.  A more recent paper by the UK Department 
of Health483 suggested that EQ-5D had less descriptive power than more detailed 
indices, such as the short-form 36 (SF-36) and HUI, but that it had broadly equivalent 
discriminant and predictive validity and measurement reliability.  These authors also 
suggested that the relative brevity of the EQ-5D led to higher completion rates, 
Chapter 3  W The Care Home Outcome Study (CHOS) 
91 
 
making it more appropriate for use in older populations which have constitutively 
lower completion rates for multi-attribute utility indices.  The relative brevity also 
gives the index intuitive appeal when used as part of a battery of evaluations, as was 
the case for CHOS.  The trade-off for brevity is what Cieza and Stucki referred to as 
 “ůŽƐƐ ŽĨ ďĂŶĚǁŝĚƚŚ ?484.  They mapped the domains of the EQ-5D, SF-36, WHODAS, 
World Health Organisation Quality of Life Assessment (WHOQoL-BREF), Nottingham 
Health Profile (NHP) and Quality of Life index (QL-I) to those of the ICF, indicating 
that all HRQoL measures were operationalisations of the international classification, 
with the EQ-5D being the briefest but also the measure with the narrowest focus.  
3.3.2.3. Describing mental wellbeing 
The GHQ-12485 is the 12 point version of the General Health Questionnaire (GHQ), a 
self-completion measure of mental health.  It has been show to be as sensitive and 
specific as longer versions of the GHQ486 487 and can be delivered within 2 minutes to 
a co-operative and cognitively intact participant.  The GHQ- ? ?ƐĐƌĞĞŶƐĨŽƌ “ĐĂƐĞŶĞƐƐ ?
 W ƚŚĂƚŝƐƚŚĞůŝŬĞůŝŚŽŽĚƚŚĂƚĂƉĂƚŝĞŶƚŝƐĂ “ƉƐǇĐŚŝĂƚƌŝĐĐĂƐĞ ? ?/ƚ ŝƐĂĨĞĂƐŝďůĞĂŶĚƵƐĞĨƵů
screening tool in mild-to-moderate cognitive impairment and can be administered 
verbally, rather than as a written questionnaire, in this group407 488.   
A particular issue with the GHQ-12 is that its sensitivity and specificity, and hence its 
cut-off scores for caseness, vary between populations407 489.  This is, in part, explained 
by the effects of language, educational-level and age on test performance, but has 
not been fully explained.  Physical illness confounds longer versions of the GHQ but 
not the GHQ-12 because it contains no somatic domains490.  
Alternatives to the GHQ abound.  The Hospital Anxiety and Depression Scale (HADS) 
is a 14-item self-completion questionnaire, with 7-item anxiety (HADS-A) and 
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Depression (HADS-D) subdomains406, initially designed for use in a hospital outpatient 
population.  Head-to-head comparisons of the GHQ-12 and HADS show them, with a 
few exceptions, to be roughly equivalent in terms of sensitivity, specificity, positive 
and negative predictive value490 491.  HADS has not been evaluated in cognitive 
impairment  W which is a significant disadvantage in the care home population. 
The Cornell Scale for Depression in Dementia (CSDD) is validated in more severe 
dementia and is administered predominantly to the caregiver, with a short patient 
interview afterwards409.  This renders it considerably more time-consuming than the 
GHQ-12.  The 15-item Geriatric Depression Scale (GDS-15) is similar in length to the 
GHQ-12 and has similar sensitivity and specificity for caseness when compared to it. 
However both CSDD and GDS-15 are unidimensional and screen only for depression 
(the CSDD contains one question on anxiety and one on agitation but is still primarily 
a depression rating scale). 
Given the high prevalence of dementia anticipated in care home residents, the role 
played by dementia as leading cause of mental morbidity and the potential for 
cognitive impairment to explain or confound other measures, it was important to 
measure cognitive function.  The Mini-Mental State Examination (MMSE) is the most-
commonly used short-questionnaire to measure cognitive function492.  It was initially 
described in 1975 as a screening test for cognitive impairment445 and has since been 
well validated and has good inter-rater and test-retest reliability493.  A significant 
shortcoming is its high false-positive rate in people with low education if a universal 
cut-off score for dementia is used494.   
Alternative measures to the MMSE have been developed.  The Modified Mini-mental 
State Examination (3MS)495 added four additional questions and provided altered 
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scoring guidelines, demonstrating increased sensitivity for mild dementia and 
otherwise close correlation with the MMSE496 497.  The Cambridge Cognitive 
Examination (CAMCOG) has similar sensitivity to and better specificity than the 
MMSE498 but is still affected by age and educational level499.  However, neither is as 
commonly used in clinical practice or has sufficient advantages over the MMSE to be 
used in preference. 
A significant proportion of the morbidity in dementia comes from behavioural and 
psychiatric symptoms of dementia (BPSD).  BPSD is an umbrella term which covers a 
number of non-cognitive manifestations of dementia  W wandering, aggressive 
behaviour, withdrawn behaviour, sexual behaviour, disinhibition  W which patients 
and carers find distressing and which are increasingly the focus of attention for old 
age psychiatrists and psychiatric nurses500.  Clearly such symptoms have significant 
implications for measurement of morbidity and could be significant baseline 
predictors of high NHS resource use  W and therefore these required to be measured 
as part of this study. Several scales are used to measure BPSD - of these, the 
Neuropsychiatric Inventory (NPI) and Behaviour Rating Scale for Dementia (BRSD) 
have both been developed exclusively for use in dementia and both attempt to 
measure symptoms comprehensively501.  Both are completed at interview with a 
carer since BPSD sufferers are unreliable witnesses to their own symptoms, 
particularly as their dementia progresses.  The BRSD consists of 48 items, recording 
the severity of symptoms in each domain, and takes approximately 25 minutes to 
complete502 503.  The NPI consists of 10 items, recording severity and frequency of 
symptoms in each domain, and is considerably briefer than the BRSD.  The NPI has 
excellent internal consistency, good inter-rater reliability and moderate-to-good test-
retest reliability504.  No direct head-to-head comparison of the NPI and BRSD has 
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been undertaken, apart from the Korean versions of both measures, which were 
evaluated in 99 carers of patients with dementia, showing a high degree of 
correlation between the two505.  Thus, given the broad equivalence of the two 
measures and the relative brevity of NPI, it was chosen for inclusion.     
3.3.3. Describing healthcare resource use      
NHS healthcare resource use is increasingly recorded on electronic databases.  A 
number of NHS databases existed which could possibly describe healthcare resource 
use in our cohort.  These were managed by separate organisations and contained 
complementary but overlapping datasets.  Work to integrate outputs from these was 
part of the broader programme of work taking place around CHOS but proved very 
complex and it quickly became clear that it would be most appropriate to work only 
with those covering acute inpatient care.   
The rationale for focussing on these databases was that they had been designed with 
ready data accessibility in-mind, enabling easy collation of service use data, and had 
robust research and development governance frameworks in place which made 
approval for data collection relatively straightforward.  In addition, much of the 
policy agenda driving innovation in healthcare delivery to care homes (as outlined in 
chapter 1) had focussed on avoidance of acute inpatient admissions.  This approach 
had some limitations  W namely that the relationship between primary and secondary 
care, and somatic and mental health, resource use could not be interrogated.  It was, 
however, the only approach manageable within available resources. 
3.4. The research team 
It was clear that a large sample of care home residents from a number of homes 
would be required to address the research aims and a team of researchers was 
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convened to enable timely recruitment and follow-up.  The core team comprised Dr 
Adam Gordon (AG), an academic geriatrician; Professor John Gladman (JG), a 
professorial-level academic geriatrician and first-PhD supervisor for AG; Dr Pip Logan 
(PL), an academic occupational therapist, and second-PhD supervisor for AG; and 
Lucy Bradshaw (LB), a medical statistician studying for her own PhD.  AG designed the 
research protocol based-upon a research-funding proposal previously submitted by 
JG, designed all study proformas, obtained ethical approval for the study, recruited 
the 11 participant homes, collected data from 110 participants at baseline and 108 
patients at follow-up, commissioned and supervised the design of the Microsoft 
ĐĐĞƐƐ ? ĚĂƚĂďĂƐĞ ĨŽƌ ƚŚĞ ƐƚƵĚǇ ? ƐƵƉĞƌǀŝƐĞĚ ƉƌŝŵĂƌǇ ĚĂƚĂ ĞŶƚƌǇ ? ĐŽŶĚƵĐƚĞĚ ƐĞĐŽŶĚ
data entry and conducted the analysis of data and reporting of findings.  JG designed 
the research-funding proposal on which the study protocol was based and helped to 
recruit the participant homes.  JG and PL between them provided supervision to AG 
at all stages of design, data collection, analysis and reporting in keeping with their 
role as PhD supervisors. Both JG and PL collected data from a small number of 
residents in order to understand the processes involved. LB helped with sample-size 
calculations and provided statistical support throughout data analysis.  A number of 
other researchers  W largely enlisted through the NHS Primary Care and Mental Health 
Research Networks  W helped with data collection for the patients not seen by AG, 
these were: Claire Litherland, Elizabeth Andrews, Mick Bachner, Philip Clissett, Yadiki 
Jayakumar, Isabella Robbins.  Claire Forster, a trainee doctor in General Practice, 
worked with AG on the STOPP-START subsection of the analysis. 
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3.5. Methods 
3.5.1. Defining a sample and the sample-size considerations 
3.5.1.1. The purposive sampling matrix 
The Care Quality Commission (CQC) care home database was searched for all care 
homes within Nottinghamshire and a ten-mile radius of the University of Nottingham 
Medical School, as it was felt these were the homes that could be pragmatically 
involved in the study.  This returned 131 homes with 4952 beds and an average 
number of beds per home of 35.  All care homes on the list were approached by 
direct mail  W 16 responded saying that they wanted to be involved in the study. 
To ensure representativeness of the wider care home population, a purposive 
sampling matrix was developed.  A meeting of researchers from the Medical Crises in 
Older People programme  W the NIHR-funded research programme of which this study 
was part  W was convened to consider this.  The group comprised a consultant 
geriatrician, old age psychiatrist, occupational therapist, social worker, qualitative 
health services researcher, health economist and statistician.  A list of possible 
variables which might bias outcome measures and therefore be relevant to purposive 
sampling was identified during the discussions as listed in Box 1.  
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Based upon a 60% recruitment rate, it was anticipated that 21 residents could be 
recruited per home and based upon the time and resources available for the study it 
was felt that 10-12 homes, (210-252 residents) could be recruited over the time of 
the study.  The ideal purposive sampling matrix would therefore have only 10-12 
categories, limiting the number of variables that could be included.  Through a 
process of iterative exclusion, the following variables were felt to be essential: 
 Nursing/residential status  W on the grounds that identified need for nursing 
input would be likely to predict for a higher prevalence of health problems 
and therefore to influence both baseline health status and healthcare 
resource use. 
 Dementia registration  W on the grounds that the need for specialist dementia 
input would be likely to predict for a higher prevalence of mental health 
problems and therefore to influence healthcare resource use.  It was also felt 
Proprietary status  W private/state-owned 
Corporate status  W large or medium-sized corporate chain/single home or small 
corporate chain 
Building type  W custom-built/renovated property 
Size of home  W bottom/middle/top tertile 
Registration status  W nursing/residential 
Specialist registration  W dementia/physical disability/older patients 
CQC rating  W excellent/good/average/poor 
Number of general practitioners per home  W bottom/middle/top tertile 
Box 1 - Possible confounding variables for inclusion in a purposive sampling matrix 
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that a high prevalence of residents lacking mental capacity in some homes 
might influence how healthcare was accessed in these settings. 
 CQC rating  W on the grounds that this would provide a broad index of quality 
of care in homes and therefore would be likely to influence how homes 
interacted with the NHS and accessed healthcare resources. 
Using the CQC care home database, the prevalence of these variables in 
Nottinghamshire care homes within a 10 mile radius of the Nottingham University 
Medical School was calculated as shown in Table 27.  Homes recently opened and 
therefore not yet classified by the CQC were excluded. 
Table 27 - Nottinghamshire care homes within a 10 mile radius of the University of 
Nottingham Medical School 
  CQC Rating 
  Poor Adequate Good Excellent 
  No of 
Residents  
(% of total) 
No of 
Residents  
(% of total) 
No of 
Residents  
(% of total) 
No of Residents  
(% of total) 
Dementia 
Registered 
Without 
nursing 
88 (2.7%) 291 (9.1%) 480 (15.0%)  228 (7.1%)  
With 
nursing 
146 (4.6%) 217 (6.8%) 226 (7.1%) 138 (4.3%) 
Non-dementia 
Registered 
Without 
nursing 
114 (3.6%) 60 (1.9%) 315 (9.9%) 113 (3.5%) 
With 
nursing 
109 (3.4%) 88 (2.8%) 493 (15.4%) 59 (1.8%) 
The number and size of volunteer homes were such that a truly representative 
sample of homes could not be produced  W the best sampling fit achievable was with 
11 of the volunteer homes and is shown in Table 28.  This clearly undersamples from 
ƚŚĞ  “ĂĚĞƋƵĂƚĞ ? Y ƌĂƚŝŶŐ ĂŶĚ ŽǀĞƌƐĂŵƉůĞƐ ĨƌŽŵ ƚŚĞ  “ĞǆĐĞůůŶƚ ? ĂŶĚ  “ƉŽŽƌ ?
categories  W although arguably this was a reasonable trade-off, with the opportunity 
to sample from the highest and lowest quality providers compensating for the loss of 
data from the middle-ground.  The most prevalent category in the wider care home 
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setting, that of good-rated non-dementia registered homes with nursing, could not 
be sampled at all, as no home in that category had volunteered. 
Table 28 - Best fit sample from volunteer care homes 
  CQC Rating 
  Poor Adequate Good Excellent 
  No of 
Residents 
(% of total) 
No of 
Residents 
(% of total) 
No of 
Residents 
(% of total) 
No of 
Residents 
(% of total) 
Dementia Registered Without 
nursing 
25 (6.4%)  46 (11.7%) 38 (9.7%) 
With nursing   30 (7.7%) 68 (17.3%) 
Non-dementia 
Registered 
Without 
nursing 
40 (10.2%)  49 (12.5%)  
With nursing 40 (10.2%) 55 (14.1%)   
 
Using these attributes a sample was therefore chosen to include 11 homes: 3 
dementia registered residential homes, 3 dementia registered nursing homes, 3 non-
dementia registered residential homes, 2 non-dementia registered nursing home.  A 
summary of each of these homes is provided in Table 29. 
Table 29 - Description of individual homes enrolled in study 
Care Home 
ID 
Registration Status CQC rating* Residents 
(n) 
1 Non-dementia registered nursing home Adequate 55 
2 Dementia registered residential home Good 46 
3 Dementia registered nursing home Excellent 41 
4 Dementia registered residential home Excellent 38 
5 Non-dementia registered residential home Good 24 
6 Non-dementia registered residential home Poor 40 
7 Dementia registered nursing home Excellent 24 
8 Dementia registered residential home Poor 25 
9 Non-dementia registered residential home Good 25 
10 Dementia-registered nursing home Good 30 
11 Non-dementia registered nursing home Poor 40 
*CQC rating at the outset of the study. 
During the study it became clear that CQC ratings were very labile amongst the study 
homes, with 5/11 homes changing their rating category during the 6 month follow-
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up. The sample distribution after removal of CQC ratings is summarised in Table 30.  
This, in fact, showed a closer match than the initial sampling matrix from Table 28. 
Table 30 - Sample distribution with CQC-rating removed 
 Proportion of Sample 
Type of home All Nottinghamshire Homes Sample 
Dementia Registered/Without 
Nursing 
33.9% 27.8% 
Non-dementia 
Registered/With Nursing 
23.4% 24.7% 
Dementia Registered/With 
Nursing 
22.8% 25% 
Non-dementia 
Registered/Without Nursing 
18.9% 22.7% 
3.5.1.1. Sample-size considerations 
Based upon this framework and the anticipated 60% recruitment rate, it was 
anticipated that 231 residents would be recruited from 11 homes.  Unpublished data 
provided by Nottinghamshire County Primary Care Trust suggested that the number 
of emergency admissions to hospital locally at the time of commencing the study was 
2 per care home per month  W and as acute trust healthcare resource use was one of 
the proposed outcome measures this provided a reasonable means by which to test 
the statistical appropriateness of the sample size. 
The sample size for the study was based on the precision to which the rate of 
emergency admissions could be estimated using a 95% confidence interval. Given 
231 residents, 11 care homes and 2 residents per month, various lengths of follow-up 
were evaluated.  6 month follow-up provided a satisfactory compromise between 
feasibility and statistical accuracy.  The supporting calculations were as follows: 
- If 231 people were followed up for 6 months then the total amount of follow-
up time in person months would be 231x6 = 1386 person-months. 
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- If the rate of unscheduled emergency admissions was 2 per care home per 
month and 11 homes were in the study for a period of 6 months then 2x11x6 
= 132 unscheduled emergency admissions would be expected in this period.  
- The approximate standard error of an incidence rate is (number of events in 
follow-up time)/total follow-up time = (132)/1386 = 0.008.   
- To calculate half the width of the approximate 95% confidence interval for 
the incidence rate of unscheduled emergency admissions, the standard error 
was multiplied by 1.96, providing the following calculation 1.96x (132)/1200 
= 0.019 or 0.02 to 2 decimal places.  
Therefore 231 people followed for 6 months would provide an estimate of the rate of 
unscheduled emergency admissions accurate to 0.02 per person per month, or 
roughly 0.5 per care home per month, suggesting that the proposed sampling 
framework was statistically appropriate to describe the chosen outcome measures.   
3.5.2. Recruitment and Consent 
Care home managers were asked to make the initial approach to residents and 
relatives and were provided with information packs to distribute on request. 
The care home manager was asked to determine which residents would have 
capacity to consent to participation.  Capacity was defined against the criteria 
specified in the Mental Capacity Act, 2005506 - it is essential for managers to have a 
working knowledge of this act for their day-to-day practice and, although it was 
offered, none of the managers requested additional training to make these 
assessments.  Residents with capacity were approached individually by a researcher, 
the study explained to them and an information sheet provided.  Consent took place 
either immediately, or within 24 hours if the resident wished to consider their 
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inǀŽůǀĞŵĞŶƚ Ăƚ ŐƌĞĂƚĞƌ ůĞŶŐƚŚ ?  ZĞƐĞĂƌĐŚĞƌƐ ǀĞƌŝĨŝĞĚ ƚŚĞ ĐĂƌĞ ŚŽŵĞ ŵĂŶĂŐĞƌ ?Ɛ
assessment of capacity before obtaining consent. For residents without capacity it 
was necessary, under the stipulations of the Mental Capacity Act, to find a consultee 
to inform the researcher of the potential-participants ? attitudes to research.  Where 
consultees were in favour of proceeding, residents were enrolled. 
The aim was to recruit all residents in all homes in order to ensure a representative 
sample.  Refusal to participate at any point, or to obtain consultee approval in those 
without capacity, excluded potential participants from further involvement.  
Potential participants were also excluded where no consultee was identified, if they 
were non-English speaking and no suitable translator was available, if they were felt 
by the manager to be in the last days of life or were receiving short term respite care.  
A recruitment algorithm is shown in Figure 6. 
 
Figure 6 - CHOS recruitment algorithm 
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3.5.3. The questionnaires 
A baseline questionnaire was developed based around the indices discussed in 
section 3.3.2.  Similar items from different scales, for example eating questions from 
the BI and MNA, were grouped together to aid the logical flow of data collection and 
minimise repetition.  Questions were then divided into an interview schedule, 
containing those questions that only the participant could answer, and a data 
schedule, containing those questions which could be answered from care home or 
medical records, or by proxy response from a member of staff or next-of-kin.  The 
eventual composition of these two documents is outlined in Box 2 and Box 3. 
Box 2 - Contents of CHOS data schedule 
1. Name, Care Home and GP contact details 
2. Demographics: age, gender, marital status 
3. Medications Prescribed 
4. Health conditions: List and Charlson Comorbidity Index  
5. Barthel Index 
6. Resource use (inventory of any regular care arrangements over and above that 
provided by the care home, e.g. district nurse visits, community physiotherapy visits, 
support from continence nurse specialists, etc.) 
7. Psychiatric morbidity: The Neuropsychiatric Inventory (NPI) 
Box 3 - Contents of the CHOS interview schedule 
1. Physiological frailty and nutritional measures: height, weight, mid arm 
circumference measured in centimetres (required to complete MNA) 
2. Cognitive function: MMSE  
3. Quality of life: EQ5D  
4. Psychological well being: GHQ-12 
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Outcome questionnaires were developed to include EQ-5D, GHQ-12, NPI and BI  W as 
it was felt that these variables might change significantly over the follow-up period 
and that changes, if they occurred, might significantly affect healthcare resource use, 
morbidity or mortality.  All outcomes were measured at 180 days (6 months).  
3.5.4. Health conditions 
In addition to collating data on health conditions from the care home records, GP 
records were also consulted.  This was done either by a researcher directly accessing 
the GP database under supervision of a member of practice staff or by collecting 
copies of anonymised paper records from practices. All diagnoses were coded against 
the ICD-10 and entered onto the study database by a consultant geriatrician.  Where 
discrepancies existed between the care home and GP records, both diagnoses were 
ůŝƐƚĞĚ ƚŽ ĞƐƚĂďůŝƐŚ ƚŚĞ ŵŽƐƚ ĐŽŵƉƌĞŚĞŶƐŝǀĞ ƌĞĐŽƌĚ ŽĨ ƚŚĞ ƉĂƌƚŝĐŝƉĂŶƚƐ ? ŵĞĚŝĐĂů
conditions. Where direct conflict existed between the GP and the care home record, 
the GP record was regarded to be the more reliable document.  
3.5.5. NHS resource use 
Acute NHS resource use was recorded over the 6 month follow-up period using data 
from the NotIS database at Nottingham University Hospitals and the ICE database at 
Sherwood Forest Hospitals Foundation NHS trusts.  These recorded inpatient stays, 
outpatient consultations, day case visits and investigations requested through these 
providers.  These hospitals represented the principal acute inpatient healthcare 
providers for all care homes involved in the study and their databases therefore 
provided comprehensive data on acute secondary and tertiary-level healthcare 
resource-use by the cohort  W with the exception of private consultations, which it 
was assumed would be uncommon amongst care home residents. Where patients 
died, date of death was recorded from the care home records. 
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3.5.6. Data analysis 
Data from the study proformas were entered into a Microsoft Access ? database held 
in duplicate on a secure sever at the University of Nottingham. Full double-entry of 
data was used as a quality control measure to ensure accuracy. 
Data were analysed in PASW statistics ? (formerly SPSS ?) version 18.0.0.  Descriptive 
statistics were used to describe the overall population and their outcomes, with 
ĚŝĨĨĞƌĞŶĐĞƐďĞƚǁĞĞŶƌĞƐŝĚĞŶƚŝĂůĂŶĚŶƵƌƐŝŶŐŚŽŵĞƐĞǆƉůŽƌĞĚƵƐŝŶŐ PƚŚĞƐƚƵĚĞŶƚ ?Ɛ ƚ-
test for continuous and normally distributed variables; the Mann-Whitney U test for 
continuous and non-normally distributed or ordinal variables; the Chi-Squared test 
ĨŽƌ ĐĂƚĞŐŽƌŝĐĂů ǀĂƌŝĂďůĞƐ ? ĂŶĚ DĐEĞŵĂƌ ?Ɛ ƚĞƐƚ ĨŽƌ ƉĂŝƌĞĚ ĐĂƚĞŐŽƌŝĐĂů ǀĂƌŝĂďůĞƐ ? 
Differences between individual care homes were explored using analysis of variance 
(ANOVA) for continuous and normally distributed variables and Kruskal Wallis non-
parametric ANOVA for non-normally distributed or ordinal variables. Type I error was 
avoided when conducting multiple tests by using the Bonferroni correction. 
The extent of care home level clustering of baseline and outcome variables was 
explored using intra-cluster correlation coefficients (ICC).  ICC provides a means of 
describing the variance in individuals within a cluster (in this case a care home) by 
comparison with the variance across the sample as a whole507.  It was calculated as 
described by Smeeth and Ng508 using the outputs from a one-way ANOVA, which 
were inputted into the ICC equation as follows: 
ICC = (MSb W MSw ?A? ?D^b+(m-1)MSw) 
Where MSb and MSw represented the mean squares from the ANOVA table for 
between and within clusters respectively and m was the average size of the cluster.  
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Standard error of the ICC was calculated on the basis that SE = (variance), where 
variance was derived using the equation: 
varianceICC = 2(1 WICC)2[1+(n-1)ICC]2/n(n-1)k 
Where n was the harmonic mean of the number of participants per cluster and k was 
the number of clusters.  
Medications and diagnoses were analysed separately in Microsoft Excel ?.  
Descriptive data on medications was compiled by categorizing drugs into chapters 
and subchapters according to the British National Formulary509  W the authoritative 
reference used for prescribing in the UK.  A secondary analysis was conducted using 
the Screening Tool of Older Person's Prescriptions and the Screening Tool to Alert 
doctors to Right Treatment (commonly co-administered as the STOPP-START) tool  W a 
clinical guideline which encourages doctors to consider stopping unnecessary or 
dangerous medications and starting those which are evidence-based for the 
treatment of older patients510.  It has been validated in a number of older 
populations across Europe511. For this part of the analysis, the STOPP-START tool was 
applied independently by a GP and geriatrician, with differences resolved by 
consensus.  Diagnoses were counted but also categorised according to ICD-10 section 
and subsection.   
3.6. Results 
3.6.1. Recruitment 
Baseline recruitment commenced on 19/1/2009 and completed on 16/12/2009.  
There were 391 bed places across the participating homes, however subtotal bed-
occupancy meant that there were only 323 residents, from which 227 (70%) subjects 
were recruited.  Reasons for non-recruitment are shown in Table 31, with the most 
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common issue being residents lacking capacity to consent to participate and having 
no consultee to inform their participation. 
Table 31 - Reasons for non-recruitment to CHOS 
Condition No. of Residents 
No consultee or consultee did not respond 61 
Declined to participate 23 
In hospital 6 
In respite 3 
Palliative care 3 
A recruitment graph is shown in Figure 7. 
 
Figure 7 - Recruitment graph for CHOS 
37 patients died during the 6-month follow-up period.  1 patient was lost to follow-
up, having left the Nottingham area with no forwarding details.  The mean number of 
days to follow-up was 185.6 (SD 22.4), the range of days of days to follow-up 177-
292, with a small number of outliers taking a longer period to follow-up due to 
unavailability at the time of scheduled data-collection, predominantly due to hospital 
admission at the time of proposed data collection. 
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3.6.2. Missing data 
174 discrete variables were recorded from 227 residents at baseline and 191 patients 
at follow-up.  114 of these were baseline variables and 65 were follow-up variables.   
Allowing for the 37 deaths and 1 withdrawal, 129 variables were complete, with no 
missing data.  17 variables had less than 5% missing data (data missing from between 
1 and 10 respondents) and were unlikely to be significantly biased as a consequence.  
These are summarized in Table 32. 
Table 32 - Variables with <5% data missing 
 
N 
 
 
Valid Missing (Corrected for deaths) Percentage missing 
Height 217 10 4.4% 
Grip strength (right) 219 8 3.5% 
Grip strength (left) 219 8 3.5% 
Mid-arm circumference R 219 8 3.5% 
Nutrition question 220 7 3.1% 
Mid-arm circumference L 221 6 2.6% 
Outcome EQ-5D pain 186 5 2.6% 
MNA full meals 223 4 1.8% 
MNA fruit 223 4 1.8% 
MNA neuropsychological 223 4 1.8% 
MNA dairy 224 3 1.3% 
MNA eggs 224 3 1.3% 
MNA meat 224 3 1.3% 
MNA food intake 225 2 0.9% 
MNA fluid 225 2 0.9% 
MNA weight loss 226 1 0.4% 
33 variables had 5% or more data missing, these are summarized in Table 33.  All 
missing data for the pension credit variable was a consequence of non-response to 
this question at face-to-face interview. Most residents did not know whether they 
received the benefit, hence the high non-response rate.  Where residents did 
ƌĞƐƉŽŶĚ ? ŝƚǁĂƐŽĨƚĞŶ ŝŶƚĞƌŵƐŽĨ  “/ƚŚŝŶŬƐŽ ?Žƌ ? “ŵĂǇďĞ ?ǇĞƐ ? ? dŚĞŵĞĚŝĂŶDD^
was 11.5 for non-respondents and 16 for respondents to this question (p<0.01 Mann-
Whitney U). 
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Table 33 - Variables with >5% data missing 
 
N 
 
 
Valid 
responses 
Missing data 
(Corrected for deaths) 
Percentage 
missing 
Do you receive pension credit 87 140 61.7% 
BMI 149 78 34.4% 
GHQ-baseline worthlessness 152 75 33.0% 
Weight 154 73 32.2% 
GHQ-12 baseline difficulties 158 69 30.4% 
GHQ-12 baseline ADLs 160 67 29.5% 
GHQ12-baseline decisions 161 66 29.1% 
GHQ-12 baseline strain 161 66 29.1% 
GHQ-12 loss of confidence 161 66 29.1% 
GHQ-12 baseline problems 162 65 28.6% 
GHQ12-baseline depressed 162 65 28.6% 
GHQ-12 baseline sleeplessness 163 64 28.2% 
GHQ-12 baseline usefulness 163 64 28.2% 
GHQ-12 baseline concentration 164 63 27.8% 
GHQ-12 baseline happiness 164 63 27.8% 
GHQ-12 outcome usefulness 143 48 25.1% 
GHQ-outcome difficulties 144 47 24.6% 
GHQ-12 outcome decisions 145 46 24.1% 
GHQ-12 outcome strain 145 46 24.1% 
GHQ12-outcome problems 145 46 24.1% 
GHQ12-outcome worthlessness 145 46 24.1% 
GHQ-12 outcome confidence 146 45 23.6% 
GHQ-12 outcome ADLs 147 44 23.0% 
GHQ-12 outcome depressed 147 44 23.0% 
GHQ-12 outcome happiness 147 44 23.0% 
GHQ-12 outcome sleeplessness 149 42 22.0% 
GHQ-12 outcome concentration 150 41 21.5% 
Are you well off? 185 42 18.5% 
EQ-5D baseline anxiety 187 40 17.6% 
Level of education? 192 35 15.4% 
Do you talk to your relatives often? 198 29 12.8% 
EQ-5D outcome anxiety 175 16 8.4% 
EQ-5D baseline pain 209 18 7.9% 
ED-5D outcome self-care 177 14 7.3% 
EQ-5D outcome ADLs 177 14 7.3% 
EQ-5D outcome mobility 178 13 6.8% 
Demispan 213 14 6.2% 
Calf circumference R 214 13 5.7% 
Calf circumference L 215 12 5.3% 
    
94% of the missing BMI data was a consequence of missing weight data, 6% was 
explained by missing height or demispan data.  All weight data was collected from 
care home records.  88% of the missing weight data came from only four homes 
(Table 34)  W with widely fluctuating practices evident regarding the recording of 
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weight.  One home did not routinely record weight, whilst one home recorded 
weight in 94.4% of respondents. 
Table 34 - Missing weights by home 
Care Home ID Weight missing (N) Weight missing (% of respondents from that home) 
6 23 57.5% 
2 20 40.8% 
16 12 100.0% 
4 10 37.0% 
1 6 27.3% 
3 2 7.7% 
5 2 14.3% 
7 2 10.5% 
14 1 5.6% 
MMSE scores did not differ significantly for those with missing weights, however 
Barthel (BI) scores were significantly lower, with a median BI of 5 in those with 
missing weights and 10 in those with data available (p<0.01, Mann-Whitney U), 
suggesting physical inability to weigh the patient as an important contributor to non-
response in this domain.    
The low-response to individual variables had knock-on effects for two of the 
summary scores  W GHQ-12 and EQ-5D.  This effect was most marked for GHQ-12, 
with 27.8-33% non-response to component variables at baseline and 21.5-25.1% at 
follow-up, resulting in only 44% of respondents providing complete GHQ-12 
responses at both baseline and follow-up.  Non-respondents had a lower median 
MMSE and BI (p<0.01; Mann-Whitney U). 
Individual EQ-5D variables, by contrast, had quite high response rates. This was 
achieved through the use of care home staff or family members as proxy 
respondents, where care home residents were unable to answer for themselves.  
Data on which questions were completed by residents and which by proxies were not 
collected.  Staff and family members frequently stated, however, that they were 
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unable to answer the question which asked whether residents were anxious or 
depressed. This was incomplete in 17.6% and 8.4% of respondents at baseline and 
follow-up respectively, resulting in complete EQ-5D data being available only in 140 
(74%) respondents. Non-respondents were, again, more likely to have a lower MMSE 
and BI (p<0.01; Mann-Whitney U), with the effect most marked for MMSE (Figure 8). 
 
Figure 8 - MMSE for EQ-5D responders vs. non-responders, extreme outliers marked by * 
Given the low completion rates for GHQ-12 and EQ-5D and likely significant bias 
introduced by non-response amongst the most disabled participants, these variables 
were not included in subsequent analyses. 
3.6.3. Baseline measurements 
The results for summary variables collected at baseline are outlined in Table 35.  The 
median (IQR) BI for the cohort as a whole was 9 (3.5-14.5), indicating moderate 
dependency. Nursing home residents were significantly younger, more dependent, 
more cognitively impaired, more malnourished, had lower grip strength, had fewer 
diagnoses and were more behaviourally disturbed.   
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Table 35 - Summary variables collected at baseline, overall and by care home type 
Variable Whole Cohort  Residential 
homes 
Nursing Homes 
Number of participants 227 124 103 
Mean Age (SD) 85.2 (7.5) 86.8 (7.3) 83.2 (7.3)** 
% of residents who are female 78.9 80.6 76.7 
Mean no of GPs per home (SD) 4.63 (2.73) 5 (2.60) 4.2 (3.11) 
Median no. of days since admitted 
to home (IQR) 
79 (5-153) 68 (0-147) 94 (28-160) 
Mean body mass index (SD) 23.8 (5.9) 24.5 (5.9) 22.8 (5.7) 
Median Barthel Index (IQR) 9 (2.5-15.5) 11 (7-15) 5 (1.5-8.5)** 
Median MMSE (IQR) 13 (4-22) 16 (8.5-23.5) 10 (1-19)** 
Median MNA Score (IQR) 20 (16.8-23.3) 21.5 (19.3-
23.8) 
17.5 (14-21)** 
Median grip strength in PSI (IQR) 4 (1.5-6.5) 5 (3.8-6.3) 3 (0-6)** 
Median Charlson Score (IQR) 2 (0.5-3.5) 2 (1-3) 2 (0.5-3.5) 
Mean no of diagnoses (SD) 6.2 (4) 6.9 (3.1) 5.5 (2.4)** 
Median no of medications (IQR) 8 (5.5-10.5) 7 (4.5-9.5) 8 (5.5-10.5) 
Median NPI score (IQR) 3 (0-7.5) 2 (0-4.5) 6 (0-13)** 
**Significant difference between residential/ nursing homes (p<0.01) 
 
The prevalence of specific dependencies from the BI is reported by home type in 
Table 36.  This shows significantly higher dependency amongst nursing home 
residents in all domains of the BI apart from stair-climbing and bathing. These 
differences persisted after correction for multiple testing. 
Table 36 - Prevalence of specific dependencies from the BI by home type 
Specific Dependencies from BI 
 
Whole cohort Residential 
Homes 
Nursing 
Homes 
p-
value* 
N % N % N %  
Incontinent of urine (regularly) 129 56.8 53 42.7 76 73.8 <0.01 
Incontinent of faeces (regularly) 95 41.9 35 28.2 60 58.3 <0.01 
Need help to wash/brush hair 135 59.5 56 45.2 79 76.7 <0.01 
Need at least some help to use 
the toilet (help on off; wiping) 
170 74.9 78 62.9 92 89.3 <0.01 
Need at least some help with 
eating (food cutting; spreading) 
103 45.4 37 29.8 66 64.1 <0.01 
Need help of two people to 
transfer to bed/chair 
87 38.3 23 18.6 64 62.1 <0.01 
Have no mobility 82 36.1 23 18.6 59 57.3 <0.01 
Need at least some help to walk 
or wheel indoors 
139 61.2 65 29 74 33 <0.01 
Need to be dressed (unable to 
do half the task unaided) 
119 52.4 51 23 58 26 <0.01 
Unable to manage stairs 183 80.6 96 77.4 87 84.5 0.12 
Needs help with bathing 213 93.8 114 91.9 99 96.1 0.15 
* Calculated using Chi-square for difference between residential and nursing homes 
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66% of respondents had evidence of BPSD as defined by at least one positive domain 
within the NPI. NPI results were further analysed for prevalence of any behavioural 
symptoms by domain.  To further evaluate the relative severity and frequency of 
symptoms in each domain, the prevalence of severe behavioural symptoms  W defined 
as the proportion of patients with symptoms of moderate to high severity  W and 
frequent behavioural symptoms  W defined as the proportion of patients with 
symptoms once weekly or more often  W was calculated. These results are presented 
in Table 37 in descending order of prevalence.  For any given domain, frequent 
symptoms were more prevalent than severe ones.  Agitation, nervousness and 
irritability were the three most common symptoms, with severe irritability and 
agitation manifesting in over a third and severe nervousness in over a quarter.  There 
was no significant difference between baseline and follow-ƵƉƵƐŝŶŐDĐEĞŵĂƌ ?ƐƚĞƐƚ
after corrections were made for multiple testing. 
Table 37 - Prevalence of NPI domains - any symptoms, severe symptoms and frequent 
symptoms at baseline and follow-up 
 Number (%) of respondents 
Any Behavioural 
Symptoms 
Severe Behavioural 
Symptoms 
Frequent Behavioural 
Symptoms 
Baseline Follow-up Baseline Follow-up Baseline Follow-up 
Agitation 86 (37.9) 85 (37.4) 38 (16.7) 33 (17.4) 58 (25.6) 55 (24.2) 
Nervousness 76 (33.5) 77 (33.9) 25 (11) 26 (13.7) 57 (27.1) 48 (21.1) 
Irritability 69 (30.4) 71 (31.3) 35 (15.4) 20 (10.5) 48 (21.1) 41 (18.1) 
Depression 52 (22.9) 64 (28.2) 19 (8.4) 23 (12.1) 39 (17.2) 35 (15.4) 
Difficulty 
sleeping 
46 (20.3) 34 (15.0) 12 (5.3) 12 (6.3) 32 (14.1) 25 (11.0) 
Appetite 
disturbance 
39 (17.2) 37 (16.3) 26 (11.5) 19 (10) 34 (15.0) 28 (12.3) 
Motor 
behaviour 
38 (16.7) 36 (15.9) 25 (11) 20 (10.5) 30 (13.2) 28 (12.3) 
Apathy 31 (13.7) 38 (16.7) 17 (7.5) 25 (13.2) 25 (11) 31 (13.7) 
Disinhibition 30 (13.2) 23 (10.1) 23 (10.1) 11 (5.8) 21 (9.3) 15 (6.6) 
Delusions 20 (8.8) 28 (12.3) 13 (5.7) 13 (6.8) 16 (17) 22 (9.7) 
Hallucinations 18 (7.9) 16 (7) 8 (3.5) 9 (4.7) 13 (5.7) 12 (5.3) 
Elation 6 (2.6) 17 (7.5) 4 (1.8) 10 (5.3) 4 (1.8) 8 (3.5) 
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3.6.4. Differences in baseline measurements by care home 
The practice of individual care homes might either select for particular types of 
patient within a home W for example by selecting patients with advanced dementia  W 
or might modify the health and social status of the cohort over time (for example by 
particular practices which influence the incidence or prevalence of frailty). To explore 
this, the differences between baseline variables for individual care homes were 
explored using ANOVA.  Those where statistically significant variability was 
demonstrated are summarised in Table 38.  Significant variability between individual 
homes persisted for the same variables when nursing homes and residential homes 
were analysed separately. 
Table 38  ? Baseline variables analysed by individual care home IDs 
 p for difference between individual care 
home IDs 
Mean Age  <.01 
Barthel Index  <.01 
MMSE  <.01 
MNA score  <.01 
Grip strength  <.01 
No of diagnoses  <.01 
No of medications  <.01 
NPI  <.01 
Tested using one-way ANOVA; Tested using Kruskal-Wallis non-parametric ANOVA; 
The differences between individual care homes for these variables where significant 
inter-home variability was identified are shown in box plots in Figure 9.   
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Figure 9  ? Box plots for baseline variables which have significant variability by care 
ŚŽŵĞ/ ?ǁŝƚŚŽƵƚůŝĞƌƐŵĂƌŬĞĚďǇ ?ĂŶĚĞǆƚƌĞŵĞŽƵƚůŝĞƌƐďǇ 踀 - numbers denote 
ŽƵƚůŝĞƌƐ ?ƐƚƵĚǇ/ 
Chapter 3  W The Care Home Outcome Study (CHOS) 
116 
 
The ICCs and their standard errors (SE) for baseline measures are summarised in 
Table 39.  The negative value for the Charlson index, although improbable, was 
checked on multiple occasions and using different statistical packages.  It suggests 
that no clustering by care homes was evident for the Charlson and that residents 
were as alike between homes as they were within them. ŶĞǆƉůĂŶĂƚŝŽŶŽĨŚŽǁ/ ?Ɛ
express clustering is given in section 3.7.7. of the discussion.  These ICCs and those in 
table 50 were the main reason that no regression analysis was undertaken to explore 
connections between baseline and outcome variables, since such analysis would have 
required to take account of clustering and the study was inadequately powered to do 
so. 
Table 39 - Intraclass Correlation Co-efficients (ICC) and Standard Errors (SE) for baseline 
measures, listed in order of descending magnitude of correlation 
 
ICC SE 
NPI .343 .11 
BI .288 .01 
MNA score .222 .09 
MMSE .216 .09 
No of medications .167 .08 
No of diagnoses .159 .07 
Grip strength .136 .07 
Age .086 .05 
BMI .035 .04 
Days since admission .018 .03 
Charlson Score -.028 .01 
The number of GPs per care home is summarised in Figure 10.  Three homes had 1:1 
relationships with GPs (IDs 3, 5 and 7).  All of these were rural homes, with the 
consequence that the number of GPs within acceptable distance of the home able to 
provide cover was limited, however all three also had policies which encouraged 
residents to select a preferred local practice over other alternatives. 
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Figure 10 - Number of General Practitioners per care home 
3.6.5. Nutritional Status 
BMI and MNA results by category are shown in Table 40 and Table 41.  Data for BMI 
were less complete than for MNA as a consequence of the missing weight data.  Of 
those with weights recorded, just over a quarter of residents were underweight on 
the basis of BMI, compared with 30% of residents who were malnourished and a 
further 56% at risk of malnutrition on the basis of MNA scores.   
Table 40 - BMI results by category 
BMI categories N(%) 
Underweight 42 (28) 
Normal Weight 50 (34) 
Overweight 35 (23) 
Obese 14 (9) 
Morbidly obese 8 (5) 
 
Table 41 - MNA results by category 
MNA categories N(%) 
Normal nutritional status 29 (14) 
At nutritional risk 113 (56) 
Malnourished 61 (30) 
 
Patients were more likely to be underweight as the severity of their malnutrition 
assessed using the MNA increased. However, 40% of the patients identified by the 
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MNA as malnourished and 82% identified as at risk were of normal weight or above.  
MNA categories are cross-tabulated with data on weight loss in Table 42.  This allows 
separation of those who would require immediate dietetics intervention (highlighted 
in red) on the basis of the MNA algorithm, from those for whom only observation 
(amber) and no action (green) would be required.  Thus using the MNA, 77 residents 
would be referred for dietetic input, as opposed to 38 residents if a referral criterion 
of being underweight according to BMI were adopted. 
Table 42  ? Cross-tabulation of MNA categories with recent evidence of weight loss 
 
MNA categories 
Total Malnourished 
At risk of 
malnutrition 
Normal 
nutritional 
status 
Weight lost No weight loss 23 97 28 148 
Weight loss 38 16 1 55 
Total 61 113 29 203 
 
3.6.6. Diagnoses at baseline 
The top 20 most common diagnoses recorded at baseline are listed in Table 43.  
Circulatory diseases predominated and hypertension was the most prevalent 
diagnosis within this category.  Musculoskeletal diseases were also common due to 
the high prevalence of osteoarthritis and osteoporosis.  The high prevalence of 
mental and behavioural disorders was explained almost entirely by dementia, with 
the third most common diagnosis in this category, depression, recorded in only 33 
participants. 
Chapter 3  W The Care Home Outcome Study (CHOS) 
119 
 
Table 43 - Top 20 most common diagnoses by ICD-10 category 
Diagnoses (n) ICD-10 Code ICD-10 Category 
102 I10 Essential (primary) hypertension 
83 M15.0 Primary generalized (osteo)arthrosis 
77 F03 Unspecified Dementia 
45 M80 Osteoporosis with pathological fracture 
38 I64 Stroke, not specified as haemorrhage or infarction, Tabular 
list and Index 
35 G30 Alzheimer's disease 
35 N18 Chronic renal failure 
34 E11 Non-insulin-dependent diabetes mellitus 
33 F33 Recurrent depressive disorder 
33 I67.9 Cerebrovascular disease, unspecified 
31 I48 Atrial fibrillation and flutter 
30 I25 Chronic ischaemic heart disease 
29 F01 Vascular dementia 
26 H90 Conductive and sensorineural hearing loss 
23 H25 Senile cataract 
22 D50 Iron deficiency anaemia 
22 G40 Epilepsy 
21 G81 Hemiplegia 
21 H35.3 Degeneration of macula and posterior pole 
19 E78.0 Pure hypercholesterolaemia 
3.6.7. Prescribing 
1795 prescriptions were recorded.  The top ten most commonly prescribed 
categories summarized in Table 44. 
When considered against STOPP-START criteria, there were 320 STOPP and 252 
START indications.  The mean number of STOPPs per resident was 1.41 (range 0-8; SD 
1.53) with the most common indications being duplicate prescription, opioids in 
dementia, proton pump inhibitors at high dose and aspirin without an indication (60, 
37 and 35 STOPPs respectively  W see Table 45).  The mean number of STARTs per 
resident was 1.11 (range 0-6; SD 1.20) with the most common being 
antihypertensives, beta-blockers for angina and calcium/vitamin D for osteoporosis 
(41, 28 and 28 STARTs respectively  W see Table 46). 
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Table 44  ? Top ten categories of medication by BNF chapter 
Prescriptions (n) Drugs by BNF chapter 
Prescriptions 
(n) Drugs by BNF chapter 
196 1.6 Laxatives 93 4.3 Antidepressant drugs 
111 Stimulant laxatives 53 
Selective serotonin reuptake 
inhibitors 
75 Osmotic laxatives 35 Tricyclic antidepressants 
6 Bisacodyl 5 Mirtazapine 
4 Bulking agents 91 
1.3 Antisecretory drugs and 
mucosal protectants 
2 Co-danthromer 85 Proton pump inhibitors 
2 Stool softeners 6 H2-antagonists 
1 Phosphate enema 75 2.2 Diuretics 
182 4.7 Analgesics 46 Loop diuretics 
127 Paracetamol 16 Thiazide diuretics 
25 
Compound paracetamol/ 
opioid preparations  7 Co amilofruse 
15 Weak opioids 6 Aldosterone antagonists 
7 Tramadol 70 
13.2 Emollient and barrier 
preparations 
3 Oral morphine 59 2.12 Lipid-regulating drugs 
2 Gabapentin 58 Statins 
1 Fentanyl patches 1 Ezetimibe 
1 Meptazinol 46 
2.5 Hypertension and heart 
failure 
1 Sumatriptan 36 
Angiotensin converting 
enzyme-inhibitors 
121 2.9 Antiplatelet drugs 6 
Angiotensin receptor 
blockers 
108 Aspirin 3 Doxazosin 
10 Dipyridamole 1 Co-ĂƉƉƌŽǀĞů ? 
3 Clopidogrel   
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Table 45 - Top 20 STOPP indications for cohort 
STOP
P 
Code Indication for drug cessation N 
J 
Any regular duplicate drug class prescription e.g. two concurrent opiates, 
E^/ ?Ɛ ?^^Z/ ?Ɛ ?ĚŝƵƌĞƚŝĐƐ 60 
I3 
Long-term opiates in those with dementia unless indicted for palliative care or 
management moderate-severe chronic pain 37 
C4 PPI for peptic ulcer disease at full therapeutic dosage for > 8 weeks 35 
A13 
Aspirin with no history of coronary, cerebral or peripheral arterial symptoms or 
occlusive arterial event 29 
A2 
Loop diuretic for dependent ankle oedema only i.e. no clinical signs of heart 
failure 24 
B8 Long-term (i.e. > 1 month) neuroleptics as long-term hypnotics 16 
B1 Tricyclic antidepressants (T ?Ɛ ?ǁŝƚŚĚĞŵĞŶƚŝĂ 14 
A3 Loop diuretic as first-line monotherapy for hypertension 12 
A8 Calcium channel blockers with chronic constipation 12 
B5 d ?ƐǁŝƚŚĂŶŽƉŝĂƚĞŽƌĐĂůĐŝƵŵĐŚĂŶŶĞůďůŽĐŬĞƌ 9 
E4 Long-term use of NSAID (>3 months) for relief of mild joint pain in osteoarthritis 9 
B4 d ?ƐǁŝƚŚĐŽŶƐƚŝƉĂƚŝŽŶ 7 
C1 
Diphenoxylate, loperamide or codeine phosphate for treatment of diarrhoea of 
unknown cause 7 
B7 Long-term (i.e. > 1 month) long-acting benzodiazepines  6 
F1 Bladder antimuscarinic drugs with dementia 5 
H4 
Vasodilator drugs known to cause hypotension in those with persistent postural 
hypotension 5 
D2 
Systemic corticosteroids instead of inhaled corticosteroids for maintenance 
therapy in moderate-severe COPD 4 
G2 
Beta-blockers in those with diabetes mellitus and frequent hypoglycaemic 
episodes 4 
A1 Digoxin at a long-ƚĞƌŵĚŽƐĞAN ? ? ?ʅŐ ?ĚĂǇǁŝƚŚŝŵƉĂŝƌĞĚƌĞŶĂůĨƵŶĐƚŝŽŶ 2 
B11 Anticholinergics to treat extra-pyramidal side-effects of neuroleptic medications 2 
E3 NSAID with heart failure 2 
F3 Bladder antimuscarinic drugs with chronic constipation 2 
I2 
Regular opiates for more than 2 weeks in those with chronic constipation 
without concurrent use of laxatives 2 
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Table 46 - START indications identified in cohort 
STAR
T 
Code Indication for drug commencement N 
A4 
Antihypertensive therapy where systolic blood pressure consistently >160 
mmHg. 41 
A8 Beta-blocker with chronic stable angina. 28 
E3 Calcium and Vitamin D supplement in patients with known osteoporosis 28 
A3 
Aspirin or clopidogrel with a documented history of atherosclerotic coronary, 
cerebral or peripheral vascular 27 
A1 Warfarin in the presence of chronic atrial fibrillation. 23 
F4 
Statin therapy in diabetes mellitus if one or more co-existing major 
cardiovascular risk factor present 17 
B1 
Regular inhaled beta 2 agonist or anticholinergic agent for mild to moderate 
asthma or COPD. 16 
A6 Angiotensin Converting Enzyme (ACE) inhibitor with chronic heart failure. 14 
F3 
Antiplatelet therapy in diabetes mellitus if one or more co-existing major 
cardiovascular risk factor present 14 
F1 
Metformin with type 2 diabetes +/- metabolic syndrome (in the absence of renal 
failure) 13 
A7 ACE inhibitor following acute myocardial infarction. 7 
D2 
Fibre supplement for chronic, symptomatic diverticular disease with 
constipation 7 
E1 
Disease-modifying anti-rheumatic drug (DMARD) with active moderate-severe 
rheumatoid disease lasting > 12 weeks 6 
F2 ACE inhibitor or Angiotensin Receptor Blocker in diabetes with nephropathy 5 
E2 Bisphosphonates in patients taking maintenance oral corticosteroid therapy. 4 
C1 
L-KWŝŶŝĚŝŽƉĂƚŚŝĐWĂƌŬŝŶƐŽŶ ?ƐĚŝƐĞĂƐĞǁŝƚŚĚĞĨŝŶŝƚĞĨƵŶĐƚŝŽŶĂůŝŵƉĂŝƌŵĞŶƚ
and resultant disability 2 
3.6.8. Death  
Of the 37 participants who died during the follow-up period, 16 deaths occurred in 
residential and 21 in nursing homes. This difference was not statistically different.  
However, death rates varied significantly between individual homes, ranging from 0-
32% of respondents (p<0.05; Chi-squared).  These results are illustrated in Figure 11.   
A Kaplan-Meier plot curtailed to the planned follow-up of 180 days, by censoring 
results from those completing follow-up after this time, is shown in Figure 12.  This 
shows early and persistent separation of the curves for residential and nursing 
homes.  The decision was made to curtail the curve because this removes the 
misleading apparent sharp drop-off in survival caused by the censoring of data from 
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patients who had completed follow-up by the time the last outlier had their data 
collected at 292 days. 
 
Figure 11 - Death rate by care home 
 
Figure 12 - Kaplan-Meier Curve curtailed to 180 days to remove effect of outliers with 
longer than anticipated duration of follow-up 
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Detailed regression analysis was not undertaken because of the statistical limitations 
imposed by the small number of deaths.   
3.6.9. Acute NHS resource use 
52 admissions were recorded from 42 participants, with 1-3 admissions per admitted 
resident.  The cohort accumulated a total of 601 NHS inpatient bed days, with a 
median (IQR) length of stay of 7 (2-12) days amongst those admitted.  1010 
investigations were requested for 150 residents, with a range of 1-54 and a median 
(IQR) of 3 (1-6) investigations amongst those with tests requested  W some of these 
tests were requested as inpatient and some as outpatient investigations. 68 residents 
attended 142 outpatient appointments, with a range of 1-6 and a median (IQR) of 2 
(1.5-2.5) appointments per resident attending. There were 30 emergency 
department admissions recorded from 27 residents, with a maximum number of 
attendances per admission of 2 per resident. 
Statistically significant differences were identified between the number of 
investigations and outpatient attendances for participants from residential and 
nursing homes (p<0.05; Mann-Whitney U), with higher resource use recorded by 
participants from residential homes in both instances. 
Episode statistics rates were calculated for each home by using the following 
formula: 
Episode rate per resident per year = (Total number of episodes for home/number of 
residents enrolled in study) x (365/mean length of follow-up for residents enrolled in 
study) 
This provided a number of episodes/resident/year for each home.  These statistics do 
not include those residents living in the homes who were unable to be enrolled in the 
study.  They are presented in Table 47.  These demonstrate wide variation between 
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homes for number of days as inpatient and number of investigations conducted, with 
less significant variation for number of admissions and A+E contacts.  Home 4 was an 
obvious outlier.  This home was within the catchment area of a district general allied 
to the main teaching hospital which acted as the focus for the rest of the data 
collection  W possibly reflecting differing admission policies in that hospital 
Table 47 - NHS resource use expressed as episodes/resident/year by care home ID 
Care 
Home 
ID 
Admissions 
per resident 
per year 
Days as IP 
per 
resident 
per year 
Number of 
investigations per 
resident per year 
Number of 
OP 
contacts 
per 
resident 
per year 
Number of A+E 
attendances per 
resident per 
year 
1 0.75 7.03 12.67 1.38 0.43 
2 0.8 20.75 21.62 2.04 0.51 
3 0.08 0.34 0.51 1.02 0 
4 0.82 6.99 12.42 2.83 0.22 
5 0.15 0.15 5.21 2.45 0.15 
6 0.63 3.4 5.99 1.43 0.45 
7 0.11 1.26 4.81 0.46 0 
8 0.23 1.84 4.61 0.46 0.12 
9 0.52 6.22 19.87 0.86 0.17 
10 0.34 1.36 3.16 0 0.34 
11 0.9 4.89 12.24 0.77 0.64 
Mean 0.48  4.93  9.37   1.25 0.28  
 
3.6.10. BI, NPI, BI and NPI at outcome 
Data for the BI at baseline, follow-up and the change in BI between measurements 
are summarized in Table 48. There was a trend towards deterioration in BI for the 
cohort as a whole and a significant deterioration amongst nursing home residents, 
ǁŝƚŚƚŚĞĚŝĨĨĞƌĞŶĐĞďĞƚǁĞĞŶƌĞƐŝĚĞŶƚŝĂůĂŶĚŶƵƌƐŝŶŐŚŽŵĞŵĞĚŝĂŶ/ ?ƐƉĞƌƐŝƐƚŝŶŐƚŽ
follow-up. 
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Table 48  ? Barthel index at baseline and follow-up by care home type 
 N Median 
Baseline BI 
(IQR) 
Median 
Follow-up BI 
(IQR) 
Mean 
Change in 
BI (SD) 
p for difference over 
time (Wilcoxon 
Signed Ranks) 
Whole Cohort 22
7 
9 (3.5-14.5) 8 (2.5-13.5) -0.52 (5.22) 0.053 
Residential Homes 12
4 
11 (7-15) 10 (6.5-
13.5) 
-0.23 (6.10) 0.189 
Nursing Homes 10
3 
5 (1.5-8.5) 3 (0-7) -0.74 (4.46) <0.01 
p for difference 
between types of 
home 
 <0.01
ʏ
 <0.01
 ʏ
 0.510
 ʏʏ
  
ʏ
Mann Whitney U; 
ʏʏ
Student T-test 
Similar data is shown for NPI in Table 49, with a statistically significant increase in NPI 
 W indicating a worsening of BPSD across the cohort, both as a whole and for both 
categories of residential status.  The mean increase in NPI was greater in residential 
homes, however the nursing home cohort continued to have a higher median NPI at 
follow-up despite this.  The large standard deviations for NPI are explained by the 
fact that most residents demonstrated no change between baseline and follow-up, 
with a small proportion of residents experiencing improvement or deterioration (see 
Figure 13). 
Table 49 - NPI at baseline and follow-up by care home type 
 N Median 
Baseline NPI 
(IQR) 
Median 
Follow-up NPI 
(IQR) 
Mean Change 
in NPI (SD) 
p for difference over 
time (Wilcoxon Signed 
Ranks) 
Whole Cohort 22
7 
3 (0-10.5) 5 (0-13) 2.28 (16.28) <0.01 
Residential Homes 12
4 
2 (0-6.5) 4 (0-10) 3.85 (14.68) <0.01 
Nursing Homes 10
3 
6 (0-19.5) 8 (1.5-14.5) 0.22 (18.05) <0.01 
p for difference 
between types of 
home 
 <0.01
 ʏ
 0.01
 ʏ
 0.128
 ʏʏ
  
ʏ
Mann Whitney U; 
ʏʏ
Student T-test 
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Figure 13 - Change in NPI score between baseline and follow-up in the residential and 
nursing home populations 
3.4.11. Clustering of outcome measures 
Intraclass correlation co-efficients for scale outcome variables are shown in Table 50, 
with the negative ICC for BI indicating the absence of clustering for this variable. 
Table 50 - Intraclass correlation co-efficients, standard errors and design effect for scale 
outcome measures, listed in order of descending magnitude of correlation 
 
ICC SE 
NPI .245 .09 
BI .172 .08 
Number of investigations per home .111 .06 
NPI .079 .05 
Number of outpatient attendances .078 .05 
Number of days as inpatient .047 .04 
Number of admissions  .024 .03 
Number of emergency department attendances .020 .03 
BI -.013 .02 
3.7. Discussion 
The cohort was physically dependent, demonstrated prevalent behavioural and 
psychiatric symptoms, was at high risk of malnutrition, demonstrated multimorbidity 
defined by chronic conditions and was prescribed complex drug regimens. These 
findings suggest a need for physiotherapy, occupational therapy, specialist nursing, 
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old age psychiatry, dietetic and pharmacy input to the management of residents.  
Management of the type of chronic conditions seen could be within the competency 
of many GPs, but the high prevalence of multimorbidity and conditions routinely 
cared for by geriatricians raises the possibility that they might also play a role. The 
wide-variability in measurements seen both for individual participants and homes 
suggests that individualised assessment of residents could be useful in helping to 
target expertise to residents with corresponding needs - highlighting a possible role 
for CGA.   
3.7.1. Physical Dependency 
The cohort demonstrated a high prevalence of functional dependency as evidenced 
by the median BI scores of 9, 11 and 5 for all, residential and nursing home residents 
respectively at baseline, coupled to the significant decline in nursing home residents 
 W and trend towards decline in other groups  W at 6 months.  Table 36 demonstrates 
that, even in the residential sector, over three quarters of residents required help 
with bathing and dressing, around half with toileting and grooming and over a 
quarter with eating and walking indoors.  28% were incontinent of faeces and 43% of 
urine.  These figures were significantly worse in the nursing sector for all BI domains 
except stairs and bathing, where functional status was so universally poor as to defy 
separation by home type. 
Functional status as measured using BI has been shown to map to nursing 
dependencies512 513. Comparison can be drawn with the census conducted by 
Hubbard et al514 of 889 inpatients in Cardiff and Vale NHS Trust in 2003, where the 
median BI scores were 9 and 3 in rehabilitation and continuing care settings 
respectively.  In that cohort, the NHS continuing care patients  W with similar BI scores 
to the nursing home residents in CHOS  W received 20 mins 15 secs of physiotherapy, 
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44 mins 24 secs of occupational therapy and 1 hour 30 mins of dietetics input per 
patient per day.  The CHOS cohort did not receive such input. 
Aside from their implications for nursing, the BI dependencies illustrated in Table 36 
suggest possible targets for therapeutic intervention. At the very least, the high 
incidence of incontinence and immobility mean that specific services for continence, 
pressure care and input from physio- and occupational therapists for management 
and prevention of flexion contractures would be required.  The prevalent immobility 
might have been a consequence of a significant number of the cohort having failed to 
progress with rehabilitation prior to transfer to their care home, especially given the 
high prevalence of stroke, and might also have encompassed patients with moderate 
to advanced dementia who would be unlikely to engage with, or respond to, 
rehabilitation.  However, there might also have been a sub-cohort of residents who 
were legitimate targets for more aggressive multidisciplinary rehabilitation. Only a 
multidisciplinary team, encompassing physio- and occupational therapists, would be 
adequately placed to assess who could benefit from such intervention.   
3.7.2. Behavioural and psychiatric symptoms of dementia 
Given the high prevalence of cognitive impairment, an important consideration was 
the prevalence of BPSD, as illustrated in Table 37.  Two thirds of residents manifested 
BPSD.  The most common symptoms - agitation, nervousness and irritability  W were 
reported in around a third of residents, with the majority of these manifesting 
symptoms which were frequent but non-severe.  The prevalence of BPSD was 
significantly lower than that reported in several large European cohort studies 
(n=836 when pooled) of community dwelling dementia-sufferers, where up to 92.5% 
of participants with an MMSE of 11-20 had detectable BPSD515, or in studies of US 
Chapter 3  W The Care Home Outcome Study (CHOS) 
130 
 
and Norwegian nursing home residents with dementia, where the prevalence of 
BPSD was 75-79%516 517.    
The reason for the low prevalence in the CHOS cohort was not clear.  It was not that 
the cohort were over-medicated by comparison with other studies, Margallo-Lana et 
al reported prescribing rates of 58% for antipsychotics in their cohort of 231 US 
nursing home residents with dementia516, whilst only 12% of CHOS participants were 
receiving antipsychotics and 13% hypnotics. Based upon observations during data 
collection, physical restraint was not widely used in the CHOS cohort.   
Two of the homes in the sample specialised in the management of patients with 
behavioural disorders and, anecdotally, researchers on the project witnessed 
occasional examples of profound behavioural disturbance  W with a participant 
throwing furniture in the direction of a researcher on one occasion.  The variability 
seen between care homes for NPI-totals (Table 39) and the wide range of NPI scores 
(Table 35) suggest that there were both homes and individuals where NPI was 
significantly higher than the median.   
There might have been reporting bias due to difficulty in establishing responses to 
the NPI from a composite of care home records and the responses of minimally 
qualified care staff.  Strikingly, the prevalence of apathy, one of the most common 
manifestations of late dementia in the other studies mentioned515-517, was relatively 
low in the CHOS cohort.  This could have been due to a failure to recognise apathy on 
the part of the staff respondents, or a desensitisation towards it. 
That BPSD was present suggests a need for psychogeriatric support to care homes.  
That it was non-severe and moderately frequent, suggests that the prevalent mode 
of intervention would be non-pharmacological, particularly given concerns about the 
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adverse effects of anti-psychotic medications in this cohort and national guidelines 
which stipulate a primarily non-pharmacological response to BPSD in all but the most 
extreme cases518.  Chapter 2 reported that the evidence-base for non-
pharmacological interventions in care homes was uncertain and, whilst interventions 
such as group-therapy, music-therapy, aromatherapy and snoozelin-based relaxation 
are suggested in national guidelines, there is an acknowledged need for such therapy 
to be instituted and monitored based around a process of comprehensive 
psychogeriatric assessment in partnership with a psychogeriatric multidisciplinary 
team. That is to say, specialist input would be required if such therapies were to be 
routinely instituted. 
3.7.3. Nutritional measures in the cohort 
As illustrated by Table 40 and Table 41, 86% of participants were malnourished or at 
risk of malnutrition, whilst 28% were underweight. Table 42 showed that 34% of 
ƉĂƌƚŝĐŝƉĂŶƚƐ ǁŽƵůĚ ŚĂǀĞ ƚƌŝŐŐĞƌĞĚ ĐƌŝƚĞƌŝĂ ĨŽƌ  “ĨƵƌƚŚĞƌ ŝŶ-depth nutritional 
ĂƐƐĞƐƐŵĞŶƚ ?ĂĐĐŽƌĚŝŶŐƚŽƚŚĞDEŵĂŶĂŐĞŵĞŶƚĂůŐŽƌŝƚŚŵ ?Figure 14). This suggests 
a need for regular dietetic input in the cohort  W further building the case for 
multidisciplinary input in the care home setting. 
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Figure 14 - The MNA management algorithm 
It was unsurprising, given the comprehensive nature of the MNA, that it detected 
higher rates of malnutrition than the BMI alone.  The MNA gets around the issue of 
missing weight data in part by allowing substitution of arm and/or leg circumference 
for BMI but still relies upon data on weight loss  W i.e. longitudinal weight records  W to 
build a full score. Most alternative nutritional screening tools  W such as the 
malnutrition universal screening tool (MUST), Nutritional Risk Screening 2002 (NRS-
2002), Malnutrition Screening Tool (MST) and Subjective Global Assessment (SGA)  W 
also rely upon weight, either requiring single snapshot or longitudinal weight data, or 
substituted anthropometric measurements519.   
Based upon the data recorded, weights were clearly difficult to measure in 
dependent care home residents, whilst anthropometric measurements are time 
consuming and require specific training520. It would clearly be preferable for care 
home staff to be able to identify malnutrition without using either. The Simplified 
Nutrition Appetite Questionnaire (SNAQ) is a four-point screening test, which focuses 
around four questions on appetite and intake (Box 4), rather than anthropometric 
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measurements, to establish nutritional risk521.  Rolland et al520 compared SNAQ to the 
MNA demonstrating a positive correlation between the two but found that SNAQ 
was relatively poorly predictive of malnutrition by comparison with the MNA, 
misclassifying 28% of the population even after optimizing its cut-off score using 
threshold analysis.  Most of these misclassifications had an abnormal SNAQ with a 
normal MNA, that is to say that SNAQ tended to over-diagnose malnutrition. Used as 
a screening test which might trigger more detailed assessment SNAQ might go some 
way to reducing the need to regularly weigh patients.  
1  My appetite is: 
A. very poor 
B. poor 
C. average 
D. good 
E. very good 
  
2  When I eat: 
A. I feel full after eating only a few mouthfuls 
B. I feel full after eating about a third of a meal 
C. I feel full after eating over half of meal 
D. I feel full after eating most of the meal 
E. I hardly ever feel full 
  
3
  
Food tastes: 
A. Very bad 
B. Bad 
C. Average 
D. Good 
E. Very good 
  
4
  
Normally I eat: 
A. Less than one meal a day 
B. One meal a day 
C. Two meals a day 
D. Three meals a day 
E. More than 3 meals a day 
 
Box 4  ? The Simplified Nutrition Appetite Questionnaire (SNAQ) 
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3.7.4. Diagnoses 
The diagnoses most prevalent in the cohort (Table 43) were chronic diseases. With a 
few exceptions, such as stroke, ischaemic heart disease and diabetes, these were not 
diagnoses where hospital physicians particularly hold competencies or specific 
training. A comparison between Table 43 and the 20 common presentations which 
comprised the focus of symptom-based competencies in the 2010 curriculum for UK 
core medical training (Box 5) 522, demonstrates little overlap.   
Abdominal pain 
Acute back pain 
Blackout/collapse 
Breathlessness 
Chest pain 
Confusion, acute/Delirium 
Cough 
Diarrhoea 
Falls 
Fever 
Fits/seizure 
Haematemesis and melaena 
Headache 
Jaundice 
Limb pain and swelling  
Palpitations 
Poisoning 
Rash 
Vomiting and nausea 
Weakness and paralysis 
Box 5 - Top 20 common presentations used as the basis of UK basic medical training 
522
 
The types of chronic conditions which were seen in the cohort sit much more 
comfortably within the remit of general practitioners. Chronic disease management 
is, of course, also central to geriatric medicine and the UK curriculum for specialty 
trainees in geriatrics523 contains a curriculum grid on diagnosis and management of 
chronic disease and disability which maps closely to the diagnoses seen in the CHOS 
cohort (Box 6). 
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Ischaemic heart disease, heart failure, atrial fibrillation, hypertension 
Chronic lung disease including cancer 
Chronic liver disease, malnutrition, chronic bowel disorders including constipation 
and incontinence 
Chronic kidney disease, prostate disease, incontinence 
Sensory impairment, movement disorders, stroke 
Arthritis, polymyalgia rheumatica, osteoporosis 
Falls, dizziness, syncope 
Dementia, depression, anxiety 
Diabetes, thyroid disease 
Skin ulceration and chronic oedema 
Anaemia 
Weight loss, including sarcopenia 
Incurable cancer 
Box 6 - Curriculum grid no. 29 from the UK specialty training curriculum for geriatric 
medicine
523
 
The data therefore suggest a possible role for both geriatricians and GPs in caring for 
care home residents. It is not clear, however, whether both are required, or whether 
GPs could manage the medical problems of the cohort without specialist geriatrician 
input.  One aspect of the cohort that might suggest a role for geriatricians was the 
high prevalence of multimorbidity. The mean number of diagnoses per resident was 
6.2, considerably higher than the prevalence of multimorbidity seen in the 
community when Kadam and Croft conducted a cohort study of 9439 over-50 year 
olds across 3 UK general practices. They reported 23% of participants to have 6 or 
more morbidities (regarded as high multimorbidity for the purposes of that study)524. 
When compared with results from a representative national sample of all over-65s 
reported in the 2005 National Health Survey of England (Table 51), CHOS participants 
showed a higher prevalence of  sƚƌŽŬĞ ?ĚĞŵĞŶƚŝĂ ?ƉƐǇĐŚŝĂƚƌŝĐĚŝĂŐŶŽƐĞƐ ?WĂƌŬŝŶƐŽŶ ?Ɛ
disease and osteoporosis. Multimorbidity has been suggested as challenge in the 
management in frail older patients because aggregated pathologies in frail older 
patients present a challenge to medical decision-making as traditionally taught to 
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doctors525. It has also been identified as an area where geriatricians have particular 
expertise and skills to offer526.  
Table 51 - Comparison of prevalence of common diagnoses in CHOS and as reported in the 
National Health Survey, 2005 
Condition National Health Survey, 2005 CHOS 
Ƃ ƃ Ƃ ƃ 
Hypertension 62% 64% 46% 11% 
IHD 16% 23% 23% 21% 
Stroke 7% 9% 32% 31% 
Diabetes 10% 13% 15% 19% 
Arthritis 47% 32% 41% 27% 
Osteoporosis 12% 2% 35% 15% 
Dementia   66% 54% 
Emotional, nervous 
or psychiatric 
problems (excluding 
dementia) 
7% 4% 21% 17% 
WĂƌŬŝŶƐŽŶ ?ƐĚŝƐĞĂƐĞ 1% 1% 6% 6% 
A further piece of evidence supporting a possible role for geriatricians comes from 
the discrepancy between proportion of the cohort with a formal diagnosis of 
dementia (64%) and the proportion found to have an MMSE A? ? ? ? ? ?A? ?. This suggests 
that existing care providers  W including GPs  W have some difficulty with case-finding 
and diagnosis in dementia.  The diagnosis and management of dementia, although 
often led by GPs, is increasingly specialised.  The most recent NHS National Institute 
for Health and Clinical Excellence Guidelines on Dementia518 includes a 
recommendation for specialist involvement in psychological testing, the selection 
and interpretation of appropriate cerebral imaging and trial and maintenance of 
treatments, such that dementia management could not be conducted by a GP in 
isolation. The most appropriate support would come from an old age psychiatrist or 
geriatrician, supported by a multi-disciplinary team and leading a process of CGA. 
Although not specifically mandated by NICE, specialist support might also be required 
for the management of a number of other conditions listed in Table 43.  For some of 
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these, for example specialist orthogeriatric assessment and support for patients with 
osteoporosis, geriatricians could provide all required expertise.  For others, such as 
access to diagnostic endoscopy for patients with anaemia and referral of appropriate 
patients for cataract surgery, geriatricians might provide guidance on prognosis and 
outcome, in order to guide management plans and referral to appropriate single 
organ specialists. 
Clearly, the requirement for input by a geriatrician for any given care home resident 
would depend upon both the resident and their GP.  GPs present a varying degree of 
confidence in competence in managing both multimorbidity and the specialist 
problems of frail older patients  W evidence to this effect is presented in chapter 4.  
The transection of multimorbidity and the type of diagnoses seen are, however, such 
that geriatricians might have much to offer.    
3.7.5. Prescribing 
The median number of medications per resident recorded in this study was eight, 
which is broadly comparable with the Care Home Use of Medication Survey 
(CHUMS)13, which reviewed prescribing in 256 residents across 55 homes in 2006-7, 
revealing a mean number of prescriptions of 7.6 per person.  The STOPP-START 
analysis for CHOS suggested that there were indications for cessation or 
commencement of a drug  W i.e. possible prescribing errors  W in 68% of participants, 
again broadly comparable with the 70% prescription error rate seen in CHUMS.   
The most commonly prescribed medications were stimulant laxatives, followed by 
paracetamol and aspirin.  The former two medications are relatively innocuous and 
neither triggered high numbers of STOPP indications.  29 out of 108 (27%) patients 
prescribed aspirin triggered a STOPP, on the basis that there was no documented 
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rationale within the medical records for an anti-platelet agent.  Whether this 
represents a deficiency in documentation or in medication review is unclear.  The 
benefit of aspirin in patients without documented cardiovascular disease, or a high 
cardiovascular risk profile, is unclear and the risk of gastrointestinal bleeding is likely 
to outweigh any prognostic benefit527.  The possibility that up to a quarter of patients 
in the cohort might have been receiving it without a clear indication is therefore 
cause for concern. 
Proton pump inhibitors (PPIs) were prescribed in 85 patients, 37 (44%) of whom 
triggered a STOPP indication for persistent prescribing at the higher dose over the 
long term.  Although commonly seen as quite innocuous, PPIs are associated with 
small but significant increases in the incidence of diarrhoea, nausea and vomiting, 
abdominal pain and headache, with these effects most marked in the elderly528.  They 
are an important cause of drug-drug interactions529 and the British National 
Formulary was modified in 2011 to recommend that they be prescribed for as short a 
duration as possible, at the lowest effective dose509. 
The rate of neuroleptic (antipsychotic) prescribing in care homes has previously been 
reported to be in the region of 24-28%15 and up to 58% in one US study where those 
suffering dementia were considered in isolation516.  In this cohort, there were only 27 
prescriptions for anti-psychotics (12% of patients).  However, as previously discussed, 
despite the high prevalence of moderate-severe dementia, the mean NPI was very 
low and this may go some way to explaining the low rate of prescriptions.  It is 
equally possible that controversies surrounding the prescribing of anti-psychotic 
medications as a form of chemical restraint in care homes, coupled to the previously 
discussed MHRA warnings, influenced the low prescribing rate.  Antidepressants 
were commonly prescribed and tricyclic antidepressants and mirtazepine  W both 
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suggested as possible alternatives to traditional antipsychotic medications for the 
management of BPSD530 531  W were prescribed in 35 (15%) and 5 (2%) of patients 
respectively. 
Given the high prevalence of dementia, with 42% of patients meeting NICE criteria 
for treatment with acetylcholinesterase inhibitors and 39% for treatment with 
memantine532, it was surprising to see drugs for dementia prescribed in only 15 (7%) 
of cases.  These drugs might have been trialled and subsequently discontinued in the 
majority, however it is more likely that their omission represented a failure of 
practice to keep up with national guidelines. 
Another area in which practice seems to have lagged behind evidence and 
consensus-based practice was the treatment of hypertension.  The HYpertension in 
the Very Elderly Trial (HYVET), published in 2008, was a landmark study and 
demonstrating significant morbidity and mortality gains in older patients treated for 
hypertension533.  Recommendations for the treatment of hypertension have been 
modified based upon these findings to stipulate more aggressive management of 
hypertension in older patients using calcium channel antagonists and thiazide 
diuretics as first line therapy534.  102 (45%) of patients were documented to have 
hypertension and yet only 46 (20%) were prescribed a calcium channel antagonist or 
related drug and only 16 (7%) a thiazide diuretic.  Some of this might have been 
explained by co-existent diagnoses of non-insulin dependent diabetes and congestive 
heart failure, present in 34 (15%) and 12 (5%) of patients, which would mandate use 
of angiotensin converting inhibitors, prescribed in 36 (16%) of residents, and/or loop 
diuretics, prescribed in 46 (20%) of cases.  It should be noted, however, that 24 
patients prescribed loop diuretics appeared to be taking this only for ankle oedema, 
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which triggered a STOPP indication, whilst 41 (18%) of patients triggered a START 
indication for untreated hypertension. 
These discussions serve to underline the complexity of prescribing in multimorbidity 
whilst adhering to current evidence and consensus-based medical guidelines. To 
deliver consistent high-quality prescribing in this context would mandate regular 
medication review, almost certainly in conjunction with an expert pharmacist  W which 
chapter 2 suggested was an evidence-based intervention  W and regular updates on 
best-evidenced prescribing for frail older patients. This builds the case for 
multidisciplinary involvement in care homes further. 
3.7.6. End-of-life care 
16% of the cohort died during the 6 month follow-up period, suggesting that around 
a third would die in one year, assuming a linear progression of the mortality plots 
(Figure 12).  The NHS National End-of->ŝĨĞĂƌĞWƌŽŐƌĂŵŵĞƵƐĞƐ ƚŚĞ ƚĞƌŵ  “ŶĚ-of-
>ŝĨĞĂƌĞ ?ƚŽŝŶĐůƵĚĞƚŚĞǇĞĂƌůĞĂĚŝŶŐƵƉƚŽĚĞĂƚŚĂŶĚƐƵŐŐĞƐƚƐƚŚĂƚƚŚŽƐĞƌĞƐŝĚĞŶƚƐ
approaching the end of their lives be engaged in a process of advanced care 
planning535.   
Given that up to a third of residents at any given point in time might be at the end of 
their lives, addressing end-of-life care issues would be expected to be central to 
much of the work undertaken in care homes.  Prognostication in frail older patients, 
particularly those with dementia, can be challenging and a tension between 
appropriate palliation and inappropriate nihilism has been identified536  W identifying 
which residents in whom to target end-of-life issues might prove difficult for GPs and 
care home staff. The Gold Standards Framework (GSF) has been recommended as a 
means by which to facilitate and trigger appropriate end-of-life care for care home 
residents537 and both GPs and care home staff have reported it to be useful tool in 
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framing end-of-life decisions538. However implementing and maintaining GSF in the 
care home setting requires specialist palliative care support539, indicating an ongoing 
role for a palliative care nurse specialist, at the very least.  
3.7.7. Variability between individuals and homes 
Taking the previous points in summation, data from the cohort suggest possible roles 
for physiotherapists, occupational therapists, specialist nurses, dieticians, old age 
psychiatrists, pharmacists, palliative care nurses, GPs and/or geriatricians in providing 
care. This describes most, if not all, the members of a CGA multidisciplinary team. It 
might be argued that, given the comprehensive evidence for CGA in caring for frail 
older patients in other settings, that it would be the most intuitive and logical way to 
bring these disciplines together around a common goal. Further evidence that co-
ordinated care would be best placed to meet the needs of the cohort, comes from 
the variability seen between individual participants and homes.  
Variability between individuals was broad, as indicated by the large IQRs for BI, 
MMSE and NPI seen in Table 35. Residents ranged from fully dependent to fully 
independent in basic ADLs, profoundly cognitively impaired to fully cognitively intact 
and behaviourally normal to throwing furniture at members of the research team. 
Variability between homes, shown in Table 39, was also significant and was 
demonstrated for functional dependency (BI), cognition (MMSE), nutritional status 
(MNA), grip strength, number of diagnoses, number of medications and behaviour 
(NPI). Where a positive ICC was reported it implies that the variability between 
homes was greater than that between individuals within homes  W indicating a cluster 
effect for all of these variables.  The ICC of 0.343 for NPI, for example, means that 
two residents within a home were 34.3% more likely to have identical scores than if 
they were chosen at random.   
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The variability between individuals and homes has ramifications at a clinical level, 
challenging systematised responses to delivery of healthcare in care homes.  “ŽŶĞ-
size-fits-Ăůů ? ĂƉƉƌŽĂĐŚ ƚŽ ĐĂƌĞ ŚŽŵĞ ŚĞĂůƚŚĐĂƌĞ ĐŽƵůĚ ŶŽƚ ƚĂŬĞ ĂĐĐŽƵŶƚ ŽĨ ƚŚĞ
significant variability seen in terms of dependency, behaviour, number of diagnoses 
and medications. In a home where behavioural problems were severe or frequent, 
for example, then the desired clinical team would incorporate input from specialists 
in old age psychiatry, whether community psychiatric nurses or old age psychiatrists. 
A setting where such behaviour was infrequent, meanwhile, might require such 
specialists rarely and their regular attendance would be both surplus to requirement 
and contrary to the goal of cost-effective care. One logical solution to this problem 
would be comprehensive, individualised assessment of residents to identify which of 
the array of specialised services already described as being potentially relevant might 
be required. This adds further weight to the case for CGA.    
3.7.8. Strengths and weaknesses of the study 
The study successfully addressed a number of the shortcomings identified in the 
existing literature base.  It recorded more detailed data on diagnoses, health status, 
prescribing and NHS resource use than Bebbington439, Netten440 and Bowman2 were 
able to. The use of NHS GP records as the definitive source of diagnosis addressed 
the issue of response bias identified in those accounts.  By providing up-to-date data, 
it overcame the issue of contemporaneity affecting the 1988 OPCS survey. 
The cohort recruited was, in most ways, representative of the broader UK care home 
population. The average age and proportion of female residents were similar to 
those reported elsewhere7. As illustrated in Table 30, the proportions of residents in 
nursing and residential homes and those with and without specialist dementia 
registration mapped closely to the percentages for care homes around 
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Nottinghamshire.  The number of GPs per care home, at 5±2.3 was not far from the 7 
(range 1-50) GPs per care home identified in a survey of 765 care homes in 2002540.  
Although the number of admissions per home was, at 0.5 per care home per month, 
considerably below the 2 admissions per home per month cited in the NHS data used 
for the sample size calculation, a subsequently conducted and more detailed piece of 
work from NHS Nottinghamshire County PCT541 suggested the average non-elective 
admission rate in care homes in the region to be around 600 per 1000 residents per 
year, which is not far off the 480 per 1000 residents per year recorded here. Thus it is 
more likely that the initial informally reported statistics used in the sample 
calculation were an overestimate of admission rates, than there being any systematic 
error in the cohort data. 
One possible explanation for the slightly lower than anticipated admission rate was 
the nature of recruitment, with homes selected from volunteers who knew at the 
point of recruitment that the study would focus around medical admissions.  Homes 
which were low admitters might have self-selected for the study on the basis that 
they regarded avoiding acute hospital admission to be an important marker of 
quality, or on the basis that they were proud of their record in this regard and had 
 “ŶŽƚŚŝŶŐƚŽŚŝĚĞ ? ?ŶĂůƚĞƌŶĂƚŝǀĞĞǆƉůĂŶĂƚŝŽŶǁŽƵůĚďĞƚŚĂƚƚŚŽƐĞƌĞƐŝĚĞŶƚƐŵŝƐƐĞĚ
from recruitment (n=96), were those most likely to be frequent attenders at hospital 
and, as a consequence, the number of admissions was undersampled despite a 
representative sample of homes.  One reason that this might be the case is the most 
common reason for non-recruitment  W 61 residents (64% of non-participants) lacked 
mental capacity without a consultee, or no response was received from their 
consultee  W which may have resulted in a failure to recruit the most vulnerable 
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residents, i.e those with advanced cognitive impairment and limited or no social 
support.   
The failure to recruit these residents was based upon the insistence of the NHS Local 
Research Ethics Committee (LREC) that residents without mental capacity who were 
unable to provide consent and who had no available consultee should not 
participate.  It was asserted that care home managers or staff should not be allowed 
to act as consultees for such participants on the basis of the clause in the Mental 
ĂƉĂĐŝƚǇĐƚǁŚŝĐŚƐƚĂƚĞƐƚŚĂƚĐŽŶƐƵůƚĞĞƐŵƵƐƚďĞƐŽŵĞŽŶĞǁŚŽ “otherwise than in a 
professional capacity or for remuneration, is engaged in caring for or is interested in 
ƚŚĞ ǁĞůĨĂƌĞ ? of the participant506.  The potential harm from involvement in a 
longitudinal cohort study is very limited indeed and arguably more was lost by 
excluding these residents than would have been the case had they been included  W a 
case might therefore be made for more flexible interpretation of the Act. Indeed, 
over the course of conducting the research, it became clear through contact with 
other care home researchers, that the Act had not been applied so rigidly by other 
LRECs.  
Even though the sample was broadly representative, the in-depth focus on a small 
group of residents represents a key shortcoming when compared with earlier work.  
By focussing on a small number of residents in a single geographical region the data 
are potentially less generalisable than those from the earlier studies, which were 
more superficial in their data collection but included more residents with coverage 
across multiple regions or, in the case of Bowman and OPCS, the nation as a whole.  
Given that such studies had already been conducted, however, the accurate and 
detailed statistics on dependency, cognition, nutrition, medical diagnoses, 
prescribing and sample variability, which contributed to an understanding of the role 
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of CGA, were arguably more relevant to the national debate than further broadly-
representative surveys. 
3.7.9. Lessons from data-collection Ȃ what the missing data tells 
us 
A brief digression from the case for CGA will be taken to consider some research 
lessons from CHOS  W particularly what can be learned from the missing data.  These 
inform the discussion on how CGA might be evaluated in the care home setting going 
forward, a topic which will be revisited in chapter 5. 
The fact that only one patient was lost to follow-up over the 6 month period speaks 
to a very stable, non-migrant population which, once recruited, is liable to remain in 
situ for follow-up.  Longitudinal methodologies are therefore appropriate in this 
setting. 
The poor performance of the question around pension credits suggests that care 
home residents are poor witnesses with regard to their own financial arrangements.  
Although non-response to this question was more likely amongst residents with low 
MMSE, the fact that many of those providing a response did so in very vague terms 
underlines that financial data needs to be collected, or at least verified, by other 
means.  To collect such data centrally, for example from pension or social care 
databases, would require ethical and information governance permission, with 
consequences for how research protocols, ethics and information governance 
submissions are drafted. 
The missing data for weight indicate the technical difficulty of gathering even simple 
baseline data in dependent older patients  W the significant difference in Barthel Index 
between those with and without weights recorded and the fact that no home 
established a complete dataset for weights suggests that, in many instances, non-
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completion was due to the physical difficulty of weighing the participant.  The 
significant variability in the completeness of weight recording between homes, 
ŵĞĂŶǁŚŝůĞ ? ƵŶĚĞƌůŝŶĞƐ ƚŚĞ ƉŽƚĞŶƚŝĂů ƉŝƚĨĂůů ŽĨ ĚĞƉĞŶĚŝŶŐ ŽŶ  “ƌŽƵƚŝŶĞůǇ ĐŽůůĞĐƚĞĚ ?
care home data in quantitative research methodology. 
The difficulty in using GHQ-12 in advanced cognitive impairment, although not widely 
discussed in the literature, has been identified before407. It is, however, writ large in 
this cohort, with the complex cognitive constructs presented by this measure proving 
particularly difficult for residents with advanced cognitive impairment and 
dependency.  Quite how to measure psychiatric morbidity in this setting is unclear.  
Dementia specific measures of psychological wellbeing in dementia, such as the 
Psychological Well-being in Cognitively Impaired Persons (PWB-CIP) battery, are 
usually validated in only mild-moderate disease despite being developed as 
dementia-specific measures542. Colleagues working on the Medical Crises in Older 
People-Trial of an Elderly Acute care Medical and mental health unit (MCOP-TEAM)543 
study got at the issue of psychological wellbeing through using a combination of 
dementia-specific health-related quality of life indices and dementia care mapping.  
However, as discussed below, both of these bring conceptual and practical difficulties 
of their own544 and, even in combination, they remain an imperfect response to the 
difficult issue of measuring quality of life in this cohort. 
Considering HRQoL, possibly the most troubling aspect of missing data  W given its 
primacy to health economic evaluation within the UK healthcare sector  W is the 
failure of the EQ-5D to perform adequately.  A quarter of respondents had 
incomplete datasets, with a significant association between cognitive and physical 
impairment and non-completion  W with the implication that HRQoL is impossible to 
measure using this tool for those with the greatest morbidity. The reason the anxiety 
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variable was so significantly affected is that this is the variable for which proxy 
respondents most frequently failed to respond.  The proportion of EQ-5D responses 
where proxies were used was not routinely recorded, which is a significant oversight 
in terms of study design. Anecdotally, however, the majority of residents relied on 
proxy response for at least one domain.  Considering the broader literature around 
this, the levels of agreement between patient and proxy responses for EQ-5D have 
been poor to moderate across multiple studies (Table 52), raising further questions 
about its usefulness as a HRQoL measure in this setting. These issues reflect the 
problems with proxy measures in care homes in general, as summarised in chapter 2.   
Table 52 - Agreement measured using kappa for proxy/patient recorded EQ-5D across 
multiple studies, as summarised by Selai et al
545
 
Authors; proxy 
types; condition 
Mobility Self-care Usual 
activities 
Pain/ 
Discomfort 
Anxiety/ 
Depression 
Coucill et al
546
; 
patient-carer; 
dementia 
Fair Fair Poor Fair Fair 
Selai et al
547
; 
patient-carer; 
dementia 
Fair Good Poor Good Moderate 
Pickard et al; 
patient-informal 
caregiver; 6 
months post-
stroke 
Moderate Moderate Moderate Moderate Fair 
Pickard et al; 
patient-informal 
caregiver; 6 
months post-
stroke: 
depression 
symptom +/- 
Fair/Fair Moderate/Poor Good/Poor Moderate/Poor Fair/Poor 
Dorman et al
548
; 
patient-informal 
caregiver; stroke 
Moderate Good Moderate Moderate Fair 
 
A number of dementia specific HRQoL indices have been developed, of which the 
DemQOL tool is the most comprehensively validated.  DemQOL includes a proxy 
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version which has shown good acceptability and internal consistency and moderate 
evidence of validity in people with severe dementia549.  It has not, however, been 
evaluated in long-term care settings and, as such, it is unclear whether the issues of 
unreliable proxies in care homes, which confound the EQ-5D, also confound 
DemQOL.  Further research is required. 
Pending this, the question remains as to how, if at all, quality of life can be measured 
in this setting. One legitimate response to the difficulty of measuring quality of life, 
might be to measure quality of care, either using qualitative indices such as Dementia 
Care Mapping550, or more straightforward quantitative check-lists of healthcare 
quality, such as the International Prevalence Measurement of Care Problems551.  The 
former focuses on detailed lŽŶŐŝƚƵĚŝŶĂů ŵĞĂƐƵƌĞŵĞŶƚƐ ŽĨ ƐƵďũĞĐƚƐ ? ďĞŚĂǀŝŽƵƌ ǁŝƚŚ
interpretations of their behaviour as either positive or negative to establish a well or 
ill-being value (WIB) and to identify care interventions which have either a negative 
(personal detractors) or positive (positive events) effect. The criticism of this model is 
that, although it is a considered and highly developed attempt to see the world from 
ƚŚĞƌĞƐŝĚĞŶƚ ?ƐƉĞƌƐƉĞĐƚŝǀĞ ?ŝƚƌĞŵĂŝŶƐůĂƌŐĞůǇƐƵďũĞĐƚŝǀĞĂŶĚƚŚĞƌĞĨŽƌĞƐƵďũĞĐƚƚŽƚŚĞ
vagaries of any proxy measure.  The latter meanwhile collects detailed quality 
measures around pressure ulcers, incontinence, malnutrition, falls, physical restraints 
and intertrigo and as such can be criticised in taking a healthcare-centric world-view 
which is quite divorced from the conceptual framework underpinning HRQoL 
measures.  A pragmatic response is that either is better than nothing and potentially 
more defensible than a non-validated, proxy-dependent HRQoL measure.  A third 
legitimate response might be to consider serum, or salivary biomarkers of stress as 
more reliable measure of the experience as lived by the patient, as opposed to 
perceived by the carer.  Collection of salivary specimens appears to be feasible in 
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patients with dementia  W however, salivary cortisol maps closely to behavioural 
disturbance in dementia552, so whether the procedure conveys much advantage over 
straightforward dementia care mapping is unclear. 
Whatever the solution, or compromise position adopted, it is clear that there is much 
to be done to establish an effective conceptual framework and practical response to 
measuring HRQoL in this setting.  
3.8. Conclusions 
The cohort studied was representative of the broader care home population in terms 
of demographics, distribution of residents by care home type and arrangements for 
primary care support. It was a slightly low admitting cohort, either as a consequence 
of the voluntary nature of initial recruitment, or as a consequence of the failure to 
recruit participants without capacity and an available consultee. 
The study added to the existing literature by collecting data on functional 
dependency, cognition, behaviour, nutrition, diagnoses and medications at a level of 
detail not previously recorded.  It addressed some of the issues around response bias 
in earlier studies both by collecting data directly from residents and using a 
combination of care home and healthcare records to maximise accuracy. It provided 
contemporaneous data, addressing the major shortcoming of the OPCS dataset. 
The cohort was dependent, with a distribution of dependency which would suggest a 
role for input from specialist nurses, physio- and occupational therapists.  There was 
a high prevalence of cognitive impairment and BPSD was relatively frequent, 
suggesting a role for psychogeriatricians and specialist mental health nurses. 
Malnutrition was evident and MNA scores suggested that a significant proportion of 
participants required dietetic input. Diagnoses were dominated by chronic conditions 
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 W the preserve of GPs, geriatricians or both. Whilst geriatricians might not be 
absolutely essential in providing healthcare to care homes based upon these data, 
the high levels of multimorbidity seen and the types of diagnosis which were 
prevalent, including dementia, stroke, continence, arthritis and osteoporosis, 
suggested that they would have much to offer. Many residents were close to the end 
of their life, suggesting that GPs and care home staff should have specialist training in 
end-of-life care and a role for palliative care nurses in facilitating and maintaining 
this. 
Indications for involvement by all members of the CGA MDT were therefore present. 
Co-ordinating their efforts through CGA would seem logical  W given the evidence-
base for CGA from other settings. Further weight to the case for CGA came from the 
wide variability seen for almost all measures both between individual participants 
ĂŶĚŝŶĚŝǀŝĚƵĂůŚŽŵĞƐ ?  “ŽŶĞ-size-fits-Ăůů ?ĂƉƉƌŽĂĐŚǁŽƵůĚŶŽƚĞĨĨŝĐŝĞŶƚůǇŵĞĞƚƚŚĞ
needs of either individuals or homes. Detailed, individualised assessment to identify 
which members of the MDT were required in each case  W i.e. CGA  W would seem 
logical in this context. 
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Chapter 4 Ȃ Staff Interviews in Care Homes (STICH) 
4.1. Introduction 
The literature review in Chapter 2 demonstrated that there was a body of evidence 
which could be used by healthcare professionals to drive gold-standard care for care 
homes, either by providing care home-specific evidence where available, or by 
allowing careful extrapolation of research-based recommendations from other 
settings  W with awareness of caveats  W where it was not. 
The cohort study presented in Chapter 3 found that care home residents 
demonstrated a complex mix of functional impairment, cognitive impairment, 
malnutrition, multimorbidity and polypharmacy and had health status driven 
predominantly by chronic conditions.  On the basis of these findings it was clear that 
models of care for residents needed to be comprehensive and multidisciplinary, 
bringing together expertise in chronic disease management with specialist 
knowledge in the management of specific conditions including dementia, stroke, 
continence, arthritis and osteoporosis.  Variability between individual residents and 
individual homes was such that detailed assessment would be required to ensure 
optimal delivery of care. CGA  W and the multidisciplinary teams who characteristically 
deliver it  W would be well placed to meet these needs.   
Having reached this conclusion, it became necessary to consider the detail of 
healthcare as currently delivered to care home residents.  Given the flexible nature of 
the GMS contract and the recent focus on providing innovative models of healthcare 
to care home residents  W through, for example, NHS Quality, Innovation, Productivity 
and Prevention (QIPP) initiatives explicitly targeting care homes553  W it was possible 
that many of the components of CGA were already in place. Geriatrician-supported 
care home initiatives, whilst evident in geographical pockets around the UK, were not 
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the norm554-556. However, whilst many of the descriptions of CGA in the literature 
focused on the pivotal role of the geriatrician24 27 28, there were examples from other 
settings  W for example nurse-led community-based intermediate care557 558  W where 
the process was conducted without involvement of the specialty. It was therefore 
conceivable that the needs of care home residents might have been satisfactorily 
met through the combined efforts of care home staff, general practitioners, 
community-based nurses and allied health professionals working to the best-
available evidence under the GMS contract  W a sort of intuitive CGA, without having 
explicitly attached this label.  
If CGA was already being delivered  W albeit with no, or cursory, involvement from 
geriatricians  W the central question of this thesis regarding the role of CGA in care 
homes might have been answered by provision of concrete example. Equally, if it was 
not being delivered, then assertions that it should be tested in care homes could be 
made more robustly.  Finally, if the conclusion of the thesis was to be that CGA had a 
role in the care home setting, then some understanding of the day-to-day reality of 
existing models of care would be essential to define the extent to which 
implementation of CGA would represent a change from, or an augmentation of, 
these.  
The cohort study did not record day-to-day use of primary care resources by care 
home residents, nor was it able to take account of resident, resident family, care 
home and health service staff satisfaction with existing arrangements. It was 
therefore unable to address the question of whether CGA was already being 
provided, either in part or in full, as a consequence of measures delivered intuitively 
under GMS.  To address this question, and to provide an overview of the context in 
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which any initiative involving CGA might be launched and tested, the Staff Interviews 
in Care Homes (STICH) project was undertaken.  
4.2. Aim 
To describe how care home staff and the healthcare professionals who work with 
ƚŚĞŵŝĚĞŶƚŝĨǇĂŶĚƌĞƐƉŽŶĚƚŽĐŚĂŶŐĞƐŝŶƌĞƐŝĚĞŶƚƐ ?ŚĞĂůƚŚ ? 
4.3. Methodology 
4.3.1. Choosing a qualitative paradigm and a broad focus of 
study 
It was obvious that quantitative data, even when gathered in precise detail taking 
account of all available NHS resource use databases, could deliver only a partial 
overview of how the Health Service connected with care homes to deliver healthcare 
for care home residents. By the time of commencing STICH, research conducted at 
the University of Hertfordshire as part of the Analysis and Perspectives of integrated 
working in Primary Care Organisations and Care Homes (APPROACH) study, had 
already started to identify that day-to-day healthcare delivered to care homes 
differed significantly from that specified in commissioning documents, largely as a 
consequence of negotiated arrangements between individual homes and the 
healthcare teams that supported them1.  One could not, therefore, simply read a 
service specification from an NHS commissioning body and take it for granted that 
the service delivered to patients would meet that specification.  Heroic assumptions 
would be required to connect outcomes collected as part of a detailed cohort study, 
with the service as specified in commissioning contracts, without a detailed 
description of the day-to-day experience that connected them. Qualitative data 
would be required to better understand the way in which resources were used and 
                                                          
1
 Personal communication, Professor Claire Goodman, University of Hertfordshire 
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the rationale underpinning the resources employed. 
These insights were not going to come from interviewing residents and their families.  
Whilst both groups would clearly have a very important perspective on the lived 
experience of healthcare, they would provide a limited insight on the actual day-to-
day delivery of healthcare, and the mechanisms that governed such delivery.  Issues 
around cognition (residents) and amount of time present in a home (relatives) aside, 
they would rarely be present during interactions between healthcare professionals 
and care home staff and so would be unlikely to provide the insights required to 
address the research question specifically raised here.  
It was decided, therefore, that the research should focus on care home and NHS staff 
because they could provide a first-hand account of the systematic and organisational 
issues affecting healthcare delivery.  In doing so, it was recognised that a number of 
professionally diverse groups  W care home staff, nurses, doctors and allied health 
professionals  W each with potentially quite different perspectives on healthcare, 
would require to be involved.   
4.3.2. Data collection 
An observational study, focus groups and interview studies were considered.   
An observational study, where the researcher spends time watching care home staff 
at work, or working with them559, would have had obvious advantages in this context. 
It would, for example, have allowed interactions between residents, their families, 
care home staff and health professionals to be observed and recorded in detail.  It 
would have allowed a more detailed understanding of the culture within care homes 
and, in addition, would have allowed some degree of objectivity to be established  W 
since direct observation crosses the divide between what people say they do (as is 
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recorded in an interview or focus group study) and what they actually do559 560.  In 
conducting observational studies, varying degrees of involvement in the culture to be 
studied have been described, ranging from total abstraction, where observation is 
formal and overt, to complete immersion, where the subject is not aware they are 
being observed561.   
A particular concern with these types of study is that the act of observation changes 
the behaviour being studied  W this is sometimes referred to as the Hawthorne effect 
after an industrial study in which the influence of observation was first noted562. This 
is possibly a particular concern in interactions between care home staff  W who, in the 
case of care assistants, are frequently on low pay and have had no contact with 
higher education563  W and university researchers.  Although a study using overt 
participatory observations of low-paid staff in care settings has shown that such work 
can be undertaken without excessive difficulty564, other researchers have argued that 
covert observation is the only robust way to conduct such research565 and covert 
research is frequently subject to challenge at ethical review566.  Another important 
disadvantage of observational studies is the amount of researcher time required 
which  W in the case of STICH and the time-constraints imposed by a mixed-methods 
PhD programme  W meant that alternative methods had to be used. 
At the opposite end of the spectrum, focus groups are very resource efficient by 
virtue of bringing multiple stakeholders together at the same time to record their 
views560.  They have the additional advantage of allowing the researcher to observe 
the interplay of, and power relationships between, stakeholders567.   A focus group 
might allow the opportunity to explore the opinions and experiences of both 
healthcare staff  W including doctors, nurses and allied health professionals  W and staff 
working in care homes.  However, whilst focus groups have been used successfully to 
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explore inter-professional boundaries568, it has been noted that excessive 
heterogeneity in their composition can be counter-productive and an inhibitor to 
conversation567.  Potentially useful accounts of healthcare delivery would have been 
missed if care home staff had stayed quiet in the presence of NHS colleagues  W or 
vice versa.  Given the anticipated variability between individual homes  W truly 
balanced insights would have been unlikely unless NHS and care home staff who 
regularly collaborated were brought together, which would have increased the 
likelihood that one or more participant might choose silence over a potentially 
offensive forthright account of their day-to-day experience. Focus groups were 
therefore abandoned in favour of an interview study. 
Qualitative interviews record a detailed one-to-one conversation between 
participant and researcher and therefore avoid some of the issues of intimidation 
which may be problematic in focus groups.  There is, however, a persistent issue of 
the power relationship between the researcher and interviewee569.  The more 
structured the interview, the more likely that the conversation will focus on the 
ƌĞƐĞĂƌĐŚĞƌƐ ? ŝŶƚĞŶĚĞĚ ƚŽƉŝĐ ĂƌĞĂ ďƵƚ ƚŚĞ ŵŽƌĞ ůŝŬĞůǇ ƚŚĂƚ ? ƉŽƚĞŶƚŝĂůůǇ ƌĞůĞǀĂŶƚ ?
ancillary data will not be mentioned and therefore included in the research data570.  
The possibilities in structuring an interview range from working to a rigid 
questionnaire (not commonly used in qualitative studies), through semi-structured 
interviews, to unstructured interviews.  For STICH, a semi-structured format was 
chosen as it was anticipated that this would allow broad accounts of healthcare 
delivery to be recorded, whilst ensuring that respondents from a variety of 
professional backgrounds remained focussed around the relatively narrow issue of 
health and healthcare delivery in order to address the research question.  
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Mason571 described a useful stepwise approach to deriving a schedule for a semi-
structured qualitative interview from a research question.  Starting with the research 
question, mini-questions are derived, followed by a consideration of how such 
questions might be worked into an interview scenario, before consideration of a 
loose structure of how an interview might fit together.  Finally, if it is essential that 
any particular questions are asked to any participant, then these are singled out.  
Using this framework it became clear that questions of how health and social care 
staff interact to provide healthcare would touch on professional background and 
training, day-to-day role, communication with residents and other professionals, and 
understanding of health.  A vignette was chosen to bring interviewees from diverse 
backgrounds together around the research question.  Vignettes have been shown to 
be useful as a way of getting interviewees to tackle difficult issues  W in this case of 
role and relationships with residents and other professionals  W by using an abstract 
example to get them talking572 573.   
4.3.3. Data analysis 
The most commonly cited mode of qualitative analysis in healthcare studies is 
grounded theory  W indeed it is so commonly cited that Murphy et al560 caution 
ĂƌŽƵŶĚ ŝƚƐ ƵƐĞ ĂƐ Ă  “ďƵŵƉĞƌ ƐƚŝĐŬĞƌ ? ƚŽ ŐĂƌŶĞƌ ĂƉƉƌŽǀĂů ? ,ŽǁĞǀĞƌ ? ŐŝǀĞŶ ƚŚĂƚ ŝƚƐ
primary aim is to build a theoretical explanation of a social phenomenon under 
study574, and that little is currently known about how care home staff interact with 
ŚĞĂůƚŚƐĞƌǀŝĐĞƐƚĂĨĨ ƚŽŵĞĞƚƌĞƐŝĚĞŶƚƐ ?ŚĞĂůƚŚĐĂƌĞŶĞĞĚƐ  Wthere were, for example, 
no significant foreshadowing papers in this arena to inform our interview protocol  W 
it seemed an intuitive choice for STICH. 
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Grounded theory was first described by Glaser and Strauss in 1967575 and built upon 
by Strauss and Corbin in subsequent writings576.    It takes the stance that the 
researcher should start tabula rasa (as a blank slate) and inductively generate theory 
through thorough systematic analysis of data.  It is therefore frequently cited as a 
hypothesis-building model of qualitative research.  Grounded theory relies upon two 
central methodological concepts: constant comparison and theoretical sampling.   
Constant comparison describes the methodical, iterative, analysis of data as it is 
being collected575.  Data is initially coded in as many categories as possible, with an 
initial theory developed based upon these.  Subsequent delimitation of both theories 
and coding categories allows description of phenomena under a smaller number of 
higher-level concepts.  This process is continued throughout data collection and 
iteratively thereafter until no further refinement can be achieved  W a point which 
Glaser and Strauss called theoretical saturation.   
Theoretical sampling describes using concepts which have emerged from the 
constant comparative approach in order to guide what data is collected next  W 
perhaps by modifying the individuals or setting studied or the questions asked at 
interview560.  This allows for theories to be tested and delimited as research 
progresses and can be used as a means of ensuring that sufficient data will be 
accumulated to facilitate theoretical saturation.   
Critiques of grounded theory focus predominantly on epistemological concerns 
revolving around the clash of pragmatist and contructivist ideologies (can one be 
truly tabula rasa if reality is an internal construct?) and fears about its allegiance to 
naive inductivism (with emphasis on the power of reason, rather than the centrality 
of empirical evidence)560 577.   
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Murphy et al560 and Mays and Pope578 take a pragmatic step away from such abstract 
philosophical debate by pointing out that much of the reseĂƌĐŚůĂďĞůůĞĚĂƐ “ŐƌŽƵŶĚĞĚ
ƚŚĞŽƌǇ ?ŝƐ ?ŝŶĨĂĐƚ ? “ŐƌŽƵŶĚĞĚƚŚĞŽƌǇƐƚǇůĞ ? ?ĂŶĚƚŚĞƌĞŝƐŵƵĐŚƚŽďĞŐĂŝŶĞĚ ?ďǇǁĂǇŽĨ
rigorous objectivity, from careful application of these principles: particularly 
simultaneous data analysis and collection; analytical processes aimed at hypothesis 
generation rather than testing existing theories; and careful methodical application 
of coding categories with increasing levels of abstraction at each iteration. 
The framework approach, a deductive mode of qualitative analysis, has been 
suggested as an alternative to grounded theory research559.  It has been highlighted 
as particularly applicable in health research where the lead-times for analysis and 
publications of findings are characteristically short, precluding the more lengthy 
analyses demanded by true grounded theory-style analysis.  The key distinction 
between this approach and grounded theory is that a theoretical framework is 
established early, with data analysis then conducted to determine the extent to 
which qualitative transcripts adhere to the framework.  In some instances, the 
theoretical framework is based on a priori assumptions and, as such, data-analysis 
becomes almost entirely deductive579.  In others, the framework approach can run 
quite close to grounded theory-style research, where a long period of data 
immersion is required to establish a theoretical framework580, almost to the point 
that the framework itself is an inductively generated piece of grounded theory.  Thus, 
like many putatively distinct research paradigms, there is a continuum between 
completely grounded research, iterative and inductive to the end, and a truly 
deductive framework approach based upon a priori assumptions  W indeed some 
researchers refer to the framework approach as being an application of grounded 
theory rather than an alternative approach559 579.   
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A priori assumptions were felt to be potentially quite harmful to the establishment of 
a robust theoretical framework in STICH for two reasons.  Firstly, reflection on the 
experience of running the CHOS study within care homes suggested that the process 
of getting to know care homes had been one of continual revelation, where the 
assumptions held by health service-based researchers about day-to-day life in care 
homes were continually and repeatedly challenged by the experience of the lived 
reality. Secondly, the assertion from detailed research programmes held elsewhere 
(APPROACH) that the degree of variation in negotiated arrangements between health 
and social care providers was very broad meant that a reliable framework would be 
unlikely to be established through a small number of observations early in the 
research process.  The framework approach was therefore avoided. 
4.3.4. Defining a sample 
Although qualitative methods make no claims to representativeness, it seemed 
reasonable  W in order to describe the delivery of healthcare with some 
generalisability  W to incorporate a range of homes in an attempt to take account of 
some of the variability between and within homes.  
It was decided that staff would be recruited from homes which had been enrolled in 
the CHOS study on the basis that a relationship of trust had been built with the 
owners, managers and staff that would allow a frank exploration of issues around 
ƌĞƐŝĚĞŶƚƐ ?ŚĞĂůƚŚĐĂƌĞ ?/ŶƐĞůĞcting which homes to approach, the outputs from CHOS 
were considered.  Given the identified differences between the cohorts housed in 
residential and nursing homes respectively, it seemed reasonable to start with these 
categories as a driver to the sampling framework.  Dementia registration  W with the 
implication that the types of care provided and the expectations of staff might 
significantly differ as a result  W was identified as an additional important factor.  
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Based upon these, a purposive sampling framework was set out which aimed to 
sample residential and nursing homes, and those with and without dementia 
specialist registration. CQC ratings were abandoned as a guide to sampling from the 
outset, largely because of their lability over time as identified in CHOS.   
In deciding which staff to recruit, it was necessary to consider both care home and 
NHS staff.  Staffing structures in care homes were fairly standard, with a single 
manager, with or without a deputy, overseeing care assistants and, in the case of 
nursing homes, professional nurses.   Representatives from each of these groups 
should be recruited.  Given the central role of GPs in co-ordinating healthcare, it was 
essential to recruit several.  Given that much practical day-to-day care was also 
provided by district nursing staff and allied health professionals, it would also be 
important to recruit from these groups.  Theoretical sampling  W with movement 
backward and forward between theory and data  W played an important role in 
determining the extent to which each of these groups was sampled.  It became clear, 
through early interviews, that the relationship between GPs and care home 
managers was particularly important in determining how healthcare was delivered to 
residents.  As a consequence, the sample was subsequently around GP/manager 
dyads  W and the care home and NHS staff with which they worked  W in order to better 
understand this interaction. 
4.4. The research team 
The study was conducted by a team of researchers  W Adam Gordon (AG) an academic 
geriatrician; Isabella Robbins (IR) a post-doctoral sociologist; Jane Dyas (JD) an 
experienced qualitative health-services researcher; John Gladman (JG) a professorial-
level academic geriatrician and PhD supervisor for AG; and Pip Logan (PL) an 
academic occupational therapist and second PhD supervisor for AG.  
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AG and IR led the process throughout. As AG was a novice qualitative researcher at 
the outset, IR performed a mentorship role in addition to acting as co-researcher.  All 
researchers were involved in study design.  Interviews were conducted by AG (n=11) 
and IR (n=21); constant comparative data analysis was conducted by AG and IR  W with 
initial separate coding of all transcripts followed by a process of integration that 
allowed detailed review and refinement of emerging theoretical constructs; the final 
synthesis was led by AG and IR  W with input from JD, JG and PL.  The intellectual 
ownership of the findings as presented here is shared by all authors with IR and AG 
acting as guarantors.  IR has acted as lead author on a scholarly paper based around 
the findings which was in preparation for submission to peer-review at the time of 
writing.  Although the results section of that paper shares a common structure with 
the results section as presented here, the findings are presented here in greater 
detail and with more comprehensive discussion.   
4.5. Methods 
Using the steps outlined by Mason571, an interview schedule was developed as a 
loose framework for semi-structured interviews.  A case vignette was written around 
a patient with a urinary tract infection, which was  chosen as a common problem 
which would frequently trigger referral to NHS services.  Both the vignette (Box 7) 
and interview schedule were piloted using mock interviews with clinically trained 
research staff. 
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Staff from the following professional groups were targeted for recruitment: care 
home managers, registered nurses, care assistants, community nurses, general 
practitioners and community allied health professionals. Working on the principle of 
manager-GP dyads as the focus for recruitment, GPs were approached after 
recruitment of the care home.  We were able to enlist one GP attached to each home 
and sought, within each practice, to speak to the GP who most routinely provided 
care to the home in question.  Nurses and allied health professionals were recruited 
either opportunistically, from contacts made during conduct of research in GP 
practices and care homes, or sought-out by a combination of telephone and letter 
where their opinions were suggested by existing respondents to be particularly 
important to emerging theoretical frameworks.  There were no exclusion criteria. 
 “/ŵĂŐŝŶĞĂƌĞƐŝĚĞŶƚǁŚŽŝƐƐŚŽƌƚĂŶĚƐƚŽŽƉĞĚǁŝƚŚĂĐƵƌǀĞĚƐƉŝŶĞ ?^ŚĞƐƵĨĨĞƌƐ
from stiff, painful joints.  She is thin.  She becomes muddled and disorientated 
from time to time. She usually needs some help with personal care and wears a 
small pad for urinary incontinence  W a little leakage. 
She keeps getting urinary tract infections.  She has long spells when she is well, 
but when she gets an infections, staff notice changes in her.  She starts to 
become more confused, so that she needs more help with her personal care 
than usual.  She becomes a bit more unsteady on her feet.  The last time that 
this happened, she had a brief emergency visit to hospital and it took a week or 
two for her to get back to normal. 
Can you think about your own experience and recount a similar ĐĂƐĞ ? ? 
Box 7 - Case vignette used in STICH interviews 
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Care home managers were sent posters and information sheets for dissemination 
amongst their staff.  Staff were subsequently briefed by a researcher on the purpose 
and content of the research and invited to contact the research team directly to 
become involved.  To minimise the likelihood of actual or perceived coercion by 
managers encouraging or discouraging staff from participation, or from saying certain 
things at interview which might in turn bias their account, participants were given 
the choice of being interviewed at their place of work, at home or in the University. 
To further protect staff, researchers did not tell managers which staff had agreed to 
participate in the study.  
Interviews were recorded on a digital voice recorder.  All of the interviews lasted 
between 40 and 90 minutes. At the outset of the study, interviews followed a 
standard format. Following a brief introductory conversation, subjects were given the 
case vignette and asked to consider how it reflected their own experiences. They 
were then asked to talk about a similar anecdote based upon these. Spontaneous, 
unprompted, discourse was encouraged. As the study progressed it became clear 
that the vignette, whilst very useful in some instances was, in others, interrupting the 
flow of the interview and taking up time that might be better spent pursuing 
clarifications of comments already made during the introductory discourse. A 
decision was therefore made to allow the interviewer discretion as to when, and 
whether, the vignette was employed.  Written field notes were kept in addition to 
the voice recording.  
Interview recordings and field notes were transcribed and anonymised before 
transfer to an electronic database.  Following a constant comparative approach, data 
was analysed at the time of database entry whilst the study was proceeding.  
Emerging themes were used to guide theoretical sampling. 
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Analysis was an iterative process running in parallel with data collection. AG and IR 
met after each interview, discussing interview content. Memos were written after 
interviews recording ideas and initial analysis. These were checked against existing 
data and the emerging theoretical framework, sampling strategy and the interview 
schedule adapted accordingly (as in the decisions to focus on manager-GP dyads and 
to use the vignette more flexibly, outlined above). Transcripts were searched for 
contradicting evidence to our emerging themes. Final analysis was performed using 
NVivo 8580 as a method for organising the interview data and memos.  Coding of all 
the data was carried out by the two interviewers (AG and IR), independently initially 
with subsequent integration of subthemes.  The final overarching thesis was 
triangulated by exposing the emergent theoretical framework to the broader 
research team.  
4.6. Results 
All respondents, along with the homes and areas in which they received care are 
identified in the text below by pseudonyms. 
Thirty-two interviews took place with care providers focused around 6 homes. The 
care homes are described in Table 53. Two homes had close-to-monopoly provider 
arrangements with a single GP practice, with whom nearly all residents were 
registered.  In one instance this was a consequence of rural locality, with a limited 
choice of GPs available.  In the other home, whilst rural locality also played a part, it 
was a formal arrangement with a salaried GP maintaining a 1:1 relationship with the 
care home as part of her job description. The remainder of homes had relationships 
with multiple practices, residents either retaining their longstanding GP if 
geographically appropriate or allocated to nearby practices on the basis of 
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preference.  None of the homes had private contractual arrangements with GP 
outside of the GMS contract.   
Table 53 - Profile of Recruited Care Homes 
CHOS 
ID 
Type of care home Type of 
ownership 
Number 
of 
residents 
Location Pseudonym 
1 Non-dementia dual 
registered home 
Private; small 
chain of 15 
homes 
55 Suburban Mansfield 
Lodge 
2* Dementia registered 
residential home 
Private; small 
chain of 3 
homes 
 
46 Suburban Chadwyck 
Manor RH 
10* Dementia registered 
nursing home 
30 Chadwyck 
Manor NH 
3 Dementia registered 
nursing home 
Owner/manager 41 Rural Kimpton 
Lodge 
4 Dementia registered 
residential home 
Charity 38 Urban Brookside 
Care Home 
7 Dementia registered 
nursing home 
Owner/manager 24 Rural Edenbridge 
Care Home 
8 Dementia registered 
residential home 
Owner/manager 25 Suburban Dynasty 
Care Home 
*IDs 2 and 10 were treated as separate homes for analysis in CHOS; as, although part of the 
same home, they were housed in separate buildings, with separate managers, resident 
cohorts and staff. 
 
We interviewed 7 care home managers, including the managers of CHOS IDs 2 and 
10, which were separate residential and nursing buildings within the same institution, 
2 care home staff nurses and 9 care assistants. 6 GPs were interviewed, one for each 
home. We also interviewed 3 members of dementia outreach teams  W specialist 
nurses who provide advice on dementia on an ad hoc basis to care homes  W 2 district 
nurses, 2 advanced nurse practitioners  W specialist nurses employed by the local 
primary care trust to provide supplementary advice to care homes  W and 1 
occupational therapist.  
Health and healthcare ǁĞƌĞŝĚĞŶƚŝĨŝĞĚĂƐďĞŝŶŐĂŶŝŵƉŽƌƚĂŶƚĂƐƉĞĐƚŽĨƌĞƐŝĚĞŶƚƐ ?ůŝǀĞƐ
throughout their time in care homes from the time of admission, through adjustment 
and adaptation to the new environment, maintenance, deterioration and death.  
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There was much to suggest  W in keeping with the findings from CHOS  W that CGA had 
a role in care homes.  Despite this, there was very little evidence that CGA  W whether 
explicit or implicit  W comprised a routine part of healthcare for residents.   
The key issues emerging from the data analysis are considered below under the 
headings of Context and Practice.  Context describes the setting in which healthcare 
practice was presented as taking place and describes: care home residents and their 
healthcare needs; the organization of relationships between GPs and care homes; 
and the health and social care staff who provide healthcare to residents.  Practice 
focuses on four areas of healthcare delivery where opportunities for CGA were 
identified: assessment of residents at admission; transfers of care; access to primary 
care; and anticipatory care.        
4.6.1. Context 
4.6.1.1. Care home residents and their healthcare needs 
Care home residents were described as requiring health and social care as a 
consequence of functional dependency, multi-morbidity, cognitive impairment and 
behavioural disturbance.  Their admission to a care home was often determined by a 
new medical pathology, or a deterioration in one or more chronic conditions.  
ǲǯ         ǡ ǯ ǡ edema, chronic 
ǡǡ ǯ stomy tube, 
ǯǡǯǡǯǡǯǯ
  ?ǡǯǯ
ǯǳǤ 
Camilla, Manager, Kimpton Lodge 
ǲ
ǡǡǮǡǯ
ǡǡǡǤǤǤǤǤǳ 
Stephanie, Manager, Chadwyck Manor RH 
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Most of the respondents reported that the cohort of residents being admitted to 
residential and nursing care had increased in dependency and morbidity over recent 
years.  This was related to the fact that admission to care, previously a consequence 
of resident choice or preference, was now a consequence of crisis or necessity.  This 
had the effect  W as already described above  W that admission, already difficult for 
staff by virtue of having to come to terms with a new care recipient, was rendered 
further fraught by the uncertainty that invariably surrounds patients when they are 
medically unwell and/or unstable.  Another consequence was that there had been a 
gradual increase in the resources required to adequately look after residents. 
ǲ ǡ
  Ǥ   ǯ      Ǥ  
ǯ ? ? ? ?Ǥnd 
 ǯ      Ǥ      ǯ  
ǳ 
Camilla, Care Home Manager, Kimpton Lodge 
ǲtheir mobility is very poor now, where it used to be very good at one time, where 
you just have ladies who just come in and just, who needed security really.  Who did 
ǡǯǤǳ 
Jane, Care Assistant, Brookside Care Home 
Another consequence of marked frailty at the point of admission, was that most 
residents were at the end of their lives by the time they arrived at care homes.  All 
respondents spoke about death and dying.  This is, perhaps, surprising given that the 
interview schedule did not specifically seek to solicit commentary on end-of-life care 
and the vignette was focused on relatively routine day-to-day fluctuation.  It does, 
however, underline the importance attached by health and social care professionals 
to end-of-life care in this setting.  Occasionally, residents were described as dying 
suddenly without warning. 
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ǲǡǡ
put her in a wheelchair as quick as we could to get her out of sight from the others 
 ǡ   ǯ  ǯ    psets some 
people, and we put her in her bedroom, and we had to dial 999 and the lady 
Ǥǳ 
Agnes, Care Assistant, Dynasty Care Home 
Much more commonly, however, a period of physical and mental decline was 
described leading up to death.  This could either be a non-specific withdrawal from 
life and living, or a significant illness which clearly moved the resident into a pre-
terminal phase. 
ǲǥǥǡǡ
ea Ǥ          ǡ ǡ  ǡ Ǯǡ ǯ
ǡ ǯ   ǡ ǯ   ǫǯ  Ǯǡ  ǯ 
ǤǫǯǤǤǤǤǡǡǯ
do, apǡǤǯǡ
ǤǯǤǯǤǳ 
Jane, Care Assistant, Brookside Care Home 
ǲǯ  ǡ ǯǡ 
known anaemic and it [blood count] was eight when she came and it was seven 
   ǯ      ǡ ǯ  
 ǡ ǡ ǯ ǡ ǯ  ǡ   e might need a 
ǡǤǳ 
Dr Sandhu, GP serving Edenbridge Care Home 
ZĞƐŝĚĞŶƚƐ ? ƚŝŵĞ ŝŶ ĐĂƌĞ ŚŽŵĞƐ ǁĂƐ ĚĞƐĐƌŝďĞĚ ĂƐ ŝŶǀŽůǀŝŶŐ ĨƌĞƋƵĞŶƚ ĨůƵĐƚƵĂƚŝŽŶ ŝŶ
health and functional status. Although deviation from normality was often quite 
easily recognised, both health and social care professionals spoke of the difficulty in 
separating day-to-day fluctuation, from deterioration marking an acute medical 
pathology which might require treatment and from deterioration which marked 
progression to a pre-terminal phase.  This had implications for how and when help 
was enlisted from outside agencies including from primary care services, the 
ambulance service and acute secondary care hospitals.  In the example below, an 
Chapter 4  W Staff Interviews in Care Homes (STICH) 
170 
 
experienced GP described a patient, who fluctuated regularly, often as a marker of 
deteriorating mental or physical health requiring either acute medical or psychiatric 
input but even he, as an experienced GP, struggled to tell the difference. 
ǲǯ     ǯ     
  ǥǤǤ ǯ            
 ǥǤǤ      ǡ   
seems to get worse and she has, now, I can never remember which way round her 
ǡǳ 
Dr Cook, GP serving Brookside Care Home 
Care homes were described as the last refuge for frail older patients.  Several 
respondents reported that care homes  W by virtue of having very flexible admission 
requirements coupled to an unrestricted length of stay  W often ended up accepting 
those whose needs could, or would, not be met in other care settings.  This was the 
case even if the care home was not ideally placed to meet the very high care needs of 
a particular patient. 
ǲǡǡǡǯǡǡ
ǯ        Ǥ  ǡ  
behaviour or their needs, is too difficult ǯ
ǡǡǡǯ
ǳǤ 
Dr Cook, GP serving Brookside Care Home 
ǲ ǯ          l care 
ǡ ǯ  ǡ ǯ   ǥǥǥǯ
Ǥǯǡǫǳ 
Dr Preston, GP serving Mansfield Lodge 
4.6.1.2. Organisation of relationships between GPs and care 
homes 
GPs described care home residents taking up a substantial amount of their workload, 
with the majority of work involving visits by the GP to the home, rather than by 
residents to the surgery. 
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ǲ ? ? ?omes, and 10% of our population are over 
75... we have at least two to three out of the average of 10 visits a day are to care 
ǳ 
Dr Mater, GP serving Dynasty Care Home 
Geography played an important role in how healthcare was structured for residents.  
Many residents changed GP at the time of admission to a home, meaning that the GP 
had to come to terms with a new patient often at the time of, or immediately 
following, a medical or social crisis. 
ǲǯǯǡǥǤǤ
house, and maybe ending up in warden-aided, residential to nursing, the vast 
majority of the people in nursing homes we look after are strangers to us when they 
Ǥǳ 
Dr Preston, GP serving Mansfield Lodge 
The flip-side to this was that patients left the register of their long-term GP when 
they moved to a care home in a different area. Two of the GPs spoke of attempts to 
keep providing medical care for such patients, despite them living in care homes that 
were outside of their practice catchment.  In attempting to do this, there was a 
recognised trade-off between continuity of care and the challenge of providing 
healthcare to a functionally dependent and medically complex patient at arms 
length, with consequences for how able or ready the GP was to respond to requests 
for help. 
ǲIt is pointless going and travelling out to a nursing home when you've only got one 
Ǥǳ  
Dr Preston, GP serving Mansfield Lodge 
The two rural care homes in our sample  W Edenbridge and Kimpton Lodge - described 
1:1 relationships with a single GP practice.  This arrangement, derived in part out of 
geographical necessity, was praised by all respondents related to Edenbridge but 
roundly criticised by those from Kimpton Lodge.  At Edenbridge, a constructive 
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working relationship was described, defined by frank and open discussion of 
differences around patient care and a history of joint initiatives between GP and care 
home to improve healthcare for residents  W including a recent effort to launch and 
ĞŵďĞĚŝŶƉƌĂĐƚŝĐĞƚŚĞ'ŽůĚ^ƚĂŶĚĂƌĚƐ ?&ƌĂŵĞǁŽƌŬ ?'^& ?ĨŽƌŶĚ-of-Life Care578.   
ǲ     ǡ       ǤǤǤǤǤ 
 
covering the whole nursing home, I think also works because the nurses know what 
to expǤǡǤǳ 
Dr Sandhu, GP covering Edenbridge Care Home 
 ǲ
	 
out, get some resolutions to some of these problems, so we were looking at things 
like inappropriate admissions to hospital, and looking at the things that as a team 
ǤǤǤǤǳ 
Sarah, Manager, Edenbridge Care Home 
The relationship at Kimpton Lodge was, by contrast, defined by mistrust, conflict and 
reluctance on behalf of both care home staff and GP to engage with each other. The 
sense was that  W were it not for a geographical necessity  W a 1:1 relationship would 
not have been chosen.  Kimpton Lodge did have a small number of residents from 
neighbouring villages who had stayed with their previous GP and always described 
these relationships in preference to those with their majority provider. 
ǲȏȐǤǤǤǤ
ǯǡǮǡǯ  
are lumbered with it.  What we did propose was that we have half the patients in 
 ȏȐ  ǯ      ǡ  ǡ  
     ǡ Ǯǡ ǯ    ǯǤ    ǯ 
their areaǤǤǤǤǤǳ 
Dr Smith, GP serving Kimpton Lodge 
ǲǯǮǡǯǯǯ
ǡǯǮ
ǡǯǯǯǤǳ 
Camilla, Manager, Kimpton Lodge 
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ǲ   
  ǡ  ǯ   ǡ Ǯ     -cut 
ǯǡǮǯǡǯǯǤ
The othersǡǡǮǯǫǯǮǡ
ǡǫǯǡǯ
ǫǳ 
Camilla, Manager, Kimpton Lodge 
Suburban and urban care homes, by contrast, described a default situation where 
numerous GP practices would cover a single home (n>1:1 relationships). Contrary to 
the 1:1 relationship, this was discussed in universally negative terms, making it 
difficult both to establish close working relationships and a consistent approach to 
healthcare delivery across the home.  This was compounded by the fact that GPs 
were highly variable in their practice.  
ǲ
ǤǤǤǤǤǯ
ǯ 
ǡǮǯǡ
ǫǯǳ 
Gabrielle, Manager, Mansfield Lodge 
ǲ
ǡ
were trying to do, they were doing an examination and they were trying to do it in 
the lounge mid-morning in front of everybody.  So I walked in the lounge and took 
ǡǥǤǯ
ǡ
that, some really, really good GPs that are really supportive of what we do, that are 
ǡǤǤǤǡǯǥǡ
you want a referral, can you refer me to the dementia outreach team?  Yeah.  Can 
you put a referral in to whatever, diet, community dieticians or NHS chiropody or 
ǡǥǳ 
Helen, Manager, Brookside Care Home 
Urban and suburban GPs could see some intuitive advantages to organising a 1:1 
relationship in terms of facilitating a relationship with care home staff and getting to 
know their patients better. They also perceived barriers to this approach in the form 
of patient choice and organisational issues with neighbouring practices  W particularly 
the equitable distribution of workload when not all care homes required the same 
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level of support from their GPs. 
ǲǡ 
with one care home whereas the current situation is that we all have a few in all of 
them, probably.  And it means that the relationships that you forge, or that you 
ǡǯǡǡ
 ǡ  ǯ      ǯ      
Ǥǳ 
Dr Preston, GP serving Mansfield Lodge 
ǲǯǥǤǡ
ǯǯǡǯ
take on ten of your patients but after that, it becomes too much of a sort of, too 
much ǡǯǡǯǯ
very difficult management-ǳ 
Dr Cook, GP serving Brookside Care Home 
A related but separate issue to the number of practices per home was whether GPs 
organised regular, scheduled visits to homes.  This was the arrangement for both 
Edenbridge and Kimpton Lodge and was seen as going hand-in-hand with the 1:1 
relationship.  The Edenbridge team described this as being central to effective 
anticipatory care  W with the certainty of once weekly visits acting to limit calls from 
the home between times. 
ǲ            ǯ  
result[ing] in a visit, works really well.  Because it is very infrequently that they 
would call on the other days.  Generally everything waits for the Tuesday, and 
ǡǤǳ 
Dr Sandhu, GP covering Edenbridge Care Home   
ǲ ǯ -call out of hours, in an 
eǡ  ǯ             
ǡǯ ǥǤǯ
ǯǥǤǯ
had to riȏȐǳ 
Bella, Trained Nurse, Edenbridge Care Home 
The remainder of the homes studied did not have regular scheduled visits from their 
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GPs.  Two of the city GPs described that they had previously attempted to establish 
these types of arrangements with homes in their catchment area but had abandoned 
the practice, concluding that it had no effect on calls from the home between 
scheduled visits. 
ǲwe tried to be more proactive and make contact more regularly with the home, 
ǯǤǡǯ
 ǡ  ǡ   ǡ ǡ ǡ ǯ  ǡ
ǯǡǯǤǳ 
Dr Preston, GP serving Mansfield Lodge 
ǲn the past, we used to try and do anticipatory things like a little ward round once 
Ǥ  ǯ
letting the staff call us when they needed help.  So we were putting more hours in 
without Ǥǳ 
Dr Cook, GP serving Brookside Care Home 
Some of the care home managers treated the concept of weekly visits with suspicion, 
believing that GPs would use this as justification for not attending between times 
even if it was necessary to do so, stating a preference for rapidly responsive care 
whatever the day of the week. 
ǲǥ
out on numerous days for minor issues, and they want to come just once a week, so I 
      ǡ Ǯ       
ǡǯǡǯǯǡǯǤǯ
ǡǡǤǳ 
Stephanie, Care Home Manager, Chadwyck Manor RH 
4.6.1.3. The health and social care staff who provide care to 
residents 
A widely recognised boundary was drawn between staff employed by care homes 
and those employed by the NHS.  This was variably labelled as being between health 
and social care staff, or state and private-sector employees.  The distinction served as 
a focus for conflict and disagreement.  Interestingly, however, most perceived 
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differences actually revealed similarities in the stressors and concerns perceived by 
staff, regardless of sector.  Thus both NHS staff and care home staff complained that 
each other were undertrained and ill-equipped to deal with frail older patients, whilst 
also recognising the same shortcomings in themselves and colleagues from their own 
sector. 
ǲ           ǡ 
ǡ  ǯ       ǯ  
ǡǯ
ǳ 
Helen, Manager, Brookside Care Home 
ǲǡǡ
  ǯ          ǡ Ǯ ǡ ǯ 
ǡǯǤǯd that, you know, we kind 
ǥǤǯǥǤǤǤǤǤ
to try and anticipate when people are becoming ill and call us in to pick things up 
ǳ 
Dr Cook, GP serving Brookside Care Home 
ǲȏme staff have] a fundamental lack of understanding of dementia and how 
it affects people, failure to recognise signs, non-verbal signs, failure to recognise 
ǯǡǡǤǲ 
Abigail, Dementia Outreach Nurse 
ǲǯ  ȏ ȐǤ  ǯ
psychiatry.  So all the psychogeri stuff is, was, new to me.  And all the drugs were 
new to me.  I mean, the, referring to psycho-geriatrician before this job wasǡǯ
ǡǤǳ 
Dr Sandhu, GP serving Edenbridge Care Home 
ǲ  
  ǯ  ǤǤǤǤǤ   ǡ
basically another specialism going in and I think that would deliver better care to 
Ǥǳ 
Dr Smith, GP serving Kimpton Lodge 
Another area where perceived differences served to underscore the similarity of the 
challenge faced across sectors was highlighted around finance.  NHS staff raised 
concerns about the fact that care homes were privately owned and the perceived 
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conflict-of-interest between profit motives and duty of care, whilst care home staff 
spoke of an increasingly financially-driven NHS which attracted staff motivated by job 
security and high pay, rather than a duty of care. 
ǲǡǡǯ
step taking it back under, you know, health authority, social service control, needs 
ǡǤǳ 
Abigail, Dementia Outreach Nurse  
ǲǯ issue about owners wanting the maximum profit, and therefore 
        ǥǤ     
 ǡ  ǯ          
Ǥ   ǯ    that, I think.  But then again, we know that 
     Ǥ   ǯ    
Ǥǳ 
Dr Preston, GP serving Mansfield Lodge 
ǲ          ǡ   em at 
ǡǯ Ǥ ǡ
change, care of older people has got to get far better, they deserve better facilities, 
ǡǳ 
Camilla, Manager, Kimpton Lodge 
ǲǯ    ǡ     ǡ ǡ 
ǤǯǥǤǤ
ǡǯǯ
  ǡ  ǯ    ǡ    ǡ   
Ǥǳ 
Helen, Manager, Brookside Care Home 
ǲǡǯǡ
because they want [to ȐǤǤǤǤǤǯǤǳ 
Gabriel, Manager, Mansfield Lodge 
A final issue of division which paradoxically revealed similarities across sectors was 
fear of litigation. Healthcare staff felt this was a motivating factor in the care agenda 
for homes, whilst care home staff levied the same accusation at the NHS. 
ǲǯ  ǯ ǡ      ǡ  ǡ
 ǥ           ǯ ǡ ǯ  
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  ǡ  ǯ   ǯ Ǥ  ǯ     
ǥǤǳ 
Bella, Trained Nurse, Edenbridge Care Home 
  
ǲ             ǯ
want to be sued by anybody for not providing care for patients so if somebody is not 
well they tend to call an ambulance and tend to get them into hospital very 
Ǥǳ 
James, Care Home Nurse Practitioner 
 
Further evidence of the arbitrariness of boundaries drawn between health and social 
care staff came from the detail of the day-to-day care provided by care home staff  W 
with much of what was labelled as social care having a direct bearing upon 
ĂƐƐĞƐƐŵĞŶƚ ĂŶĚ ŵĂŝŶƚĞŶĂŶĐĞ ŽĨ ƉĂƚŝĞŶƚƐ ? ŚĞĂůƚŚ ?  ^ŽĐŝĂů ĐĂƌĞƐƚĂĨĨ ƐƉŽŬĞ ŽĨ Ă
preparedness to perform healthcare tasks where doing so might improve their 
ƌĞƐŝĚĞŶƚƐ ?ĞǆƉĞƌŝĞŶĐĞ ? 
ǲǯ
ǯǤǤǤǤǤǯ
ǯǯǯǡǯ
ǯǡǡǳ 
Helen, Manager, Brookside Care Home. 
ǲ       ǡ  ǡ ǡ ǡ se it 
    Ǥ   ǯ       
[care home nursing emergency] team or the district nurse or whoever to come out 
to put a dressing on, because we can clean it up, pop a dressing on and, and, and 
straightaway, so, no, I embrace it because it means that the needs are met at the 
ǳ 
Helen, Manager, Brookside Care Home 
ǲ         ǡ  ǯ    ?ǡ  
inform them (thȌǡǡǯ
ǯǡǯǡ
ǯǯǡǯ
let us carry oǡǯǤǳ 
Bella, Trained Nurse, Edenbridge Care Home 
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ǲif she has got on-going incontinence.... if she keeps getting urinary tract infections 
then besides liaising with the GP, I would liaise with the continence advisory people 
as well, and I would get them to come to assess her, because they would look at 
 ǯ       ǯ     
Ǥǯǯǳ 
Bella, Trained Nurse, Edenbridge Care Home 
In addition, care home staff described a body of experientially-derived, often tacit 
and unrecognised, knowledge that allowed day-to-day monitoring and management 
of aspects of health including nutrition, behavioural disturbance and functional 
dependency that belied the complaints about their lack of preparedness for their 
care role. 
ǲǯǯǡǮǡ
ǡǯǡǡcken say, and fish fingers 
  ǡ    Ǯǯ  ǯ      ǯ  
ǡǯǡǯ
onto something else then, and see. Because you know that when anybody eats their 
Ǥǳ 
Agnes, Care Assistant, Dynasty Care Home 
ǲ         ǡ     ǡ   ǡ
Ǯ  ǫǯ    ǮǤǯ   ǡ Ǯǡ ǯ   ǡ  the 
ǡǡǤǯǯ
ǡǯǫǳ 
Gillian, Manager, Dynasty Care Home 
 
ǲǥ ȏ Ȑ   ǯ ǡ   ǯ   
ǯǡǯǤ
Ǥǳ 
Gillian, Manager, Dynasty Care Home 
 ǲ          ǡ     
ǡǥ  eft them a bit (...) and then went, 
 ǡ  ǡ ǡ     ǡ ǯ   ǡ 
ǡǯǤǳ 
Abigail, Dementia Outreach Nurse 
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A further body of knowledge held by care home staff, that allowed effective 
ŵĂŶĂŐĞŵĞŶƚ ŽĨ ƌĞƐŝĚĞŶƚƐ ? ŚĞĂůƚŚ ? ǁĂƐ Ă ĚĞƚĂŝůĞĚ ƵŶĚĞƌƐƚĂŶĚŝŶŐ ŽĨ ƚŚĞ ĚĂǇ-to-day 
condition of longer-ƐƚĂǇ ƌĞƐŝĚĞŶƚƐ ?  dŚŝƐ ŵĞĂŶƚ ƚŚĂƚ ? ǁŚĞŶ Ă ƌĞƐŝĚĞŶƚ ?Ɛ ƐƚĂƚƵƐ
changed, appropriate healthcare interventions could be initiated.   
ǲ       ǡ        
being really depressed and then sort of coming out of it again, and we really 
thought that behaviour had followed the pattern that she was going into one of her 
lulls  Ǥ        ǥǥ 
ǡǡǯ
quite a lot of glucose in and ketones, and so I did her blood sugar and that was off 
ǳ 
Bella, Trained Nurse, Edenbridge Care Home 
ǲǯ
ǡǯ
ǤǡǯǤǯǤǳ 
Jane, Care Assistant, Brookside Care Home 
 ǲǯǡǮ
ǡǯǡǯǡ
you notice that there is a moo ǡ    ǯ    
ǯǳ 
Bella, Trained Nurse, Edenbridge Care Home 
Despite this body of expertise, there were clearly a number of situations where 
workers trained predominantly to support residents with day-to-day activities of 
ĚĂŝůǇůŝǀŝŶŐ ? “ƐŽĐŝĂůĐĂƌĞ ? ? ?ǁĞƌĞŝůů-equipped to deal with healthcare needs.  This was 
particularly the case with acute deteriorations in health which required ongoing 
monitoring against deterioration. 
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ǲOften what happens the GP will go in, see the patient with a chest infection 
ǡǤǯǯ
 ǯ        ǡ  
ǤǤǯ  ot of responsibility for untrained staff to care for these people.  
ǯ
ǯǤǳ 
James, Care Home Advanced Nurse Practitioner 
Nursing homes, by virtue of a trained nurse working on each shift, were possibly 
better equipped to deal with such issues. 
ǳǤǤǤǤǡǡǯ
bit..change their mood and all, we can pick certain things, and then from there we 
need to observe them regularly and then if they really need a doctor we call the 
Ǥǳ 
Jean, Trained Nurse, Mansfield Lodge 
However, the presence of trained nurses in nursing and dual-registered homes also 
presented a challenge in that both care home and NHS staff often struggled to 
identify the boundary between care which should be provided by care home nurses 
and that which should be provided by NHS district nursing services.  
ǲǯ intervening their care and 
we will be in trouble. Even just sometimes dressing, I said to my nurses to avoid 
ǡǡǯ
dressing to it, but as far as I know we are trying to avoid putting anything in there, 
ǯǤǳ 
Gabriel, Manager, Mansfield Lodge 
ǲ  ǯ     ǯ      
ǡǯǡǯth you.  
ǯ
ǳ 
Dr Cook, GP serving Brookside Care Home 
Respondents from a number of backgrounds spoke of the need for increased 
involvement by specialist multi-disciplinary teams in the management of care home 
ƌĞƐŝĚĞŶƚƐ ?  dŚŝƐ ǁĂƐ ůĂƌŐĞůǇ Ă ƌĞƐƉŽŶƐĞ ƚŽ ƚŚĞ ĐŽŵƉůĞǆŝƚǇ ŽĨ ƌĞƐŝĚĞŶƚƐ ? ŚĞĂůƚŚ
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problems and overlapping functional dependency alongside the challenge that these 
presented to the training and accumulated experience of care home staff and GPs. 
ǲǡhealthcare team, multidisciplinary team of 
ǡ ǯǡǡ

ǯǯǯ
Ǥǳ 
Camilla, Manager, Kimpton Lodge 
ǲǡ
into a nursing home, multidisciplinary meaning, you know, which there is now but 
at the moment we have to request it but it should be just rotating around.  You 
ǡǯ-geriatrician, there should 
be dieticians, you know, for the people that have had strokes, the feeding, etcetera, 
Ǥǳ 
Dr Smith, GP serving Kimpton Lodge 
ǲBut, health-wise, I think they do need quite a lot of input.  Not everybody, but there 
are some people in some homes that do, and that they would be better served by the 
kind of model of having more of a team that can give them more intensive care.  
 ǯ          
 ǡ 
Ǥǳ 
Dr Cook, GP serving Brookside Care Home 
Despite this, teams interposed between GPs and care home managers, such as the 
dementia outreach team, community allied health professionals, and care home 
nurse practitioners, described a difficulty in negotiating boundaries to their 
responsibilities when the relationship in which they were interposed (GP and care 
home) was already relatively uncertain and fluid.  This could render them impotent in 
their attempts to influence GPs, care home staff, or both. 
ǲȏ
Ȑǡǡǯ
  ǡ  ǡ       Ǥ    ǡ  ǯ
ǡǯǤǳ 
Abigail, Dementia Outreach Nurse 
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ǲ   ǡ       n ask them [care home staff] to do 
ǡ ǡ ǡ  ǡ ǯǡ 
 ǡ  ǡ ǯ  ǥǤǤǯ 
ǡǯǯǤǳ 
Abigail, Dementia Outreach Nurse 
From the opposite perspective there was a sense, at times, of silo working  W where 
specialist members of the MDT brought recognised expertise but communicated this 
inadequately to GPs, care home staff, or both. 
ǲǯ
ǡ         ǥǥǤ  ǯ   
Ǥǯǡǡ
contact wi Ǥ  ǡ  ǡ ǯ        
ǳ 
Dr Cook, GP serving Brookside Care Home 
Some care home managers described working in an informal capacity to manage and 
co-ordinate the MDT, or to arbitrate between members of the MDT and the GP. 
ǲǯǯ
ǯǡ
ǯǯǡǯǯǡ
ǡǯ
  ǯ   Ǥ       ǡ  
would go through the back door to the dietician and have a word with her and then 


Ǥǳ 
Gillian, Manager, Dynasty Care Home  
Once these issues around negotiated role and routes of communication had been 
addressed, services provided by members of specialist MDTs were recognised as 
having positive effects on the care delivered to residents. 
ǲǯ   ǡ  Ǥ   ǡ ǡ ǡ
best thing that could have happened and I think everybody in the UK or wherever 
ǡǤǳ 
Stephanie, Manager, Chadwyck Manor RH 
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ǲǯǯǡǯ
much they can do.  They come and assess and they caseload, so they do what the 
ǥǤǡ
come and, the activities person come and work with my activities coordinator, they 
deal with the medication, they get the GP to change it and review it as necessary, 
ǡǯǤǳ 
Helen, Manager, Brookside Care Home 
ǲ ȏ   Ȑ ǯ ǡ  ǯ   ǡ
ǯǡǯ
ǡǡis 
ǳ 
Helen, Manager, Brookside Care Home 
4.6.2. Practice 
4.6.2.1. Assessment of patients at admission 
Given the frail, dependent and multimorbid nature of care home residents, alongside 
the fact that they were likely to live in a home from the time of admission until they 
died, it might have been expected that they would receive a comprehensive medical 
assessment at the time of admission.  However, although care home managers 
sometimes assessed residents prior to admission, no respondent spoke of systematic 
assessment by GPs or other healthcare staff at this point.   
ǲǯȏȐ-ǡǯ
ǯǤǳ 
Bella, Trained Nurse, Edenbridge Care Home 
Although systematic assessment might have taken place in hospital prior to 
admission to the care home, it often did not inform management in the home as a 
consequence of missing or poor quality discharge correspondence. 
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ǲ             ǥǤ 
ǡǤǤǤǡǯǡ
you could have some information.  I mean, Sarah [manager] goes to the hospital 
ǯet as much information in advance, and 
ǯǡǯǡ
ǡǯǤǳ 
Dr Sandhu, GP serving Edenbridge Care Home 
Where patients were admitted from the community, as opposed to hospital, it was 
described that social work staff might try to compensate for this lack of medical 
assessment by passing on what healthcare information was available to them.  Care 
home managers, quite reasonably, treated second-hand information of this type with 
a degree of caution, understanding that it was likely to be incomplete. 
ǲ     ǡ      ǯ    
ǯǯistory of heart problems 
ǡǡǡǯ
ǡǡ
ǡǯǤǳ 
Gillian, Manager, Dynasty Care Home 
There was a sense, from some GP respondents, that the reason for not assessing 
patients comprehensively at admission was that to do so would be too difficult and 
time consuming to contemplate. 
ǲ   ǡ  ǡ        ǡ
four iǤǳ 
Dr Smith, GP serving Kimpton Lodge 
4.6.2.2. Transfers of information 
Information flow was described as being particularly poor after a hospital stay.  
Respondents described poor quality discharge summaries and inadequate verbal 
communication, even when hospital staff were asked quite specific questions.    
ǲǡ
weeks, but she went in on, she was already ǥǤǤǡǡ
anaemia which we knew about, and DVT excluded but nothing to justify the new 
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drugs, ondansetron  ǥǥ      ǯ  
ǡǫǳ 
Dr Sandhu, GP serving Edenbridge Care Home 
ǲǯǯ
  ǯ        ǯ  
ǡǯǡǡǮ what 
      ǫǯ    ǡ Ǯ     
ǡǯǯǡǮ
     ǯ    ǯ   
because ǯǤǯǲ 
Camilla, Manager, Kimpton Lodge 
Similar issues were seen, however, when patients were admitted from the 
community.  This was an issue because of delays in transfer of notes when patients 
registered with a new GP. 
ǲǡǥǤǤ
      ǯ  Ǥ       
Ǥǳ 
Dr Cook, GP serving Brookside Care Home   
ǲǯǡǡ
ǯǡ 
    ǯ         ǡ  
wh    ǡ   ǯ       
ǯǥǤeventually, we worked it out that she should be having that one and so, 
ǯǡǯǤǳ 
Gillian, Manager, Dynasty Care Home 
An assumption was made by hospitals that further management and additional care, 
such as occupational therapy and physiotherapy, would follow with ease of access for 
care homes.  This was not the case, with the consequence that care home staff often 
ended up making detailed functional assessments and constructing ad hoc 
rehabilitation plans for themselves. 
ǲǯǤ ǡǯ
 ǯ ǡ  ǡ ǯ    ǯ ǡ   eep getting him to 
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stand, and get a little bit of strength into his legs and things like that, you see.  And 
ǡǯǡǯǯ
that and if we do it like that on a daily basis, then, eventǡǯǡǯ
ǡǯǡǯǡǯǫǳ 
Gillian, Manager, Dynasty Care Home 
ǲ ? ?ǥǤǯǡǯ
ǥ ǯǡǯ
ǡǯ-ǡǯǯ
ǡǯǡǤǳ 
Gabrielle, Manager, Mansfield Lodge 
4.6.2.3. Access to primary care 
Care home staff frequently stated the importance of ready access to advice and/or 
visits from GPs.  This resource was viewed as important regardless of whether homes 
received regular weekly visits, as there was always a possibility that residents may 
deteriorate between times. 
ǲǯ
ǡǤǡ
ǡǡǡǯǡ
 ǯ    ǯ      
ǯ ǥǳ 
Helen, Manager, Brookside Care Home 
ǲ  ǡ ǯǡ
           ǯ  ǯ 
ǯǤǳ 
Bella, Trained Nurse, Edenbridge 
GPs also stated the importance of easy availability, with the possibility that patients 
could deteriorate if medical advice was not provided in a responsive and timely 
fashion.  A tension was noted, however, between ready availability and the 
possibility that this might result in calls of increased frequency to the point that they 
became unmanageable, making it difficult to identify the calls of greatest 
importance.  A number of GP rĞƐƉŽŶĚĞŶƚƐ ĚƌĞǁ Ă ĚŝƐƚŝŶĐƚŝŽŶ ďĞƚǁĞĞŶ  “ŐŽŽĚ ?
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homes, ǁŚŝĐŚ ŵĂĚĞ  “ĂƉƉƌŽƉƌŝĂƚĞ ? ĐĂůůƐ, ĂŶĚ  “ďĂĚ ? ŚŽŵĞƐ, which made frequent 
 “ŝŶĂƉƉƌŽƉƌŝĂƚĞĐĂůůƐ ? ? 
ǲ            
treated and kept them in the residential or nursing home, but by the time you get 
ǡ ǯ  ǡ  
ǡ ǡ  ǡ ǯ   ǡ  ǡ
ǡǯ
ǳ 
Dr Cook, GP serving Brookside Care Home 
ǲǡǡǯ
  ǯ ǡ          
ǡǮǡǯǡǯ
ǡǯ
Ǥǳ 
Dr Mater, GP serving Dynasty Care Home 
ǲ    ǡ     ǡ       
nurses who have, who ǯǡǥǤǤǯ
to the same home, consecutive days for different patients or with ongoing issues 
ǡǯǳ 
Dr Preston, GP serving Mansfield Lodge 
GP practices responded to this tension with an assortment of measures designed to 
organise, triage, or restrict the calls for home visits from care homes, with the knock-
on effect that care home staff found that gaining access to primary care could be 
difficult and slow.  The mechanisms described were loose and informal.  No practice 
spoke of formal and specified triage criteria for dealing with calls from care homes.  
GP receptionists were often cited as performing this difficult role. 
ǲimit, sometimes you have to call before 10, but if something 
like that after 10 I have to do it myself because I have to use my charm again with 
ȏȐǡǤǡǮ
ǯǡǯǤǯǳ 
Gabrielle, Care Home Manager, Mansfield Lodge   
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Informal triage measures could fail in a number of ways.  They could, for example, 
result in failure to identify medically unwell patients, who subsequently deteriorated, 
requiring admission. 
ǲǡǡ
had been put through to reception as just a routine sort of unwell sort of thing, the 
ǯǡǤǳ 
Dr Cook, GP serving Brookside Care Home 
Or they could place unreasonable demands on care home staff, which contrary to the 
stated aim of informing the GP assessment, simply added delays to care. 
ǲȏȐom a demented patient so they [GP receptionist] 
ǯǯǡǯ
one so they [care home staff] end up with the patient getting more and more 
confused and more and more ill until they end up having to get the doctor to do a 
ǳǤ 
James, Care Home Nurse Practitioner 
A knock-on effect was that some care homes spoke of being afraid to contact GPs on 
ďĞŚĂůĨŽĨƚŚĞŝƌƌĞƐŝĚĞŶƚƐ ?^ŽŵĞŵĂŶĂŐĞƌƐƐƉŽŬĞŽĨĂĚĞƐŝƌĞƚŽĂǀŽŝĚ “ŝŶĂƉƉƌŽƉƌŝĂƚĞ ?
callƐ ƚŽ ĂǀŽŝĚ ďĞŝŶŐ ŝĚĞŶƚŝĨŝĞĚ ĂƐ Ă  “ďĂĚ ? ŚŽŵĞ ? ŝŶ ŽƌĚĞƌ ƚŽƉƌŽƚĞĐƚ ĂŶ ĞĨĨĞĐƚŝǀĞ
working relationship with their GPs. 
 ǲ  ǯ   ǡ     -call doctor, you know, instead of 
ǡǮǡǯǯǡǯǤǯǳ 
Gabrielle , Care Home Manager, Mansfield Lodge 
ǲ
  Ǥ       Ǥ  ǯ      ǯ  
doctors in this area who want to come and do home visits.  They will come if they 
Ǥǳ 
James, Care Home Nurse Practitioner 
ǲ   
ǡ  
   ǡ    ǡ
because I think they know that we respect them and how busy they are and, and I 
think they, you know, they understand that, like, if they come into Dynasty House, 
ǯǤǳ 
Gillian, Manager, Dynasty Care Home 
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This meant that some homes installed informal and loose triage measures of their 
own.  The end result being that residents faced not just one, but two, possible delays 
between becoming ill and seeing a doctor. 
ǲǯǡǯolour today, that you should 
ǡǯ
ǯ      ǡ   ǯ       
ǡǡǯ
ǳ 
Gillian, Manager, Dynasty Care Home 
ǲǡǡ
or a few people is very confused and we check has got no urine infection or 
temperature, you know, or and we call doctor and make appointment for few 
peopl ? ?ǳǤ  
Agnes, Care Assistant, Dynasty Care Home 
4.6.2.4. Anticipatory care  
As already described, residents were reported to have prevalent chronic illness, 
manifest frequent fluctuation and/or decline and be in the last months or years of 
life.  Despite this, examples of anticipatory care which attempted to put in place 
advanced plans against such deterioration were few and far between.  This stemmed, 
in part, from the failure to assess residents at the point of admission to the home, 
meaning that no structure existed around which to consider the impact of medical 
morbidity on either quality of life or health service resource use.  This led to conflict 
around the management of progressive conditions that might have been avoided had 
anticipatory care plans been in place. 
ǲ          ǡ    ǡ 
daughter was here on a regular basis, and all I wanted [was] adequate pain relief 
for him, we all knew what wǡǯ
ǡǡǡǮ
ǯǡǯǯǡǮǤǯȏǡȐǮǤǯ
ǯǡǮǯǤǯǡǮǯǡǯǡǮǡ
ǯǳ 
Bella, Trained Nurse, Edenbridge Care Home 
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ǲǥǤǡ
chest infections and she was asthmatic, and we had a GP come out to visit us from 
ǥǤǤȏȐǡ
 ǡ     ǡ   ǯ    
right...myself and the team, the nurse that was on was really quite upset about it, 
ǯǯǡǯ
ǯǳ 
Sarah, Manager, Edenbridge Care Home 
ǲ tests came through, this lady was desperately in need of blood 
     ǡ ǮǤǯ  ǡ      
  ǡ   ǡ    ǡ  ǡ  ǯ  
decent quality of life, I mean, ǯǡ
her blood was down to something like four or something like that, and, and she 
  ǡ     ǡ ǮǤǯ  ǡ    
ǡǤǳ 
Gillian, Manager, Dynasty Care Home 
A further consequence was admissions to hospital, or attendances at outpatients, 
that were either distressing for patients, or did not influence their prognosis and thus 
might have been regarded as both avoidable and inappropriate. 
ǲǡǡ
of hospital, and the GP was quite triumphant because she survived, because she was 
on IV antibiotics. She died eight days later, and I was not quite so triumphant 
  ǯ      ǯ       
ǳ 
Sarah, Manager, Edenbridge Care Home 
 ǲǡǡ
hours of consoling her, reassuring her, she was beside herself, she was shaking, 
ǡǡ  ȏȐǡǡ Ǥ ǯǡ 
          ǡ  ǯ    
ǡǯǡǯǯ
ǯǤǤǳ 
Helen, Manager, Brookside Care Home 
On a day-to-day basis, the failure to anticipate fluctuation or decline  W or to institute 
an advanced care plan which allowed for the possibility of such decline  W led to the 
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need to use out-of-hours services. These were generally recognised as providing sub-
ŽƉƚŝŵĂůĐĂƌĞĚƵĞ ƚŽĚŝƐĐŽŶƚŝŶƵŝƚǇŽĨƉƌŽǀŝƐŝŽŶĂŶĚ ƚŚĞ ŝŶĂďŝůŝƚǇ ƚŽĂĐĐĞƐƐ ƌĞƐŝĚĞŶƚƐ ?
normal healthcare records. 
ǲ ȏut-of- Ȑ ǯ     ǡ  ǫ  ǯ
ǡǯǡǡ-ǡǡǡǮǡ
ǯǯǡǯ
that persǡǤǤǤǤǡǯǤǳ 
Gillian, Manager, Dynasty Care Home 
ǲǯat Kimpton Lodge that when we do 
need to put somebody on the [Liverpool Care Pathway] ǯ	 
ǯ
ǯǤ
ǯ
ǯǳ 
Camilla, Manager, Kimpton Lodge 
Some of the GPs spoke of feeling disempowered to make decisions for their own 
patients in conditions which, by consequence of their life-threatening nature, had 
been identified as the preserve of the emergency services.  This was the case for 
chest pain, where the policy was for GPs to advise homes to call an ambulance rather 
than to attend and assess the resident, for fear that they might delay timely 
treatment of a myocardial infarction. One GP spoke of her fear that attempts to 
develop hyper-acute stroke care within the UK along similar lines might further 
disempower her.  None of the respondents identified advanced care planning as a 
means whereby control could be asserted over such situations. 
ǲ          ǯ    a barge 
ǥǤǯǡǡ
 ǡ   ǡ     ǯ    
attacks, that this is something that affects young people and the quicker we can get 
the anti-embolism stuff into them then the better....but I think strokes are hugely 
different from heart attacks because I do think they affect an older population and 
....ǯǤǳ 
Dr Mater, GP serving Dynasty Care Home 
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Some of the GPs seemed to provide paradoxical accounts of their attitudes towards 
anticipatory care, providing some evidence of a failure to learn, or reflect upon, this 
topic in the elderly.  This was the case when preventative medicine and anticipatory 
care were conflated, rather than treated as being separate.  Thus Dr Preston, below, 
described inevitable decline as a rationale for not instituting proactive care plans, 
using the lack of evidence for preventative medicine in this cohort as his justification. 
ǲǯǡǡ
the problem is, they are just very old and frail and things are going to go wrong, 
ǯǫ  ǡ  Ǥ ǯ
sort of in your eighties and nineties, all that sort of preventative idea, might have 
ǡȏȐǯǤǳ 
Dr Preston, GP serving Mansfield Lodge 
GPs spoke about difficulty in deciding whether generic preventative medicine 
guidelines applied in care home patients. However, even those who were cynical 
about preventative medicine in this population could cite examples where it might 
have relevance  W with calcium and vitamin D therapy quoted by several respondents 
as an example. 
ǲǡǫ-ǯ
    ǯ    ǯ ǡ    
ǫǳ 
Dr Sandhu, GP serving Edenbridge Care Home 
 ǲ     ǯ      ǥǥ ǡ ǡ
Fosamax, alendronate acid, you know, things have, preventative strategies that are 
ǡǡǤǳ 
Dr Preston, GP serving Mansfield Lodge 
All respondents seemed to accept the fact that residents within homes were 
approaching the end of their life.  GPs tended to speak of this in epidemiological 
terms and with a degree of detachment, whilst care home staff more often became 
emotional.  Importantly, any attempts described to formalise advanced care planning 
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that might encompass end-of-life plans had been led by the care home staff rather 
than GPs. Some GPs spoke of care home leadership on such issues with a degree of 
discomfort but also acknowledged that the close relationship built between care 
home staff, residents and their families, meant that staff in homes were well placed 
to do this. 
 ǲǮǯ
these [advanced care planning] forms and a lot of you have sent them back saying 
 ǯ  Ǥǯ    Ǯ    
ǯǯ
is isǯ                 
ǯǳ 
Camilla, Manager, Kimpton Lodge 
ǲȏȐǡ Ǯǡǯ
ǯǡǯǯǤ
          ǡ  ǯ
       Ǯǡ ǡ   ǯ   
ǡǯǯǤ  ȏȐǯǳ 
Dr Sandhu, GP serving Edenbridge Care Home 
ǲǡȏȐǡǡǡ
 ǡ ǡ ǯ    ǥǤ ǯ ǥǤǯ
just, there are some medical questions because they, that the nursing home, 
ǡ ǯ ǤǥǤǤ     Ǥ  ǡ  
ǡǯǡǳ 
Dr Sandhu, GP serving Edenbridge Care Home 
Some of the vulnerability felt by GPs in this context seemed to stem from 
nervousness around the prescribing of opioids in patients who had non-oncological 
diagnoses and a feeling that such practice might leave them vulnerable to challenge  W 
particularly in dementia, where prognostication was felt to be difficult.  This 
remained the case even when guidelines such as the GSF, were used. 
ǲǯ    
	          ǯ   
drugs in it, and basically we have those drugs so that we can use them, that are 
prescribed, we have to have them prescribed specifically for the patient, but with 
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       ǡ   ǯ 
finding is that the GPs are saying tǡǮǯ
     ǯ     ǡ ǯ     
ǯǳ 
Bella, Trained Nurse, Edenbridge Care Home 
ǲǯ
	 ǯǡ Ǥ ǡw we 
ǯǡǯǤǯ
ǡǫǳ 
Dr Sandhu, GP serving Edenbridge Care Home 
4.7. Discussion 
/Ŷ ƚŚĞ ŝŶƚƌŽĚƵĐƚŝŽŶ ƚŽ ƚŚŝƐ ƚŚĞƐŝƐ ? ' ǁĂƐ ĚĞĨŝŶĞĚ ĂƐ ?  “ĂŵƵůƚŝ-
dimensional interdisciplinary diagnostic process focused on determining a frail 
ĞůĚĞƌůǇƉĞƌƐŽŶ ?ƐŵĞĚŝĐĂů ?ƉƐǇĐŚŽůŽŐŝĐĂůĂŶĚĨƵŶĐƚŝŽŶĂů capability in order to develop a 
coordinated and integrated plan for treatment and long-term follow-ƵƉ ? ?24  Several 
of the respondents to STICH, whilst stating their discomfort or dissatisfaction with 
current healthcare arrangements for care home residents, defined an idealised 
service as one which was multidisciplinary and sufficiently expert and resourced both 
to assess the current health status of complex frail older people and to plan for 
future changes in their health.  Although not mentioned by name, this seems close to 
a call for CGA. 
It was evident from the transcripts that CGA was not being delivered.  Healthcare was 
described as being, for the most part, defined by discontinuity and lack-of-
anticipation.  Residents frequently moved to a new GP when they moved to a care 
home or changed between homes. It was described that appropriate and available 
care home places were often not geogrĂƉŚŝĐĂůůǇĐůŽƐĞƚŽƌĞƐŝĚĞŶƚƐ ?ůŽŶŐƚĞƌŵŚŽŵĞƐ ?
GP interviewees, meanwhile, spoke about the need to visit most care home residents 
in situ, with consequent difficulty in looking after residents who were geographically 
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remote.  Taking these points in summation it seems logical, or at least defensible, for 
a resident to change GP when they are admitted to a care home.  This would allow 
them to have a doctor close enough to visit their home rather than remain under the 
care of a long-term GP who might struggle to attend.  
Discontinuity at the point of admission was made more challenging by residents 
arriving at a home either following a progression in a chronic condition or whilst 
recovering from an acute medical crisis.  This seems unavoidable given the position 
that care homes occupy in the modern health and social care continuum, widely 
acknowledged by interviewees, as the point of final refuge  W the place that care 
recipients go when nowhere else will, or can, provide care.  
ĐĐĞƉƚŝŶŐ ƚŚĂƚ Ă ƌĞƐŝĚĞŶƚ ?Ɛ ĂĚŵŝƐƐion to a home will often be defined by medical 
instability and change of GP, it would seem intuitive that they undergo 
comprehensive medical assessment to establish management priorities at this time. 
Much of this medical assessment might have taken place before the resident arrives 
at a care home, given that they will previously have been seen by a GP or hospital 
doctor about the chronic conditions, or the acute medical crisis, which shaped their 
admission. Interviews suggested, however, that the results of such pre-admission 
assessments were usually not passed onto the new GP, or to care homes.  Discharge 
communication from hospitals was inadequate, whilst GP records could take months 
to catch up with the resident.  New GPs made no attempt to compensate for this by 
undertaking comprehensive medical assessment at the point of arrival to the care 
home.  GPs, where they discussed this, seemed to perceive such comprehensive 
assessment as being too much work. Attempts to establish advanced care plans  W 
predominantly focused around end-of-life care  W were occasionally described as 
being undertaken by care home managers and staff.  However, due to the lack of 
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medical assessment already described, these were conducted in partial or complete 
ignorance of medical problems.  They were also, for the most part, conducted with 
minimal or limited input from primary healthcare teams. 
One key component of CGA  W multidisciplinarity  W was evident in the transcripts. 
Doctors, nurses, care assistants, physiotherapists, occupational therapists, dieticians, 
social workers and speech and language therapists were either interviewed, or 
spoken about as being involved in care delivery by interviewees.  However, far from 
acting as a single coherent multidisciplinary team, they showed evidence of silo 
communication where each profession would speak only to the care home staff, or 
only to the GP, or occasionally only to another professional attending the home.  This 
is different from the type of MDT communication which sits at the core of CGA, 
which is multidirectional and, by virtue of taking place at widely-attended MDT case 
conferences, allows broad understanding and sharing of ideas (illustrated in Figure 
15).   
 
Figure 15 - MDT communication as routinely conducted during CGA 
Chapter 4  W Staff Interviews in Care Homes (STICH) 
198 
 
The mode of communication described in interview transcripts was variable. At its 
best, the care home manager, or occasionally the GP, was used as a de facto care 
coordinator and therefore all communication was channelled through them (see 
Figure 16).  This had the advantage, at least, of ensuring that there was one person 
ǁŝƚŚĂŶĞĂƌĐŽŵƉůĞƚĞŽǀĞƌǀŝĞǁŽĨĂ ƌĞƐŝĚĞŶƚ ?ƐŚĞĂůƚŚĐĂƌĞ ? /ƚ ŚĂĚ ƚŚĞĚŝƐĂĚǀĂŶƚĂŐĞ
that the person chosen  W either care home manager or GP  W had to act as an 
information conduit to other professions and might not understand, for example in 
discussions with a physiotherapist, which aspects of that discussion would be most 
relevant to a social worker, or general practitioner.  This represents a challenge to 
effective multi-disciplinary working. 
 
Figure 16 - MDT working in care homes where care home manager acted as de facto care 
co-ordinator 
However, in some instances, it was clear that not all communications were 
channelled through the care home manager or GP, with the result that no single 
professional was able to co-ordinate care. This was the least functional model of 
MDT communication described.  It had implications for the resident, with poorly 
coordinated and disjointed care (see Figure 17).  
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Figure 17 - Dysfunctional MDT communication as seen in some care home settings 
Accepting that CGA did not take place for residents, whilst acknowledging that most 
respondents seemed to call for a process analogous to CGA, the next question is why 
it did not take place.  The transcripts suggest the explanation to encompass: a lack of 
training and expertise in managing frail older patients, which was evident in all 
professional groups; the arbitrary boundaries drawn between care homes and the 
NHS that interfered with effective multidisciplinary care; and a failure to adequately 
structure GP relationships with care homes. 
4.7.1. Inadequate training and expertise in the management of 
frail older patients 
CGA could not take place because those providing care felt insufficiently 
knowledgeable to conduct detailed assessment of residents and put in place 
individualized care plans. Staff from all sectors reported struggling with complexity, 
multi-morbidity, cognitive impairment, functional dependency and, perhaps most 
tellingly, the ethical dilemmas and communication challenges that surrounded end-
of-life care.  GPs spoke of difficulties in applying their generic skills, for example the 
preventative medicine that they practice so competently for other population 
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groups, in this cohort.  They identified challenges in weighing the benefits and risks of 
treatments, including when to admit residents to hospital following acute 
deterioration.  They found management of cognitive impairment, behavioural 
problems and prognostication in patients with dementia particularly challenging.  
The minimal training required to work as a member of care home staff was a source 
of concern for respondents working in both the NHS and care home sectors, however 
it was evident from several of the transcripts that care home staff possess a body of 
tacit expertise in day-to-day assessment and management of health problems.  They 
described how these skills were brought to bear to support nutrition, mobility, 
continence and manage cognitive deficit and behavioural disturbance. Care home 
staff were also clearly experts on their own residents and what represented 
normality for them. This meant that they were able to identify, often subtle, 
deviations from the norm which might herald a medical problem. Failure by NHS staff 
to recognize and capitalize on these bodies of expertise was arguably to the 
detriment of residents.   
Specialist expertise was available in the community in the shape of dementia 
outreach nurses, district nurses, care home nurse practitioners and routine provision 
from community SALT, OTs, physiotherapists and dieticians.  This expertise might 
have gone some way to addressing the identified knowledge deficiencies amongst 
both GPs and care home staff.  These specialists, however, found it difficult to 
integrate themselves into existing relationships between GPs and care homes.  At its 
worst, they found themselves unable to influence care homes, GPs or both. 
Integration might have been less difficult had communication taken place along the 
more open lines typical of a CGA MDT as described above, however, this group in 
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particular were singled out for failure to include all relevant parties in their 
correspondence.  
4.7.2.  Arbitrary boundaries between care homes and the NHS 
Both of these failures  W to recognize the expertise of care home staff and to 
effectively capitalize on the specialist knowledge of community-based specialists  W 
were a symptom of the larger issue of the arbitrary but widely acknowledged 
boundaries drawn between care homes and the NHS.  
It was clear from the transcripts that care homes were a venue for care in all its 
forms.  Care and caring, in their lay sense, were evident in the strong sense of 
responsibility and advocacy which care home staff spoke of feeling  W and, by 
anecdote, of delivering  W for their residents.  Social care, when defined as support 
with activities of daily living and functional impairment, comprised a significant 
amount of the routine work described by staff. Healthcare  W as evidenced by the 
detailed attention to nutrition, mobility, continence, behaviour and cognition, 
alongside daily vigilance for evidence of medical deterioration  W was also an 
important part of their role.  Many of the routines described in homes were focused 
around these health domains.  Thus, for care home staff, the boundaries between 
caring, social care and healthcare were blurred.  Healthcare staff, meanwhile, 
seemed more able to identify a clear boundary around their professional obligations 
to residents.  This is perhaps unsurprising given that their contact with residents was 
usually indication-specific and time-limited.        
Despite the fact that care home staff were an integral part of healthcare delivery, 
most respondents showed a readiness to draw clear distinctions between health and 
social (or private- and state-employed) care which at times amounted to battle-lines.  
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These comments generally served, however, to reveal a marked similarity in the 
challenges faced by staff across care sectors.  All recognized that training in their 
sector was inadequate.  All recognized significant stresses in delivering care which is 
of high quality, whilst also responding to cost pressures  W albeit that in care homes 
these were around maintaining a working profit, whilst in the NHS they were around 
cost-reduction.  All recognized the growing threat of litigation, perhaps using this as 
an expression of the increasing role of regulation, accountability and governance in 
all aspects of care.   
As discussed above, failure to establish effective lines of communication between 
health and social care staff frustrated attempts at multidisciplinary working and 
contributed to failure to recognize or capitalize upon expertise already present. 
There is a significant body of health and social policy literature suggesting that the 
boundaries between health and social care, as drawn within the UK, are in many 
ways arbitrary582-584. From a political standpoint, attempts to integrate or harmonise 
social care, which is means-tested and locally coordinated, with healthcare, which is 
free at the point of delivery and nationally coordinated, have long been seen as 
contentious and difficult to deliver without wide-sweeping and potentially unpopular 
reforms to the finance of health and social care585-587.  A detailed interrogation of 
these issues is beyond this thesis. It is perhaps sufficient to note that, within STICH, 
ĐĂƌĞǁĂƐƌĞƉŽƌƚĞĚĂƐďĞŝŶŐĂƚŝƚƐ ?ŵŽƐƚĞĨĨĞĐƚŝǀĞǁŚĞƌĞE,^ĂŶĚĐĂƌĞŚŽŵĞƐƚĂĨĨŚĂĚ
established clear lines of responsibility and communication, which allowed frank 
ĚŝƐĐƵƐƐŝŽŶŽĨ ƚŚĞĚŝĨĨŝĐƵůƚ ŝƐƐƵĞƐ ĨĂĐĞĚ ŝŶ ƐƵƉƉŽƌƚŝŶŐ ƌĞƐŝĚĞŶƚƐ ?ŚĞĂůƚŚ ?dŚŝƐwas the 
case in Edenbridge care home.  To deliver this, front-line staff had to recognize the 
arbitrariness of the boundaries drawn between health and social care and work to 
mitigate them.  Broader systematic reform might act a facilitator to this type of 
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integrated working but dedication to teamwork amongst front-line staff is the 
necessary pre-requisite, regardless of the policy context.   
4.7.3. Failure to adequately structure GP relationships with care 
homes 
Care homes which had to engage with multiple GPs from different practices  W n>1:1 
relationships  W found it difficult to accommodate their differing approaches to 
healthcare and acute medical crises.  This was contrasted by the consistency of 
relationships described by homes with 1:1 relationships with GPs.  These 
relationships were not always described as satisfactory.  Both the staff of Kimpton 
Lodge and the GP who served the home described a relationship which, although 
consistent, was consistently dysfunctional and defined by conflict and mistrust.  City-
based GPs, whilst acknowledging some benefits to 1:1 working, described the 
significant challenges in establishing such relationships, including work and 
contractual arrangements with neighbouring practices and the need to account for 
patient choice. 
Similar difficulties were identified around the issue of scheduled weekly contact.  
Staff at Edenbridge described this as central to effective anticipatory care and the 
multidisciplinary work across health and social care boundaries which defined their 
approach.  GPs in other settings acknowledged theoretical benefits to regular visiting, 
particularly building closer relationships with care home staff and establishing a 
ĐůŽƐĞƌ ƵŶĚĞƌƐƚĂŶĚŝŶŐ ŽĨ ŚŽǁ ƌĞƐŝĚĞŶƚƐ ? ŚĞĂůƚŚ ĐŚĂŶŐĞĚǁĞĞŬ-to-week. They 
conducted pilots of regular visiting but reported abandoning these, not because of 
failure to realize the hoped-for gains in communication, teamwork and continuity, 
but because they failed to reduce the number of calls for GP attendances between 
programmed visits. This is, perhaps, typical of local initiatives in the NHS, where 
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failure to establish sufficiently robust outcome measures at the commencement of a 
service result in its abandonment for reasons unrelated to the specified service 
objectives. 
Why some GP:care home dyads were able to realize the benefits of structured 
relationships invoking 1:1 relationships and regular visiting, whilst others were not, is 
unclear.  It is, however, likely that the satisfactory results seen by Edenbridge were a 
factor not only of their structured relationship with a GP but also broader aspects of 
their practice, such as their work to overcome and dispense with the arbitrary 
boundaries between health and social care already described above.  This allowed 
them to make the most of their structured relationship.  A structured GP-care home 
relationship is perhaps, therefore, necessary but not sufficient to ensure delivery of 
integrated, organized care. 
 ?Ǥ ?Ǥ ?ǤǥǤ
 
Bringing these threads together, STICH suggests that in order for CGA to work in care 
homes the following criteria would require to be met: 
 It would have take place in the care home because residents find it difficult 
to travel to healthcare due to their significant functional dependency and 
cognitive impairment. 
 Staff from all disciplines necessary to conduct a comprehensive assessment 
ŽĨ ƌĞƐŝĚĞŶƚƐ ? ŚĞĂůƚŚ ĂŶĚ ĨƵŶĐƚŝŽŶĂů ƐƚĂƚƵƐ ǁŽƵůĚ ŚĂǀĞ ƚŽ ǁŽƌŬ ŝŶ ƚŚĞ
community and be able to travel to care homes.  For the most part these 
team members were described as already being in place. 
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 Staff from all disciplines would have to be appropriately trained in the 
assessment and management of frail older patients in order to participate.  
For specialists based in the community  W such as care home nurse 
practitioners, dementia outreach teams, dieticians, physiotherapists and 
occupational therapists  W this expertise was reported already to be in place. 
For care home staff and general practitioners, deficiencies were reported. 
The possible responses to this are manifold. Taking the issue of GPs, for 
example, additional training in the management of older patients could be 
provided. Alternatively specialist geriatricians could replace GPs in some or 
all aspects of care home support. A third possibility would be more robust 
provision of specialist advice from geriatricians and old age psychiatrists for 
GPs.  
 Staff from all disciplines would have to function like a geriatric medicine 
MDT, with open and transparent communication to which all team members 
were party. Within this context, a nominated care coordinator or key worker, 
whether doctor, nurse or member of care home staff, would have to be 
recognized. 
 To facilitate the above, clear roles and lines of responsibility within the MDT 
would require to be identified. These would have to be aligned with patient 
care requirements rather than arbitrary distinctions between health and 
social care which, although widely recognized, seem to have little resonance 
with the needs of residents. 
 If such a team were to function effectively and if GPs were to remain central 
to management of care home residents, then structured relationships 
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between GPs and care homes would be required.  1:1 relationships and 
regular visiting seem logical and were reported to provide consistency of care 
where they were part of a broader programme of multidisciplinary working. 
Whilst such arrangements were not always reported as meeting with 
success, a positive impact would seem more likely if the other measures 
outlined above were in place.   
4.8. Conclusion 
Numerous frustrations with the existing model of healthcare delivery for care homes 
were identified.  Some of these are unlikely to change.  Residents will inevitably be 
frail, dependent and approaching the end of their life.  They will continue to have to 
change GP at the time of admission to care home.  They will frequently arrive at care 
homes following a deterioration in chronic conditions or an acute medical crisis. 
CGA seems a reasonable response to these challenges and maps closely to the sort of 
multidisciplinary care models, driven by assessment and appropriate expertise, 
highlighted by many respondents as a solution to the daily challenges of delivering 
care in care homes. 
CGA is not currently being delivered. The staff required to deliver it are, for the most 
part, already in place but they are prevented from acting to deliver coordinated 
multidisciplinary care by a combination of: lack of training and expertise; arbitrary 
boundaries drawn between health and social care, which hamper communication 
and have little relevance to the lived reality of residents; and inadequate 
organizational structures around which MDTs can coalesce.  
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Chapter 5 Ȃ Conclusion 
In conclusion, there is a role for Comprehensive Geriatric Assessment in UK care 
homes. 
Chapter 1 presented care homes as integral to long-term care of older people in the 
UK. It suggested that care homes would be part of the care landscape for the 
foreseeable future.  Demographics are such that the sector is likely, in fact, to grow.  
It highlighted that care homes have evolved significantly over the last 25 years, with a 
trend towards increasing dependency amongst residents (an assertion which was 
subsequently borne out by the findings of CHOS and STICH in chapters 3 and 4). 
Healthcare support to care homes has been slower to evolve.  The default model of 
healthcare delivery  W the GMS contract  W is the same for care home residents as it is 
for community dwelling patients.  This has been shown to result in failures of quality 
and safety in healthcare, and inequalities in healthcare access to the disadvantage of 
residents. Quality Outcomes Framework targets, meanwhile, have been shown to be 
either not achieved, or not achievable.   
CGA is a model of healthcare delivery which involves comprehensive and detailed 
ĂƐƐĞƐƐŵĞŶƚ ŽĨ Ăůů ĂƐƉĞĐƚƐ ŽĨ Ă ĨƌĂŝů ŽůĚĞƌ ƉĂƚŝĞŶƚ ?Ɛ ŚĞĂůƚŚ ĂŶĚƐƵďƐĞƋƵĞŶƚ
implementation of an individualised management plan, with regular review and 
follow-up.  It is defined by multidisciplinarity and regular meetings of the MDT, 
where each part of the team is kept abridged as to what is happening elsewhere in 
ƚŚĞƉĂƚŝĞŶƚ ?ƐĐĂƌĞ ?  /ƚŚĂƐĂƐƚƌŽŶŐĞǀŝĚĞŶĐĞ-base in a number of settings, including 
acute hospital inpatients, day hospital and early supportive discharge in a community 
hospital setting.    
It was suggested, based upon the available evidence, that the cohort in care homes 
had much in common with the cohorts from other settings where CGA had been 
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shown to improve care, in so much as they were old and frail. There was reason to 
believe, therefore, that CGA might have a role in improving care for residents. Indeed 
CGA had been shown to work in the long-term care sector in other countries but the 
significant international differences in how long-term care was provided were such 
that these interventions could not be assumed to have a role within the UK. 
Three discrete but overlapping pieces of research were proposed to address the 
question of whether CGA had a role in the UK care home sector: 
 The Care Home Literature review (CHoLiR) would describe the research 
conducted using RCTs in care homes to establish whether an evidence base 
for CGA  W or component interventions which might comprise part of CGA  W 
had already been built. 
 The Care Home Outcome Study (CHOS) would comprehensively describe the 
health and functional status of care home residents, and how they use NHS 
resources. 
 The Staff Interviews in Care Homes (STICH) would describe how care home 
staff and the healthcare professionals who work with them identify and 
respond to ĐŚĂŶŐĞƐŝŶƌĞƐŝĚĞŶƚƐ ?ŚĞĂůƚŚ ? 
CHoLiR was presented in Chapter 2. It started from the premise that, in order to 
review the evidence-base for CGA in care homes, it would be necessary not only to 
search for studies focussing on CGA, but also studies of sub-components of CGA 
which, when combined, might build some of the case for the intervention.  It 
focussed on RCTs on the basis that these are perceived as the gold-standard 
evaluative methodology in medical research. CHoLiR demonstrated that much 
research work had been undertaken in care homes, that most of it had taken place 
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outside of the UK but that a significant proportion of the findings were applicable 
here. It showed an acceleration of the rate of care home publications over the last 10 
years. It found 10 studies which evaluated CGA or case management as a whole 
intervention, however these were either too narrow in their remit  W focussing on 
predominantly psychogeriatric interventions  W to shed light on the broader question 
of whether CGA had a role, or had significant methodological shortcomings, a 
recurrent theme being the failure to account for clustering in the population.  There 
was, however, evidence for a number of component interventions which might 
comprise a part of CGA: advanced care planning; pharmacy interventions to reduce 
prescribing; staff education around prescribing, dementia and end-of-life care; 
calcium and vitamin D in preventing fractures; alendronate in preventing 
osteoporosis; influenza vaccination; oseltamivir or zanamivir for influenza 
prophylaxis; functional incidental training and bladder training for incontinence; and 
risperidone and olanzapine for agitated behaviours in carefully selected patients 
under expert guidance. Only hip protectors had been conclusively shown not to 
work.  For all other interventions, the literature was inconclusive.  The breadth of 
interventions evaluated and the relatively broad spectrum of targets suggested a 
need for broad-ranging expertise transecting a number of disciplines, making a case 
for multidisciplinarity in the healthcare response to care homes.   
One of the outstanding questions at the end of Chapter 2, was the extent to which 
the gaps identified in the care home literature could be filled by evidence from other 
settings. Considering the data from CHOS, it is clear that there are many similarities 
between the frail older patients seen in care homes and those seen elsewhere. This 
was seen, for example, in comparison with the historical cohort studied by Hubbard 
et al
514 from NHS long-term care. Clearly, if RCT-evaluations previously conducted in 
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these long-term care patients had shown positive outcomes, there would be a case 
for considering them in care homes. This line of argument is much more logical for 
interventions at the individual resident level, such as drug-based and some 
rehabilitative interventions, than it would be for home-level interventions, such as 
changes to institutional routines to, for example, promote feeding or reduce 
restraint. The answer seems to be that, if there were demonstrable similarities 
between the sample in an individually-randomized RCT and the cohort described in 
CHOS, then there might be a case for extrapolating findings to care home residents. 
Deciding which research findings to extrapolate, and in which patients, would be 
likely to require skill and knowledge both of the care home cohort in general and the 
home and patient under consideration in particular. 
CHOS was presented in Chapter 3.  Existing cohort studies and surveys conducted in 
care homes had described a cohort of patients that was disabled, cognitively 
impaired and near the end-of-their lives, with prevalent syndromes and diagnoses 
matching the profile of other cohorts where CGA had been shown to be effective.  
Residents were thought to access NHS resources differently to patients who lived in 
their own homes. Detail was lacking, however, and some of the data was out of date. 
There were issues with the accuracy with which medical diagnoses had been 
recorded and some issues around response bias in existing studies. By conducting a 
detailed longitudinal cohort study, which took data from health and social care 
records, as well as directly from residents and care home staff, CHOS addressed the 
issues of accuracy, response bias and contemporaneity in the existing literature, as 
well as providing data on diagnoses, dependency, prescribing and resource use at a 
level of detail not previously seen for care homes. It described a cohort with 
significant physical dependency, with care needs driven by immobility, incontinence, 
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cognitive impairment and behavioural disturbance. It demonstrated a high 
ƉƌĞǀĂůĞŶĐĞ ŽĨ ŵĂůŶƵƚƌŝƚŝŽŶ ? Žƌ ƌŝƐŬ ŽĨ ŵĂůŶƵƚƌŝƚŝŽŶ ? /ƚ ĚĞƐĐƌŝďĞĚ ƌĞƐŝĚĞŶƚƐ ? ŵĞĚŝĐĂů
problems as being dominated by chronic illnesses and end-of-life considerations. It 
identified significant issues with polypharmacy and under-diagnosis of dementia 
ǁŚŝĐŚ ƐƵŐŐĞƐƚĞĚ ƚŚĂƚ ĐƵƌƌĞŶƚ ĐĂƌĞ ŵŽĚĞůƐ ǁĞƌĞ ŶŽƚ ŵĞĞƚŝŶŐ ƌĞƐŝĚĞŶƚƐ ? ŶĞĞĚƐ ? /Ŷ
presenting these findings it demonstrated a need for input from specialist nurses, 
mental health services, palliative care services, occupational therapists, 
physiotherapists, dieticians and general practitioners. The extent to which 
geriatrician involvement was mandated by the findings was not clear. Obviously, 
general practitioners are experts in the management of chronic diseases and might 
not require much support in this respect. However, the high prevalence of 
multimorbidity and of syndromes in which geriatricians have specialist expertise, the 
under-diagnosis of dementia and the dominance of end-of-life issues  W which are 
notoriously complex in frail elders  W all suggested a possible role for geriatricians.   
An additional important finding from CHOS was the significant variability seen 
between residents within homes, and between homes. Dependency, cognition, 
behaviour, multimorbidity, prescribing, death rate, proximity to death and NHS 
resource use all demonstrated both wide variability and significant clustering. In this 
context, the level of input from each of the specialists already described would be 
expected to vary significantly from individual to individual and, more importantly, 
home to home. The only logical response to this  W if redundancy of staff and 
resources was to be avoided  W would be to ensure that management planning and 
allocation of resources was preceded by comprehensive and detailed assessment of 
individuals and homes.   
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Given that many of the resources required to fulfil the needs identified in Chapter 3  W 
specialist nurses, occupational therapists, physiotherapists, dieticians, end-of-life-
care teams, mental health teams, and general practitioner  W were already in place in 
the community, it was possible that CGA was already taking place intuitively under 
the auspices of the GMS contract.  STICH, summarised in Chapter 4, set out to 
explore the existing healthcare arrangements in place for care homes.  It did not 
describe that CGA was already in place. Instead it described a situation defined by 
discontinuity and lack-of-anticipation. These were driven by failures of 
communication, inadequate training and expertise in the management of frail older 
patients, arbitrary boundaries drawn between care homes and the NHS which acted 
as barriers to care and did not stand up to close scrutiny, and failure to adequately 
structure GP relationships with care homes. Importantly, it described that much day-
to-day healthcare was provided by care home staff and identified a body of tacit 
expertise amongst the care home workforce which, if harnessed, could help to 
optimise the management of resideŶƚƐ ? ŚĞĂůƚŚ ? ZĞƐƉŽŶĚĞŶƚƐ ƚŽ ^d/, ĚĞĨŝŶĞĚ ƚŚĞ
idealised model of healthcare as being one which was multidisciplinary, defined by 
expertise in care of the elderly and sufficiently resourced to assess residents in detail 
and plan for their future based upon these assessments. 
Thus there is evidence that the ideal model of healthcare for care home residents 
would be one which: 
 Takes place in the care home. 
 Recognises and keeps up-to-date with the growing body of care home-
specific literature. 
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 Has the skills and knowledge to implement the findings from the emerging 
care home evidence-base and to interpret when evidence from other 
settings can be applied in the care home sector. 
 Has the specialist expertise required to meet the care needs identified in 
CHOS and reported by the respondents to STICH.  This would mandate input 
from physiotherapists, occupational therapists, nurses, dieticians, mental 
health and end-of-life care teams, general practitioners and geriatricians. 
Although all of these specialties currently work in the community, it was clear 
from STICH that many felt inadequately trained in management of frail older 
patients. This was particularly the case for general practitioners. 
 Recognises the variability between homes, and between residents. In this 
context, efficient use of resources would demand that the care plans 
implemented, and expertise harnessed in order to deliver them, would vary 
from case to case. The only logical response to this would be to use detailed 
assessment to shape management plans. 
 Draws staff together as an MDT in order to counter the deficiencies in 
communication seen in STICH. Within this context, a nominated care 
coordinator or key worker, whether doctor, nurse or member of care home 
staff, would have to be recognized. 
 Dispenses with arbitrary boundaries drawn between health and social care 
ĂŶĚ ƐƚƌƵĐƚƵƌĞƐ ǁŽƌŬŝŶŐ ƌĞůĂƚŝŽŶƐŚŝƉƐ ? ŝŶƐƚĞĂĚ ? ĂƌŽƵŶĚ ƉĂƚŝĞŶƚƐ ? ŶĞĞĚƐ ? dŚŝƐ
would allow for the expertise of care home staff to be recognised and for 
open MDT communication to be conducted. 
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 Puts structures in place that reinforce effective working-relationships 
between GPs, the rest of the primary care team, and the care home. Based 
upon the findings from CHOS and STICH it seems reasonable to suggest the 
following structures would be necessary, if not sufficient, to support best 
care: comprehensive baseline assessment of residents at the point of 
admission; 1:1 GP:care home relationships; regular contact between GPs and 
care home staff (and residents); and open channels of communication, with 
sharing of records between GPs, care homes and acute healthcare providers. 
Taken in summation, these points describe a model of individualised, assessment-
driven, multi-disciplinary healthcare supported by appropriate expertise  W 
Comprehensive Geriatric Assessment. 
Accepting that CGA has a role, the next question becomes how it should be 
delivered. Healthcare to care homes in the UK underwent further evolution during 
the writing of this thesis. Whilst GMS-driven healthcare remains the norm, the types 
and number of innovative interventions developed by the NHS have continued to 
grow. Because of the regional nature of NHS commissioning and provision  W and the 
paucity of a clear evidence-base to drive healthcare provision in care homes  W they 
have shown significant regional variability. They include but are not limited to: care 
home nurse practitioners, care home rapid-response teams, care home outreach 
teams, care home practices, locally enhanced service contracts and partnership-
initiatives between health and social care driven through the My Home Life 
project554.  Most, if not all, of these have aspects of the ideal service specified above 
 W and therefore features of CGA. Because they all differ significantly in their 
commissioning, funding and staffing arrangements, not to mention their day-to-day 
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delivery, it is likely that they will have variable effects on measurable clinical 
outcomes, and differing cost-benefit ratios. 
It would be wrong to assert, given the array of models already in place which partially 
or fully embrace the principles of CGA, that the next step is an RCT of CGA in care 
homes. It would be impossible to know which of the existing models in place should 
be trialled, or whether an entirely new model should be developed, without first 
undertaking further descriptive work to define the strengths and weaknesses of the 
systems already implemented. The need to understand a complex intervention with 
absolute clarity before subjecting it to RCT, intrinsic to the MRC framework62, is 
particularly acute in care homes, given the assorted challenges of conducting RCTs 
and of measuring resident and home-level outcomes in this setting discussed in 
Chapters 2 and 3.  Indeed, in reflecting on the MRC framework, Campbell et al46 
suggested that phases zero, one and two be considered as a single iterative process  
(Figure 18).  Further iteration is required. 
 
Figure 18 - The early stages of the MRC framework for design and evaluation of complex 
intervention, from Campbell et al
46
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A logical approach would be to consider the service models already in place and 
the extent to which they reflect the idealised service defined above. It is likely 
that, by studying them, the specification of an idealised service could be further 
developed. Such research would be likely to be mixed-methods and would draw 
heavily on qualitative paradigms. In defining services and how they impact 
residents, systems-oriented methodologies would be appropriate, an example 
being the CATWOE framework, derived from the soft-systems approach 
described by Checkland and Scholes588. This would describe, for each model of 
care: the Customers (in this case the residents and their families); Actors (health 
and social care staff); Transformations (perceived changes in health or wellbeing 
as a consequence of healthcare interventions); World-view (the prevalent 
perceptions and philosophies in the health, social care and resident communities 
regarding healthcare delivery); Owners (in this case health and social care 
commissioners); and Environment in which the model of healthcare operates.  
The data collected under each of these headings would be used to generate a 
root-definition of each of the service-models studied. The next steps would 
depend upon the observations made. If care home healthcare interventions were 
to continue to develop at the rate recently witnessed, it might be that care-home 
specific models would, in a few years, become the norm. If this were the case, 
then the evidence-based assertion, stated here, that CGA has a role in care 
homes, coupled with root definitions of the services which most effectively 
deliver CGA, might be sufficient to ensure that it sits at the core of healthcare to 
care homes going forward. If specific evaluation of CGA were required to prove 
its effectiveness, then the dilemma would be between a naturalistic evaluative 
methodology, such as realistic evaluation  W which draws together qualitative and 
quantitative data to compare interventions accepting that some questions are 
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beyond the reach of probability theory589  W and randomized controlled trial.  The 
challenge of such an RCT would be to ensure that it was adequately powered, 
allowing for clustering and accounting for all possible sources of confounding, 
that it was adequately blinded, that the intervention was delivered with 
sufficient uniformity and that it used outcome measures unlikely to be 
confounded by the dependency, cognitive impairment and multimorbidity of the 
cohort. Such a trial would, if successful, be large, technically demanding and 
operate at the skill limits of even the most accomplished triallists. 
There is a role for CGA in UK care homes. Based upon the available evidence it is 
not currently being delivered. Or rather, whilst pockets of CGA might exist, its 
delivery is not the norm. Many of the resources and much of the expertise that 
would facilitate its delivery are already in place. The ideal service, as specified 
here, could perhaps be seen as a checklist against which aspiring healthcare 
providers could evaluate existing, or proposed, models of care. Given the 
variability of care homes and care home residents, it may be that CGA can be 
accomplished by a number of different systems. It is likely that some, if not all of 
the new, innovative models of healthcare developed by the NHS for the care 
home sector contain components of CGA. Some may contain all of the 
components of the idealised service. Further research is required to work out 
which of these best fulfils the goal of optimising outcomes for care home 
residents and address issues around cost-benefit. Given the challenges to RCT 
methodology in this setting, it would be wrong to conduct one evaluating CGA In 
this care homes before further, significant work is undertaken to describe the 
existing models of care. 
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Appendix 1 Ȃ Glossary of abbreviations 
AARS=Apparent Affect Rating Scale 
ABID=Agitated Behaviours in Dementia 
ABRS=Agitated behaviour rating Scale 
ADAS=Alzheimer's Disease Assessment Scale 
ADCS-ADL= Alzheimer ?Ɛ Disease Cooperative Study Activities of Daily Living Scale 
ADCS-ADL-SEV=Alzheimer ?Ɛ Disease Cooperative Study Activities of Daily Living Scale-
Severe 
ADL=Activities of Daily Living 
AES=Apathy Evaluation Scale 
AFBS=Aversive Feeding Behaviour Scale 
AGECAT=Automated Geriatric Examination for Computer Assisted Taxonomy 
AICT=Advanced Illness Care Teams  
AIMS=Abnormal Involuntary Movements Scale 
AMED= Allied and Complimentary Medicine Database 
D^A?ůǌŚĞŝŵĞƌ ?ƐDŽŽĚ^ĐĂůĞ 
AMT=Abbreviated Mental Test 
BAGS=Behavioural Assessment Graphical System 
BASDEC=Brief Assessment Schedule Depression Cards 
BARS=Brief Agitation Rating Scale 
BBS=Berg Balance Scale 
BEHAVE-AD=Behavioural Pathology in Alzheimer's Disease Rating Scale 
BGS=British Geriatrics Society 
BI=Barthel Index 
BIP=Behavioural Observation Scale for Intramural Psychogeriatrics 
BMD=Bone Mineral Density 
BMI=Body Mass Index 
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BNI=British Nursing Index 
BPRS=Brief Psychiatric Rating Scale 
BPSD=Behavioural and Psychological Symptoms of Dementia 
BRS=Behaviour Rating Scale for Dementia 
BSAP=Bone Specific Alkaline Phosphatase 
BSI=Behavioural Status Index 
BUN=Blood Urea Nitrate 
CAM=Confusion Assessment Method 
CAMCOG=Cambridge Cognitive Examination 
CANE=Camberwell Assessment of Need in the Elderly 
CAREBA=Care Recipient Behaviour Assessment 
CAS=Clinical Anxiety Scale 
CAS-COG=Communication Assessment Scale for the Cognitively Impaired 
CDR-SB=Clinical Dementia Rating Scale-Sum of Boxes 
CDS=Care Dependency Scale 
CFSEI=Culture-free Self-esteem Inventory 
CFU=Colony Forming Units 
CGA=Comprehensive Geriatric Assessment 
CGI=Clinical Global Impression Scale 
CGI-2=Clinical Global Impression Scale  W item 2 
CGI-C=Clinical Global Impression for Change 
CGI-S=Clinical Global Impression for Severity 
CHoLiR=Care Home Literature Review 
CHOS=Care Home Outcome Study 
CHS-M=Modified Caregiving Hassles Scale 
CHUMS=Care Home Use of Medications Study 
CI=Charlson Index 
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CIRS-G=Cumulative Illness Rating Scale-Geriatrics 
CINAHL=Cumulative Index to Nursing and Allied Health Literature 
CMAI=Cohen-Mansfield Agitation Inventory 
CMS=US Centres for Medicare and Medicaid Services 
CONSORT=Consolidated Standard of Supporting Trials 
COS=Communication Observation Scale for the Cognitively Impaired 
COVS=Clinical Outcomes Variables Scale 
CQC=Care Quality Commission 
CRBRS=Crichton Royal Behavioural Rating Scale 
CRP=C-Reactive Protein 
CSDD=Cornell Scale for Depression in Dementia 
CST=Cognitive Screening Test 
DBS=Disruptive Behaviour Scale 
DMAS=Dementia Mood Assessment Scale 
DMSS=Dementia Management Strategies Scale 
DS-dA?ŝƐĐŽŵĨŽƌƚ^ĐĂůĞĨŽƌĞŵĞŶƚŝĂŽĨƚŚĞůǌŚĞŝŵĞƌ ?ƐƚǇƉĞ 
DSST=Digit Span Substitution Test 
EBAS-DEP=Even Briefer Assessment Scale for Depression 
EMG=Electromyography 
EPPI= /ŶƐƚŝƚƵƚĞŽĨĚƵĐĂƚŝŽŶ ?ƐEvidence for Policy and Practice Information and Co-
ordinating Centre 
EQ-5D=EuroQoL 5 Dimension Quality of Life Scale 
ESBL=Extended-spectrum beta-lactamase producing bacteria 
EXIT=Executive Interview 
FAM=Functional Assessment Measures 
FES=Falls Efficacy Scale 
FICSIT 4= Frailty and Injuries: Cooperative Studies of Intervention Techniques Scale 4 
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FIM=Functional Independence Measure 
GDS=Geriatric Depression Scale 
GHQ-12= General Health Questionnaire-12 point version 
GHQ-28=General Health Questionnaire-28 point version 
GIPB=Geriatric Indices of Positive Behaviour 
GMS=General Medical Services Contract 
GP=General Practitioner 
GPM-M=Modified Geriatric Pain Measure 
HADS=Hospital Anxiety and Depression Scale 
HAM-D=Hamilton Rating Scale for Depression 
HDL=High Density Lipoprotein 
HIV=Human Immunodeficiency Virus 
HRQoL=Health Related Quality of Life 
HUI=Health Utility Index 
ICD-10=10th version of the WHO International Classification of Diseases 
ICED=Index of Co-existent Disease 
ICF=WHO International Classification of Functioning, Disability and Health 
IL-6=Interleukin-6 
LDL=Low Density Lipoprotein 
LEIPAD=Leiden-Padua Quality of Life in the Elderly Questionnaire 
LSES=Salamon-Conte Life Satisfaction in the Elderly Scale 
LSI=Life Satisfaction Index 
LSI-A=Life Satisfaction Index-Form A 
LRTI=Lower Respiratory Tract Infection 
MADRS= Montgomery-Asperg Dementia Rating Scale 
MBI-D=Maslach Burnout Inventory 
MDS=Minimum Dataset 
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MDS-COGS=Minimum Dataset Cognition Scale 
MDT=Multidisciplinary Team 
MeSH=Medical Subject Headings for Medline 
MHAQ=Modified Health Assessment Questionnaire 
MHQ=Multidimensional Health Questionnaire 
MHRA=UK Medicines and Healthcare Products Regulatory Agency 
MOSES=Multidimensional Observation Scale for Elderly Subjects 
MNA=Mini-Nutritional Assessment 
M-NCAS=Modified Nursing Care Assessment Scale 
MPB=Management of Problem Behaviours 
MRC=UK Medical Research Council 
MRSA=Methicillin-resistant Staphylococcus Aureus 
MSQ=Mental Status Questionnaire 
MUNAI= Memorial University of Newfoundland Activities Inventory 
MUNSH= Memorial University of Newfoundland Scale of Happiness 
NHS=National Health Service 
NICE=UK National Institute of Health and Clinical Excellence 
NHP=Nottingham Health Profile 
NOSIE=Nurses' Observation Scale for Inpatient Evaluation 
NP=Nurse Practitioner 
NPI=Neuropsychiatric inventory 
NPI-NH=Neuropsychiatric Inventory-Nursing Home version 
NSAID=Non-steroidal Anti-inflammatory Drug 
NTX=N-telopeptide 
OAS=Observed Affect Scale 
ODAS=Observable Displays of Affect Scale 
PEFR=Peak Expiratory Flow Rate 
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PCS=Perceived Competence Scale 
PGCARS=Philadelphia Geriatric Centre Affect Rating Scale 
PGCMS=Philadelphia Geriatric Centre Morale Scale 
PGDRS=Psychogeriatric Dependency Rating Scale 
POMS=Profiles of Mood States 
POTTI=Performance-based Assessment of Toileting skills  
PPT=Physical Performance Test 
PRISMA=Preferred Reporting Items for Systematic Reviews and Meta-Analyses 
PRN=Pro Re Nata (as required medication) 
PSMS=Physical Self-maintenance Scale 
PTH=Parathyroid Hormone 
QL-I=Quality of Life Index 
QoL=Quality of Life 
QoL-A?YƵĂůŝƚǇŽĨ>ŝĨĞŝŶůǌŚĞŝŵĞƌ ?ƐŝƐĞĂƐĞ^ĐĂůĞ 
QWS=Quality of Wellbeing Scale 
QOF=NHS Quality Outcomes Framework for GPs 
PAINAD= Pain in Advanced Dementia 
PCT=Primary Care Trust  
PDI=Physical Disabilities Index 
PGC=Philadelphia Geriatric Centre Morale Scale 
RAFS-II=Risk Assessment for Falls Scale II 
RCT=Randomized Controlled Trial 
RMBPC=Revised Memory and Behaviour Problems Checklist 
RMDQ=Roland Morris Disability Questionnaire 
RTI=Respiratory Tract Infection 
SADQ=Stroke Aphasic Depression Questionnaire 
SALSA=Search, Appraisal, Synthesis and Analysis Framework 
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SAPS=Scale for the Assessment of Positive Symptoms 
SCAG=Sandoz Clinical Assessment-Geriatric 
SCES=Sheltered Care Environment Scale 
SF-12=Short Form-12 Question Version 
SF-36=Short Form-36 Question Version 
SF-MPQ=Short Form-MCGIll Pain Questionnaire 
SHBG=Sex-hormone Binding Globulin 
SIB=Severe Impairment Battery 
SIP=Sickness Impact Profile 
SIP-NH=Sickness Impact Profile for Nursing Homes 
SIL-2R=Soluble Interleukin-2 Receptor 
SIPO=Social Interaction Scale for Psychogeriatric Older People 
SKT=Syndrom Kurz Test 
SSCQ=Short Sense of Competence Questionnaire Competence Questionnaire 
SSRI=Selective Serotonin Reuptake Inhibitor 
STI=Serial Test Intervention  
STICH=Staff Interviews in Care Homes  
TDF=Thiamine Diphosphate 
TNFR =Tumour Necrosis Factor Receptor 
TUG=Timed Up and Go 
hWZ^A?hŶŝĨŝĞĚWĂƌŬŝŶƐŽŶ ?ƐŝƐĞĂƐĞZĂƚŝŶŐ^ĐĂůĞ 
URTI=Upper Respiratory Tract Infection 
UVB=Ultraviolet B spectrum 
VF-14=Visual Function Index-14 point version 
VRE=Vancomycin Resistant Enterococci 
WAIS=Wechsler Adult Intelligence Scale 
WHO=World Health Organisation 
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WHO-DAS=World Health Organisation-Disability Assessment Scale 
WHOQoL-BREF=World Health Organisation Quality of Life Scale, Brief Version
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Appendix 2 Ȃ Table of Care Home Interventions Studied at RCT by Target 
Interventions targeting behaviour 
Intervention 
Subjects in 
intervention arm 
Control 
Subjects in 
control arm 
Outcome measures 
(for glossary of abbreviations see end 
of document) 
Findings 
Pharmacological 
Acetaminophen160 25 Placebo 25 
Behaviour and emotional 
well-being recorded using 
dementia care-mapping; 
CMAI; psychotropic 
medication administration 
Intervention subjects had 
better social interaction, 
media engagement, work-
like activity engagement 
and social interaction but 
more unattended distress 
and talked to themselves 
more. 
Alprazolam102 48 
Low-dose 
haloperidol 
48 
Number of behavioural 
episodes; Blessed 
dementia scale; Abnormal 
involuntary movements 
scale; CGI;  SCAG 
No effect. 
Aripiprazole109 131 Placebo 125 
NPI-NH; BPRS; CGI; CMAI; 
CSDD; ADCS-ADL-SEV 
Improvements in NPI-NH 
total, BPRS total; CGI and 
CSDD total with 
intervention; no difference 
in adverse effects between 
arms. 
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Carbamazepine112 27 Placebo 24 
BPRS; CGI; Overt 
aggression scale; BRS; 
MMSE; PSMS; comorbidity 
Decreased agitation and 
aggression but no effect on 
cognitive or functional 
status. 
Divalproex sodium111 75 Placebo 78 
BPRS; CGI-C; CMAI; safety; 
tolerability 
No effect 
Donepezil154 103 Placebo 105 
NPI-NH; CDR-SB; MMSE; 
PSMS; adverse effects. 
Improvement in CDR-SB 
and MMSE but no effect on 
NPI-NH in intervention 
arm. 
Haloperidol104 20 
Oxazepam/ 
Diphenhydramine 
19/20 BPRS; ADAS; PSMS; NOSIE 
Less agitated behaviour 
and improved functional 
status in all three arms 
with no difference 
between arms; similar 
levels of adverse events. 
Melatonin131 24 Placebo 17 Actigraphy; CMAI; ABRS No effect. 
Olanzapine 5mg per 
day/olanzapine 10mg per 
day/olanzapine 15mg per 
day103 
42/41/38 Placebo 32 
NPI-NH; BPRS; MMSE; 
Extra-pyramidal symptoms; 
Simpson-Angus Scale; 
AIMS; Barnes Akathisia 
Scale 
Hallucinations less 
common with increasing 
dose, no significant 
difference between groups 
for delirium. 
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Olanzapine 5mg per 
day/olanzapine 10mg per 
day/olanzapine 15mg per 
day108 
56/50/53 Placebo 149 
NPI-NH; BPRS; 
Occupational 
Disruptiveness Scale; 
MMSE; Simpson-Angus 
Scale; Barnes Akathisia 
Scale; AIMS 
Occupational 
disruptiveness and NPI-NH 
significantly lower in 
olanzapine group. 
Olanzapine group drowsier. 
Propranolol168 17 Placebo 14 NPI; CGI-C 
Improvement in NPI and 
CGI-C scores for 
propranolol arm. 
Risperidone106 20 Usual care 14 
Observed wandering 
behaviour and sleep 
pattern; BEHAVE-AD 
Less daytime sleep, more 
night-time sleep and less 
wandering in the 
intervention arm. 
Risperidone101 46 Placebo 45 BEHAVE-AD; CGI-C; CGI-S 
Risperidone reduced 
psychosis and improved 
global functioning - only 
significant side-effect was 
somnolence. 
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Risperidone110 60 Haloperidol 60 
BEHAVE-AD; CMAI (Korean 
Versions) 
Risperidone better for 
wandering, agitation, 
diurnal rhythm 
disturbances, anxiety 
regarding upcoming 
events, physical sexual 
advances, intentional 
falling, hoarding things, 
performing repetitious 
mannerisms. 
Risperidone105 143 Placebo 136 M-NCAS; CMAI 
Significant early and 
sustained reduction in 
nursing staff burden 
measured by M-NCAS in 
risperidone arm. 
Risperidone100 167 Placebo 170 
CMAI; BEHAVE-AD; CGI-S; 
CGI-C 
Significant improvement in 
CMAI; BEHAVE-AD; CGI but 
significantly higher serious 
adverse events, extra-
pyramidal symptoms and 
gait disorder in 
intervention arm. 
Appendix 2  W Table of Care Home Interventions Studied at RCT by Target 
268 
 
 
Risperidone107 235 Placebo 238 BEHAVE-AD; CGI 
Somnolence more common 
with risperidone; 
significant improvement in 
CGI-C subscale for patients 
with severe dementia but 
not for cohort as a whole; 
otherwise no change. 
Withdrawal of 
antipsychotic 
medication172 
15 Usual care 15 NPI; Actigraphy 
Decreased average sleep 
efficacy; no significant 
change in NPI with 
cessation. 
Withdrawal of 
antipsychotic 
medication171 
27 Usual care 28 
Successful withdrawal of 
medication; NPI 
No change following 
withdrawal of medication. 
Physical therapy 
Group exercise 
programme193 
67 Usual care 67 
Katz ADL Score; 6 meter 
walk; TUG; one leg balance; 
MNA; NPI; MADRS 
Improved six-meter walk 
speed; slower decline in 
ADLs - otherwise no effect. 
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Morning bright 
light/afternoon bright 
light221 
29/24 Usual care 17 NPI-NH 
Agitation and aggression 
increased, as did aberrant 
behaviour for both 
treatment groups; 
depression decreased in 
morning light group and 
increased in afternoon 
bright light group. 
Morning bright light225 15 
Morning Dim Red 
Light 
15 
Sleep log; BEHAVE-AD; 
CSDD 
Improved sleep at night but 
no change in agitated 
behaviours. 
Morning bright light222 30 
Evening Bright 
Light/Morning Dim 
Red Light 
31/31 CMAI; ABRS 
Delayed acrophase of 
agitation, otherwise no 
effect. 
Occupational therapy, aids and appliances 
Activity programme, 
guidelines for psychotropic 
prescribing and 
educational rounds262 
42 Usual care 39 
Behaviour disorder 
present/absent; CMAI; 
PGDRS; antipsychotic and 
restraint use; MMSE; 
patient activity level; cost 
of care 
Intervention patients were 
less likely to be prescribed 
neuroleptics, demonstrate 
behavioural disorder, or be 
restrained during activities 
and were more likely to 
participate in activities at 
follow-up. 
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ADL 
intervention/psychosocial 
intervention/combination2
74 
28/29/22 Placebo visit 29 
DBS; MMSE; ODAS; AARS; 
Positive and Negative 
visual analogue scales 
No effect. 
Backward chaining 
protocol for orientation387 
17 Usual care 15 
Pittsburgh Agitation Scale; 
Spatial orientation subscale 
of the abilities assessment 
instrument. 
Improved ability to find 
room one week after the 
intervention but no 
persistent improvement.  
Agitation got worse in the 
intervention group. 
A canary/a plant248 48/43 Usual care 53 
MMSE; LEIPAD-short 
version; BSI 
Significant improvement in 
BSI and LEIPAD-SV in 
animal group. 
Live music/recorded 
music264 
32/32 Silent periods 32 
Dementia care mapping of 
muted video recordings by 
blinded observer 
Significant and positive 
improvement in response 
to live music, not seen in 
recorded music or silence 
arms 
Music therapy260 20 Usual care 18 BEHAVE-AD 
Mild reduction in activity 
disturbance with effect 
disappearing at one month. 
Music with movement 
therapy261 
18 Usual care 18 CMAI 
CMAI better in intervention 
arm. 
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Staff education 
Education package 
delivered to staff on goal 
planning for BPSD279 
54 Usual care 51 AGECAT; CRBRS; BI 
Improved scores for 
depression and cognitive 
impairment but not 
behaviour rating or BI. 
Family visit education 
programme286 
32 Usual care 34 
MOSES; CSDD; CMAI; GIPB; 
MPB; psychotropic 
medication and restraint 
use; DMSS; CHS-M; visit 
satisfaction questionnaire 
Decreased problem 
behaviours; decreased 
symptoms of depression 
and irritability in 
intervention arm. 
Staff training in non-verbal 
emotion signals in 
dementia280 
41 
Staff training in the 
cognitive and 
behavioural 
aspects of 
dementia/no 
training 
23/27 
BEHAVE-AD; CMAI; CDS; 
BSI; facial expressions of 
emotion during a brief 
interview 
Facial expressions of 
emotion became more 
positive in intervention 
group - otherwise no 
treatment effect. 
Nursing assistant 
communication skills 
programme288 
49 Usual care 56 
Knowledge of Alzheimer's 
test; Penn State MHQ in 
Nursing Assistants; 
Prevalence of BPSD; CSDD; 
CMAI; MOSES; 
psychotropic medication 
use in residents 
No impact on knowledge of 
dementia in staff; 
reduction in behavioural 
disturbance and aggressive 
behaviour in intervention 
residents. 
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Psychological or Behavioural therapy 
Integrated emotion-
oriented care328 
67 Usual care 79 
Assessment scale for 
elderly patients; CSDD; 
CMAI; Geriatric Resident 
Goal Scale; Philadelphia 
Geriatric Centre Morale 
Scale 
Residents in intervention 
arm less anxious about 
maintaining an emotional 
balance and preserving a 
positive self image. 
Psychomotor activation 
programme263 
45 Usual care 47 
BI; CST-14; CST-20; BIP; 
SIPO 
Improvement in cognition 
and better group 
behaviour. 
Sheltered 
workshop/reality 
orientation334 
8/7 Usual care 8 
LSI-A; NOSIE; Behaviour 
Mapping Index 
Improvement in LSI-A for 
sheltered workshop. 
Staff training on dementia 
management293 
Not clear Usual care Not clear 
GDS; CAS; RMBPC; ABID; 
NPI; SSCQ 
Improvement in all 
measures at 8 week follow-
up. 
Nursing 
Towel bath386 25 
Person-centred 
showering/usual 
care 
24/24 
CAREBA; Health skin 
condition data form; CIRS-
G; CMAI; MMSE; MDS-
COGS 
Positive effect on agitation 
and aggression from 
intervention. 
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Case management/CGA 
Comprehensive 
psychogeriatric 
assessment373 
48 
Delayed 
intervention 
arm 
51 CMAI; MMSE; BAGS 
Modest but significant 
decrease in agitation with 
intervention. 
Individual assessment and 
individualized non-
pharmacological behaviour 
management330 
89 
Education 
package 
delivered to 
staff 
78 
Agitation behaviour 
mapping instrument; 
Lawton's modified 
behaviour stream 
Decrease in agitation and 
increase in interest and 
pleasure sub-domains in 
intervention arm. 
Individual case 
management, with 
stimulation or retreat 
determined329 
49 Usual care 48 
BEHAVE-AD; CMAI; MOSES; 
Mattis Dementia Rating 
Scale; Global Deterioration 
Scale 
Marginal effect - lesser 
decline in positive affect 
and increased external 
engagement in 
intervention arm. 
Psychogeriatric Case 
Management376 
19 
Psychogeriatric 
consultation/ 
usual care 
17/16 
EBAS-DEP; HAM-D; CSDD; 
GDS; NPI; BEHAVE-AD; 
SAPS; Clinical interview 
No difference between 
groups. 
Aromatherapy 
Lavender aromatherapy388 70 
Sunflower 
aromatherapy 
(inactive aroma) 
70 
CMAI; NPI (Chinese 
versions) 
Improvement in both 
measures in the 
intervention arm. 
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Interventions targeting prescribing 
Intervention Subjects in intervention arm Control Subjects in control arm Outcome measures Findings 
Pharmacological 
Benzodiazepines 
weaned to placebo174 
20 Usual care 17 
Benzodiazepine 
withdrawal symptom 
questionnaire; 
Groningen sleep quality 
scale; the Geriatrics 
Behaviour Observation 
Scale 
Some aspects of 
behaviour observation 
scale improved with 
withdrawal. 
Withdrawal was 
possible. 
Medication review by 
pharmacist176 
158 Usual care 172 
MMSE; GDS; BASDEC; 
CRBRS 
Pharmacist reduced 
number of drugs in the 
intervention arm but 
there was greater 
cognitive deterioration 
and behavioural 
disturbance in 
intervention arm. 
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Medication review by 
pharmacist179 
331 Usual care 330 
Number of changes in 
medication per 
participant; number and 
cost of repeat medicines 
per participant; 
medication review rate; 
mortality; falls; hospital 
admissions; GP 
consultations; BI; MMSE 
Significant number of 
drug changes (3.1 per 
patient) in intervention 
group, leading to 
significant reduction in 
falls.  No significant 
change in any other 
outcome measure. 
Medication review by 
pharmacist and 
cardiologist178 
43 Usual care 37 
Changes of drug 
therapy; global scores 
computed from 
symptom scales (21-
item symptom list 
questionnaire; Health 
Index questionnaire; 
ADL questionnaire) 
No effect. 
Neuroleptic 
withdrawal169 
22 Usual care 14 
Physical aggressiveness; 
verbal aggressiveness; 
wandering 
98% of the patients 
completed withdrawal 
regimen; physical and 
verbal aggressiveness 
the same between 
groups. 
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Once daily IM 
cefipime122 
32 
Once daily IM 
ceftriaxone 
29 
Clinical success: cure or 
improvement; cost; 
serum levels of 
antibiotic; adverse 
events 
No difference in 
effectiveness; 
Cefepime considerably 
cheaper. 
Pharmacist medication 
review and nurse 
education177 
905 Usual care 2325 
Continuous drug use 
data; cross-sectional 
drug use data; deaths 
and morbidity indices 
(hospitalization rates, 
adverse events and 
disability indices) 
Decreased medication 
use in intervention arm 
with associated cost 
savings without 
adverse effect on 
morbidity or mortality. 
Pharmacist outreach 
visit to prescribing 
physicians182 
381 Usual care 334 
3 month fall rate; 12 
month fall rate; 
antipsychotic 
prescription; aspirin and 
warfarin prescription 
No effect 
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Pharmacy discharge 
co-ordinator184 
56 Usual care 54 
Medication 
Appropriateness Index;  
emergency department  
visits; hospital  
readmissions; adverse 
drug events; falls; 
worsening  
mobility; worsening  
behaviours; increased  
confusion and 
worsening pain 
Less worsening of pain, 
fewer hospital 
admissions, less 
deterioration in 
medications 
appropriateness index 
and fewer new drugs 
commenced in 
intervention arm. 
Protocol for diagnosis 
and management of 
UTIs181 
2156 Usual care 2061 
Antimicrobial 
prescribing for UTI; total 
antibiotic prescribing; 
admission to hospital; 
deaths 
Change in antibiotic 
prescribing for UTIs in 
favour of the 
intervention. 
Team prescribing 
meetings389 
626 Usual care 1228 
Number of 
antipsychotics 
prescribed; number of 
medicines prescribed; 
appropriateness of 
medications 
Levels of antipsychotic, 
benzodiazepines and 
antidepressant 
prescribing decreased 
in intervention arm. 
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Withdrawal of 
antipsychotic 
medication170 
35 Usual care 35 BPRS; CMAI No effect 
Withdrawal of 
dopaminergic therapy 
in parkinsonian 
patients175 
6 Usual care 5 
UPDRS; Hoen and Yahr 
Scale; MMSE; Nursing 
Assistant Behavioural 
Detection Form 
No effect. 
Withdrawal of SSRI173 35 Usual care 35 
MADRS; Global 
Assessment for 
Functioning Health 
Index; Symptom 
Assessment Form 
No effect. 
Staff education 
Education package 
delivered to MDT at 
homes295 
Not clear 
Education package 
delivered to 
physicians only 
Not clear 
Oral vs parenteral 
antibiotic prescribing 
rates; hospitalisation 
rates. 
No effect. 
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Education package on 
geriatric 
psychopharmacology183 
349 Usual care 326 
MMSE; delayed-
recognition-span test of 
memory; ADL 
performance; letter-
cancellation test; 
anxiety; depression; 
behaviour; self-reported 
sleep problems; distress 
amongst staff members; 
prescribing 
Less inappropriate 
prescribing and less 
antipsychotic 
prescribing in 
intervention group. 
Education package on 
management of 
psychotic behaviours282 
575 Usual care 577 
Change in days of 
antipsychotic use per 
100 days of nursing 
home residence; 
withdrawal from 
antipsychotics; 
reduction in 
antipsychotic dose by 
50% or more 
Significantly lower 
antipsychotic use in 
intervention homes at 6 
months. 
Appendix 2  W Table of Care Home Interventions Studied at RCT by Target 
280 
 
 
Educational package 
aimed at pain 
management and 
reducing NSAID 
prescribing294 
81 Usual care 77 
NSAID and Paracetamol 
prescription rates; 
analogue pain scale; 
MHAQ; MMSE; SIP-NH 
No difference in pain 
scores between groups.  
Significant reduction in 
NSAID prescribing and 
uptake of paracetamol 
prescribing in the 
intervention group. 
Regular MDT 
discussions about drug 
therapy389 
1228 Usual care 626 
Change in self-perceived 
staff-knowledge about 
drug therapy 
Staff felt more 
knowledgeable in 
intervention arm. 
Staff training on 
dementia 
management292 
181 Usual care 168 
Neuroleptic prescription 
rates; CMAI 
Number of neuroleptics 
prescribed significantly 
less in intervention 
homes at 12 months; 
no change in CMAI. 
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Interventions targeting malnutrition 
Intervention 
Subjects in 
intervention arm 
Control 
Subjects in control 
arm 
Outcome measures Findings 
Pharmacological 
Megestrol 
acetate129 
26 Placebo 25 
Weight and appetite change; sense of well-
being; enjoyment of life; change in 
depression scale; laboratory nutrition 
parameters; energy intake counts; body 
composition; adverse events 
Better appetite, enjoyment of 
life and wellbeing in 
intervention arm. 
Megestrol 
acetate130 
36 Placebo 33 
Prealbumin; IL-6; TNFR-p 55; sIL-2R; Osoba 
and Murray enjoyment checklist; appetite 
grade; assessment of wellbeing 
Rise in prealbumin, decrease 
in IL-6, TNFR-p55 in the 
intervention arm.  These 
correlated to improvement in 
appetite and quality of life. 
Megestrol 
acetate128 
36 Placebo 33 
 
TNFR subunits, TNFR-p55 and TNFR-p75; 
interleukin 6 (IL-6); and the soluble 
interleukin-2 receptor (sIL-2R). Weight and 
mortality 
No difference in weight or 
cytokine levels but 
correlation between weight 
and cytokine levels and trend 
towards lower CK levels and 
higher weight in intervention 
arm. 
Multivitamin 
supplement137 
379 Placebo 384 
Total number of clinical infections per 
subject 
Less antibiotic prescribing in 
intervention arm, although 
no effect on infection rate. 
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Nutritional interventions 
Buffet-style 
dining318 
20 
Tray 
style 
dining 
20 
Weight; haemoglobin; haematocrit; 
cholesterol; prealbumin; lymphocyte 
count 
No effect. 
Family style 
meals317 
94 
Usual 
care 
84 
Energy intake; MNA; Body mass; Body 
composition 
Weight gain recorded in 
intervention arm and weight 
loss in controls; better 
macronutrient intake; 
improvement in MNA risk-
stratification. 
Feeding 
Assistance315 
63 
Usual 
care 
61 BMI; Food and fluid intake 
When receiving the 
intervention participants 
increased total caloric intake 
and increased or maintained 
weight. 
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Flavour plus monosodium glutamate 
added to food/monosodium glutamate 
alone added to food/flavouring alone 
added to food322 
22/19/19 
Usual 
care 
23 
Anthropometry; Dietary intake; MNA; 
Pleasantness; GDS; Anger, hunger feelings and 
sensory perception questionnaire 
No effect. 
Fortification of breakfast and 
lunch/fortification of lunch only304 
33/33 
Usual 
care 
33 Amount of food consumed 
No effect from fortified foods on 
amount of food consumed. 
Fortified diet305 22 
Usual 
care 
30 
BMI; MNA; Bioelectrical impedance; Handgrip; 
BI; PEFR; SF-36 
Improved protein intake and 
improved PEFR in intervention 
arm - all other variables 
unchanged. 
Low-lactose powdered-milk323 28 
Usual 
care 
21 
Bowel frequency; anthropometry; grip 
strength; BI; AMT; nutrient intake 
No significant effect. 
Medical nutrition therapy protocol308 222 
Usual 
care 
171 
Dietician questionnaire; medical records audit; 
weight; rate of unintentional weight loss 
Intervention arm most likely to 
identify unintentional weight loss 
but both arms equally effective 
at treating it. 
Nutritional supplementation313 15 Placebo 18 
Food consumption; body weight; grip strength; 
blood pressure; serum thiamine; pyridoxine; 
pre-albumin; CRP; alpha-glycoprotein; 
transferrin; vitamin C; homocysteine 
Improved thiamine, pyridoxine, 
body weight and decreased 
serum homocysteine in 
intervention arm. 
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Nutritional supplementation309 19 Placebo 16 
Dietary and medication intake; BI; 
anthropometry; plasma homocysteine 
levels; thiamine; TDF and pyridoxine 
levels; vitamin D and B12 levels 
Improvement was observed for body 
weight, homocysteine, vitamin B1, TDF, 
vitamin B6, vitamin B12, folate and vitamin 
D levels in the intervention arm. 
Nutritional supplementation312 24 Placebo 26 
Food weighing; anthropometry; body 
composition; gait velocity; habitual 
spontaneous activity levels; Katz ADL; GDS 
Improved BMI; body weight; energy and 
water intake in intervention arm. 
Nutritional supplementation307 34 Usual care 34 
Food intake; Body Weight; Severe 
Impairment Battery; Global Deterioration 
Scale; NPI-NH; London Psychogeriatric 
Rating Scale 
Increased protein energy intake but 
tendency for those with lower body mass 
index to compensate by reduction of intake 
at other meals. 
Nutritional supplementation310 47 Usual care 41 
MNA; Weight; Body Mass Index; grip 
strength; energy intake; protein intake 
MNA improved in those receiving 
supplements. 
Nutritional supplementation 
following acute illness311 
18 Usual care 16 
Body weight; upper arm circumference; 
calf circumference; triceps skinfold 
thickness; dietary intake; need for care. 
Significant weight gain in intervention arm 
and weight loss in control. 
Nutritional supplementation 
plus exercise programme plus 
routine oral care186 
62 Usual care 59 
Senior fitness test; BBS; MDS; handgrip 
strength 
Improvement in weight, BMI, protein intake, 
calorie intake, BBS - no effect on handgrip 
strength. 
Nutritional supplementation 
plus oral functional training314 
7 
Nutritional 
supplementation 
7 
Nutritional status: serum total protein; 
albumin; total cholesterol; HDL; 
haemoglobin 
Significant increase in serum albumin and 
serum total protein in intervention group, 
with additional significant weight gain. 
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Interventions targeting depression 
Intervention Subjects in intervention arm Control Subjects in control arm Outcome measures Findings 
Pharmacological 
Low-dose nortriptyline150 22 
Regular-dose 
nortriptyline 
47 
HAM-D; CGI; GDS; plasma 
nortriptyline levels 
Improvement in HAM-D 
for both groups but no 
difference between. 
Normal dose was better 
in cognitively intact 
(MMSE>24) sub-group. 
Paroxetine152 12 Placebo 12 
CGI-S; CGI-C; HAM-D; 
CSDD; GDS; 
anticholinergic activity 
No effect. 
Sertraline151 17 Placebo 14 
CMAI; CSDD; Gestalt 
scale; AFBS; Facial 
behaviours 
No effect. 
Venlafaxine149 27 Sertraline 25 
HAM-D; time to 
discontinuation; adverse 
events; side-effects 
Venlafaxine less well 
tolerated and no more 
effective than sertraline. 
Physical therapy 
10,000 lux light therapy224 10 
300 lux light 
therapy/usual 
care 
10/10 GDS scores 
Significant improvement 
in GDS in intervention 
arm. 
Combined exercise and 
behavioural 
intervention336 
13 Usual care 7 
Schedule for affective 
disorders; MMSE; GDS 
Improvements in activity 
and affect in the 
intervention arm. 
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Exercise 
programme/supervised 
walking190 
Not clear 
Social 
conversation 
Not clear CSDD; DMAS; AMS; OAS 
OAS positive and AMS 
negative subscale better 
in treatment group. 
Morning bright light225 15 
Morning dim 
red light 
15 
Observed sleep pattern; 
BEHAVE-AD; CSDD; 
Improved sleep at night 
but no change in 
agitated behaviour. 
Seated exercise, 40-60 
mins twice weekly for 5 
weeks214 
28 Usual care 28 
Rivermead Mobility 
Index; HADS; SADQ 
No effect. 
TENS235 17 Placebo 17 
General self-efficacy scale 
(Dutch); Groninger 
activity scale; Philadelphia 
geriatric centre morale 
scale; GDS 
Mild improvement in 
mood and self-efficacy in 
intervention group but 
significant deterioration 
in placebo arm - 
therefore strongly 
significant difference. 
Wheelchair Bicycling219 Not clear 
Delayed 
wheelchair 
bicycling 
Not clear GDS; CMAI; data on sleep 
Improvement in GDS, 
sleep pattern and 
activity participation. 
Wheelchair Bicycling218 19 Usual care 20 Mean GDS Scores 
Significant reduction in 
GDS score for the care 
group. 
Yoga/ayurveda233 18/12 Usual care 20 GDS 
Significantly lower 
depression in yoga 
group. 
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Occupational therapy, aids and appliances 
Recreation therapy259 11 
Wait-list for 
cross-over 
11 
HAM-D; GDS; Global rating of 
depression; PCS; SCES; AES; EXIT; CIRS-
G; Keitel and Barthel Measures 
Participants categorised into responders and non-responders. 
Responders (n=14) improved significantly during the intervention 
but improvement was not persistent after the intervention 
stopped. 
Psychological or Behavioural therapy 
Reminiscence 
therapy324 
12 
Planned 
activities 
12 GDS; Self-transcendence scale No effect 
Self-worth therapy332 31 Social visit 32 GDS; MMSE; Barthel Depressive symptoms reduced in intervention arm. 
Case management/CGA 
Psychogeriatric case 
management372 
44 Usual care 41 
GDS; Mood subset of MDS; MMSE; 
LSES; functional ability 
Reduced depressive symptoms in the intervention group. 
Psychogeriatric case 
management376 
19 Usual care 16 
EBAS-DEP; HAM-D; CSDD; GDS; NPI; ; 
BEHAVE-AD; NPI; SAPS; Clinical 
interview 
No statistical significance between groups. 
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Interventions targeting influenza 
Intervention 
Subjects in intervention 
arm 
Control 
Subjects in control 
arm 
Outcome measures Findings 
Pharmacological 
Long term amantadine 
prophylaxis147 
170 
Short term 
amantadine 
prophylaxis 
244 
Laboratory confirmed 
clinical influenza 
No difference. 
Oseltamivir148 272 Placebo 276 
Laboratory-confirmed 
clinical influenza 
Significantly lower 
rates of influenza in 
intervention arm. 
Rimantadine 
100mg/rimantadine 
200mg145 
132/130 Placebo 66 
Influenza-like illness; 
laboratory confirmed 
clinical influenza; 
influenza virus infection 
No difference. 
Zanamavir/rimantadine14
4 
238/231 Placebo 13 
Laboratory-confirmed 
clinical influenza 
Zanamavir more 
effective in 
prophylaxis. 
Zanamavir143 240 Placebo 249 
Laboratory-confirmed 
clinical influenza 
Reduction in 
laboratory-confirmed 
influenza with fever in 
intervention arm. 
Zanamavir146 100 Rimantadine 40 
Laboratory confirmed 
influenza 
No difference between 
zanamivir and 
rimantadine. 
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Vaccine Studies 
60 mcg 
haemaglutinin 
influenza vaccine/20 
mcg haemaglutinin 
influenza vaccine360 
26/28 
10 mcg haemaglutinin 
influenza vaccine 
25 
IgG, IgA, Haemaglutinin inhibition 
titres 
20 mcg represents optimal dose for 
elderly (60 mcg produced no 
additional immunity). 
60 mcg 
haemaglutinin 
influenza vaccine/20 
mcg haemaglutinin 
influenza vaccine361 
31/30 
10 mcg haemaglutinin 
influenza vaccine 
31 Haemaglutinin inhibition titres 
Higher titres in higher doses for some 
but not all vaccines and/or centres. 
Haemagglutinin-
diptheria (HA-D) 
toxoid conjugate 
vaccine363 
204 
Haemagglutinin 
subunit vaccine 
204 
Antibody titres; clinically 
confirmed influenza 
HA-D was more immunogenic and 
resulted in lower levels of confirmed 
influenza infection. 
Influenza 
vaccination359 
Not clear Placebo Not clear 
Serum antibody response; rates 
of influenza-like illness 
Combination influenza vaccine most-
effective. 
Influenza 
vaccination booster 
programme366 
73 Usual care 204 
Hospitalisation, antibiotic use, 
death, seroprotection 
No benefit from booster programme. 
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Intranasal bivalent 
live attenuated 
vaccine364 
25 Placebo 25 Nasal wash antibody response 
Enhanced local antibody response in 
intervention group, however clinical 
relevance uncertain. 
Intranasal influenza A 
vaccination390 
162 Placebo 169 
Laboratory confirmed influenza 
A; adverse events 
Lower rates of laboratory confirmed 
influenza in the intervention group. 
L-cystine and L-
threonine co-
administration with 
vaccine370 
32 
Placebo 
administration with 
vaccine 
33 Serum influenza antibody titres 
Improved vaccine response in 
intervention arm. 
New vaccine 
(influsome)369 
48 Old vaccine 33 
Seroconversion rates; 
neuraminidase levels 
Increased seroconversion rates with 
increased neuroaminidase-N2 
response in new vaccine group. 
Staff vaccination 
against influenza358 
1270 Usual care 1391 
All cause mortality, influenza-like 
illness and health service use in 
residents 
Lower mortality, health service use 
and influenza like illness in the 
intervention group. 
SU/MF99 influenza 
vaccination SU/VIR 
influenza vaccination 
368 
99/93 
SPLIT influenza 
vaccination 
93 
Protections and seroconversion 
rates. 
SU/MF59 vaccine gave best immune 
response. 
Subunit adjuvated 
influenza 
vaccination/virosomal 
subunit influenza 
vaccination367 
41/37 
Inactivated whole 
virus vaccination 
33 
Influenza-like illness rates; 
influenza antibody titres 
Better influenza titres in two 
intervention arms. 
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Virosome vaccine365 32 Whole virus vaccine 32 Serological response to vaccine 
Better immune response from 
virosome vaccine. 
Interventions targeting quality of life 
Intervention 
Subjects in intervention 
arm 
Control 
Subjects in 
control arm 
Outcome measures Findings 
Pharmacological 
Donepezil plus 
reminiscence 
therapy and reality 
orientation153 
12 Donepezil 12 MMSE; QoL-AD 
No difference between groups for 
MMSE; better QoL indices for the 
intervention arm. 
Physical therapy 
26 weeks of 
structured tai chi231 
66 Usual care 73 
Chinese versions of State 
Self-Esteem Scale; SF-12; 
satisfaction with the 
nursing home instrument. 
Improvement in composite of all three 
measures in intervention arm. 
Back rubs230 6 Rest period 6 
Heart rate; Respiratory 
rate; EMG activity of 
trapezius and masseter; 
skin temperature; tactual 
minimizing scale; 
territorial intrusions and 
personal space scale 
Positive psychological effect from back 
rub - more so than for rest alone; no 
difference between groups on 
physiological parameters. 
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Functional incidental 
training210 
74 Usual care 74 
Incidence of Comorbid 
Conditions - Cost of Care 
No difference. 
Occupational therapy, aids and appliances 
Immediate spectacle 
correction of 
refraction error253 
78 
Delayed 
spectacle 
correction of 
refractive error 
64 
Nursing Home Vision-
Targeted Health-Related 
Quality-of-Life 
Questionnaire; VF-14; 
GDS 
Better quality of life and lower 
depression in the intervention group. 
Resident 
involvement in 
voluntary activity 
(mentorship of 
"teaching English as 
a foreign language" 
group)256 
15 Usual care 13 
GDS; LSI-A; self-rated 
health question 
Improvement in self-rated wellbeing in 
the intervention group. 
Robotic dog247 12 
Living dog/usual 
care 
13/13 UCLA Loneliness Scale 
Robot and living dog groups less lonely - 
no difference between robot and living 
dog groups. 
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Staff and family education 
Staff training in end-
of-life care290 
Not clear Usual care Not clear 
Depression factor of 
POMS; Srole's alienation 
scale; Sherwood's Self-
Esteem Scale; Rotter's 
Locus of Control Scale; 
Rapid Disability Rating 
Scale; Satisfaction with 
Care Scale 
Less depression and more satisfaction 
with care in the care homes. 
Training in dementia 
management/ 
training in relaxation 
techniques281 
68/68 No training 74 
Assessment of staff 
knowledge and 
competencies; MBI-D; 
level of staff health 
complaints; use of 
physical restraints and 
drugs on residents. 
Significant improvement in staff 
knowledge in intervention group; less 
use of restraints in the intervention 
group; relaxation group reported less 
health complaints following intervention. 
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Training on conflict 
resolution for 
families and 
relatives289 
431 Usual care 468 
Interpersonal conflict 
scale; staff provision to 
relatives scale; staff 
behaviours scale; staff 
empathy scale; the 
nursing home hassles 
scale; the family 
involvement scale; Zarit 
burden interview; studies 
for epidemiological 
studies - depression 
Less staff burnout; better family 
communication with staff and less 
perceived negative behaviour from staff; 
residents less agitated. 
Nutritional interventions 
Family style 
mealtimes316 
95 Usual care 83 
Dutch Quality of Life of 
Somatic Nursing Home 
Residents Questionnaire; 
physical performance; 
body weight; energy 
intake 
Overall quality of life, fine motor 
function and body weight better in 
intervention group. 
Psychological or behavioural interventions 
Counselling 
intervention to 
promote self-
esteem333 
9 Usual care 12 
CFSEI; Hunter Self-esteem 
inventory 
Significant improvement in self-esteem 
in the intervention group. 
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Life review group 
programme325 
36 Waiting list 39 
LSI-A; Rosenberg self-
esteem scale 
Improvement in self-esteem and life-
satisfaction in intervention arm. 
Reminiscence 
therapy326 
36/35 
Social talking 
group/usual 
care 
36 
Social Engagement Scale; 
Wellbeing/Ill-being Scale. 
No effect. 
Reminiscence 
therapy discussion 
group327 
Not clear 
Current topics 
discussion 
group/usual 
care 
Not clear/not clear 
MUNSH; MUNAI; SGRS; 
MUMS 
Significant improvement in MUNSH in 
both intervention groups with no 
difference between.  Patients who talked 
the most showed the greatest change. 
Nursing 
Comfort touch384 Not clear 
Verbal 
interaction 
only/no 
interaction 
Not clear/not clear MSQ scores 
Improvement in MSQ scores in the 
intervention arms. 
Care home administration 
Resident controlled 
visitation/pre-
scheduled 
visitation/random 
visitation345 
10/10/10 No visitation 12 
Wohlford Hope Scale; 
Subjective ratings of "zest 
for life" and "Health 
status"; activity diaries 
Improvement in all variables where 
residents could have control over 
visitation. 
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Visitation344 12 Usual care 12 
Vocabulary subtest of 
WAIS; Raven's Coloured 
Progressive Matrices; 
Strategic-semantic 
Memory Test; Twenty-
Questions Problem-
solving Test; LSI-A; PGC 
and Self-perceived Health 
Scale; subjective ratings 
of home activity 
coordinators re.: 
alertness/sociability 
Significant improvement in self-
perceived health and activity directors' 
ratings of sociability, physical health and 
alertness. 
Case management/CGA 
Psychogeriatric case 
management374 
53 Usual care 53 
GDS; HoNOS 65+; MMSE; 
NPI 
No effect. 
Interventions targeting mobility 
Intervention 
Subjects in 
intervention arm 
Control 
Subjects in 
control arm 
Outcome measures Findings 
Physical therapy 
Assisted walking/assisted 
walking with 
conversation196 
21/26 
Conversation 
only 
24 
Modified  6 minute 
walk; fidelity of 
treatment 
Less decline in walking performance in 
combined walk and talk group, followed by 
talk group, followed by walk group. 
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Exercise classes187 34 Usual care 37 Sit-stand test 
Significant decrease in sit-stand times in 
intervention arm. 
Exercise programme195 42 Social visit 39 
Fear of falling; balance; 
ankle strength; walking 
speed; MMSE; RAFS II; 
FES 
Smaller decline in semi-tandem stance and 
improvement in fear of falling in 
intervention arm. 
Functional Fitness for 
Long-term care 
programme197 
36 
Seated ROM 
exercises 
32 
TUG; BBS; Gait speed; 
Stair Climbing Power; 
FIM; flexibility 
measures; hand; 
shoulder; hip; and knee 
strength 
Significant improvement in mobility, 
flexibility, balance, knee and hip strength 
for intervention arm. Shoulder strength only 
improved for controls. 
Functional Incidental 
Training208 
32 Usual care 29 
Timed walk; sit-to-
stand; upper and lower 
body strength; 
continence 
Improvement in all variables for 
intervention group. 
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Group exercise192 17 Self-directed exercise 15 
Fear of falling; muscle strength; 
Timed Up and Go; BBS 
Improvement in balance, functional mobility and 
flexibility in intervention arm. 
Mobility exercise, safety 
practice and rowing 
exercise210 
35 Usual care 37 
Maximum time walking, wheeling, 
rowing; number of sit to stands; 
safety of walking; judgement; 
transitions. 
Improvements in upper body strength and safe 
mobility. 
Seated exercise 
programme216 
15 Reminiscence sessions 26 
Postural sway; grip strength; knee 
flexion and extension; spinal 
flexion; BI; GDS; LSI; MMSE; sit-to-
stand time 
Grip strength, spinal flexion, sit-to-stand, ADLs all 
improved in intervention group.  Lower self-rated 
depression in intervention group (although both 
groups lowered over time). 
Strength and Flexibility 
Programme217 
11 
Recreation therapy 
with art therapist or 
social worker 
9 TUG; BBS; PPT; MMSE 
Decreased TUG, increased PPT, increased BBS and 
increased MMSE in intervention group. 
Seated exercise, 40-60 
mins twice week for 5 
weeks214 
28 Usual care 28 
Rivermead Mobility Index; HADS; 
SADQ 
No effect. 
Vibration therapy plus 
physiotherapy234 
22 Physiotherapy 20 
Tinnetti Balance Assessment Tool; 
TUG; SF-36 
Improved SF-36 and body balance in intervention 
arm. 
Occupational therapy, aids and appliances 
Goal setting and 
individual ADL 
activities275 
330 Social conversation 352 
Late-life Function and Disability 
Instrument; Timed Up and Go; EQ-
5D; Elderly Mobility Score; FICSIT 4 
Balance Test 
No effect. 
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Hip protectors; staff education; 
environmental modification; physical 
therapy202 
59 
Usual 
care 
42 BBS; Functional ambulation categories 
Improvements in independent ambulation in 
intervention arm. 
Visual feedback balance training200 28 
Usual 
care 
8 
Standing body sway; dynamic weight 
shifting; and BBS performance 
Improvement in dynamic balance tests and 
BBS at follow-up in intervention group. 
Interventions targeting oral health 
Intervention Subjects in intervention arm Control Subjects in control arm Outcome measures Findings 
Pharmacological 
Subantimicrobial dose 
doxycycline (SDD)121 
12 Placebo 12 Dental examination. 
Significant 
improvement in 
intervention arm. 
Dental and oral health interventions 
0.05% phenoxyethanol and 
0.05% chlorhexidine 
mouthwash/ 0.05% 
phenoxyethanol and 0.025% 
chlorhexidine mouthwash 355 
10/8 
0.12% 
chlorhexidine 
mouthwash 
9 
CFU/ml of salivary mutans 
streptococci 
Control group 
showed greater 
reduction in CFU/ml 
of mutans 
streptococci. 
0.4% stannous fluoride 
toothpaste351 
32 
0.2% sodium 
fluoride 
toothpaste 
32 
Plaque-index (PI) on four 
anterior teeth and four 
molars and gingival index 
(GI). 
Stannous fluoride 
produced 
significantly lowered 
PI but had no effect 
on GI. 
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Advanced Restorative 
Dentistry Techniques (ART)356 
78 Usual care 84 Restoration survival rate. No difference. 
Chewable toothbrush (patient 
administered)251 
14 
Conventional 
toothbrush (staff 
administered) 
14 Plaque index 
Effective at plaque removal - better than a control for 
lingual plaque removal. 
Chlorhexidine acetate and 
xylitol chewing gum/xylitol 
chewing gum354 
43/37 Usual care 31 
Plaque index (PI) and 
gingival index (GI); 
participants attitudes 
towards gum. 
Lower PI and GI for chlorhexidine than for xylitol alone 
and for chewing vs non-chewing.  Improvements in 
taste and chewing function vs decline in non-chewing 
group. 
Fluoride containing tooth 
varnish353 
52 Placebo 50 
Size and severity of caries; 
number of type of salivary 
micro-organisms 
Severity of caries increased in control arm but 
remained static in intervention arm.  No change in 
salivary micro-organisms. 
Microwave dentures357 15 Soak dentures 19 
Thrush growth on dentures 
and in mouth. 
Microwaves reduced recurrence of thrush on 
dentures. 
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Oral healthcare 
education301 
144 Usual care 151 Knowledge and attitude test 
Improved knowledge and attitude scores 
in intervention arm 
Oral healthcare 
education302 
155 Usual care 182 
Denture plaque scores; denture 
induced stomatitis prevalence; dental 
plaque scores; gingivitis prevalence 
Denture plaque and dental plaque scores 
and prevalence of denture induced 
stomatitis lower in the intervention group. 
Profylin fluoride gel with 
buffering components352 
14 
Profylin fluoride gel without 
buffering components; 
rinsing with water 
14 
Plaque pH; stimulated salivary 
secretion rate; buffer capacity; number 
of colony forming units of various 
bacteria 
No significant difference. 
Regular tongue 
brushing350 
50 Tongue rinsing only 40 
Taste thresholds for sweet, salty, sour 
and bitter 
Fall in salty and sour taste thresholds - no 
effect for bitter or sweet. 
Sonic electric 
toothbrush252 
17 Manual Toothbrush 20 Plaque index (PI) Sonic toothbrushes better. 
Interventions targeting falls 
Intervention Subjects in intervention arm Control Subjects in control arm Outcome measures Findings 
Pharmacological 
Vitamin D 800 
IU/vitamin D 600 
IU/vitamin D 400 IU114 
23/25/25 Placebo 25 
Number of falls; compliance; 
serum vitamin D levels 
Reduced incidence rate 
of falls in highest dosage 
group but time to first 
fall remained the same. 
Vitamin D 
supplementation116 
313 Placebo 312 
Rate of falls and fractures; 
serum vitamin D levels 
Reduction in rate of falls 
in treatment arm. 
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Physical therapy 
Ankle strengthening 
exercises and 
walking201 
9 Usual care 7 
Parallel stance; semi-tandem 
stance; tandem stance; ankle 
strength; six meter walking; 
fear of falling; falls efficacy; 
number of falls 
No effect. 
High-intensity 
functional exercise 
programme191 
91 
Seated 
activities 
100 
Falls rate and number of 
residents sustaining a fall; 
MMSE; BBS; BI; GDS 
No real effect - some 
evidence that those 
who improved balance 
fell less on subgroup 
analysis. 
Occupational therapy, aids and appliances 
Education, physical 
exercises, 
environment, hip 
protectors188 
509 Usual care 472 Fall rate; fracture rate 
Reduction in falls and 
fallers, although no 
reduction in number of 
fractures, in 
intervention arm. 
Falls prevention 
programme215 
77 
Reminiscence 
sessions 
56 
Number of falls sustained;  
functional reach; reaction 
time; TUG; grip strength, 
spinal flexibility; PGC; MMSE 
No change to number of 
falls sustained or risk of 
falling but postural 
hypotension and poor 
visual acuity reduced in 
the intervention arm. 
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Falls prevention 
programme267 
102 Usual care 94 
Number of falls/recurrent 
falls per person; number of 
medications per person; 
Tinetti gait and balance 
score. 
Modest reduction in falls 
rate but failed to reach 
statistical significance. 
Falls prevention 
programme266 
200 Usual care 269 Number of falls 
Significantly lower falls 
incidence in the 
intervention group. 
Falls prevention 
programme269 
239 Usual care 177 
Falls; injurious falls; seriously 
injurious falls 
No effect. 
Falls prevention 
programme268 
261 Usual care 221 
Number of recurrent fallers; 
number of injurious falls 
Reduction in the number 
of recurrent fallers; no 
change in the number of 
injurious falls 
Staff education 
Education about falls 
prevention284 
210 Usual care 169 Falls rate 
Intervention reduced 
rate of falls by 50%. 
Care home administration 
Falls menu driven 
incident reporting 
system337 
424 Usual care 428 Falls, documentation of falls 
Better documentation of 
circumstances around 
falls and near falls in 
intervention arm 
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Interventions targeting quality of care 
Intervention 
Subjects in 
intervention arm 
Control 
Subjects in control 
arm 
Outcome measures Findings 
Staff education 
Education on person 
centred care for 
bathing/education for 
person centred care for 
towel bath297 
Not clear/not 
clear 
Usual care Not clear 
Caregiver Behaviour Bathing Rating 
Scale; Care Effectiveness Scale; 
Confidence Scale; Hassles During 
Bathing Scale; Stevens Caregiving 
Hassles Scale 
Improvements in 
gentleness; 
confidence; and ease 
but not hassles 
Education package on 
communication delivered to 
families and staff287 
456 Usual care 227 
Interpersonal Conflict Scale; Staff 
Behaviours Scale; Staff Empathy Scale; 
Zarit Burden Interview; Family 
Behaviours Scale; Family Empathy 
Scale; Maslach Burnout Inventory; 
intention to quit 
Families had more 
empathy for and less 
conflict with staff; 
staff less likely to quit 
job in next 12 months. 
Training about death and 
dying290 
296 No training 290 
Collett-Lester Death Anxiety Scale; 
attitudes towards caring measured 
using Semantic Differential Technique 
More fear of own 
dying, less fear of 
residents dying. More 
positive attitude 
towards care of dying 
amongst staff in 
intervention. 
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Care home administration 
Advanced directive support 
programme343 
636 Usual care 656 
Resident and 
family satisfaction 
with healthcare; 
health resource 
use 
Fewer hospital admissions and 
shorter length of stay per resident 
in intervention arm.  No difference 
in resident satisfaction. 
Interview assessing appropriateness 
for hospice-care, with results 
revealed to patient and their 
physician236 
107 
Interview assessing 
appropriateness for 
hospice-care, without 
results revealed 
98 
Venue of care; 
hospital 
admissions; days in 
hospital; symptom 
control 
More appropriate venue of care in 
intervention group. Fewer 
admissions and days in hospital in 
the intervention group. Better 
objective quality of end-of-life in 
the intervention group. 
Invitation for family to be involved in 
care (and involvement in care)346 
16 Usual care 15 
Family perceptions 
of care tool (FPCT) 
No difference. 
MDS quality indicator workshop+ 
quarterly MDS score feedback/ MDS 
quality indicator workshop + 
quarterly MDS feedback + clinical 
consultation (clinical nurse 
specialist)342 
Not clear/not clear Usual care Not clear 
MDS quality 
indicators. 
No significant difference between 
groups. 
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Quality assurance package 
with support from quality 
assurance nurse 
consultant339 
768 Usual care 757 
Quality of care determined 
by note abstraction against 
predetermined quality 
markers 
Improvement in constipation and mobility care for homes where 
quality assurance took place. 
Quality assurance package 
with support from quality 
assurance nurse 
consultant341 
345 Usual care 113 
Knowledge test on staff; pre-
determined palliative care 
quality indicators. 
Improvements in knowledge test scores for care workers. 
Improvements in number of residents appropriately admitted to 
hospice, receiving appropriate analgesia, receiving non-
pharmacological therapy, with do not resuscitate order, with 
advanced care plan. 
Quality improvement 
programme338 
102 Usual care 99 QUALCARE Scale No change. 
Relocation to new home348 34 
Staying in 
current 
home 
43 
Salivary Cortisol; AARS; 
MMSE; Blood pressure; Pulse 
intensity 
Early-morning serum cortisol higher one week after move. 
Afternoon cortisol significantly lower 4 weeks after the move. 
AARS significantly lower 4 weeks after the move. 
Case management/CGA 
CANE followed by case 
management375 
92 Usual care 100 CANE; QoL-AD No change in unmet needs relative to control group. 
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Interventions targeting urinary incontinence 
Intervention 
Subjects in intervention 
arm 
Control 
Subjects in 
control arm 
Outcome measures Findings 
Pharmacological 
Antimicrobial 
eradication of 
bacteriuria125 
71 Usual care 71 
Frequency and volume of 
urinary incontinence 
No effect. 
Oral oestrogen 
and 
progesterone134 
15 Placebo 17 
Measures of incontinence 
severity; the clinical 
appearance of the vagina; 
vaginal and urethral cytology; 
urine and vaginal cultures 
No effect. 
Oxybutynin 
MR156 
26 Placebo 24 CAM; MMSE; SIB; BARS No effect. 
Oxybutynin 
plus prompted 
voiding157 
63 
Placebo plus prompted 
voiding 
63 
Amount and frequency of 
urinary incontinence 
No effect. 
Physical therapy 
Functional 
incidental 
training212 
94 Usual care 96 
Endurance; upper and lower 
body strength; severity of 
incontinence 
Intervention residents 
maintained or improved 
performance whereas the 
ĐŽŶƚƌŽůŐƌŽƵƉ ?Ɛ
performance declined on 14 
of 15 outcome measures. 
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Occupational therapy, aids and appliances 
Bladder training270 65 Usual care 68 
Incontinence episodes, time spent by care 
staff, and supplies used 
Reduction in severity of 
incontinence; cost-
effectiveness uncertain 
Bladder training and Kegel exercises272 25 Usual care 25 
Frequency and volume of urinary 
incontinence 
Decrease in urgency, 
frequency, nocturia 
and volume of 
incontinence in 
intervention group. 
Mobility and toileting skills training273 29 Usual care 28 
Frequency and volume of urinary 
incontinence; POTTI 
Reduction in 
incontinence in 
intervention arm by 
37.7% 
Mobility programme; staff education 
in continence care189 
17 Usual care 16 
Continence questionnaire; Rivermead 
Mobility Index 
Improved continence 
questionnaire scores 
and mobility in the 
intervention group; 
intervention feasible 
and well received; 
compliance good. 
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One-step incontinence system255 15 Usual care 9 
Time to clean and change patient; use 
of cloth towels; use of disposable 
wipes; use of disposable gloves; 
interruptions during cleaning. 
Reduced use of cloth 
towels; increased use 
of disposable, 
emollient 
impregnated, 
disposable towels; 
decreased time for 
continence care. 
Patterned-urge response 
toileting271 
51 Usual care 37 
Amount and frequency of urinary 
incontinence 
Significant reduction 
in urinary 
incontinence in 
intervention arm. 
Nursing 
Clean intermittent 
catheterisation383 
38 Sterile intermittent catheterisation 42 Clinical urinary tract infection 
No difference 
between arms. 
Interventions targeting cognitive performance 
Intervention Subjects in intervention arm Control Subjects in control arm Outcome measures Findings 
Pharmacological 
Donepezil155 128 Placebo 120 
SIB; ADCS-ADL; adverse 
events 
Intervention group showed more in 
improvement in SIB and less decline in ADCS-
ADL. 
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Donepezil154 103 Placebo 105 
NPI-NH; CDR-SB; MMSE; PSMS; 
adverse effects 
No effect on NPI-NH, improvement in CDR-SB and 
MMSE in intervention arm. 
Ginkgo biloba167 79 Placebo 44 
SKT; CGI 2; Nuremberg 
Gerontopsychological Rating Scale for 
Activities of Daily Living 
No effect. 
Physical therapy 
Bright white light +/- 
melatonin +/- 
placebo132 
98 
Dim light +/- 
melatonin +/- 
placebo 
94 
MMSE; CSDD; PGCMS; PGCARS; 
MOSES; CMAI; Actigraphy; NPI-Q; NI-
ADL 
Melatonin led to low mood but not in combination 
with light. Light attenuated aggressive behaviour, 
depressive symptoms and increase in functional 
impairment. 
Exercise 
programme203 
24 
Social visit/Usual 
care 
21/30 Clock drawing test; REPDS 
Better clock drawing test results in intervention group; 
better scores in self-help and sociability subdomains 
of REPDS but overall score unaffected. 
Exercise 
Programme198 
10 
Video of Exercise 
Programme 
10 
SET test; symbol digit test; word 
fluency 
Improvement in semantic memory immediately post-
test for the intervention group. 
Planned walking199 15 Conversation only 15 COS; CAS-COG 
Communication improved significantly in the 
intervention group. 
Occupational therapy, aids and appliances 
Psychomotor 
activation 
programme263 
45 Usual care 47 BI; CST-14; CST-20; BIP; SIPO 
Improvement in cognition and better group behaviour 
in intervention group 
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Psychological and behavioural interventions 
Conversational skills 
training331 
4 
Placebo 
discussion 
group/ Usual 
care 
6/6 
Objectively rated conversation skills; Zung's 
Self-rated Depression Scale 
Better conversation skills and less depression 
in intervention arm. 
Donepezil plus 
reminiscence therapy and 
reality orientation153 
12 Donepezil 12 MMSE; QoL-AD 
No difference between groups for MMSE; 
better QoL indices for the intervention arm. 
Care Home Administration 
Visitation/visitation plus 
cognitive games344 
12/15 Usual care 12 
Vocabulary subtest of WAIS; Raven's Colored 
Progressive Matrices; Strategic-Semantic 
Memory Test; Twenty-Questions Problem-
Solving Test; LSI-A; PGC and Self-Perceived 
Health Scale; subjective ratings of home 
activity coordinators re.: alertness/sociability 
Significant improvement in self-perceived 
health and activity directors' ratings of 
sociability, physical health and alertness for 
both treatment arms, greatest improvement 
for visitation plus cognitive games. 
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Interventions targeting sleep 
Intervention 
Subjects in 
intervention arm 
Control 
Subjects in control 
arm 
Outcome measures Findings 
Pharmacological 
Temazepam/diphenhydramine163 17/17 Placebo 17 
Sleep diary; morning 
drowsiness; sleep 
latency; DSST; Tapping 
Board Test; Digit Span 
Test; Standardised 
Vocabulary Test; 
Cancellation Test; Word 
Lists 
Shorter sleep latency 
and longer sleep with 
diphenhydramine but 
otherwise placebo 
better. 
Melatonin131 24 Placebo 17 
Sleep (actigraphy); 
CMAI; ABRS 
No effect. 
Withdrawal of antipsychotic 
medication172 
15 Usual care 15 NPI; Actigraphy 
Decreased average sleep 
efficiency; no significant 
change in NPI with 
cessation. 
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Physical therapy 
Controlled sunlight exposure; 
sleep hygiene; physical activity 
regimen204 
62 Usual care 56 
Night-time sleep; 
night time 
awakenings; duration 
of night-time 
awakenings recorded 
using actigraphy; day-
time sleep recorded 
by observation 
Amount of time 
spent asleep during 
day reduced by 
intervention. 
Functional incidental training205 33 
Row-wheel-
walk training 
32 
Mobility endurance; 
physical activity levels; 
daytime sleep; night-
time sleep 
No effect. 
Morning bright light/evening 
bright light223 
Not clear 
Morning dim 
light/daytime 
sleep 
restriction 
Not clear. 
Night-time sleep; 
daytime alertness; 
circadian rhythms - all 
recorded via 
actigraphy 
No effect. 
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Morning bright light220 24 Usual care 17 
Night-time sleep 
efficiency; sleep time; 
wake time; numbers 
of awakenings; 
daytime activity - all 
recorded using 
actigraphy 
No effect. 
Morning bright light plus evening 
melatonin133 
16 
Morning 
bright light 
plus evening 
placebo/usual 
care 
17/16 
Night-time sleep 
variables; day sleep 
time; day activity; 
day:night sleep ratio; 
rest Wactivity 
parameters  W all 
recorded using 
actigraphy 
Decreased daytime 
sleep increased 
daytime activity, 
improved day to 
night activity ratios, 
increased 
amplitude in sleep 
wake cycle in 
treatment arm. 
Sleep hygiene; physical activity 
regimen206 
15 
Sleep hygiene 
alone 
14 
Night-time noise; 
night-time light; night-
time sleep; day-time 
sleep; physical activity 
monitor recordings 
Improved night 
time sleep and 
decreased day-time 
agitation in the 
intervention arm. 
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Sleep hygiene; physical activity 
regimen (FIT) ; increased exposure 
to daytime bright light213 
54 Usual care 46 
Actigraphy; 
behavioural 
observation; bedside 
light and noise 
monitoring 
Improvement in 
daytime activity, 
not much effect on 
night-time activity. 
Interventions targeting fractures 
Intervention Subjects in intervention arm Control Subjects in control arm Outcome measures Findings 
"Safehip" hip 
protectors242 
109 
"Hipsaver" 
hip 
protectors 
53 
Compliance with hip 
protectors 
No difference in hip protector use.  
Low BI, residence in a dementia 
specialist home and injurious fall in 
last 12 months predictive of 
compliance with treatment. 
Hip 
protectors240 
1042 Usual care 1042 Hip fracture incidence No effect. 
Hip 
protectors246 
86 Usual care 88 
Falls; fractures; other 
injuries; rate of fall injury; 
mortality; adherence 
No effect but poor adherence.  Study 
underpowered. 
Hip 
protectors244 
276 Usual care 285 
Time to first hip fracture; 
fall and fracture rate 
No effect. 
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Hip protectors245 459 Usual care 483 
Hip fractures; compliance with intervention; other 
fractures; falls; hospital admissions; consultations; 
QoL; costs 
No effect. 
Hip protectors241 459 Usual care 483 Hip fractures; cost; cost-effectiveness 
Lower fracture rate but not cost effective - 
would become cost-effective if cost of hip 
protectors < $22. 
Hip protectors 
freely available243 
1366 Usual care 2751 Uptake rate of hip protectors; fracture rate No effect. 
Soft hip 
protectors239 
660 
Hard Hip 
Protectors 
576 Compliance with hip protectors No effect. 
Interventions targeting immune function 
Intervention Subjects in intervention arm Control Subjects in control arm Outcome measures Findings 
Pharmacological 
17g supplemental arginine per 
day/8.5g supplemental arginine 
per day139 
11/11 
0g supplemental 
arginine/day 
10 
Immune status; nutritional 
status; plasma arginine; 
ornithine levels 
No 
effect. 
Ferrous gluconate/chelated 
iron142 
4/4 Usual care 6 
Serum iron studies; influenza 
serology 
No 
effect. 
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L-arginine138 12 Placebo 14 
Serum immunoassays; serum 
arginine, citrulline and 
ornithine levels; MNA; serum 
nitric oxide levels 
No effect. 
Vitamin A supplementation141 56 Placebo 53 
Clinically diagnosed antibiotic 
treated infections; vitamin A 
levels 
No effect on infections despite 
good serum vitamin A levels. 
Vitamin 
supplementation/trace 
element 
supplementation/vitamin and 
trace element 
supplementation135 
Not clear/not clear/not clear Placebo Not clear 
Serum beta carotene; retinol; 
alpha-tocopherol; selenium; 
zinc; red blood cell selenium 
dependent glutathione 
peroxidase; superoxide 
dismutase; total glutathione; 
oxidised glutathione; 
thiobarbituric acid reactants. 
Supplementation with vitamins 
improved superoxide dismutase 
activity and levels of alpha 
tocopherol, beta carotene and 
vitamin C. Trace element 
supplementation improved serum 
zinc and serum selenium. Both 
improved glutathione peroxidase 
activity. 
Vitamin 
supplementation/trace 
element 
supplementation/vitamin and 
trace element 
supplementation136 
33/34/35 Placebo 32 
Vitamin and trace element 
levels; red blood cell selenium 
dependent glutathione 
peroxidase; superoxide 
dismutase; total glutathione; 
reduced glutathione; oxidised 
glutathione; interleukin 2 
levels; lymphocytes subsets 
Increase in glutathione 
peroxidase, CD2 and CD19 
lymphocyte subset levels in 
intervention arms. 
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Physical therapy 
Resistance and endurance 
exercises209 
94 
Usual 
care 
96 
Motion sensor; behavioural 
observation; heart rate; 
immune measurements 
No effect. 
Nutritional 
EXP nutritional formula306 81 
Standard 
liquid 
nutrition 
76 
Immune response to 
influenza vaccination; fever; 
number of prescribed 
antibiotics 
Better immune response in 
intervention arm. 
Interventions targeting decubitus ulcers 
Intervention Subjects in intervention arm Control Subjects in control arm Outcome measures Findings 
Pharmacological 
Collagen protein 
hydrolysate 
supplement164 
56 Placebo 33 
Pressure Ulcer Scale for 
Healing (PUSH) scores 
Significantly better 
PUSH scores in 
intervention arm. 
Oxyquinolone 
containing ointment123 
Not  clear Standard emollient Not clear 
Rate and extent of ulcer 
healing 
Better and quicker 
healing with 
quinolone ointment. 
Physical therapy 
Massage with 
sulmethydioxyl229 
59 
Massage with 
indifferent 
cream/Usual care 
55/29 
Pressure ulcer presence, 
size and grade. 
No effect. 
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Ultrasound therapy232 45 Sham ultrasound 43 
Surface reduction; volume reduction; 
healing velocity; overall impression. 
No effect. 
Occupational therapy, aids and appliances 
Low air-loss bed250 43 
Corrugated foam 
mattress 
41 Ulcer healing; wound surface area. Better ulcer healing in low-air loss beds. 
Pressure-relieving 
cushion249 
15 Foam cushion 17 
Incidence, size and stage of pressure 
ulcers. 
Pressure-reducing cushions better at preventing 
ischial pressure ulcers.  No effect on other pressure 
ulcers. 
Nursing interventions 
Turning with unequal 
time intervals382 
122 
Turning with equal 
time intervals 
113 Pressure ulcer size and grade. No effect. 
Interventions targeting osteoporosis 
Intervention Subjects in intervention arm Control Subjects in control arm Outcome measures Findings 
Pharmacological 
Alendronate162 Not clear Placebo Not clear 
BMD of spine and hip; 
biochemical markers of bone 
turnover. 
BMD significantly better in 
intervention arm at 24 
months. 
Daily vitamin D/weekly 
vitamin D/monthly 
vitamin D115 
55/54/57 Placebo 172 
Serum levels of 25-hydroxy 
vitamin D3; PTH; bone 
turnover markers. 
Daily vitamin D 
administration had most 
significant effect on all 
biomarkers. 
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Risedronate plus calcium and 
vitamin D113 
Not clear 
Placebo 
plus calcium 
and vitamin 
D 
Not 
clear 
BSAP; NTX; Vitamin D; PTH levels. No effect. 
Vitamin D every three 
months118 
1762 Placebo 1955 Non-vertebral fractures; falls; vitamin D; PTH levels. No effect. 
Vitamin D three times a 
year120 
1725 Placebo 1715 
Incidence of first fracture; incidence of hip fracture; 
fracture at common osteoporotic sites; mortality; 
serum vitamin D; PTH. 
No effect. 
Staff education 
Osteoporosis nurse led 
education day for care home 
staff285 
3315 Usual care 2322 
Total fractures; total hip fractures; total falls; number 
of residents sustaining a fall; number of residents 
prescribed bisphosphonates; number of residents 
prescribed calcium and Vitamin D; number of 
residents wearing hip protectors. 
Calcium and vitamin D and 
bisphosphonate prescribing 
increased in intervention group.  
No effect on other outcomes. 
Care home administration 
Audit and feedback loops, 
educational modules, 
teleconferences, and 
academic detailing340 
293 Usual care 313 Adherence to osteoporosis prevention guidelines. No difference. 
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Interventions targeting pain 
Intervention Subjects in intervention arm Control Subjects in control arm Outcome measures Findings 
Pharmacological 
Regular 
paracetamol161 
18 PRN paracetamol 21 DS-DAT No difference. 
Physical therapy 
Functional 
incidental 
training211 
27 Usual care 24 
GPM-M; Count of number 
of verbal and non-verbal 
expressions of pain. 
No effect. 
Reflexology391 21 Social visit 21 
Salivary alpha-amylase; 
Apparent Affect Rating 
Scale; checklist of 
nonverbal pain indicators; 
blood pressure; pulse; 
MMSE 
Significant reduction 
in observed pain 
and salivary alpha 
amylase. 
Staff training 
Education package 
about the Back 
Book (activity 
therapy for back 
pain)296 
233 
Education package about 
the Back Manual 
(postural therapy for 
back pain)/education 
package about 
optimizing 
cardiovascular health 
199/241 
Visual Analogue Scale for 
Pain; RMDQ; Fear 
Avoidance Beliefs 
Questionnaire; SF-12 
The Back Book 
showed 
improvement 
measured against 
the RMDQ in 
subjects with and 
without back pain. 
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Behavioural and psychological interventions 
Cognitive behavioural therapy335 11 
Attention-
support therapy 
10 
SF-MPQ; RMDQ; GDS; Pain 
medication use 
Less pain and pain related disability in 
intervention arm; no effect on depression or 
physician prescribing. 
Case management/CGA 
Case management378 57 Usual care 57 BEHAVE-AD; DS-DAT Reduction in discomfort in intervention arm. 
Medication review; pain control; activity 
review; psychological review; behavioural 
review379 
57 Usual care 61 
CMAI; Faces Leg Activity Cry 
Consolability Scale; CSDD; 
PAINAD 
Significant reduction in physically non-
aggressive behaviour on CMAI - otherwise no 
effect. 
Interventions targeting physical function 
Intervention Subjects in intervention arm Control Subjects in control arm Outcome measures Findings 
Pharmacological 
Donepezil155 128 Placebo 120 
SIB; ADCS-ADL; adverse 
events 
Intervention group 
improved more in SIB and 
declined less in ADCS-ADL. 
Physical therapy 
Physiotherapy programme228 97 Social visit 97 
PDI; Katz ADL scale; SIP; 
MMSE; GDS; Upper and 
lower limb muscle 
strength 
Improvement in mobility 
subscale of PDI - less likely 
to use aids for locomotion 
in the intervention group. 
Exercise programme203 24 Usual care 30 
Clock drawing test; 
revised elderly physical 
Better clock drawing test 
results in intervention 
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disability scale (REPDS) group; better scores in self-
help and sociability 
subdomains of REPDS but 
overall score unaffected. 
Occupational therapy, aids and appliances 
Help with jigsaw 
(verbal)257/Encouragement 
with jigsaw 
Not clear/not clear Usual care Not clear 
Performance in 
completing jigsaw. 
Performance of 
encouragement group 
improved and of help 
group deteriorated. 
1 PT and 1 OT per 50 
residents227 
58 
1 PT and 1 
OT per 200 
residents 
57 FIM; FAM; COVS 
Improvement in all 
measures with higher 
intensity rehabilitation.  
Higher intensity 
rehabilitation more cost 
efficient, saving $283 per 
patient per year. 
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Interventions targeting constipation 
Intervention Subjects in intervention arm Control Subjects in control arm Outcome measures Findings 
Pharmacological 
Resistance training/functional 
independence training194 
40/41 Education 31 
Accelerometer recordings; bowel 
frequency chart 
No 
effect. 
Functional 
training276 
Not clear 
General 
stimulation/Usual 
care 
Not clear/not clear 
Physical Self Maintenance 
Scale; Performance Test of 
Activities of Daily Living; 
goal attainment 
Functional training best for physical self 
maintenance scale and goal attainment tests, 
followed by stimulation, followed by control; no 
significant differences for performance test of 
activities of daily living. 
Occupational 
therapy278 
63 Usual care 55 
BI; "poor outcome"; 
Rivermead Mobility Index 
Less deterioration in BI; less likelihood of "poor 
outcome" in intervention arm. 
Care home administration 
Negotiated family 
involvement in 
care347 
93 Usual care 71 
Global Deterioration Scale; 
Functional Assessment 
Checklist 
No difference. 
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Nutritional interventions 
Bran 
mixture319 
12 
Usual 
care 
12 Bowel frequency; laxative prescribing 
Reduction in medication use and 
improved bowel frequency in 
intervention arm. 
Fermented 
oat drink 
with 
bifidobacteria 
longum/ 
Fermented 
oat drink 
with 
bifidobacteria 
lactis321 
56/86 Placebo 67 
Regularity and consistency of bowel movements; MNA; 
Cognitive Performance Scale; Hierarchical ADL Scale; 
Depression Rating Scale; laxative use 
Bowel movements normalised in both 
intervention arms - no difference 
between intervention arms. 
Oat bran in 
diet320 
15 
Usual 
care 
15 Body weight; bowel habit; laxative use 
Laxative use decreased significantly in 
intervention arm. 
Smooth 
Move herbal 
tea158 
42 Placebo 44 Bowel movements; no of treatments dispensed; cost 
Significantly increased no of bowel 
movements in intervention arm.  No 
difference in cost. 
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Interventions targeting respiratory infections 
Intervention Subjects in intervention arm Control Subjects in control arm Outcome measures Findings 
Pharmacological 
Intramuscular 
cefoperazone126 
50 
Intramuscular 
ceftriaxone 
54 
Days of therapy; final 
maximum temperature; clinical 
and bacteriological response; 
adverse effects 
No difference between 
groups. 
OM-85 BV bacterial 
extract127 
147 Placebo 143 
Incidence of respiratory 
infections; serum 
immunoglobulin levels; 
adverse events 
Reduced incidence of 
bronchitis in treatment 
group. 
Pneumococcal 
vaccination371 
59 
Tetanus 
vaccination 
59 Seroconversion rate 
Higher seroconversion 
rates in intervention 
arm. 
Vitamin E140 231 Placebo 220 
Incidence of RTI; no of people 
and no of days with RTI; no of 
new antibiotic prescriptions for 
RTI 
Lower incidence of URTI 
and cold in intervention 
arm; no effect on LRTI. 
Care home administration 
Protocol for 
management of 
pneumonia in situ181 
314 Usual care 347 
Hospital admission rates and 
length of stay 
Fewer admissions and 
shorter length of stay 
and cheaper care in 
intervention arm. 
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Interventions targeting physical restraint use 
Intervention Subjects in intervention arm Control Subjects in control arm Outcome measures Findings 
Educational package299 55 
Usual 
care 
96 
Restraints per patient in 
nursing home and BARS. 
Significant reduction in the use 
of restraints in intervention 
group - but follow-up 
immediately after intervention. 
Educational package300 86 
Usual 
care 
58 
Percentage of residents 
with restraint use; type of 
restraints in use. 
No effect. 
Restraint 
education/restraint 
education with 
consultation298 
152/127 
Usual 
care 
184 Restraint use 
Education resulted in larger 
reductions in restraint use 
(however intervention home 
was a lower restraining home 
to start with). 
Interventions targeting skin health 
Intervention Subjects in intervention arm Control Subjects in control arm Outcome measures Findings 
Physical therapy 
Continence care 
and mobility 
intervention; 
FIT207 
70 Usual care 74 Skin Health; skin hydration. 
Overall improvement in skin 
health. 
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Nursing 
No-rinse cleanser 
during bathing385 
24 
Detergent 
cleanser 
during 
bathing 
24 
Skin condition; skin-related 
prescriptions; odour control; 
cleansing efficacy; patient 
comfort; bathing time; cost. 
No difference in clinical 
measures. No rinse 
detergent cost more. 
Whirlpool 
bath/ultrasound 
bath254 
29/29 Usual care 29 
Skin condition; skin cultures; 
microbial content of water; 
staff satisfaction. 
No effect.  Nursing 
assistants preferred 
whirlpool or ultrasound 
baths as easier to clean 
residents and had a better 
sound. 
Interventions targeting vitamin D deficiency 
Intervention Subjects in intervention arm Control Subjects in control arm Outcome measures Findings 
Pharmacological 
Vitamin D117 Not clear Placebo Not clear 
Vitamin D metabolites, PTH, bone 
GLA hormones 
Serum 25 OH Vitamin D 
increased with treatment. 
Vitamin D 800 IU 
per day/vitamin D 
400 IU per day119 
Not clear/not clear 
Usual 
care 
Not clear 
25 OH-D; PTH; calcium; phosphate 
creatinine; alkaline phosphatase; 
gamma-GT; albumin; LDL; HDL; 
urinary hydroxyproline; 
osteocalcin. 
400 IU resulted in sufficient 
improvements of Vitamin D 
levels, with some PTH and 
bone turnover suppression. 
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Physical therapy 
UVB therapy/oral 
vitamin D226 
15/15 
Usual 
care 
15 
Serum Vitamin D; Serum PTH; 
Serum SHBG; Serum calcium 
Higher serum Vitamin D, 
higher serum calcium, lower 
serum PTH in both treatment 
groups.  No difference 
between treatment groups. 
Interventions targeting general health 
Intervention Subjects in intervention arm Control Subjects in control arm Outcome measures Findings 
Care home administration 
NHS Nursing 
Home349 
236 
NHS 
Continuing 
Care 
228 
Survival; Satisfaction at 
interview 
No difference. 
Case management/CGA 
Physician-led 
CGA380 
33 Usual care 36 
Prescription medication 
use; Health service 
utilization 
Greater health service utilization and 
fewer medications prescribed at 6 
months in CGA group. No difference in 
hospital admissions or longevity. 
Interventions targeting swallowing 
Intervention Subjects in intervention arm Control Subjects in control arm Outcome measures Findings 
Pharmacological 
Oral theophylline166 32 Placebo 31 
Latent-time 
swallowing reflex 
Significant improvement in 
the theophylline group. 
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Physical therapy 
Cervical 
mobilization 
therapy237 
15 
Social visit by 
physiotherapist 
15 
Feasibility; dysphagia 
limit 
Improvement in the 
dysphagia limit in the 
intervention group. 
Interventions targeting other domains 
Intervention Subjects in intervention arm Control 
Subjects in control 
arm 
Outcome measures Findings 
Target: Compliance with OT 
Added 
purpose 
exercise258 
15 Rote exercise 15 
Frequency of stirring 
some cookie mix. 
Much more compliant (higher 
frequency of stirring) in the added 
purpose group. 
Target: COPD 
Protocol on 
COPD 
management 
for 
community 
nurses to 
follow377 
48 Usual care 41 
Barthel Index; GHQ-
28; respiratory 
function; satisfaction 
Significantly higher satisfaction; 
significantly higher lower scores 
for psychological distress and 
anxiety and insomnia subset of the 
GHQ-28. 
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Target: Cough Reflex Sensitivity 
Oral care by 
caregivers 
after every 
meal for 
1/12303 
30 Usual care 29 
Cough reflex 
sensitivity to citric 
acid; serum substance 
P concentration; 
cognitive function; 
ADL performance 
Improved cough reflex sensitivity 
in intervention arm. All other 
outcome measures the same. 
Target: Dehydration 
Prompting 
and 
preferred 
beverage 
programme 
(3 phase) to 
promote 
fluid 
intake277 
48 Usual care 15 
Fluid consumption 
between and during 
meals; serum 
osmolality; BUN; 
creatinine 
Significant increase in fluid intake 
and drop in BUN in intervention 
group. 
Target: Dementia 
Training in 
identification 
and 
management 
of 
dementia283 
198 Usual care 228 
GDS; Staff recognition 
of dementia; 
treatment of dementia 
Detection rates increased and a 
non-significant increase in 
treatment rates in intervention 
arm. 
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Target: Hypertension 
Music 
therapy265 
15 Usual care 15 
Twice weekly blood 
pressure recordings 
Substantial reduction in systolic 
blood pressure with music 
therapy. 
Target: Interpersonal skills 
Interpersonal 
skills 
training392 
9 
Discussion 
control/Usual 
care 
9/9 
Interpersonal 
Situation Inventory; 
Behaviour Roleplay 
Test; Behaviour 
Roleplay Test 
Satisfaction Rating; 
Simulated Real-life 
Test 
Interpersonal skills training best 
for situations which training 
covered  W skills did not transfer 
well to other situations. 
Target: Microbial colonization 
Routine 
glove use381 
136 
Contact isolation 
precautions 
147 
MRSA; ESBL; VRE 
swabs 
No difference between routine 
glove use and contact isolation 
precautions in preventing 
infection. Contact isolation 
precautions (i.e. Routine care) 
more expensive. 
Target: UTI 
Antibiotics 
for all 
bacteriuria124 
24 
Antibiotics for 
symptomatic 
bacteriuria only 
26 
Bacteriuria; re-
infection rates; signs 
and symptoms of UTI 
No difference between arms. 
 
